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Abstract 
Body fluids may be considered the most important form of trace evidence 
within forensic analysis. The detection and identification of fluids, such as 
blood, semen and saliva, can often help advance criminal investigations 
by providing information on the nature of an offence, as well as a source 
of genetic material that may be used to construct a scientific link between 
an individual and a crime through DNA profiling.  
However, current techniques used to locate and attribute the identity of 
fluids deposited at crime scenes are often disadvantaged by issues of low 
analytical specificity, detrimental effects on DNA recovery and an inability 
to be performed simultaneously as part of multiplex assays. This project 
therefore explores the use of fluorescent biosensors as novel strategies 
for the detection and identification of body fluids. Such sensors may have 
the potential to reduce overall fluid screening times by producing ‘turn-on’ 
fluorescence emissions in response to specific biological interactions with 
intra-fluidic targets. 
As previous investigations into the ability of biosensors to detect analytes 
in situ remain limited, efforts were first made to establish the fluorescent 
sensing mechanisms exhibiting greatest potential for use as novel fluid 
analysis strategies. This was achieved by assessing the performance of 
four commercially available biosensing assays against targets deposited 
on a range of surfaces commonly encountered within forensic casework.  
With biosensors based on enzymatic substrate digestion demonstrating 
ideal in situ detection ability during commercial assay testing, explorations 
were made into the application of previously reported fluorogenic peptide 
substrates specific to prostate specific antigen (PSA), kallikrein 8 and 
thrombin towards the detection of semen, saliva and blood respectively. 
Attempts to improve upon these assays were then conducted through the 
construction of custom substrates containing rhodamine-110 and cresyl 
violet fluorophores, using a novel solid-phase peptide synthesis route. 
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A displacement immunosensor specific to PSA was also developed via 
the conjugation of anti-PSA antibodies to highly-fluorescent quantum dot 
nanoparticles. Emissions from this antibody-nanoparticle complex were 
initially quenched through the moderate binding of a quencher-labelled 
peptide analogue to PSA. In the presence of the native PSA protein, this 
analogue is displaced, relieving quenching effects and restoring quantum 
dot fluorescence. This immunosensor complex was subsequently used to 
successfully detect nanomolar amounts of PSA within solution. 
Attempts were also made in the construction of a multiplex fluid detection 
biosensor based on the displacement of fluorescently-labelled aptamers 
from graphene oxide. In this assay, emissions from three single-stranded 
DNA sequences, each labelled with a different fluorophore, were initially 
quenched upon adsorption to the surface of graphene nanosheets. These 
sequences, specific to the proteins thrombin, PSA and lysozyme, are then 
individually displaced as a result of target binding, producing emissions at 
particular wavelengths to indicate the type of target present. Efforts to 
increase the specificity of this aptasensor were then undertaken through 
the selection of novel aptamer sequences towards human sperm cells. 
Analysis of obtained aptamer pools using next generation sequencing 
and a novel bioinformatics pipeline successfully identified a number of 
promising sperm-cell binding ligands. 
Forensic taggants, materials containing unique coding elements used for 
the monitoring of contact transfer during a criminal offence, were lastly 
developed using the fluorophore and peptide components employed for 
fluorogenic substrate construction. These materials exploit the particular 
amino acid sequence of incorporated peptides as identifiable ‘codes’ that 
may be registered to a specific taggant formulation. It is hoped that such 
components will eventually allow for the production of ‘reactive’ taggants 
containing biosensor molecules, which become fluorescent as a result of 
handling contact.  
Page | V  
Table of Contents 
Acknowledgments ............................................................................................ II 
Abstract ............................................................................................................ III 
List of Figures .................................................................................................. X 
List of Tables .................................................................................................. XV 
List of Abbreviations .................................................................................... XVI 
Chapter 1 - Introduction ................................................................................... 1 
1.1 Biological Fluid Testing ................................................................................. 2 
1.2 Current Testing Strategies ............................................................................ 3 
1.3 Current Challenges ....................................................................................... 8 
1.4 Recent Advances ........................................................................................ 10 
1.4.1 Infrared Spectroscopy .............................................................................. 11 
1.4.2 Raman Spectroscopy ............................................................................... 13 
1.4.3 Hyperspectral Imaging ............................................................................. 14 
1.4.4 RNA Profiling ........................................................................................... 16 
1.4.5 DNA Methylation Profiling ........................................................................ 19 
1.4.6 Metagenomic Analysis ............................................................................. 22 
1.4.7 Immunofluorescence ................................................................................ 23 
1.5 Biosensors .................................................................................................. 25 
1.5.1 Enabling Biosensors for the Analysis of Biological Fluids ........................ 27 
1.6 Project Aims and Objectives ....................................................................... 29 
Chapter 2 - Biosensors ................................................................................... 32 
2.1 Introduction ................................................................................................. 33 
2.2 Review of Fluorescent Biosensors .............................................................. 34 
2.2.1 Environmentally-Sensitive Fluorophores .................................................. 34 
2.2.2 FRET-based Biosensing .......................................................................... 35 
2.2.2.1 Intramolecular FRET ............................................................................. 36 
2.2.2.2 Intermolecular FRET ............................................................................. 38 
2.2.3 Static Quenching-based Biosensing ........................................................ 40 
2.3 Materials and Methods ................................................................................ 42 
2.3.1 Reagents .................................................................................................. 42 
2.3.2 Slide Microscopy ...................................................................................... 43 
Page | VI  
2.3.3 Surface Microscopy ................................................................................. 44 
2.3.4 Image Analysis ......................................................................................... 45 
2.3.5 Blood Collection and Storage ................................................................... 46 
2.3.6 DNA Profiling ........................................................................................... 46 
2.4 Results and Discussion ............................................................................... 47 
2.4.1 Commercial Assay Selection ................................................................... 47 
2.4.2 Slide Microscopy ...................................................................................... 48 
2.4.3 Surface Microscopy ................................................................................. 50 
2.4.4 DNA profiling ............................................................................................ 53 
2.5 Conclusion .................................................................................................. 54 
Chapter 3 - Fluorogenic Substrates .............................................................. 56 
3.1 Introduction ................................................................................................. 57 
3.2 Review of Fluorogenic Substrates .............................................................. 58 
3.2.1 Transduction Mechanism ......................................................................... 58 
3.2.2 Previously Reported Fluorogenic Substrates ........................................... 60 
3.3 Published Article 1: ‘Application of Fluorescent Substrates to the in situ 
Detection of Prostate Specific Antigen’ ............................................................. 61 
3.3.1 Manuscript ............................................................................................... 61 
3.4 Published Article 2: ‘Solid-phase Synthesis of Rhodamine-110 Fluorogenic 
Substrates and their Application in Forensic Analysis’ ...................................... 73 
3.4.1 Manuscript ............................................................................................... 74 
3.4.2 Supplementary Information ...................................................................... 82 
3.5 Published Article 3: ‘Fluorogenic Substrates for the Detection of Saliva’ .... 90 
3.5.1 Manuscript ............................................................................................... 90 
3.6 Fluorogenic Substrates for the Detection of Blood ...................................... 95 
3.6.1 Materials and Methods ............................................................................. 95 
3.6.1.1 Reagents ............................................................................................... 95 
3.6.1.2 Body Fluid Collection and Storage ........................................................ 96 
3.6.1.3 Commercial Substrate Testing .............................................................. 96 
3.6.1.3.1 Spectrofluorometry ............................................................................. 96 
3.6.1.3.2 Slide Microscopy ................................................................................ 97 
3.6.1.3.3 DNA Profiling ..................................................................................... 97 
3.6.1.4 Custom Substrate Synthesis and Testing ............................................. 98 
3.6.1.4.1 Resin-CV-NH2 ................................................................................... 98 
Page | VII  
3.6.1.4.2 Resin-CV-R(Pbf)-OH.......................................................................... 98 
3.6.1.4.3 Resin-CV-R(Pbf)VF-Bz ...................................................................... 99 
3.6.1.4.4 Ac-CV-RVF-Bz ................................................................................... 99 
3.6.1.4.5 Spectrofluorometry ........................................................................... 100 
3.6.2 Results and Discussion .......................................................................... 101 
3.6.2.1 Commercial Substrate Testing ............................................................ 101 
3.6.2.1.1 Spectrofluorometry ........................................................................... 101 
3.6.2.1.2 Slide Microscopy .............................................................................. 102 
3.6.2.1.3 DNA Profiling ................................................................................... 103 
3.6.2.2 Custom Substrate Synthesis and Testing ........................................... 104 
3.6.2.2.1 Substrate Synthesis ......................................................................... 104 
3.6.2.2.2 Spectrofluorometry ........................................................................... 107 
3.6.3 Conclusion ............................................................................................. 108 
Chapter 4 - Immunosensors......................................................................... 110 
4.1 Introduction ............................................................................................... 111 
4.2 Review of Displacement Immunosensors ................................................. 112 
4.2.1 Transduction Mechanism ....................................................................... 112 
4.2.2 Quantum Dot Nanoparticles ................................................................... 113 
4.3 Materials and Methods .............................................................................. 114 
4.3.1 Reagents ................................................................................................ 114 
4.3.2 Body Fluid Collection and Storage ......................................................... 115 
4.3.3 DVCAQV-NH2 ....................................................................................... 115 
4.3.4 Biacore Analysis .................................................................................... 116 
4.3.5 BHQ-3-DVCAQV-NH2 ........................................................................... 116 
4.3.6 Antibody-QDot Conjugation ................................................................... 117 
4.3.7 Displacement Assay .............................................................................. 117 
4.3.8 DNA Profiling ......................................................................................... 118 
4.4 Results and Discussion ............................................................................. 118 
4.4.1 Immunosensor Design ........................................................................... 118 
4.4.2 Quenching Peptide Synthesis ................................................................ 120 
4.4.3 Biacore Analysis .................................................................................... 121 
4.4.4 Antibody-QDot Conjugation ................................................................... 123 
4.4.5 Displacement Assay .............................................................................. 124 
Page | VIII  
4.4.6 DNA Profiling ......................................................................................... 125 
4.5 Conclusion ................................................................................................ 126 
Chapter 5 - Aptasensors .............................................................................. 128 
5.1 Introduction ............................................................................................... 129 
5.2 Published Article 4: ‘Developing Aptasensors for Forensic Analysis’ ........ 130 
5.2.1 Manuscript ............................................................................................. 130 
5.3 Graphene Oxide Displacement Multiplex Sensor ...................................... 155 
5.3.1 Materials and Methods ........................................................................... 157 
5.3.1.1 Reagents ............................................................................................. 157 
5.3.1.2 Body Fluid Collection and Storage ...................................................... 157 
5.3.1.3 GO Quenching .................................................................................... 158 
5.3.1.4 Buffer Optimisation ............................................................................. 158 
5.3.1.5 Quencher Optimisation ....................................................................... 159 
5.3.1.6 Purified Protein and Whole Fluid Spectrofluorometry ......................... 159 
5.3.1.7 Multiplex Spectrofluorometry ............................................................... 160 
5.3.2 Results and Discussion .......................................................................... 160 
5.3.2.1 GO Quenching .................................................................................... 160 
5.3.2.2 Buffer Optimisation ............................................................................. 162 
5.3.2.3 Quencher Optimisation ....................................................................... 164 
5.3.2.4 Purified Protein and Whole Fluid Spectrofluorometry ......................... 166 
5.3.2.5 Multiplex Spectrofluorometry ............................................................... 170 
5.3.3 Conclusion ............................................................................................. 172 
5.4 Aptamer Selection against Human Sperm Cells ....................................... 172 
5.4.1 Materials and Methods ........................................................................... 173 
5.4.1.1 Reagents ............................................................................................. 173 
5.4.1.2 Body Fluid Collection and Storage ...................................................... 175 
5.4.1.3 Cell Isolation ....................................................................................... 175 
5.4.1.4 Incubation and Elution ........................................................................ 175 
5.4.1.5 PCR Amplification ............................................................................... 176 
5.4.1.6 Strand Separation ............................................................................... 178 
5.4.1.7 Flow Cytometry ................................................................................... 179 
5.4.1.8 Next Generation Sequencing and Data Analysis ................................ 180 
5.4.2 Results and Discussion .......................................................................... 181 
Page | IX  
5.4.2.1 Aptamer Selection ............................................................................... 181 
5.4.2.2 Flow Cytometry ................................................................................... 184 
5.4.2.3 Next Generation Sequencing and Data Analysis ................................ 185 
5.4.3 Conclusion ............................................................................................. 191 
Chapter 6 - Taggants .................................................................................... 192 
6.1 Introduction ............................................................................................... 193 
6.2 Published Article 5: ‘Taggant Materials in Forensic Science: A Review’ ... 194 
6.2.1 Manuscript ............................................................................................. 195 
6.3 Published Article 6: ‘Establishing Evidence of Contact Transfer in Criminal 
Investigation by a Novel ‘Peptide Coding’ Reagent’ ........................................ 210 
6.3.1 Manuscript ............................................................................................. 210 
6.4 Published Article 7: ‘Monitoring Criminal Activity through Invisible 
Fluorescent ‘Peptide Coding’ Taggants’ ......................................................... 223 
6.4.1 Manuscript ............................................................................................. 224 
Chapter 7 - Discussion and Conclusion ..................................................... 237 
7.1 Biosensors ................................................................................................ 238 
7.2 Fluorogenic Substrates ............................................................................. 240 
7.3 Immunosensors ........................................................................................ 244 
7.4 Aptasensors .............................................................................................. 245 
7.5 Taggants ................................................................................................... 248 
7.6 Future Work .............................................................................................. 249 
7.7 Final Remarks ........................................................................................... 251 
References..................................................................................................... 253 
Appendix ....................................................................................................... 296 
A.1 Fluorogenic Substrates for the Detection of Blood ................................... 297 
A.2 ‘Establishing Evidence of Contact Transfer in Criminal Investigation by a 
Novel ‘Peptide Coding’ Reagent’ .................................................................... 301 
A.3 ‘Monitoring Criminal Activity through Invisible Fluorescent ‘Peptide Coding’ 
Taggants’ ........................................................................................................ 305 




Page | X  
List of Figures 
Figure 1: Typical NIR spectra of urine, semen and vaginal fluid samples. ....... 12 
Figure 2: An illustration of hypercube construction. ......................................... 15 
Figure 3: Scheme of body fluid detection using fluorescently-labelled antibodies 
conjugated to magnetic nanoparticles. .............................................................. 24 
Figure 4: Types of spectral emission change upon sensor-target interaction .. 28 
Figure 5: Ideal application of biosensors to the detection of body fluids.. ........ 29 
Figure 6: Chemical structure of PicoGreen® ................................................... 34 
Figure 7: Examples of intramolecular FRET sensing mechanisms. ................. 37 
Figure 8: Examples of intermolecular FRET sensing transductions. ................ 39 
Figure 9: Examples of static quenching-based sensors ................................... 41 
Figure 10: Instrumental set-up for evaluating in situ sensor performance. ....... 44 
Figure 11: Semi-quantitative analysis of in situ biosensor assay fluorescence 
using Adobe Photoshop™ software. ................................................................. 45 
Figure 12: Demonstration of in situ commercial assay performance against six 
concentrations of wet and dry analyte deposits on glass slides. ....................... 49 
Figure 13: Percentage fluorescence increase of commercial assays upon in 
situ application to analytes on ten forensically relevant surfaces ...................... 51 
Figure 14: STR profiles generated from blood samples after commercial 
biosensor application. ....................................................................................... 54 
Figure 15: Scheme of fluorogenic susbtrate sensing mechanism. ................... 60 
Figure 16: PSA fluorogenic substrate structure................................................ 65 
Figure 17: Fluorogenic PSA substrate emission in response to different 
dilutions of seminal fluid. ................................................................................... 69 
Figure 18: Demonstration of in situ PSA substrate testing against seminal 
depositions upon glass slides ........................................................................... 70 
Figure 19: Successful detection of human semen across eight forensically 
relevant surfaces by fluorogenic PSA substrate................................................ 71 
Figure 20: Genetic profiles generated from semen reference profile and semen 
sample with applied PSA substrate. .................................................................. 72 
Figure 21: Schematic of Rh-110 PSA substrate development ......................... 76 
Figure 22: Fluorescence response of substrate Ac-Rh-110-QLKSSH-Ac to 
concentrations of PSA protein and seminal fluid dilutions over time. ................ 79 
Figure 23: Detection of semen across six surfaces by substrate Ac-Rh-110-
QLKSSH-Ac. ..................................................................................................... 80 
Page | XI  
Figure 24: ESI-MS data demonstrating free Rhodamine-110 presence after 
cleavage from a solid support. .......................................................................... 83 
Figure 25: ESI-MS data demonstrating successful Resin-Rhodamine-110-
Glutamine conjugation after ‘soft’ cleavage from a solid support ...................... 84 
Figure 26: HPLC data demonstrating purity of substrate product Ac-Rh-110-
QLKSSH-Ac ...................................................................................................... 85 
Figure 27: High-resolution MS data of substrate product Ac-Rh-110-QLKSSH-
Ac ...................................................................................................................... 86 
Figure 28: Fluorescence response of Ac-Rh-110-QLKSSH-Ac to concentrations 
of Proteinase K, Aminopeptidase M, Trypsin and PSA. .................................... 87 
Figure 29: Fluorescence response of substrate Ac-Rh-110-QLKSSH-Ac after 
incubation with blood and saliva. ...................................................................... 88 
Figure 30: Generated STR profiles from human semen sample treated with 
substrate Ac-Rh-110- QLKSSH-Ac and reference human semen sample ........ 89 
Figure 31: KLK8 fluorogenic substrate structure. ............................................. 92 
Figure 32: Fluorescence response of Boc-VPR-AMC and Ac-VPR-Rh-110-Ac 
to saliva dilutions deposited on glass slides. ..................................................... 94 
Figure 33: Fluorescence response of substrate Bz-FVR-AMC over time to 
different dilutions of plasma and whole blood.. ............................................... 102 
Figure 34: Demonstration of in situ Bz-FVR-AMC substrate testing of plasma 
depositions upon glass slides across a range of eight dilutions.. .................... 103 
Figure 35: STR profiles generated from whole blood samples containing Bz-
FVR-AMC and thrombin triggering solution, and SDW. .................................. 104 
Figure 36: Scheme of solid phase peptide synthesis of cresyl violet based 
thrombin substrate. ......................................................................................... 105 
Figure 37: Confirmation of substrate product Ac-CV-RVF-Bz purity and identity 
as established by RP-HPLC and ESI-MS respectively. .................................. 106 
Figure 38: Fluorescence response of Ac-CV-RVF-Bz over time to different 
concentrations of purified thrombin protein.. ................................................... 108 
Figure 39: PSA immunosensor assembly. ..................................................... 113 
Figure 40: Normalised spectral overlap of BHQ-3 absorption compared to 605 
and 625 nm QDot emissions. .......................................................................... 119 
Figure 41: Structure of quenching peptide BHQ-3-DVCAQV-NH2. ................ 120 
Figure 42: MS of peptide DVCAQV-NH2.. ...................................................... 121 
Figure 43: Schematic representation of Biacore affinity analysis. .................. 122 
Figure 44: Agarose gel demonstrating the separation of unconjugated QDots, 
SMCC-activated QDots and anti-PSA antibody-QDot conjugates. ................. 123 
Page | XII  
Figure 45: Fluorescence emissions of antibody-QDot conjugates before and 
after incubation with quencher-labelled peptides. ........................................... 124 
Figure 46: Fluorescence emissions of antibody-QDot conjugates incubated with 
quencher-labelled peptide before and after PSA addition. .............................. 125 
Figure 47: STR profiles generated from seminal fluid samples containing 
immunosensors and sterile distilled water ...................................................... 126 
Figure 48: Workflow of the Illumina sequencing-by-synthesis approach ........ 138 
Figure 49: Schema of various aptamer-based sensing formats ..................... 143 
Figure 50: Schema of a FRET-based aptasensor for the detection of thrombin 
developed by Wang et al. ............................................................................... 148 
Figure 51: Schema of a colorimetric Au-NP aptasensor for the detection of 
methamphetamine developed by Yarbakht and Nikkhah ................................ 150 
Figure 52: Schema of a graphene-quenching fluorescence aptasensor for the 
detection of ochratoxin A developed by Sheng et al. ...................................... 151 
Figure 53: Schema of an optical fibre-based aptasensor for the detection of 
TNT developed by Ehrentreich-Förster et al. .................................................. 154 
Figure 54: GO multiplex displacement aptasensor design. ............................ 157 
Figure 55: Fluorescence emissions of Cy5, 6-FAM and ROX-labeled aptamers 
before and after the addition of GO ................................................................. 161 
Figure 56: Fluorescence emissions of aptamers before and after GO addition in 
the presence of varying concentrations of MgCl2.. .......................................... 163 
Figure 57: Fluorescence emission intensities of aptamers after incubation with 
varying concentrations of GO ......................................................................... 165 
Figure 58: Emission intensities of GO-aptamer complexes after incubation with 
varying concentrations of relevant purified protein targets .............................. 167 
Figure 59: Emission intensities of GO-aptamer complexes after incubation with 
varying concentrations of relevant whole fluid targets. .................................... 168 
Figure 60: Fluorescence intensities of multiplex GO-aptasensors after 
incubation with a various protein targets and body fluids ................................ 171 
Figure 61: Microscopic examination of haemotoxylin and eosin-stained sperm 
cells pre- and post-isolation using denisty gradient centrifugation .................. 181 
Figure 62: Gel electrophoresis images of trial and preparative amplifications 
from the 4th round of aptamer selection. ........................................................ 182 
Figure 63: Concentrations of ssDNA recovered after strand separation from 
each round of the Cell-SELEX process. .......................................................... 183 
Figure 64: Flow cytometry histograms of sperm cells incubated with enriched 
aptamer pools obtained from round 4, 7, 10 and 14 of selection and N40 library 
template sequences. ....................................................................................... 185 
Page | XIII  
Figure 65: Scheme of the developed Cell-SELEX Galaxy pipeline and example 
data outputs. ................................................................................................... 187 
Figure 66: Total number of NGS reads obtained from sequenced aptamer pool 
samples before and after data processing ...................................................... 189 
Figure 67: The four main applications of forensic taggants. ........................... 196 
Figure 68: The different components of forensic taggants ............................. 198 
Figure 69: The main types of coding used for taggant identification. ............. 199 
Figure 70: Schematic of peptide-based taggant application and analysis. ..... 208 
Figure 71: Demonstration of peptide taggant recovery and analysis. ............ 214 
Figure 72: Quantitative analysis of MHF and lubricant transfer rates from 
forensically relevant surfaces through touch contact. ..................................... 218 
Figure 73: Positive ESI-MS spectrum of synthesised peptide Ac-HSSKL. ..... 219 
Figure 74: ESI-MS spectra of Ac-KQQSP-NH2, Ac-HSSKL-COOH and Ac-
hsskl-COOH samples extracted six weeks after application to paper. ............ 232 
Figure 75: ESI-MS spectrum of Ac-KQQSP-NH2 and Rhodamine-110  samples 
applied to glass slides and incubated for six weeks. ....................................... 234 
Figure 76: Peptide coding reagent successfully transferred upon physical 
contact ............................................................................................................ 235 
Figure 77: Schemes of unsuccessful substrate development attempts ......... 242 
Figure 78: Normalised spectral overlap of haemoglobin absorption compared to 
CV emissions. ................................................................................................. 243 
Figure 79: Fluorescence emissions of anti-MUC5B antibody-QDot conjugates 
after incubation with quencher-labelled peptide. ............................................. 245 
Figure 80:  Thrombin molecular aptamer beacon design. .............................. 247 
Figure 81: Confirmation of substrate product 2HN-CV-NH2 purity and identity as 
established by RP-HPLC and ESI-MS respectively. ....................................... 297 
Figure 82: Confirmation of substrate product 2HN-CV-R-Fmoc purity and 
identity as established byRP-HPLC and ESI-MS respectively. ....................... 298 
Figure 83: Confirmation of substrate product 2HN-CV-RVF-Bz purity and 
identity as established by RP-HPLC and ESI-MS  respectively. ..................... 299 
Figure 84: Confirmation of substrate product Ac-CV-RVF-Bz purity and identity 
as established by RP-HPLC and ESI-MS respectively. .................................. 300 
Figure 85: Microscopy images of four chosen media transferred from different 
surfaces after 0, 6 and 24 hr from application. ................................................ 301 
Figure 86: Mass spectra obtained from MHF extracts after primary transfer of 
reagent containing 5 mg, 2.5 mg and 1 mg of peptide. ................................... 302 
Page | XIV  
Figure 87: Fluorescence microscopy images obtained after mixing different 
concentrations of AFC and Rhodamine-110 with MHF. .................................. 303 
Figure 88: Mass spectrum of the reagent containing both fluorophore (Rh-110) 
and peptide (Ac-HSSKL) after liquid/liquid extraction. .................................... 303 
Figure 89: Mass spectra of peptide reagent samples extracted six weeks after 
application to surfaces. ................................................................................... 304 
Figure 90: ESI-MS spectra of Ac-KQQSP-NH2, Ac-HSSKL-COOH and Ac-
hsskl-COOH after synthesis. ........................................................................... 305 
Figure 91: ESI-MS spectra of Ac-KQQSP-NH2 samples extracted six weeks 
after application to surfaces. ........................................................................... 306 
Figure 92: ESI-MS spectra of Ac-HSSKL-COOH samples extracted six weeks 
after application to surfaces. ........................................................................... 306 
Figure 93: ESI-MS spectra of Ac-hsskl-COOH samples extracted six weeks 
after application to surfaces. ........................................................................... 307 
Figure 94: ESI-MS spectra of Ac-KQQSP-NH2, Ac-HSSKL-COOH and Ac-
hsskl-COOH extracted after exposure to 4°C or 39°C for six weeks .............. 308 
Figure 95: ESI-MS spectra of Ac-KQQSP-NH2, Ac-HSSKL-COOH and Ac-
hsskl-COOH extracted after exposure to 70% or 90% humidity for six weeks 308 
Figure 96: ESI-MS spectra of Ac-KQQSP-NH2 and Rhodamine-110 samples 
extracted after exposure to all experimental conditions. ................................. 309 
Figure 97: ESI-MS spectra of Ac-HSSKL-COOH and Rhodamine-110 samples 
extracted after exposure to all experimental conditions. ................................. 310 
Figure 98: ESI-MS spectra of Ac-hsskl-COOH and Rhodamine 110  samples 
extracted after exposure to all experimental conditions .................................. 311 
Figure 99: ESI-MS spectra of Ac-HSSKL-COOH and Rhodamine 110 samples 
extracted from the surface of a finger after one, two, three, four and five 








Page | XV  
List of Tables 
Table 1: Techniques currently used for the detection of latent body fluids. ........ 4 
Table 2: Techniques currently used for the attribution of body fluids.................. 6 
Table 3: mRNA markers used in body fluid identification multiplex assays. ..... 17 
Table 4: A selection of biosensors developed for use in forensic analysis ....... 26 
Table 5: Analyte concentrations used for in situ commercial assay testing. ..... 43 
Table 6: Microscopy parameters used for in situ commercial assay testing. .... 43 
Table 7: A list of pro-fluorophores used within fluorogenic substrate assays. .. 59 
Table 8: Fluorogenic substrates previously developed for protease detection. 61 
Table 9: SELEX protocols used to select aptamers ....................................... 135 
Table 10: Techniques used to determine the affinity of aptamers. ................. 140 
Table 11: ssDNAs used to construct a GO displacement aptasensor. ........... 157 
Table 12: Protein concentrations/ fluid dilutions used for aptasensor tests. ... 159 
Table 13: Reaction mixed used for pre, trial and preparative PCRs ............... 177 
Table 14: Cycling conditions used for pre, trial and preparative PCRs. .......... 177 
Table 15: Cycling conditions used for NGS sample preparation. ................... 181 
Table 16: Sequences from round 14 of selection exhibiting over 25 reads. ... 190 
Table 17: Commercially available forensic taggants ...................................... 200 
Table 18: Advantages and disadvantages of commercial taggants. ............... 206 






Page | XVI  
List of Abbreviations 
AFC - 7-amino-4-trifluoromethylcoumarin 
AMC - 7-amino-4-methylcoumarin 
ALS - Alternate light source 
AP - Acid phosphatase 
BHQ-3 - Black hole quencher 3 
CE - Capillary electrophoresis 
CP - Conjugated polymer 
CV - Cresyl violet 
ESI - Electrospray ionization  
FRET - Förster resonance energy transfer 
GO - Graphene Oxide 
HSI - Hyperspectral imaging 
HPLC - High-performance liquid chromatography 
HTF - Human tubal fluid 
ICT - Intramolecular charge transfer 
IR - Infrared 
ITC - Isothermal titration calorimetry 
KCL - King’s College London 
MALDI-TOF - Matrix-assisted laser desorption-ionization time of flight 
MHF - Mixed hydrocarbon formulation 
MIP - Molecularly imprinted polymer 
MIR - Mid-infrared 
MS - Mass spectrometry 
mRNA - Messenger RNA 
NGS - Next generation sequencing 
NIR - Near-infrared 
PCR - Polymerase chain reaction 
PSA - Prostate specific antigen 
QDot - Quantum Dot 
RPM - Revolutions per minute 
Rh-110 - Rhodamine 110 
RT-PCR - Reverse transcriptase-polymerase chain reaction 
Page | XVII  
SD - Standard deviation 
SDW - Sterile distilled water 
SELEX - Systematic evolution of ligands by exponential enrichment 
SNP - Single nucleotide polymorphism 
SPPS - Solid-phase peptide synthesis 
SPR - Surface plasmon resonance 


































Page | 2  
1.1 Biological Fluid Testing 
Biological fluids represent one of the most important types of trace 
evidence in forensic casework. The detection and identification of fluids, 
such as blood, semen and saliva, may be of enormous evidential value to 
a case, both in terms of investigative information and personal 
identification. This importance is reflected by the fact that over 90% of the 
items submitted each year to the Evidence Recovery Unit of the 
Metropolitan Police Service (the largest police force in the UK) are tested 
for the presence of body fluids (Metropolitan Police Service, personal 
communication, 2013). 
Biological fluids may allow investigators to learn more about the specific 
nature of an offence. For example, establishing the presence of seminal 
fluid at a scene may help determine if a crime should be investigated as a 
sexual assault, rather than a physical one. The location and morphology 
of biological fluid stains can also provide information on the actions and 
movements of individuals/objects during an offence. In fact, the entire 
discipline of forensic Blood Pattern Analysis (BPA) is dedicated to the 
reconstruction of events based on the shape and directionality of 
bloodstains found at crime scenes. 
Body fluids also have significant value in forensic casework as a major 
source of DNA. The analysis of genetic material contained in fluids can 
allow investigators to draw scientific links between individuals and an 
offence with great reliability. In 2016/17, DNA profiling technologies were 
used to match over 31,000 DNA samples recovered from crime scenes to 
profiles present on the UK National DNA Database (NDNAD) [1]. DNA 
analysis techniques have been expanded upon in recent years to also 
provide phenotypic information directly from fluid samples. Assays based 
on the analysis of single nucleotide polymorphism (SNP) markers have 
now been developed for the prediction of an individual’s externally visible 
characteristics (including hair/eye colour and geographic ancestry) and 
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may be used for the identification of potential fluid donors that cannot be 
matched via traditional DNA typing [2]. 
However, obtaining such sources of DNA can be a significant challenge, 
as fluids left behind during a criminal offence are often difficult to detect. 
Many fluid traces are deposited at scenes in extremely low amounts 
(often in microlitre or lower volumes) or may be heavily diluted as a result 
of mixing with other body fluids or liquid substances. Most fluids (including 
semen, saliva, urine, vaginal secretions and sweat) are also transparent, 
making them difficult to observe against black or dark-coloured 
backgrounds. In some instances, the perpetrators of a crime may attempt 
to remove, wash or disguise fluid stains to avoid detection [3].  
1.2 Current Testing Strategies 
The first stage of the body fluid detection process involves the visual 
inspection of an item for any areas of potential fluid staining. This 
inspection requires a considerable amount of time to conduct, as every 
area of the item must be examined in detail using the naked eye and/or 
optical microscopy. Furthermore, because of the challenges listed in 
Section 1.1, it is still possible for forensic scientists to miss vital fluid 
evidence during this process.  
Several tools have been developed to facilitate fluid detection. Alternate 
light sources (ALS) are devices that may be used to visualise some latent 
fluids by providing greater contrast between a stain and the surface on 
which it is deposited. These devices produce fixed wavelengths of 
ultraviolet, visible or infrared radiation that can be absorbed by specific 
molecules present within biological fluids. In some instances (particularly 
in the case of blood), this absorption will cause stains to appear darker in 
comparison to their surrounding background. However, some molecules 
present in semen, saliva and urine, may become excited by ALS radiation 
and emit their own light (at a longer wavelength than the original source), 
making the fluids fluorescent [4]. Some of the chemical tests used to 
establish the identity of a fluid (which are discussed in more detail later 
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within this section) also possess the ability to detect areas of latent 
staining. A comprehensive list of the techniques currently used to detect 
each type of body fluid may be found in Table 1. 
Table 1: Techniques currently used for the detection of latent biological fluid stains. 
Fluid Test Type Notes Ref. 
Blood ALS Spectroscopic Blood appears as dark spots when exposed 
to an ALS wavelength of 415 nm. 
[4] 
Luminol Chemical Haemoglobin acts as a catalyst in a reaction 
between luminol and an oxidant (typically 
H2O2) to produce chemiluminescence. 
[5] 
Bluestar® Chemical A proprietary luminol formulation containing 
H2O2 and NaOH, offering greater detection 
sensitivity and signal strength. 
[6] 
Fluorescein Chemical Reduced fluorescein (fluorescin) is oxidised 
by H2O2 in the presence of haemoglobin, 
producing fluorescence at 521 nm. 
[7] 
Hemascein® Chemical A commercial preparation of fluorescein, 
NaOH and zinc with greater shelf life than 
traditional fluorescein formulations. 
[8] 
Lumiscene® Chemical A proprietary mixture of both luminol and 
fluorescein, producing chemiluminescence at 
a wavelength of 525 nm. 
[9] 
Semen ALS Spectroscopic Choline and Flavin-conjugated proteins cause 





Chemical Moist paper sheets are applied to items and 
treated with a solution containing α-napthyl 
phosphate and brentamine salts, which turns 
purple in the presence of acid phosphatase 
(AP). 
[10] 
Saliva ALS Spectroscopic Fluoresces weakly upon UV and visible 
excitation. Molecules responsible for emission 




Chemical Commercially available paper sheets 
impregnated with starch microspheres that 
can be placed over items. Digestion of 
spheres by salivary amylase causes a blue 




None N/A No methods currently accepted for use in 
forensic casework. 
N/A 
Urine ALS Spectroscopic Exhibits weak fluorescence at multiple ALS 
wavelengths. 
[4] 




Several high-profile UK criminal cases have served to highlight the 
potential miscarriages of justice that can occur as a result of missed fluid 
evidence. The most prominent of these involved the racially motivated 
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murder of British teenager Stephen Lawrence by a group of individuals in 
1993. As part of the initial investigation, clothing seized from six men 
accused of the murder was subjected to two forensic screenings (one in 
1993 and another in 1995) for the presence of blood, both yielding 
negative results. However, in a re-examination of all forensic evidence as 
part of a cold case review started in 2006, a previously missed blood spot 
was discovered dried into the fibres of a jacket belonging to one of the 
suspects. Identified through DNA profiling as having originated from 
Stephen Lawrence, this blood (along with other forensic evidence) was 
used to convict two of the perpetrators in 2012, almost 20 years after the 
murder had taken place.   
In some cases, characterising the type of body fluid present is equally as 
important as detection. For example, in an instance of alleged sexual 
assault in which DNA from a suspect is found on the surface of the 
victim’s skin, a defendant may argue that such DNA may have been 
indirectly transferred from saliva present on surface of their hands. 
However, if that DNA is proven to have instead originated from seminal 
fluid, evidence that a sexual assault did take place will be significantly 
stronger. Although not always possible, DNA evidence is much more 
useful to the courts if its origins can be attributed at the ‘source-level’ (i.e. 
to a specific biological fluid) [12].   
Many assays are available to the forensic scientist for the purpose of 
body fluid attribution. These tests vary significantly in their mechanism of 
action as well as their specificity, sensitivity and ease of operation. 
Assays are often classified as to whether they are ‘presumptive’ or 
‘confirmatory’ in nature. Presumptive tests are those only able to indicate 
that a fluid may be present or establish the absence of a fluid from a 
sample. These assays cannot be used to conclusively identify a fluid 
species as they may also positively react in the presence of non-body 
fluid substances or cross react with different fluid types [3]. In contrast, 
confirmatory tests are able to discriminate fluids with a higher degree of 
certainty. Presumptive tests are inexpensive and rapid to perform and are  
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Table 2: Techniques currently used within forensic casework for the attribution of body fluids. 




Hemastix® Chemical Presumptive Plastic test strips coated at one end with H2O2 and Tetramethylbenzidine (TMB) 
impregnated filter paper. Haemoglobin catalysis causes paper to change blue/green.   
[13] 
Kastle-Meyer  Chemical Presumptive A colourless reduced form of Phenolphthalein is oxidised by H2O2 in the presence of 
haemoglobin to produce an intense pink colouration. Usually applied to a swab or 
filter paper that has been rubbed over the surface of a suspected stain.  
[14] 
LMG Chemical Presumptive Oxidation of colourless Leucomalachite Green to Malachite Green by H2O2 occurs in 









Presumptive Dye-labelled haemoglobin-antibody complexes are formed after the addition of 
extracted blood-stains to an immunochromatographic cartridge. These complexes 
migrate through the device to a ‘test’ zone and are captured by a second anti-
haemoglobin antibody. A coloured line produced as a result of dye aggregation is 




RSID™ - Blood Immunological Presumptive Immunochromatographic cartridge targeting red blood cell protein Glycophorin A.  [19] 
Takayama Crystal Confirmatory Heating of a bloodstain treated with pyridine and glucose under alkaline conditions 
causes the formation of pink, needle-shaped crystals made of pyridine 
ferroprotoporphyrin. Crystals may be observed using bright-field microscopy. 
[20] 
Teichmann Crystal Confirmatory Brown hematin crystals are formed by heating a dried bloodstain in the presence of 
glacial acetic acid and a halide, which can be observed microscopically. 
[21] 
Microscopy Visual Confirmatory The visual identification of red blood cells, white blood cells and fibrin within a liquid 






AP Test Chemical Presumptive A reagent containing α-napthyl phosphate and a diazonium salt is applied to filter 
paper or swabs that have been rubbed over a suspected semen stain. Hydrolysis of 






Immunological Presumptive Immunochromatographic cartridges targeting the seminal fluid protein prostate 





Page | 7  
Body Fluid Test Type Specificity Notes Ref. 
Semen (Cont.) RSID™ - Semen Immunological Presumptive Immunochromatographic cartridges targeting the seminal fluid protein semenogelin. [26] 
Microscopy Visual Confirmatory The microscopic identification of spermatozoa may be used to confirm semen 
presence. Cell staining reagents may be utilised to facilitate observation. These 
include the Christmas tree and hematoxylin-eosin cytological stains. 
[3] 
Saliva Phadebas® Chemical Presumptive A propriety product (produced in tablet or paper form) containing starch microspheres 
labelled with and insoluble blue dye. Spheres are digested in the presence of salivary 
α-amylase, releasing the dye, which can be identified visually or by using a 
spectrophotometer at 620 nm. 
[27] 
RSID™ - Saliva/ 
SERATEC® 
Amylase  
Immunological Presumptive Immunochromatographic cartridges targeting the salivary protein α-amylase. Have 
been shown to cross react with urine, semen and breast milk. 
[28] 
[29] 
SALIgAE® Unknown Presumptive A commercially available colorimetric assay for the detection of saliva. The exact 
mechanism of the test has not been disclosed. Stain extracts are added to a glass vial 
containing the SALIgAE® solution, which turns yellow within 10 minutes in the 
presence of salivary α-amylase.  
[30] 
Vaginal Fluids None N/A N/A No methods currently accepted for use in forensic casework. N/A 
Urine 
 
DMAC Chemical Presumptive Suspected urine stains are extracted onto filter paper using distilled water before a 
drop of 0.05-0.1% para-dimethylaminocinnamaldehyde (DMAC) solution is applied. 
Ammonia, released in the breakdown of urea by the enzyme urease, reacts with the 
DMAC compound, resulting in a pink colour change after 30 min.  
[31] 
Uritrace® Chemical Presumptive Lateral flow cartridges containing reagent strips impregnated with picric acid. 
Creatinine from urine extracts added to the cartridge reacts with the acid, forming 
creatinine picrate and causing the strips to turn from yellow to orange. 
[32] 
RSID™- Urine Immunological Presumptive Immunochromatographic cartridge targeting the urinary Tamm-Horsfall protein. [32] 
Sweat None N/A N/A No methods currently accepted for use in forensic casework. N/A 
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therefore often initially applied to a suspected fluid stain to determine 
whether or not a secondary confirmatory test is required. 
As previously mentioned, some fluid discrimination tests may also be 
used for the purpose of stain detection. The luminol assay for the 
identification of blood relies on iron present within haemoglobin to 
catalyse the oxidation of the luminol molecule by hydrogen peroxide. A 
positive reaction results in the luminescence emission of luminol at a 
wavelength of 431 nm. Consequently, investigators are able to disperse 
the luminol reagent over surfaces on which blood is suspected to be 
present to rapidly locate areas of fluid staining (albeit presumptively) 
through the production of blue-coloured light [5]. However, not all fluid 
identification assays have the ability to visualise latent stains. Those 
relying on the generation of colorimetric products (which cannot be 
observed against most coloured surfaces) or necessitating analytical 
instrumentation to observe positive signals usually require stains to be 
located through traditional visual searching methods before tests can be 
undertaken. A list of fluid identification strategies currently used within 
forensic casework may be found in Table 2. 
1.3 Current Challenges 
Many of the assays currently used for the detection and attribution of 
body fluids have been routinely employed in forensic casework for several 
decades. In fact, the first use of the Kastle-Meyer reagent for the 
identification of bloodstains was reported in the late 1920s [14]. However, 
in recent years, forensic science (and its use within the legal system) has 
changed significantly. Increases in the DNA profiling capabilities of 
forensic service providers, as well as mounting pressure on scientists to 
assure courts of the reliability of analytical tests, has led many members 
of the forensic and academic communities to question whether or not 
these fluid testing strategies are still fit for purpose. Several 
disadvantages associated with current body fluid analysis methods have 
been identified: 
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• The impractical length of the fluid detection process. 
• The low specificity of presumptive testing assays. 
• The inability to multiplex current testing methods. 
• The potential interference of assays with DNA profiling processes. 
Rapid profiling technologies (such as the IntegenX® RapidHIT® or 
ParaDNA® systems) are poised to revolutionise forensic DNA analysis by 
providing full genetic profiles from crime scene samples in less than two 
hours [33]. However, casework turnaround times are still likely to be 
constrained by the lengthy fluid detection and identification processes 
that must be conducted prior to DNA testing. This is largely due to the fact 
that both processes cannot be conducted simultaneously, as there are no 
methods currently available to locate latent stains and confirm fluid 
identity at the same time. As previously mentioned, current attempts to 
increase search efficiency largely centre upon the use of ALS devices, to 
exploit the auto-fluorescent properties exhibited by some fluids upon 
wavelength-specific excitation. However, this fluorescence is highly 
conditional, with demonstrated signal variability between fluid types and 
surface materials on which a stain is deposited [34]. Many non-body fluid 
substances such as laundry detergents, make-up products and skin 
creams are also highly fluorescent at the ALS wavelengths used for fluid 
detection [35, 36]. 
With few exceptions, existing presumptive tests do not demonstrate high 
degrees of specificity towards target body fluids. Many of these tests have 
been proven to cross-react between fluid types, as well as with an 
assortment of non-fluid substances [37-39]. This is especially prevalent 
with regard to the peroxidation mechanisms exploited in the detection of 
blood, which may produce false positive results for a range of oxidative 
products endogenous to the sampling environment [37]. Furthermore, as 
presumptive tests are generally not based on reactions with species-
specific fluid components, the vast majority of fluid-attribution tests are 
incapable of differentiating human fluids from their non-human analogues. 
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This low specificity limits the evidential value of presumptive fluid tests, as 
the potential for false positive or false negative results to occur is well 
known to the courts [40]. Therefore, any expert witness opinions based 
on the outcomes of such assays are likely to be contested by defence 
barristers, who may provide other equally plausible alternative 
explanations for the test results.  
Another limitation of current fluid testing methods is that they cannot be 
used concurrently in one multiplex reaction. There is no single widely 
adopted methodology to test for all possible body fluids at the same time. 
Therefore, in cases where the type of body fluid likely to be present on an 
item is unknown, investigators may have to perform multiple fluid 
discrimination tests in sequence on the same stain. This not only 
increases analysis times, but also reduces the amount of DNA available 
for downstream profiling applications, as portions of a stain are consumed 
with every test [41]. 
Studies have also shown that some presumptive testing reagents may 
adversely affect the recovery rate of genetic material from fluid stains [37, 
42]. The destructive nature of these methods can be extremely 
detrimental in cases where only limited amounts of biological material are 
available. In circumstances where minimizing the loss of genetic material 
is paramount, suspected body fluids may even forgo a presumptive 
identification step and proceed directly to DNA analysis, prompting a 
potential loss of investigative information [43].  However, as previously 
mentioned, there are many times when knowing the type of fluid from 
which a DNA source has originated is of vital importance, as this 
information can have a probative value and can strengthen the 
significance of DNA profiling.  
1.4 Recent Advances 
The need for the development of new rapid, sensitive, specific and non-
destructive body fluid detection and identification strategies is evidenced 
by the growing research efforts made in the field. These efforts are often 
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undertaken as part of collaborative partnerships between academia, 
police organisations and/or private forensic science providers. In recent 
years, a range of techniques designed to circumvent the issues 
associated with current fluid tests have been reported. Those techniques 
that have shown the most promise as replacements for conventional body 
fluid testing methods are summarised below.  
1.4.1 Infrared Spectroscopy 
Infrared (IR) spectroscopy involves the analysis of a sample based on its 
interaction with IR radiation. This radiation is traditionally divided into 
three distinct regions based on relative distance from the visible portion of 
the electromagnetic spectrum: near- (800 - 2500 nm), mid- (2500 - 25000 
nm) and far-IR (25000 - 106 nm). As each of these regions is able to 
induce different measurable vibrations in covalently bonded atoms and 
groups, IR spectroscopy may be used to identify unknown compounds by 
providing information on their molecular structure. IR spectroscopy has 
become extensively employed in the forensic analysis of drugs [44], 
explosives [45], inks [46], paints [47], fibres [48] and hairs [49]. 
Investigations into the identification of biological fluid samples using IR 
spectroscopy have also been undertaken and have mainly focused on the 
use of near (NIR) and mid-Infrared (MIR) radiation [34].  
NIR is the most energetic form of IR radiation. It is used to detect 
overtones (electronic transitions of more than one energy level) and 
combinations (vibrational signals of two identical bonds that appear split 
due to Fermi resonance), which can provide structural information on 
bonds involving hydrogen [50, 51]. NIR spectroscopy may be considered 
particularly amenable as a method of body fluid attribution as it is non-
destructive, rapid, requires little-to-no sample preparation and is capable 
of analysing samples through plastic or glass containers. The NIR spectra 
of body fluids relevant to forensic investigation have been extensively 
characterised (Figure 1). 
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Figure 1: Typical NIR spectra of urine, semen and vaginal fluid samples. 
Furthermore, advances in instrumental miniaturisation have allowed the 
development of portable NIR devices, which are already being explored 
for the analysis of biological fluid stains directly at crime scenes [52, 53]. 
In one recent study, a handheld NIR device was used to identify 
bloodstains on a series of surfaces commonly encountered in forensic 
casework. This device was able to successfully differentiate blood from 
several blood-like substances (including red wine, ink, tomato sauce, 
coffee fake blood, food colouring, paint and beetroot juice) in up to 94% 
of cases [52]. As NIR spectra are often disadvantaged by the presence of 
broad, overlapping peaks that cannot be distinguished by the naked eye, 
this study also used a series of chemometric models for the automated 
interpretation of spectroscopic signals. Such an approach may allow for 
the operation of the device by police staff or scenes of crime officers that 
have not been trained in IR spectra interpretation. 
Conversely, MIR spectroscopy may be used to detect changes in both the 
vibrational and rotational states of bonds between carbon and other 
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investigated as a method of fluid attribution, with previous studies able to 
identify patterns of spectral peaks characteristic of macromolecules 
present in blood, semen, saliva, urine and vaginal secretions [54, 55]. 
However, all studies conducted so far have relied on the use of benchtop 
MIR instrumentation, preventing the deployment of this technique directly 
at crime scenes. Another disadvantage currently associated with MIR-
based biofluid analysis includes the prominent spectral bands observed 
as a result of water molecule presence, which may potentially mask 
detectable protein analytes.  
1.4.2 Raman Spectroscopy 
While most spectroscopic techniques involve observing the amount of 
radiation absorbed, reflected or emitted by a sample, Raman 
spectroscopy relies on measuring the inelastic scattering of light to 
identify molecules. In this technique, samples are irradiated with low-
energy monochromatic laser beams, causing the scattering of incident 
photons. A small percentage of these photons will exhibit a change in 
frequency in an effect known as a Stokes (or anti-Stokes) shift [56]. The 
wavenumbers and intensities of these shifts may be used to provide 
valuable information on the molecular structure, intermolecular 
interactions and internal environment of a sample. Such information can 
now be obtained from femtolitre or picogram amounts of liquid and solid 
samples respectively [57]. As a result, Raman spectroscopy has been 
extensively studied for the detection and identification of body fluid traces 
within forensic casework.  
The first investigation into the use of Raman spectroscopy for the 
identification of biological fluids involved the characterisation of whole 
blood deposited onto glass slides, as well as dried blood particles present 
on tape lifts [58]. In this study, four laser wavelengths were successfully 
used to establish blood presence by monitoring the vibrational spectrum 
of differently oxygenated haemoglobin molecules. However, this 
technique was unable to distinguish human blood from that obtained from 
Page | 14  
other mammalian species. This research has been expanded upon in 
many studies for the identification of multiple body fluids (including 
peripheral blood, semen, saliva, sweat, vaginal fluid and menstrual blood) 
based on their Raman signature [59]. In fact, a number of studies have 
recently demonstrated the extraction of phenotypic information, such a 
donor age, sex and race directly from fluid samples through Raman 
spectroscopy [60-62]. Recent efforts to increase the sensitivity of Raman-
based fluid attribution methods have also been made through the use of 
surface enhanced Raman spectroscopy (SERS), in which samples are 
placed on the surface of metallic sheets or nanostructures to enhance 
Raman signal strength [63]. This approach is likely to be extremely useful 
in cases where trace amounts of fluid are present, or for use with portable 
Raman spectrometers, which are considerably less sensitive than 
laboratory-based instruments. 
One major disadvantage associated with Raman spectroscopy is the 
potential for signal interference caused by auto-fluorescence from 
background surfaces on which a fluid is deposited. The intensity of these 
fluorescence emissions, which are produced through the excitation of 
substrates by the laser light used to affect photon scattering, is often 
several orders of magnitude larger than that of Raman signals. Such 
interference may prevent the identification of a body fluid stain by 
masking portions of its vibrational signature [64]. However, this issue may 
be solved by utilising a radiation source from the NIR region of the 
electromagnetic spectrum. 
1.4.3 Hyperspectral Imaging 
Originally designed for the purpose of remote sample sensing, 
hyperspectral imaging (HSI) combines regular imaging and spectroscopy 
for the simultaneous collection of spatial and spectral information from an 
object. In this technique, reflectance, absorbance, fluorescence or Raman 
spectra from tens-to-hundreds of narrow wavebands across the 
electromagnetic spectrum are obtained for each pixel in a two-
Page | 15  
Figure 2: An illustration of hypercube construction. Image data from two spatial 
dimensions (x,y) is combined with spectral data from a series of narrow wavebands (λ) 
to form a three-dimensional data structure. 
dimensional image [65]. These spectra are then used to construct a 
three-dimensional data structure, comprising two spatial dimensions (x 
and y) and one wavelength dimension (λ), known as a hypercube (Figure 
2). Hypercubes are able to provide users with a complete image for every 
collected wavelength, as well as a contiguous reflectance spectrum for 
each image pixel. As such, HSI is emerging as a powerful tool for probing 
the chemical composition of forensic samples, including biological fluid 
traces. 
A series of studies have recently demonstrated the exceptional 
performance of HSI techniques in the detection and identification of 
human bloodstains [66-69]. In these studies, hyperspectral images taken 
in the visible and NIR regions of the electromagnetic spectrum were used 
to rapidly identify blood deposited on a range of coloured surfaces, whilst 
also allowing them to be differentiated from other blood-like substances. 
HSI has been shown to possess excellent analytical sensitivity with one 
study being able to detect blood diluted 1:512 deposited on white paper 
[68]. Furthermore, the use of HSI as a potential method for the estimation 
of bloodstain time-since-deposition has also been established [66, 67]. 
Subsequent studies have sought to extend this research by utilising HSI 
for the identification of other biological fluids, including semen, saliva and 
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With the introduction of HSI to the field of forensic analysis remaining 
relatively recent, extensive validation studies to assess method 
performance under differing environmental conditions are likely to be 
required before this technique can be deployed for the analysis of 
biological fluids in routine forensic casework. Such conditions may include 
the variability of ambient lighting at crimes scenes (especially those 
located outdoors), which is known to exert significant influence over the 
quality of collected HSI spectra [65]. Other challenges to the use of HSI 
within forensic analysis include the interpretation of complex spectra from 
mixed or contaminated samples. This is especially important in the testing 
of biological fluids, which are often found as part of multi-fluid mixtures 
[65]. 
1.4.4 RNA Profiling 
In order to fulfil its biological function, each type of cell present within a 
tissue will exhibit a distinct pattern of gene expression. These patterns 
can be characterised by measuring the type and/or abundance of RNA 
transcripts expressed by the cell. As biological tissues contain multiple 
cellular components, much research has gone into the forensic 
discrimination of body fluids based on their overall transcriptomic 
‘signature’. This process is known as RNA profiling. Although several 
types of RNA molecule have been investigated for fluid identification 
purposes, most studies have focused on the analysis of messenger RNA 
(mRNA) [72].  
One of the main advantages of mRNA profiling over traditional body fluid 
identification techniques is that multiple types of body tissues can be 
tested for simultaneously in a single multiplex reaction. This includes 
fluids that cannot be identified by conventional means, such as menstrual 
blood and vaginal fluid [72]. The analysis of multiple mRNA markers per 
body fluid also ensures a high degree of assay specificity [73]. A list of 
core mRNA markers used in fluid attribution assays, as well as the 
proteins with which they are associated, may be found in Table 3. 
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Table 3: mRNA markers commonly used in body fluid identification multiplex assays. 




ALAS2 Delta-aminolevulinate Synthase 2 - Erythroid protein.  [74] 
ANK1 Ankyrin 1 - Helps attach membrane proteins to cytoskeleton. [75] 
SPTB Spectrin Beta Chain - Membrane structure and organisation. [76] 
CD3G T-Cell Surface Glycoprotein CD3 Gamma Chain - Immunity  [77] 
CD93 Cluster of Differentiation 93 - Transmembrane receptor. [78] 
AMICA1 Junction Adhesion Molecule Like - Leukocyte membrane. [79] 
Semen 
 
PRM1 Protamine 1 - Replaces histones in spermatogenesis. [80] 
PRM2 Protamine 2 - Replaces histones in spermatogenesis. [80] 
TGM4 Transglutaminase 4 - Reproduction protein. [75] 
SEMG1 Semenogelin 1 - Dominant semen protein. Forms gel matrix. [75] 
SEMG2 Semenogelin 2 - Dominant semen protein. Forms gel matrix. [75] 
KLK3 Kallikrein 3 - PSA. Breaks down seminal matrix. [75] 
Saliva HTN3 Histatin 3 - Responsible for antimicrobial activity in oral cavity. [81] 
HTN1 Histatin 1 - Responsible for antimicrobial activity in oral cavity. [76] 
STATH Statherin - Limits precipitation of calcium phosphate in saliva. [81] 
PRB3 Proline Rich Protein BstNI Subfamily 3 - Bacterial receptor. [81] 
PRB4 Proline Rich Protein BstNI Subfamily 4 - Bacterial receptor. [75] 
PRH2 Proline Rich Protein Haell Subfamily 2 - Dental enamel. [82] 
PRB1 Proline Rich Protein BstNI Subfamily 1 - Bacterial receptor. [81] 




CYP2B7P1 Cytochrome P450 Subfamily 2B Member 7 Pseudogene 1. [84] 
DKK4 Dickkopf WNT Signalling Pathway Inhibitor 4 - Development. [84] 
FAM83D Family with Sequence Similarity 83 Member D - Proliferation. [85] 
CYP2A6 Cytochrome P450 2A6 - Oxidation of nicotine and cotinine. [85] 
CYP2A7 Cytochrome P450 2A7 - Inactive cytochrome P450 enzyme. [85] 
Menstrual 
Blood 
MMP10 Matrix Metalloproteinase 10 - Breaks down cellular matrix. [86] 
LEFTY2 Left-right determination Factor 2 - Endometrial bleeding. [87] 
MMP7 Matrix Metalloproteinase 7 - Breaks down cellular matrix. [76] 
MMP11 Matrix Metalloproteinase 11 - Breaks down cellular matrix. [86] 
SFRP4 Secreted Frizzled-related Protein 4 - Uterine morphology. [87] 
Skin LCE1C Late Cornified Envelope 1C - Precursor of stratum corneum. [88] 
 CCL27 C-C motif Chemokine 27 - Attracts lymphocytes to skin sites. [88] 
 IL37 Interlukin 37 - Suppresses immunity and inflammation. [88] 
 SERPINA12 Serpin Family A Member 12 - Modulates insulin in tissues. [85] 
 KRT77 Keratin 77 - Epithelial structure in skin and sweat glands.  [89] 
 COL17A1 Collagen Type XVII Alpha 1 Chain - Strengthens skin tissue. [89] 
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Initial investigations into forensic mRNA profiling involved the use of the 
reverse transcriptase-polymerase chain reaction (RT-PCR) for the 
identification of epithelial cells in menstrual blood stains [86]. This 
technique was subsequently improved upon to allow the analysis of 
markers from multiple fluids through the incorporation of a capillary 
electrophoresis (CE)-based detection step [76]. Since then, RT-PCR with 
CE has largely been accepted as the standard method for mRNA-based 
fluid attribution in most forensic laboratories. However, a large 
collaborative exercise recently carried out by the European DNA Profiling 
group (EDNAP) and EUROFORGEN Network of Excellence has also 
demonstrated the potential of massively parallel sequencing (MPS) 
technologies for the targeting of fluid-specific transcripts [82]. 
These validation studies have cemented mRNA profiling as the most 
likely candidate to replace conventional body fluid identification methods. 
In fact, a number of forensic laboratories, including the Netherlands 
Forensic Institute (NFI) and the Institute of Environmental Science and 
Research (ESR) in New Zealand have already begun to utilise mRNA 
profiling methods within their operational casework [83]. However mRNA 
profiling has yet to be adopted on a global scale. This is likely due to the 
forensic community’s lack of general consensus on how to present mRNA 
profiling evidence in court. Unlike the analysis of short tandem repeats 
(STRs) in DNA profiling, there is currently no established framework for 
the statistical reporting of mRNA results that incorporates a probabilistic 
measure of uncertainty [90]. However, research in this area is currently 
underway [91]. 
A major challenge to the uptake of mRNA profiling by forensic providers is 
the complex laboratory procedures required for transcriptome analysis. 
This includes the transcription of mRNA into cDNA by RT-PCR and the 
removal of contaminating genomic DNA from samples via DNAse 
treatment [92]. Many authors have also expressed concern over the 
reliability of methods used to quantify total amounts of RNA, which if not 
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carried out correctly, can result in the production of non-specific profiling 
artefacts through target over-amplification [92, 93].  
One disadvantage of mRNA profiling compared to other recent advances 
in body fluid testing is that it can only be used for the purposes of fluid 
attribution and not detection. All fluid stains subjected to mRNA analysis 
must still be located using the time-intensive searching methods 
previously listed [34]. However, the use of mRNA profiling in forensic 
casework is still likely to result in a reduction in fluid analysis times, as 
both RNA and DNA from stains can be extracted simultaneously [94]. The 
stability of RNA molecules within body fluid stains is also highly contested 
[95]. In order to meet the changing demands of protein synthesis, RNA 
transcripts are rapidly degraded by cells through a number of enzymatic 
pathways. As a result, these transcripts typically possess much shorter 
half-lives in comparison to their DNA counterparts (although some 
specific transcripts have been shown to be more stable than others) [95]. 
However, several studies have also demonstrated the sufficient recovery 
of RNA from a range of aged and environmentally compromised body 
fluid stains [96, 97].  
1.4.5 DNA Methylation Profiling 
The unique patterns of gene expression analysed as part of mRNA 
profiling are regulated in the cell through a number of biochemical 
pathways. ‘Epigenetic’ changes in expression are those that do not 
depend on the nucleotide sequence of DNA, but instead involve 
alterations to the packaging and structure of the DNA molecule itself. 
These alterations include histone modification, chromatin structuring and 
DNA methylation [98]. The latter of these has recently become of great 
interest to the forensic community, due to the established variability of 
methylation patterns between body tissues.  
In mammalian DNA, methylation is achieved almost exclusively by the 
addition of a methyl group (-CH3) at the 5-carbon position of a cytosine 
base to form 5-methylcytosine. This process is mediated by DNA 
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methyltransferase enzymes and usually occurs at ‘CpG sites’, where 
cytosine nucleotides are directly followed by guanine residues in the 
linear sequence of bases. Unmethylated CpG sites are often grouped 
together towards the regulatory region of genes in areas known as ‘CpG 
islands’, where they exercise control over transcription activities [98]. 
In recent years, several forensic applications based on the analysis of 
DNA methylation have been proposed. Many studies have demonstrated 
that methylation patterns are altered in response to various lifestyle and 
environmental stressors, including diet, physical activity, stress and 
chemical exposure [99]. As a result, DNA methylation analysis has been 
suggested as a possible method for the genetic differentiation of 
monozygotic twins, a feat that cannot be accomplished by standard STR 
typing [100]. Some research groups have also begun to investigate the 
use of methylation analysis for the estimation of an individual’s 
chronological age directly from biological samples [101]. 
However, one of the most promising applications of methylation analysis 
to forensic investigation is as a method of discriminating biological fluids. 
Much like RNA expression, DNA methylation patterns have been shown 
to exist in a tissue-dependent manner [102]. Since initial work on 
epigenetic-based fluid attribution began in 2011 [103], a range of 
differentially-methylated regions (DMRs) specifically associated with 
forensically relevant tissues, including peripheral blood, semen, saliva, 
vaginal fluid and menstrual blood, have been identified. Whilst 
significantly more research has been undertaken in the identification of 
fluid stains through mRNA profiling, DNA methylation analysis may be 
considered an attractive option for use in forensic casework due to the 
potential for analysing methylation and STR loci in the same reaction, 
allowing body fluid attribution and DNA profiling processes to be carried 
out simultaneously [103].  
Many techniques have been employed for the detection of fluid-specific 
DNA methylation. These can be separated into three distinct categories 
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based on the type of DNA pre-treatment methods used prior to analysis: 
methylation sensitive restriction enzyme digestion, protein/antibody 
affinity binding and sodium bisulfite conversion [104]. However, as each 
of these methods is disadvantaged by issues of either analytical 
sensitivity or specificity, no assay has been universally recognised by the 
forensic community as the standard method of fluid methylation analysis. 
Techniques able to detect many epigenetic markers as part of large 
multiplexes generally require significant amounts of high-quality input 
DNA in order to function efficiently, which is likely to be problematic in the 
profiling of low volume body fluid traces typically found at crime scenes 
[105]. Conversely, sensitive methods that may be used to analyse sub-
nanogram amounts of DNA are currently restricted in the number of 
methylation markers that can be detected in a single reaction, thereby 
increasing the potential for erroneous results [105]. However, MPS 
technologies, such as the Illumina® MiSeq™ platform, have recently 
shown great promise for the sensitive and reliable multiplex analysis of 
epigenetic markers [101, 106].   
The technical challenges associated with current DNA methylation assays 
are not the only factor preventing the large-scale adoption of epigenetics-
based fluid attribution methods by forensic laboratories. Some studies 
have demonstrated that tissue-specific methylation markers may be 
susceptible to change as a result of individual ageing and/or 
environmental exposure [107]. A more extensive validation of previously 
reported fluid attribution markers is likely to be required before DNA 
methylation technologies are accepted for use within operational 
casework. The Israeli company Nucleix has already conducted one 
attempt at the commercialisation of a tissue-specific methylation assay; 
DSI-Semen™ is a 5-loci methylation multiplex for the identification of 
seminal fluid, analysed using methylation-sensitive restriction enzyme 
digestion coupled with PCR amplification [108]. However, this product 
appears to have been later removed from the market. 
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1.4.6 Metagenomic Analysis 
The human ‘microbiome’ refers to the population of microbes that reside 
within or on the surface of human bodily tissues. Such microbes, which 
include bacteria, archaea, fungi, protists and viruses, have been reported 
to be present in the body in amounts ten times greater than that of human 
cells (although this number is highly disputed, with some authors claiming 
the ratio to be closer to 1:1) [109, 110]. Recent studies have shown that 
despite the variation in microbiomes between individuals (as well as in the 
same individuals over time), particular body sites tend to be inhabited by 
distinct microbial communities [110]. As a result, these communities may 
serve as the basis for the forensic attribution of body fluid stains based on 
their metagenomic ‘signature’. 
The most prevalent method of identifying the type of microbes present 
within a specific community is through the targeted sequencing of the 16S 
ribosomal RNA gene. This gene is generally present in all microbiota but 
contains a number of hypervariable regions that may be used for the 
purpose of species discrimination [111]. Recent improvements in 
sequencing technologies (as well as reductions in sequencing costs), 
have also led some forensic researchers to consider the use of whole-
genome sequencing for the characterisation of certain microbiomes [112]. 
Although not yet applied to the field of biological fluid attribution, such 
techniques may be able to provide investigators with greater levels of 
taxonomic discrimination, as well as an indication of relative species 
abundance, by analysing the entire genome of each type of microbe 
present within a population. 
So far, only a small selection of the body fluids commonly found at crime 
scenes have been able to be identified through metagenomic analysis 
[72]. Furthermore, those microbial markers that have been reported for 
the purpose of attribution may only be used to determine the body site 
from which a fluid has originated, but not the identity of the fluid itself. For 
example, successful detection of the bacterial species L. crispatus or L. 
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gasseri within a sample may be able to establish that a fluid is either 
menstrual blood or vaginal fluid, but cannot distinguish between the two 
as both originate from the vaginal cavity [113]. Other tissues for which 
body site-specific markers have been identified include saliva, faeces and 
skin [72]. Some authors have also stated that microbial profiling is unlikely 
to be suitable for the analysis of ‘sterile’ fluids, such as blood and semen, 
in which bacteria is not usually present in large quantities [114]. 
Other challenges currently associated with this approach include the 
potential for a fluid’s microbial signature to change after it has been 
deposited at a crime scene. Changes in the relative abundance of 
particular microbe species as a result of growth or degradation may make 
it difficult to identify fluids left at scenes over prolonged periods of time 
[72]. Inter-individual variation also makes the selection of standardised 
metagenomic markers problematic, as even some widespread microbe 
species have been shown to be absent in certain individuals [115]. An 
established overlap between the microbiome of humans and other 
mammalian species also means it is unlikely that microbial-based 
attribution methods will be able to determine whether or not body fluid 
samples are of human origin [116]. 
1.4.7 Immunofluorescence 
Two recent studies conducted within the forensic science research group 
at King’s College London have successfully demonstrated the 
simultaneous detection and confirmatory identification of several 
biological fluids in situ. The first of these involved the visualisation and 
differentiation of erythrocytes and nucleated leukocytes within blood 
through interaction with fluorescently-labelled antibodies [117]. In this 
study, antibodies specific to the erythroid membrane protein Glycophorin 
A and leukocyte membrane protein CD45 were labelled with the 
fluorescent dyes Alexa Fluor 568 and Alexa Fluor 488, respectively. 
These antibodies were then incubated with blood deposited on glass 
slides and dark-coloured cotton before the visualisation of cells by 
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fluorescence microscopy. This method was able to detect both 
erythrocytes and leukocytes at the single cell level. Furthermore, no cross 
reaction was observed with cells present in semen and saliva, as well as 
with blood from other mammalian species.  
Whilst this method proved suitable in terms of sensitivity and specificity, a 
series of wash steps were required in order to remove any remaining 
unbound antibody complexes. Consequently, there is a chance that this 
technique may negatively affect the recovery of DNA from a biological 
stain, as minor portions of the fluid are likely to be removed with each 
successive wash. A follow up study sought to overcome this limitation 
through the conjugation of iron-oxide nanoparticles to the antibody-
fluorophore complex, which allowed unbound fractions to be removed 
magnetically (Figure 3) [118]. The technique was also extended to the 
detection of saliva using anti-mucin 7 antibody complexes. Despite 
resolving issues of potential fluid destruction, magnetic removal is 
considered cumbersome and cannot provide a confirmation that a 
complete unbound removal has taken place, which may lead to an 
overestimation of fluid presence. 
 
Figure 3: Scheme of body fluid detection using fluorescently-labelled antibodies 
conjugated to magnetic nanoparticles: a) antibody-nanoparticle complexes are 
deposited over a suspected fluid stain, b) unbound complexes are removed 
magnetically and c) remaining bound complexes are detected via fluorescence 
microscopy. Taken with permission from [118]. 
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1.5 Biosensors 
Biosensors are a group of devices capable of turning biological 
interactions into observable signal outputs. Such devices have previously 
demonstrated the delivery of real-time information regarding the presence 
and activity of specific molecules within complex sample matrices for 
many biological and medical applications [119]. Biosensing is usually 
achieved by use of a supramolecular complex comprised of two 
components; a sensitive biological detection element for the recognition 
of a testing antigen and a physiochemical transduction element that 
stimulates the production of an observable output upon successful 
interaction [120]. Biosensing assays may be regarded as a single 
integrated system, with direct spatial contact between recognition and 
transduction elements.  
Biosensor construction is facilitated by extensive design flexibility, with a 
wide range of recognition moieties, signal outputs and intrinsic 
transduction mechanisms available to meet specific assay requirements. 
Components such as enzymes, antibodies, peptides, MIPs and nucleic 
acid sequences may all be utilised for analyte recognition, allowing the 
detection of almost any molecular target [120]. Sensing outputs also exist 
in many different formats, including optical, electrochemical, thermal, 
magnetic or mass-sensitive-based signal detection, which allows analysis 
to take place over a range of different environments and sample types. 
Despite these assets, biosensors have yet to find routine employment 
within any forms of forensic analysis. In fact, only a small number of 
sensors have been reported in literature for the detection of targets 
relevant to criminal investigation (Table 4). This is likely due to the 
challenges associated with both the complexity of biosensor design, as 
well with the difficult nature of forensic casework samples (which are 
often subject to contamination and/or environmental exposure), 
necessitating a meticulous optimisation and validation of all new sensors 
before they can be deployed for operational use [121]. 
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Table 4: A selection of analytical biosensors developed for use in forensic analysis 
Field Target Recognition Transduction Notes Ref. 
Explosives TNT Peptide Absorbance The UV absorbance of 
graphene oxide functionalised 
with peptides specific to 
2,4,6-trinitrotoluene (TNT) is 
increased in the presence of 
explosive compounds.   
[122] 
TNT MIP Fluorescence Quantum dots (QDot) 
nanoparticles conjugated to 
molecularly imprinted 
polymers (MIPs) are 
quenched through polymer 
interaction with TNT. 
[123] 
Multiple Antibody Fibre-optic Anti-TNT and RDX antibodies 
present on the surface of a 
fibre-optic probe are labelled 
with fluorescent analogues, 
which are displaced upon 
analyte binding.  
[124] 
Illicit Drugs Cocaine Antibody Fibre-optic Cocaine molecules displace 
fluorescently-labelled 
benzoylecgonine bound to 
antibodies immobilised on the 
surface of quartz fibres. 
[125] 
Cocaine Aptamer Electrochemical Aptamers labelled with a 
chemiluminescent ruthenium 
complex interact with the 
electrode surface on which 
they are immobilised as a 
result of cocaine binding. 
[126] 
Multiple Antibody SPR Antibodies present on the 
surface of a protein array chip 
indicate cocaine, heroin, 
MDMA or amphetamine 
presence through surface 





Anthrax Aptamer SWNTs Aptamers bound to the 
surface of single-walled 
carbon nanotubes (SWNTs) 
are used to detect the anthrax 
protein, protective antigen 
(PA) through binding. 
[128] 
Cyanide Enzyme Electrochemical The activity of horseradish 
Peroxidase (HRP) enzymes 
immobilised on the surface of 
an electrode is inhibited by 
cyanide interaction, resulting 
in a reduced current. 
[129] 
Ricin Antibody SPR A handheld sensor employing 
surface-bound antibody 
fragments is used to detect 
the presence of the biological 
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1.5.1 Enabling Biosensors for the Analysis of Biological Fluids 
The use of biosensor technology for the simultaneous detection and 
identification of biological fluid stains may provide an ideal resolution to 
the disadvantages associated with traditional fluid testing methods [131]. 
Biosensors may be considered particularly amenable to fluid analysis for 
a number of reasons. The use of biological elements for the recognition of 
target analytes ensures that biosensing assays exhibit exceptionally high 
degrees of analytical selectivity [132]. This selectivity may allow for the 
development of new body fluid tests that are able to provide an absolute 
confirmation of tissue identity through interaction with fluid-specific 
biomarkers. 
Locating body fluids within forensic casework generally requires a low-
cost detection strategy that employs simple instrumentation applicable to 
scene analysis. Such qualities may be easily afforded by biosensors 
employing transduction mechanisms based on fluorescence signalling. 
These sensors have been extensively employed in the sensitive, versatile 
and real-time detection of numerous analytes for a variety of biomedical 
applications [133]. Furthermore, fluorescence biosensing outputs may be 
easily observed using instrumentation already routinely utilised within 
body fluid analysis, such as excitation light sources, optical filters and 
CCD cameras. Forensic investigators are therefore unlikely to require 
additional specialised knowledge in order to successfully conduct 
biosensor-based fluid testing. 
Unlike the immunofluorescence methods previously described in Section 
1.4.7, biosensor signals are produced only after a biological interaction 
event has taken place. As such, there is no prerequisite for the removal of 
any remaining unbound reagent prior to sample measurement. Detection 
based on sensing may therefore be considered entirely homogeneous, as 
it does not require additional sample component processing or 
enhancement. This lack of extraction, isolation or washing steps is likely 
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to mitigate the risk of stain destruction during the fluid identification 
process. 
Figure 4: Types of spectral emission change upon sensor-target interaction: a) Stokes-
shift wavelength change, b) ‘turn-on’ emission production, c) ‘turn- off’ emission 
quenching. Taken with permission from [131]. 
One assay based on ‘turn-off’ fluorescent biosensing has already been 
explored for the purpose of body fluid identification [134]. This study 
involved the use of an anti-glycophorin A antibody conjugated to a highly 
fluorescent QDot nanoparticle. In the presence of blood, fluorescence 
emission from the QDot-antibody complex was quenched in a 
concentration-dependent manner. However, with the presence of blood 
indicated through the absence of fluorescence, it is unlikely that this 
sensor could be used for stain visualisation purposes. Depending on the 
transduction mechanism employed, biosensors may cause various 
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or off, or shifting its output wavelength (Figure 4). For fluid detection 
purposes, ‘turn-off’ reporting mechanisms may be considered unsuitable 
as, while potentially allowing for the confirmation of fluid identity in 
solution, a decrease in observable signal prevents the localisation of fluid 
deposits in situ. Conversely, ‘turn-on’ signals, in which emissions are 
generated from an initially non-fluorescent sensor, may allow for the 
visualisation of fluid stains through the production of discrete areas of 
coloured light. 
1.6 Project Aims and Objectives 
The purpose of this study was to design, develop and test a range of 
fluorescent biosensors for the location and identification of body fluid 
traces. This thesis documents the construction of several molecular 
sensing reagents which, upon interaction with intra-fluidic targets, indicate 
fluid presence through ‘turn-on’ fluorescence emission.  
 
Figure 5: Ideal in-situ application of biosensors to the detection of body fluids. Sensing 
molecules are dispersed across surfaces via aerosol spray, generating different 
fluorescent wavelengths upon multiple fluid target interaction. Taken with permission 
from [131]. 
The spray dispersal of these reagents across the surface of large items 
may allow for the specific and non-destructive localisation of fluid staining 
areas in real-time. Furthermore, it may eventually be possible to combine 
several of the biosensing molecules reported within a single multiplex 
assay (which produces specific wavelengths of light depending on the 
type of fluid present) for the simultaneous visualisation and attribution of 
Saliva
Blood
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fluid stains (Figure 5). Employment of these reagents within routine 
forensic casework may lead to a significant reduction in the labour and 
time expense associated with current manual stain search and 
identification strategies.  
This thesis has been divided into chapters based on the types of sensing 
mechanisms explored. A chapter outlining the potential incorporation of 
developed sensors within forensic taggant materials is also provided. A 
final discussion of results is given in Chapter 7: 
Chapter 2 (Biosensors) - Several commercially available biosensors are 
tested against their relevant targets within a forensic context. The ability 
of sensing mechanisms to detect wet and dry analyte deposits in situ is 
explored, as well as effect of each sensor on the production of DNA 
profiles from biological fluid samples. 
Chapter 3 (Fluorogenic Substrates) - Three commercially available 
fluorogenic peptide substrates are utilised to detect human semen, saliva 
and blood (both in solution and deposited on surfaces relevant to criminal 
investigation). Attempts to increase assay performance are then made 
through the production of custom substrates using a novel solid phase 
peptide synthesis strategy. 
Chapter 4 (Immunosensors) - A custom displacement immunosensor 
specific to PSA is constructed. Consisting of an antibody-quantum dot 
conjugate initially quenched by a moderately bound quencher-labelled 
peptide analogue, this sensor is shown to successfully detect nanomolar 
amounts of PSA within solution. 
Chapter 5 (Aptasensors) - Three different aptamer-based sensing 
mechanisms are tested against purified protein and whole fluid samples. 
The discovery of aptamers against human sperm cells is then undertaken 
using the Cell-SELEX process and next generation sequencing 
technologies.   
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Chapter 6 (Taggants) - The potential for the incorporation of fluorescent 
sensing molecules within forensic taggant materials is investigated. Novel 
taggants are produced for establishing evidence of contact transfer in 
criminal investigations. 
Chapter 7 (Discussion & Conclusion) - An overall analysis of the 
results obtained within each of the previous chapters is presented, along 
with final conclusions and potential future work. 
This thesis will be prepared incorporating publications. Research and 
review articles that have been produced from this project will therefore be 
included within the text. These articles will be presented in their final 
published format and will be accompanied by an appropriate introduction 
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2.1 Introduction 
A significant number of fluorescent biosensors have already been 
developed for the rapid, sensitive and specific detection of target 
analytes. These sensors vary drastically in the transduction mechanisms 
used to indicate positive biological interactions. The vast majority of these 
biosensors have been designed for the analysis of targets in solution, 
using spectrofluorometry to monitor changes in fluorescence emission. 
However, in order to be applied to the analysis of latent body fluids at 
crime scenes, biosensing reagents must also possess the ability to detect 
analytes deposited in situ on different surface types (or on swabs/paper 
to which a portion of the stain has been transferred). It may therefore be 
beneficial to investigate the adaptability of previously developed 
fluorescent transduction mechanisms towards the in situ detection of 
fluid-specific analytes. 
In this chapter, a selection of fluorescent biosensing mechanisms 
demonstrating potential applicability to the localisation and identification 
of body fluid stains are first reviewed. The in situ detection ability of these 
mechanisms is then evaluated by testing several commercially available 
biosensor assays against their relevant analytes deposited on surfaces 
commonly encountered in forensic investigation. These assays were not 
selected on the basis of target analyte, but on the unique transduction 
methods in which ‘turn-on’ fluorescence signalling is achieved.  
The objectives of this particular study were to establish if fluorescent 
biosensors are still able to generate positive emission signals after 
application to wet and dry surface-deposited analytes in situ and 
moreover, whether such signals can be observed in the absence of a 
spectrofluorometer via fluorescence microscopy. The potential 
interference of different surface types on sensor emission, either as a 
result of cross-reaction or physical fluorescence screening, is also 
investigated, along with each sensor’s effects on downstream DNA 
profiling. Those transduction mechanisms displaying greatest in situ 
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detection performance are likely to be utilised for the subsequent 
development of biosensing assays for the detection and identification of 
body fluids. 
2.2 Review of Fluorescent Biosensors 
2.2.1 Environmentally-Sensitive Fluorophores 
One class of sensing transduction mechanism demonstrating potential for 
use within fluid sensing strategies is that of environmentally-sensitive 
fluorophores, fluorescent molecules that display variable spectroscopic 
properties in response to changes in local environment. Such 
fluorophores include those able to exhibit several energetically favourable 
conformational isomers whilst free in solution. In these states, quantum 
yield and fluorescence lifetimes are limited, rendering total fluorescence 
relatively negligible. However the process of target binding forces these 
molecules into specific structural conformers, stabilising the arrangement 
of atomic systems responsible for fluorescence and resulting in an 
exponential increase in emission intensity [135]. 
Figure 6: Chemical structure of the DNA-intercalating fluorophore PicoGreen®  
Many of these molecules are DNA intercalators, which in the presence of 
nucleic acids undergo non-covalent insertion between helical base pairs 
as a result of hydrophobic screening and van der Waals interactions 
[135]. Intercalating dyes such as PicoGreen® (Figure 6) have not only 
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already found common use in the quantitation of double stranded DNA 
within biological fluid extracts for forensic purposes [136], but have also 
established a level of in situ applicability, aiding in the detection of 
bacterial biofilms upon historic window glass [137]. However, despite 
demonstrating usefulness in the visualisation of DNA molecules in 
general, the lack of sequence selectivity exhibited by such dyes prevents 
direct application to the identification of tissue-specific DNA sources, such 
as biological fluid stains.  
Instead, the application of environmentally-sensitive fluorophores to the 
analysis of body fluids may be achieved through the use of conformer-
sensitive dyes that suppress isomerisation upon interaction with fluid-
specific protein biomarkers. After target binding occurs, the local 
environment surrounding the fluorophore changes, altering emissions to 
signify analyte presence. In fact, several previous studies have already 
explored the biosensing properties of stilbene, a fluorescent dye existing 
in two isomeric forms, for the detection of monoclonal antibodies. 
Interactions between antibodies and stilbene molecules results in the 
formation of a conformer ‘exciplex’, an excited state heterodimer that 
allows fluorescence emission [138]. Such work provides a firm basis for 
the future design of single-molecule sensors with fluorescence 
sensitivities relative to the macromolecular environment. 
2.2.2 FRET-based Biosensing 
Förster Resonance Energy Transfer (FRET) refers to the phenomenon of 
non-radiative energy transfer between two spectrally-active molecules as 
a result of electrostatic dipole-dipole interactions. This process principally 
culminates in the quenching of an excited donor fluorophore emission by 
alternative transmission to a proximate acceptor molecule, which may or 
may not consequently fluoresce. Energetic transfer is distance-
dependent, with fluorophore separation greater than a length of ~10 nm 
alleviating quenching effects and allowing signal output as either simple 
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donor emission observation or through ratiometric measurement of an 
acceptor-donor spectral shift [139].  
FRET is often exploited within a number of macromolecular sensing 
applications for monitoring biological interactions that facilitate a proximity 
change between two or more chromophore molecules. As FRET occurs 
across an order of several nanometres, it may be considered ideal for the 
sensing of biomolecular targets [139]. Furthermore, whilst some FRET 
methods exploit the spectral properties of organic recognition molecules 
themselves (such as the intrinsic fluorescence of tryptophan residues in 
analyte-binding proteins [140]), the additional labelling of non-fluorescent 
moieties with synthetic dyes allows virtually any bio-recognition element 
to be used within FRET sensing assays. 
Two distinct approaches are applied to the detection of molecular targets 
through FRET biosensing. The first involves the labelling of a sensor with 
both donor and acceptor moieties as a single intramolecular complex. 
Interaction with a testing analyte upon this complex alters the relative 
proximity of fluorophore molecules through the induction of a structural 
change within the sensor molecule, resulting in an increase or decrease 
in energy transfer [141]. 
The second form of FRET sensing comprises fluorescent labels located 
upon two separate and independent biological elements, which 
subsequently unite as a result of binding interactions or disassociate via 
competitive displacement (the former of which may be impractical for the 
in situ identification of biological fluid residues since it is largely 
impossible to label the initial testing antigen). 
2.2.2.1 Intramolecular FRET 
Recent research has demonstrated the use of intramolecular FRET 
sensing for the successful detection of enzyme activity in situ, with 
previous studies utilising catabolic events to monitor increased protease 
expression in wound-infecting bacterial biofilms and during enteroviral 
pathogenesis [142, 143]. Testing is reliant upon the hydrolysis of a 
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terminally labelled substrate conjoining two fluorophores to disrupt energy 
transfer processes (Figure 7a). As the specific physiological function of 
each body fluid necessitates unique enzyme production, similar turn-on 
fluorescence assays may be potentially developed for the in situ detection 
and identification of biological fluids based on their proteolytic activity. 
Figure 7: Examples of intramolecular FRET sensing mechanisms: a) a terminally 
labelled fluorogenic substrate is digested by catalytic enzymes, releasing a fluorescent 
by-product, b) a fluorophore-quencher pair in an initially quenched oligonucleotide 
hairpin is separated upon binding, restoring fluorescence, c) analyte-induced 
conformational change upon antibody binding changes donor–acceptor proximity, 
resulting in a wavelength shift. Taken with permission from [131]. 
Intramolecular FRET transduction mechanisms have also been integrated 
into oligonucleotides capable of specific binding to other nucleotide 
sequences [144], proteins [145] and inorganic molecules [146]. These 
assays employ a flexible dual-labelled oligonucleotide strand known as a 
‘molecular beacon’, that forms a self-complementing hairpin structure in 
order to bring donor and acceptor dyes within appropriate proximity for 
FRET quenching to occur. Subsequent hybridization or binding of the 
probe to the analyte causes separation of the fluorophore moieties to 
successfully inhibit quenching and enhance fluorescence (Figure 7b). 
Recent research has demonstrated the in situ applicability of this 
technique to detect Pseudomonas putida bacteria in activated sludge and 
a) b)
c)
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river water [147]. Advances in the use of combinatorial libraries now allow 
the selection of oligonucleotides with binding capabilities towards virtually 
any target molecule, potentially allowing for the development of beacon-
based sensors for the analysis of body fluid biomarkers.  
Intramolecular FRET has also been exploited to induce energy transfer 
between chromophores located at two specific sites on the surface of 
antibody moieties (Figure 7c). Prior to target interaction, fluorescence 
signals are produced at the emission wavelength of the donor 
fluorophore, with limited fluorescence from the acceptor. Analyte binding 
results in a conformational change in the structure of the antibody, 
causing a change in fluorophore proximity and switching emission 
wavelength. Similar systems have already been employed to detect 
biochemical markers of myocardial infarction [148], as well as bacterial 
contamination in food products [149]. Immunological-based target 
recognition makes this type of sensor particularly suitable for body fluid 
analysis. Antibodies are presently considered a gold standard in protein 
detection and would ensure high degrees of specificity towards fluid 
targets with the added value of human species selectivity.  
2.2.2.2 Intermolecular FRET  
As previously mentioned, the use of intermolecular FRET processes 
within fluid sensing assays may be confined to displacement only 
mechanisms, as unknown testing analytes cannot be pre-labelled. 
Development of a displacement-based FRET assay involves the 
preliminary integration of donor fluorophores within a molecular sensing 
unit, which subsequently binds with moderate affinity to a non-testing 
substrate alternatively labelled with acceptor moieties, thereby permitting 
proximal FRET quenching. A positive signal response occurs when 
moderately bound quenching ligands are competitively removed by a 
macromolecular target with higher binding affinity (Figure 8a).  
Sensors for the detection of maltose have been designed on this 
principle, which utilise the dissociation of a quencher labelled β-
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cyclodextrin competitor from an E. coli maltose-binding protein [150]. 
Other studies have produced similar success in the observation of 
mycotoxin-producing Amstelodami fungal spores via the displacement a 
moderately bound quencher-labelled fungal species from an anti-
Aspergillus antibody complex [151]. 
Figure 8: Examples of varying intermolecular FRET transductions: a) moderately 
bound acceptor ligands are displaced via a higher affinity competitive analyte, b) a 
fluorophore-labelled oligonucleotide sequence is initially hybridized to a complementary 
quenching strand which is subsequently displaced by a target analyte, producing 
fluorescence. Taken with permission from [131]. 
Other assays employ specific oligonucleotide aptamer sequences for 
fluorescent detection. DNA known to bind to a specific analyte is labelled 
with a fluorophore and subsequently hybridized to a complementary 
sequence bearing a quencher molecule, making the system non-
fluorescent. The assay exploits conformational changes that aptamers 
undergo upon target interaction, which displaces the complementary 
quenching strand and restores fluorescent signal (Figure 8b).  
Displacement-based FRET biosensors show high adaptability to the 
analysis of biological fluid depositions, with modifications likely to focus 
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able to bind intra-fluidic molecules. Such mechanisms also afford 
excellent analytical sensitivity, with the majority of sensing 
macromolecules allowing multiple donor fluorophore labelling, thereby 
enhancing signal output upon successful interaction. Regardless of the 
numerable benefits, evaluation into in situ the application of FRET-
displacement sensors towards any forms of biomedical or industrial 
analysis currently remains unexplored.  
2.2.3 Static Quenching-based Biosensing 
Since energetic transfer occurs whilst the donor molecule exists within an 
excited state, the phenomenon of FRET may be described as a ‘dynamic’ 
quenching mechanism. Conversely, a number of spectral processes also 
exist based on the phenomenon of ‘static quenching’, in which two 
fluorophores form a dimeric ground-state intermolecular complex. 
Physical contact between the fluorescent moieties results in the creation 
of an entirely new excitation absorption spectrum, thereby inhibiting 
fluorescence emission [152]. This effect is particularly prevalent when 
interaction occurs between two identical fluorophores in the formation of 
homodimers. 
Within free solution, fluorophores may aggregate of their own volition due 
to hydrophobic, electrostatic or steric forces [153]. However, the high 
fluorescence contribution from remaining unbound dye molecules renders 
the total reduction in fluorescence intensity negligible. Substantial or even 
total quenching arises from the integration of the fluorophore moieties into 
a macromolecular substrate with a significantly high degree of 
substitution, forcing the majority of dye molecules into dimeric quenching 
complexes [154]. 
Efficient substrate-based quenching via homodimeric binding interactions 
has been utilised in the recent development of analytical biosensors for 
enzymatic activity. Sensing depends on the initial labelling of numerous 
dye moieties in a heavy stoichiometric ratio on an individual substrate 
molecule, with consequent digestion of the substrate backbone by 
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enzyme activity, allowing the dissociation of dimeric complexes (Figure 
9). Although the dimerization of all fluorophores results in the 
diminishment of fluorescence emission, these assays customarily utilise 
rhodamine or BODIPY derivatives, which display increased aggregation 
rates compared to other organic dyes [153]. Previous studies employing 
these substrate-confined dyes have already successfully demonstrated 
the in situ detection of elastase activity associated with dental pellicle 
production by salivary glycoproteins [155], as well as the proteolytic 
action of calpain enzymes during cataract formation in sheep [156]. 
Figure 9: Examples of static quenching-based sensors: a) the liberation of dimerized 
fluorophores from a heavily labelled backbone by digestive enzymes, b) a recognition 
moiety is conjugated to methyl viologen (MV2+), which is electrostatically attracted to 
the CP, quenching fluorescence. In the presence of the analyte, the recognition moiety 
and therefore the MV2+ are pulled away from the CP, restoring fluorescence. Taken 
with permission from [131]. 
The modification of previous in situ assay technologies for application to 
the differentiation of biological fluid depositions would largely revolve 
around the development of a substrate capable of binding, and 
subsequently separating, a large number of dimerized fluorophores upon 
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comprise any macromolecule that can be successfully derivatised to 
include a considerable number of exposed amine binding groups for 
conjugation with organic dyes via simple covalent chemistry. 
The application of fluorescent conjugated polymers (CPs) may also allow 
for the development of static-quenching based sensors for fluid detection 
purposes. It has been demonstrated that polyanionic conjugated 
polymers can be quenched by cationic electron acceptors in aqueous 
solutions. By conjugating biotin to the cationic acceptor and allowing 
interaction to take place between the CP and the conjugate, complete 
quenching of polymer fluorescence can be achieved [157]. In the 
presence of streptadivin, binding to the biotin molecule ligand takes 
place, displacing the quencher from the polymer, restoring its 
fluorescence. Adapting this assay to identify fluid-specific molecules 
would require the quencher to be linked to an antibody or binding protein. 
This complex can then be removed from the polymer by interaction with a 
fluid biomarker. What makes the interaction between CPs and cationic 
acceptors advantageous over dynamic FRET-based sensing for in situ 
target detection is the complete absence of any background 
fluorescence, allowing improved localisation of discrete fluid deposition 
areas. 
2.3 Materials and Methods 
2.3.1 Reagents 
The Quant-iT™ PicoGreen® dsDNA Assay Kit, EnzChek® 
Protease/Peptidase Assay Kit, FluoReporter® Biotin Quantitation Assay 
Kit and EnzChek® Ultra Amylase Assay Kit were all purchased from 
Thermo Fisher Scientific (California, USA). Assay analytes; trypsin from 
bovine serum, human α-amylase and biotin were all purchased from 
Sigma-Aldrich (Dorset, UK), whilst a λ viral DNA source was supplied with 
the Quant-iT™ PicoGreen® dsDNA Assay Kit.  
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2.3.2 Slide Microscopy 
A preliminary demonstration of in situ mechanism performance was 
achieved by testing each commercial assay reagent against its relevant 
analyte deposited on the surface of glass slides. Reagent concentrations 
were modified from those given by manufacturers for use in 
spectrofluorometric assays to account for the decrease in sensitivity 
associated with observation by fluorescence microscopy.  
Table 5: Analyte concentrations used for in situ testing of commercial assay reagents. 
Reagent Analyte Deposit Concentrations  
Quant-iT™ PicoGreen® dsDNA  λ viral DNA 100, 10, 1, 0.1, 0.01, 0.001 (μg/ml) 
EnzChek® Protease/Peptidase  Bovine Trypsin 10, 1, 0.1, 0.01, 0.001, 0.0001 (mg/ml) 
FluoReporter® Biotin Quantitation  Biotin 10, 1, 0.1, 0.01, 0.001, 0.0001 (mg/ml) 
EnzChek® Ultra Amylase α-amylase  10, 1, 0.1, 0.01, 0.001, 0.0001 (mg/ml) 
 
Six different concentrations of each analyte solution (Table 5) were 
applied in 5 μl volumes to the centre of glass slides before the direct 5 μl 
addition of assay reagent. Negative reagent-only controls were also 
applied on the same slide to measure potential background reagent 
emission, whilst blank controls consisting of analyte-only applications 
were used to monitor analyte auto-fluorescence (Figure 10). The testing 
of sensor performance against dry depositions was also undertaken 
through the application of 5 μl of analyte solutions to slides, which were 
allowed to dry overnight. Assay reagents were then applied in the same 
manner as wet deposit testing. Each concentration of both wet and dry 
analytes was prepared in triplicate. 
Table 6: Microscopy and reagent parameters used for in situ slide and surface testing. 
Reagent [Reagent Increase]  Contrast Brightness Exposure 
Quant-iT™ PicoGreen® dsDNA  5000% 1023 131 -2 
EnzChek® Protease/Peptidase  400% 1023 131 -2 
FluoReporter® Biotin Quantitation  75% 1023 131 -1 
EnzChek® Ultra Amylase 400% 1023 131 -2 
 
Images were taken immediately after reagent application on an Olympus 
SZX12 fluorescence microscope (Tokyo, Japan) using an internal CCD 
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camera. As each assay shared similar excitation and emission 
wavelengths, GFP optical filtration (Ex460-490/Em510 nm) was utilised 
throughout testing. Microscopy parameters for each assay (optimised 
during the first measurement of highest concentration analytes) were also 
kept constant for all subsequent in situ studies in order to restrict result 
variation (Table 6). 
Figure 10: Representation of instrumental set-up for evaluating in situ sensor 
performance. An Olympus SZX 12 fluorescence microscope is used to illuminate and 
observe samples deposited on glass slides or surfaces relevant to forensic casework. 
Positive samples consist of assay reagent applied to wet or dry analyte deposits. 
Negative and blank controls were also included. 
2.3.3 Surface Microscopy 
Assays indicating an acceptable level of in situ performance during glass 
slide testing (Section 2.3.2) were then applied to analytes deposited on a 
range of different surface types. Ten surfaces, consisting of cardboard 
(brown), cotton (100%, white), denim (100% cotton, dark blue), felt (100% 
acrylic, black), leather (black, genuine), paper (white), plastic (dark blue), 
polyester (black), wood (untreated, brown), and wool (blue) were chosen 
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All surfaces were cut to fit the size of a microscope slide. Analyte 
concentrations producing the largest fluorescence signal for each assay 
reagent during dry deposit glass slide testing were applied to surfaces in 
5 μl volumes and allowed to dry overnight before reagent addition. Blank 
and negative controls were also applied in the same manner as 
previously described (Section 2.3.2). Microscopy parameters were kept 
consistent with those used during glass slide testing (Table 6). 
2.3.4 Image Analysis 
Images recorded during surface microscopy testing were subjected to a 
semi-quantitative measurement of fluorescence intensity using Adobe 
Photoshop™ (California, USA) imaging software. Deposit areas were first 
isolated within each image using the magnetic lasso tool, selecting a 
defined number of pixels. Use of the ’green’ channel histogram function 
subsequently allowed each of these pixels to be assigned a value from 0-
255 as a representation of signal intensity.  
Figure 11: Semi-quantitative analysis of in situ biosensor assay fluorescence using 
Adobe Photoshop™ software. Areas of positive signal emission are defined using the 
magnetic lasso tool before the image histogram function is used to assign a mean 
intensity value for that area. 
An average value for all selected pixels was then recorded as a 
measurement of mean fluorescence within the entire analyte deposit area 
(Figure 11). Percentage differences between assigned negative control 
and positive sample values were then plotted for each commercial assay 
Value = 165.38
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reagent to establish numerical changes in relative fluorescence intensity 
against different surface types. 
An independent investigation into the accuracy of this processing method 
was conducted through the deposition and measurement of different 
concentrations of the fluorophore Alexa Fluor 488 (Thermo Fisher 
Scientific, California, USA) on glass slides. Software-assigned intensity 
values were then plotted against fluorophore concentration to determine 
method linearity.   
2.3.5 Blood Collection and Storage 
Blood samples were taken upon informed consent from the same healthy 
donor. Samples were drawn by venipuncture and stored in a BD 
Vacutainer® Plus tube (Oxford, UK) containing 3.2% sodium citrate 
coagulation preservative and stored at 4 °C until analysis.  
Ethical clearance for the collection of biological fluids for this specific 
study was granted by the King’s College London Biomedical Sciences, 
Dentistry, Medicine and Natural & Mathematical Sciences Research 
Ethics Subcommittee (reference number BDM/13/14-26). 
2.3.6 DNA Profiling  
Potential effects on the recovery of DNA from body fluids after the 
application of each sensor were observed by adding 50 μl of each 
reagent at their respective working concentrations to 150 μl of human 
blood. DNA was extracted using the QIAmp® DNA Mini kit (Qiagen, 
Manchester, UK) according to the manufacturer protocol and quantified 
using the Quantifiler™ Human DNA Quantification Kit (Thermo Fisher 
Scientific, California, USA). Samples were diluted to 0.1 ng/μl prior to 
amplification (1 ng total DNA) with the AmpFlSTR® SGM Plus® PCR 
Amplification Kit (Applied Biosystems, Paisley, UK) using a Perkin Elmer 
9700 thermal cycler (Cambridge, UK). STR amplicons were resolved on 
an Applied Biosystems® 3130 Genetic Analyser and evaluated using 
GeneMapper® software (California, USA). 
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2.4 Results and Discussion 
2.4.1 Commercial Assay Selection 
Each of the commercial biosensing assays tested employed one of the 
sensing transduction mechanisms previously reviewed. These 
mechanisms were chosen for study based on reported high ‘turn-on’ 
emission intensities, instantaneous signal production and a potential 
adaptability towards the forensic analysis of biological fluids. The 
commercial assays used for testing were as follows:  
• Quant-iT PicoGreen dsDNA Assay Kit (Environmentally-Sensitive)  
An initially non-fluorescent probe that intercalates into DNA bases, 
stabilising thiazol-quinolinium coupled systems and forcing the 
molecule into a preferred conformational state responsible for 
fluorescence emission [135]. 
• EnzChek Protease/Peptidase Assay Kit (Intramolecular FRET)   
A substrate comprised of donor and acceptor fluorophores held within 
close proximity by an amino acid chain, allowing FRET-based 
quenching to occur. Enzymatic hydrolysis of the chain by a range of 
proteases separates the pair to relieve quenching effects and produce 
fluorescence at 528 nm (Figure 7a). 
• FluoReporter Biotin Quantitation Assay Kit (Intermolecular FRET)  
Multiple 2-(4’-hydroxyazobenzene) benzoic acid (HABA) molecules 
are bound with moderate affinity to avidin labelled with Alexa Fluor 488 
dyes, quenching emission via intermolecular FRET. In the presence of 
biotin, HABA molecules are competitively displaced, resulting in 
increased fluorescence [158].  
• EnzChek Ultra Amylase Assay Kit (Static Quenching)  
A substrate comprised of a proprietary starch derivative (DQ™ starch) 
heavily labelled with self-quenching BODIPY® FL fluorophores to such 
a degree that emission is quenched. Digestion of the starch backbone 
by α-amylase yields numerous fluorescent fragments (Figure 9a). 
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2.4.2 Slide Microscopy 
Three out of the four transduction mechanisms tested were able to 
demonstrate a level of in situ sensing performance that may be 
considered suitable for the forensic detection and identification of body 
fluid stains. Fluorescence increases in response to deposits were 
exhibited by the EnzChek® Protease/Peptidase, FluoReporter® Biotin 
Quantitation and EnzChek® Ultra Amylase assay kits and were found to 
be proportional to analyte concentration (Figure 12). Furthermore, these 
emission changes occurred immediately after reagent application, thereby 
promising the potential for rapid fluid screening without extended 
incubation or development times. 
In comparison to wet deposits, a small general decrease in fluorescence 
intensity was observed upon the application of sensors to dried targets, 
with lower analyte concentrations (1 µg and 100 ng/ml for both EnzChek® 
Protease/Peptidase and EnzChek® Ultra Amylase assay kits) remaining 
indistinguishable from negative controls. This phenomenon may be due 
to the restriction of analyte movement as a result of solute evaporation, 
which may limit potential target-sensor interaction. However, previous 
studies investigating differences in the sensitivity of current presumptive 
testing reagents between wet and dry fluid stains did not find such effects 
to be statistically significant [38]. 
Greatest assay sensitivity was shown by the FluoReporter® Biotin 
Quantitation assay kit, with 100 ng/ml concentrations of biotin 
differentiated in both wet and dry deposits. This is likely due to the 
virtually non-existent background emission of the assay reagent, which is 
achieved through the binding of multiple quencher moieties to a single 
fluorescently-labelled avidin molecule, resulting in a greater level of 
intermolecular FRET quenching [158]. 
Whilst acceptable detection at concentrations of 10 μg/ml and 1 μg/ml for 
wet and dry deposits respectively was achieved by the EnzChek® Ultra 
Amylase Kit, this assay also exhibited the highest background
Page | 49  
Figure 12: Demonstration of in situ commercial assay performance against six 
concentrations of wet and dry analyte deposits on glass slides. Triplicate 
measurements all displayed similar results: a) Quant-iT™ PicoGreen® dsDNA Assay 
Kit, b) EnzChek® Protease/Peptidase assay Kit, c) FluoReporter® Biotin Quantitation 
Assay Kit and d) EnzChek® Ultra Amylase Assay Kit. 
100 μg/ml 10 μg/ml 1 μg/ml 100 ng/ml 1 ng/ml10 ng/ml
10 mg/ml 1 mg/ml 100 μg/ml 10 μg/ml 100 ng/ml1 μg/ml
10 mg/ml 1 mg/ml 100 μg/ml 10 μg/ml 100 ng/ml1 μg/ml
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fluorescence. This may indicate that the static self-quenching processes 
of the DQ™ starch substrate are not as effective as those employed 
within other fluorescence transduction mechanisms, leaving a number of 
labelled BODIPY dye molecules that have not undergone homodimeric 
pairing. This high background may potentially inhibit the ability of static-
quenching-based sensing mechanisms to visualise areas of fluid staining.  
Despite the success of other commercial assays, the Quant-iT™ 
PicoGreen® dsDNA assay kit failed to generate adequate in situ results, 
with wet and dry depositions under a concentration of 100 µg/ml 
remaining difficult to distinguish from reagent-only negative controls. The 
reason for this poor performance is unclear, but may have resulted from 
the immiscibility of the reagent and analyte deposits. Whilst the exact 
formulation of assay reagent has not been disclosed by the 
manufacturers, separation from all aqueous DNA samples was observed 
upon sensor addition. Such separations are likely to lead to a reduction in 
overall fluorescence emission signals by restricting interaction of sensing 
molecules with target analytes. As these effects are likely to have a 
negative impact on in situ fluid analysis, this sensor was excluded from 
further surface testing. 
2.4.3 Surface Microscopy 
The ‘green’ channel of the histogram tool in Adobe Photoshop™ image 
software was used to assign a value of fluorescence to each of the 
analyte samples deposited on prepared surfaces. This was performed to 
augment observations of emissions made by visual inspection and assign 
a semi-quantitative value of signal strength for the purpose of data 
comparison. Since emission wavelengths of all assays tested within this 
study are produced in the ‘green’ region of the visible spectrum, it may be 
assumed that these assigned values directly correlate to a measure of 
fluorescence intensity.  
Whilst this approach has already found acceptance in the scientific 
community for the quantitative analysis of fluorescence emissions in
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Figure 13: Percentage fluorescence increase from reagent-only negative controls of 
commercial assays upon in situ application to analytes on ten forensically relevant 
surfaces; a) EnzChek® Protease/Peptidase Assay Kit, b) FluoReporter® Biotin 
Quantitation Assay Kit, c) EnzChek® Ultra Amylase Assay Kit. Data represents the 
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digital images [159], an independent assessment of method validity was 
conducted by depositing serial dilutions of Alexa 488 fluorescent dye onto 
glass slides. Intensity values given for recorded images were then plotted 
in a calibration curve against fluorophore concentration, which confirmed 
technique linearity (results not shown).  
Despite established validity, it must be noted that there are several 
limitations to this method. Whilst reagent and analyte sample volumes 
remained consistent throughout testing, analyte deposits areas are rarely 
identical in shape or size. Consequently, the number of pixels chosen to 
provide average intensity values will be different for each measurement. 
Furthermore, assay emissions may only be recorded by internal CCD 
camera up to a maximum light intensity threshold. Samples exhibiting 
fluorescence above this level will saturate images and will be designated 
a maximum software intensity value of 255, which will be lower than the 
actual intenisty. However, such saturation occurred only once during 
testing, resulting in EnzChek® Ultra Amylase assay performance on 
wood being excluded from plotted results. 
Both the EnzChek® Ultra Amylase and EnzChek® Protease/Peptidase 
assays were able to detect analyte depositions across all surfaces without 
the need for any further magnification or exposure enhancements (Figure 
13). These assays both demonstrated high transduction efficiency, 
utilising the ability of enzymes to interact with multiple substrate 
molecules, thereby resulting in an amplification of fluorescence signals. 
Such effects consequently make enzymatic-based signal transduction 
mechanisms an attractive option for biological fluid sensing.  
Despite exhibiting the greatest sensitivity during slide testing, the 
FluoReporter® Biotin Quantitation assay kit failed to detect analyte 
deposits on porous surfaces. Absorption of the reagent into these 
surfaces resulted in the physical screening of fluorescence, preventing 
emission observation. Enhancements in microscopy magnification and 
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exposure allowed further detection of analytes deposited on card and 
denim but still failed to generate results for cotton, felt, paper and wool. 
It should also be noted that no fluorescence emission increases were 
observed from reagent-only negative control samples across all surfaces 
upon the addition of assay reagent. Such results are likely to indicate the 
resistance of sensors to cross-reaction with substances endogenous to 
forensic sampling environments. 
2.4.4 DNA profiling 
With previous studies establishing a reduced recovery of high molecular 
weight STR loci (amplicons that are less likely to undergo successful PCR 
as a result of DNA degradation) from fluids after some presumptive test 
applications [37, 42], investigations were undertaken to examine the 
effects of the fluorescent sensing mechanisms explored in this study on 
DNA profiling. Such effects may potentially include a reduction in the 
amount of DNA able to be quantified and/or amplified (which in turn would 
lead to a decreased number of alleles detected during CE) as a result of 
sensor-induced PCR inhibition or DNA degradation. 
Each of the three commercial reagents used for surface testing were 
applied to a volume of human blood before DNA was extracted, 
quantified, amplified and profiled using protocols and techniques standard 
to most forensic laboratories. Comparisons were then made to a blood 
reference standard (both in terms of DNA quantification values and 
electropherogram allele numbers/peak heights), in which distilled water 
was added in place of assay reagent. 
No differences between sensor-added and reference samples outside the 
limits of normal experimental variation were observed at any stage of the 
DNA profiling process. DNA extracted from samples containing 
EnzChek® Protease/Peptidase Assay Kit, FluoReporter® Biotin 
Quantitation Assay Kit and EnzChek® Ultra Amylase Assay Kit reagents 
was quantified at 2.09, 2.71 and 5.04 ng/µl respectively, whilst the blood 
reference sample was found to contain DNA at a concentration of 3.23 
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ng/µl. Furthermore, full STR profiles were obtained from all samples, with 
no detrimental effects on high molecular weight loci (Figure 14). 
Figure 14: STR profiles generated from blood samples after biosensor application: a) 
EnzChek® Protease/Peptidase Assay Kit, b) FluoReporter® Biotin Quantitation Assay 
Kit and c) EnzChek® Ultra Amylase Assay Kit. All alleles were observed at each locus 
compared to a blood reference profile, with relative peak heights also consistent 
between samples. 
2.5 Conclusion 
In this study, the fluorescent signal transduction mechanisms of four 
commercial biosensing assays were investigated for their adaptability 
towards the in situ detection and identification of biological fluids. Such 
sensing mechanisms may potentially provide a number of advantages 
over current presumptive fluid testing methods, such as increased 
specificity and a compatibility with downstream DNA profiling processes.  
Three out of the four assays tested were successfully able to detect a 
range of wet and dry analytes deposited in different concentrations on 
glass slides, each exhibiting ideal increases in fluorescence emission 
upon target interaction. Two sensors (the EnzChek® Protease/Peptidase 
Assay Kit and EnzChek® Ultra Amylase Assay Kit) were further able to 
visualise analytes present on a number of surfaces likely to be found at 
crime scenes. With the transduction mechanisms of both of these sensors 




Page | 55  
decided that subsequent efforts in the development of novel fluid analysis 
methods should first focus on the sensing of intra-fluidic enzyme targets. 
Importantly, all sensing mechanisms demonstrating in situ detection 
ability were found to have no effect on downstream DNA profiling 
processes after application to human blood, thereby allowing the potential 
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3.1 Introduction 
The two signal transduction mechanisms displaying greatest in situ 
performance during biosensor feasibility tests (Chapter 2) both relied 
upon the hydrolysis of substrates by enzyme activity. Fluorescence 
transduction based on the selective recognition of enzymes present in 
bodily tissues is therefore likely to have great potential for use in the 
development of biosensors for the forensic analysis of biological fluids 
(although approaches based on static quenching are likely to be less 
promising, due to the background signals associated with assay 
reagents). 
Although intramolecular signalling via FRET was found to be the most 
effective method of detecting singular surface-deposited analytes, it may 
be challenging to combine several sensors based on this mechanism 
within a single multiplex fluid-biosensing reagent. Assays employing more 
than one donor-acceptor pair for the analysis of multiple targets within the 
same sample are often subject to spectral ‘crosstalk’, in which an overlap 
in the emission wavelengths of commonly utilised fluorophores results in 
erroneous signal reporting [160].  
A solution to this problem may involve the use of fluorogenic peptide 
substrates, amino acid chains singly-labelled with specific fluorescent 
molecules that are quenched as part of the conjugation process itself. A 
range of these molecules, known as ‘pro-fluorophores’, have been 
produced with emission wavelengths in many areas of the visible spectra 
and have found wide employment as assays for the measurement of 
protease activity in biological samples [161]. 
As each body fluid contains a set of unique protease enzymes (produced 
in order to fulfil an individual physiological function [162]), fluorogenic 
substrates may be considered ideal candidates for use as fluid-specific 
biosensors. Such substrates are often noted for their high target 
sensitivities, being able to detect proteases at extremely low 
concentrations within complex biological matrices [163]. The ‘turn-on’ 
Page | 58  
increase in emission intensity exhibited by substrates upon enzymatic 
digestion is also likely to allow the visualisation of in situ body fluid 
deposits. Furthermore, unlike irreversible antibody-analyte binding 
interactions, enzymes may react with multiple sensing substrates in 
succession, resulting in a cumulative amplification of fluorescence signal 
[164].  
This chapter first provides a brief overview of the specific biochemical 
pathways behind fluorogenic substrate transduction as well as those 
substrates previously reported for the sensing of various protease 
enzymes. The application of several commercially available substrates 
specific to the intra-fluidic proteases prostate specific antigen (PSA), 
kallikrein 8 (KLK8) and thrombin towards the detection of deposited 
semen, saliva and blood respectively, is then investigated. Attempts to 
improve upon these assays are then made through the construction of 
custom substrates using a novel solid-phase peptide synthesis (SPPS) 
route.  
This chapter contains both published research articles and unpublished 
work. An introduction to each published manuscript is given explaining 
the contributions of each listed author. Supplementary material is also 
provided where available. 
3.2 Review of Fluorogenic Substrates 
3.2.1 Transduction Mechanism 
The capacity of enzymes to distinguish between different molecules is 
integral to the maintenance of cellular function. Whilst this selectivity is 
regulated by a range of factors, such as the spatial and temporal location 
of enzymes (as well as their concentration), protease activity is mainly 
controlled by the recognition of specific amino acid sequences [165]. In 
order to study this activity, a wide range of synthetic metabolic substrates 
have been produced that are able to generate measurable signals, such 
as a change in absorbance or fluorescence, as a result of protease 
interaction [166]. 
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Fluorogenic substrate production relies on the attachment of a pro-
fluorophore at the C-terminus of a specific peptide chain. Such chains are 
usually based on the amino acid structure of protein cleavage sites, areas 
that proteolytic enzymes are able to recognise and bind in order to 
catalyse the hydrolytic cleavage of peptide bonds [167]. In synthetically 
produced substrates, this cleavage occurs in the bond between the pro-
fluorophore and the P1-position amino acid of the peptide. 
Table 7: A list of pro-fluorophores commonly used within fluorogenic substrate assays. 
Fluorophore Abbreviation Ex/Em λ (nm) Type Ref. 
β-naphthylamine βNA 330/415 Naphthylamine [168] 
4-methoxy-β-naphthylamine 4MβNA 340/430 Naphthylamine [169] 
7-amino-4-methylcoumarin AMC 339/439 Coumarin [170] 
4-methylumbelliferyl 4MU 386/448 Coumarin [171] 
7-amino-4-carbamoylmethylcoumarin AAC 350/450 Coumarin [165] 
7-amino-4-chloromethylcoumarin CMAC 353/466 Coumarin [172] 
7-amino-4-trifluoromethylcoumarin AFC 380/500 Coumarin [173] 
Fluorescein - 490/514 Xanthene [174] 
Rhodamine-110 Rh-110 498/520 Xanthene [175] 
Resorufin - 571/585 Phenoxazinone [176] 
Cresyl violet CV 601/632 Oxazine [177] 
 
The pro-fluorophores used within these substrates are typically 
phenoxazinone, coumarin or xanthene-based compounds [178]. Whilst 
highly fluorescent at specific wavelengths within a free state, conjugation 
of either coumarin or phenoxazinone derivatives to peptides results in the 
blue-shifting of fluorophore absorbance and emission via intramolecular 
charge transfer (ICT) processes [179]. Consequently, fluorescence at the 
emission wavelengths of the free molecules is suppressed, quenching the 
entire system [179].  
Conversely, xanthene-based fluorophores, such as Rhodamine-110 or 
fluorescein, are quenched via the internal conversion of molecular 
structure upon peptide attachment. This conversion, which generally 
involves the transition of the fluorophores to colour-less lactone forms, 
results in the disruption of conjugated systems responsible for 
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fluorescence [180]. A full list of pro-fluorophores commonly used in the 
production of fluorogenic substrates may be found in Table 7. 
Figure 15: A short peptide chain terminally labelled with a fluorescent moiety, creating 
a non-fluorescent substrate system. Resulting protease activity separates the 
fluorophore and relieves quenching effects. 
Positive ‘turn-on’ emission signals from fluorogenic peptide substrates 
therefore arise from the liberation of pro-fluorophore leaving groups from 
peptides as a result of protease digestion (Figure 15). This separation 
causes the fluorophores to revert to their original highly-fluorescent forms, 
allowing protease activity to be directly observed in real-time. 
3.2.2 Previously Reported Fluorogenic Substrates 
An extensive range of fluorogenic peptide substrates have been 
developed over the last several decades for the detection of many 
different proteolytic enzymes. These substrates are prominently 
employed (in both in vitro and in vivo settings) to investigate the role of 
specific proteases in the progression of human disease states, such as 
cancer, cystic fibrosis and chronic obstructive pulmonary disease [178, 
181].  
Other substrate applications include the identification and enumeration of 
microorganisms within microbial communities based on the detection of 
distinct metabolic enzyme activities [166]. A selection of fluorogenic 
peptide substrates that have been previously reported in literature is 
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Table 8: Fluorogenic substrates previously developed for protease activity detection. 
Target Substrate Leaving Group Ref. 
Aminopeptidase Leu-AMC AMC [182] 
DPPIV [Ala-Pro]2-CV CV [177] 
Caspase 1 & 5 Ac-Trp-Glu-His-Asp-AMC AMC [183] 
Caspase 2 Ac-Val-Asp-Val-Ala-Asp-AFC AFC [184] 
Caspase 3 & 7 Ac-Asp-Glu-Val-Asp-Rh-110-MC Rh-110 [185] 
Cathepsin B Z-Phe-Arg-AMC AMC [186] 
Cathepsin D Bz-Arg-Gly-Phe-Phe-Pro-4MβNA 4MβNA [187] 
Cathepsin K Z-Leu-Arg-AMC AMC [188] 
Chymotrypsin Suc-Ala-Ala-Pro-Phe-AMC AMC [189] 
Elastase MeO-Suc-Ala-Ala-Pro-Val-AFC AFC [190] 
Factor Xa Boc-Ile-Glu-Gly-Arg-AMC AMC [191] 
Kallikrein 4, 5, 8, 13 &14 Boc-Val-Pro-Arg-AMC AMC [191] 
Plasmin Suc-Ala-Phe-Lys-AMC AMC [192] 
PSA Mu-His-Ser-Ser-Lys-Leu-Gln-AFC AFC [193] 
Thrombin Bz-Phe-Val-Arg-AMC AMC [194] 
Trypsin [Z-Arg]2-Rh-110 Rh-110 [175] 
 
3.3 Published Article 1: ‘Application of Fluorescent Substrates 
to the in situ Detection of Prostate Specific Antigen’ 
The content of following section was published as an original research 
article in: Gooch, J., Daniel, B. and Frascione, N. Application of 
fluorescent substrates to the in situ detection of prostate specific 
antigen. Talanta, 2014. 125: p. 210-214. 
All experimental work was performed by the candidate, who also drafted 
the initial manuscript. Dr. Barbara Daniel and Dr. Nunzianda Frascione 
provided supervisory and technical support throughout the research and 
had final approval over manuscript submission. 
3.3.1 Manuscript 
Authors: James Gooch,a Barbara Daniel,a and Nunzianda Frascione.a* 
Authors Address: a) Department of Forensic and Analytical Science, 
King’s College London, Franklin-Wilkins Building, 150 Stamford Street, 
London SE1 9NH, UK. 
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Abstract: The forensic identification of body fluids frequently presents an 
important source of genetic material and investigative interpretation. 
However, presumptive testing techniques presently employed in the 
discrimination of biological fluids are subject to criticism for poor 
specificity, lack of fluid localisation ability and detrimental effects on DNA 
recovery rates. The recognition of fluid-specific biomarkers by fluorogenic 
substrates may provide a novel resolution to these issues but research 
has yet to establish any pertinent in situ fluid detection applicability. This 
study therefore utilises a fluorogenic substrate (Mu-HSSKLQ-AFC) 
specific to the seminal protein prostate specific antigen in an effort to 
detect human semen deposited on a number of surfaces typical to 
criminal investigation. The ability of fluorescent fluorogenic substrates to 
simultaneously identify and visualise biological fluids in situ is 
demonstrated for the first time, whilst the production of complete STR 
profiles from fluid sources is also confirmed to be completely unaffected 
by substrate application. 
Introduction 
Locating and identifying body fluids such as semen, blood and saliva can 
often aid the progression of criminal investigation by providing intelligence 
on the nature and circumstance of an offence and may additionally 
associate or exonerate a suspect through the isolation of genetic 
material. 
A number of ‘presumptive’ screening assays exist to rapidly exclude or 
indicate fluid presence, employing simple biochemical processes in order 
to generate colorimetric changes within a given substrate. Those 
indicating the presence of blood rely on the oxidation of haem to catalyse 
substrate-specific reactions [5, 14, 195] whilst intra-fluidic enzyme activity 
provides the basis for the testing of semen and saliva [27, 196]. However, 
previous validation studies have established limitations in the usefulness 
and evidential strength of these assays. With the exception of the 
chemiluminescence phenomenon exploited in the detection of blood by 
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Luminol, presumptive tests cannot be used to localise fluid depositions, 
thereby necessitating time-consuming visual searches prior to analysis. 
Furthermore, the molecular targets examined by these tests are not fluid-
specific, often leading to false positives between different fluid types and 
other non-fluid substances [197-199]. Detrimental effects on the recovery 
of DNA from fluid depositions have also been demonstrated after some 
presumptive test applications [30, 37]. 
Currently the most widely used presumptive test for semen identification 
is the Brentamine assay for the detection of acid phosphatase, an 
enzyme secreted into semen by the prostate gland [196]. However, the 
requirement of specialist knowledge and equipment often makes this test 
problematic. Results are subject to a high level of expert interpretation 
[200-202], whilst Brentamine toxicity also necessitates use of a fume 
hood. 
Recent improvements in fluid assay specificity have utilised 
immunological testing strips for the detection of fluid-endogenous protein 
biomarkers [203-205]. However, these testing processes do not allow for 
the retention of fluids following application, potentially sacrificing a 
valuable source of material for genetic profiling [117]. 
Our research group has made initial efforts in the design of novel body 
fluid analysis techniques, developing a fluorescent biosensor complex 
specific to Glycophorin A, an erythrocyte membrane protein used in the 
identification of human blood [134]. However, whilst demonstrating 
effective glycophorin detection via decreases in fluorescence intensity, 
the ‘turn-off’ nature of signalling restricts the use of this sensor in 
visualising discrete fluid deposits in situ. A ‘turn-on’ fluorescence based 
assay is therefore preferable for simultaneous identification and 
localisation purposes. 
The proteolytic digestion of peptide substrates to release fluorescent by-
products within the same molecular unit may be considered an attractive 
signalling mechanism for in situ fluid detection. High specificities make 
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enzyme recognition elements ideal candidates for fluid analysis, whilst 
‘turn-on’ increases in fluorescence intensity upon target interaction may 
allow the visualisation of in situ fluid depositions. Furthermore, unlike 
irreversible antibody-based reactions, enzyme targets may interact with 
multiple substrate molecules to amplify signal production. Simultaneous 
detection of multiple fluid enzymes may also potentially be achieved by 
exploiting fluorophores of differing wavelengths in a single multiplex 
assay. 
A central appeal of fluorogenic substrates as an alternative to current 
presumptive assays is that DNA-degrading oxidative processes, such as 
those exploited by Luminol and Leucomalachite green, are not required to 
generate a positive response [197]. With research yet to explore the 
effect of substrates on genetic material, investigation into the possible 
interference of reagents with DNA amplification, quantitation or profiling 
may be considered pertinent. 
This study therefore explores the use of fluorogenic peptide substrates 
specific to prostate specific antigen (PSA) for the simultaneous 
visualisation and identification of human seminal fluid. PSA is a semen-
endogenous protein responsible for proteolysis of gel-forming 
Semenogelin 1 and 2 [206]. The unique expression level of PSA within 
seminal fluid, often produced in milligram levels per millilitre [206], has 
established its wide acceptance as a forensic biomarker for semen 
identification. 
Denmeade et al. [193] produced 12 peptide substrates for monitoring 
PSA activity based on amino acid sequences directly adjacent to mapped 
PSA cleavage sites of Semenogelin 1 and 2. These substrates utilise 7-
amino-4-methylcoumarin fluorophores, which after amide bond 
conjugation to peptides undergo excitation and emission wavelength 
shifts, restricting fluorescence output. Subsequent separation of the 
fluorophore from the peptide by serine protease hydrolysis occurs in the 
presence of PSA and restores fluorescence. 
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The particular substrate MU-HSSKLQ-AFC (Figure 16) displayed the 
highest specificity for PSA, arising from its resistance to similar proteolytic 
enzymes found within body fluids. Whilst this substrate has found routine 
use in the recognition of prostate cancer markers, it has yet to be applied 
towards the detection of human semen. 
Figure 16: PSA fluorogenic substrate - a hexapeptide consisting of amino acid 
sequence HSSKLQ, terminally labelled with a fluorescent coumarin derivative. Specific 
digestion of the peptide by PSA yields fluorescent 7-amino-4-trifluoromethyllcoumarin. 
The fluorescence response of substrate MU-HSSKLQ-AFC to dilutions of 
semen within solution, as well as to whole semen extracted from in situ 
swabs, was measured via spectrofluorometry to determine the ability of 
the fluorogenic substrate to detect free PSA within seminal fluid. Further 
in situ detection ability was examined, testing substrate performance 
against semen deposits on glass slides and a number of surfaces 
typically encountered within forensic casework. Assay reagent was also 
applied to depositions of blood, saliva and urine to confirm substrate 
specificity. MU-HSSKLQ-AFC was lastly applied to semen samples for 
subsequent SGM plus profiling to assess reagent effect on each stage of 
the profiling process. 
Materials and Methods 
Reagents 
Fluorogenic PSA Substrate 
Lyophilised Prostate Specific Antigen Fluorogenic Substrate (Mu-
HSSKLQ-AFC) was purchased from EMD Millipore (Massachusetts, 
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USA) and dissolved in 109.5 μl DMSO to make an 8 mM stock solution 
before dilution in PBS to a working concentration of 400 μM. 
Body Fluid Collection and Storage 
Blood, semen, saliva and urine samples were taken after informed 
consent. Blood samples were drawn by venipuncture and stored in a BD 
Vacutainer® Plus tube (Oxford, UK) containing 3.2% sodium citrate 
coagulation preservative. All tissue samples were stored at 4 °C until 
analysis. 
Instrumentation and Procedures 
Spectrofluorometry 
Fluorescence measurements were conducted on a BioTek Synergy HT 
spectrophotometer (Vermont, USA). Dilution curves were constructed 
through the addition of 100 μl of diluted semen (1:1, 1:2, 1:4, 1:8, 1:16, 
1:32, 1:64) in a 96-well microplate to 100 μl of 400 μM PSA fluorogenic 
substrate and measured with appropriate blank (200 μl PBS) and 
negative controls (100 μl PBS, 100 μl assay reagent). Swabs taken from 
in situ semen depositions were extracted in 100 μl of PBS and added to 
100 μl of working concentration substrate. All fluorescence emissions 
were recorded at room temperature in duplicate using Ex400/Em528±20 
nm wavelengths (for the measurement of emissions at 508 nm) 
immediately after mixing. 
Slide Microscopy 
Fluorogenic PSA reagent was tested against seminal dilutions (1:25, 
1:50, 1:100, 1:200, 1:500, 1:1000) deposited on glass slides as a 
demonstration of in situ substrate sensitivity. Semen volumes of 10 μl 
were applied to the centre of each slide before the direct 10 μl addition of 
substrate. Duplicates of each dilution were performed. Negative reagent-
only controls were applied on the same slide as a measure of background 
reagent fluorescence, whilst blank controls consisting of semen-only 
applications were also used to monitor possible analyte auto-
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fluorescence. The simulation of dry depositions was achieved through the 
application of 10 μl of seminal fluid to glass slides, which were 
subsequently allowed to dry overnight. Reagent was then applied directly 
at the point of analysis. 
Images were taken in the dark immediately after application on an 
Olympus SZX12 fluorescence microscope (Tokyo, Japan) and internal 
CCD camera. BV filtration (Ex 400-440 nm) was used for substrate 
excitation, whilst all additional microscopy parameters were kept constant 
(hue = 359, saturation = 255, white balance = 64, contrast = 0, brightness 
= 1023, gamma = 10, magnification = ×8.5) in order to restrict result 
variation. 
Investigations into substrate specificity were also undertaken with 
application to depositions of whole blood, urine and saliva on slides in 
order to exclude the possibility of inter-fluidic cross-reaction. 
Surface Microscopy 
Eight different surfaces consisting of cotton, denim, felt, leather, paper, 
plastic, polyester and wood were chosen to reflect materials on which 
body fluids are commonly deposited within criminal investigations. All 
surfaces were cut to fit the size of a microscope slide. In a similar manner 
as commercial assay testing, 10 μl depositions of human semen were 
applied to the surfaces and allowed to dry overnight. PSA substrate was 
applied directly to depositions in 10 μl volumes with the same negative 
and blank controls previously described. 
Images were once again recorded on an Olympus SZX12 fluorescence 
microscope utilising BV filtration (Ex 400-440 nm). All measurements 
were performed in duplicate. 
200 μl of working concentration substrate was lastly dispersed directly 
over a semen deposition on leather using a common atomising spray 
bottle to reflect ideal future application methods. 
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DNA Profiling 
50 μl of PSA substrate at working concentration was added to 150 μl of 
human semen to observe effects on DNA recovery after application. DNA 
was extracted using the QIAmp® DNA Mini kit (Qiagen, Manchester, UK) 
according to the supplied protocol and quantified with the Quant-iT™ 
PicoGreen® dsDNA Assay Kit (Invitrogen, Paisley, UK). Samples were 
diluted to 0.1 ng/μl prior to amplification with the AmpFlSTR® SGM Plus® 
PCR Amplification Kit (Applied Biosystems, Paisley, UK) using a Perkin-
Elmer 9700 thermal cycler (Cambridge, UK). STR amplicons were 
resolved on an ABI3130 genetic analyser and evaluated using 
GeneMapper® software. Generated profiles were compared to a semen 
reference profile to examine potential inhibition. 
Results and Discussion 
Spectrofluorometry 
Whilst regularly demonstrating detection of purified PSA protein within 
solution [193, 207] this fluorogenic substrate has never been used to 
target the native PSA contained within seminal fluid. The potential for 
reagent inhibition or physical fluorescence screening by other 
biomolecules present in a complex matrix makes it pertinent to investigate 
whether a positive signal can be generated from whole semen. 
Appropriate fluorescence intensity changes to varying dilutions of seminal 
fluid were observed through spectrofluorometry. Constructed calibration 
curves were found to be consistent with those demonstrated by Niemelä 
et al. [207] for the detection of PSA within solution and established a 
quantitative linear relationship between semen concentration and 
substrate fluorescence (Figure 17).  
A commonplace practice within forensic investigation is to swab potential 
fluid depositions that require analysis at a later point. It is consequently 
vital that substrates react to material extracted from these swabs in the 
same manner as whole fluid. Swabs were therefore taken of semen 
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deposited on a leather surface prior to extraction in PBS via brief 
vortexing. The collected material was analysed using the same procedure 
as whole fluid and did not display any differentiation in fluorescence 
response from its neat fluid counterpart (results not shown). 
Figure 17: Dilution curve demonstrating the relationship between seminal 
concentration and fluorogenic PSA substrate emission. 
Slide Microscopy 
The main benefit of many presumptive tests is their ability to be 
performed at the point of fluid discovery. It is important that substrate 
reagents designed to detect biological fluids may do so in situ with only 
basic instrumental assistance for fluorescence observation, such as a 
portable alternative light source. Human semen was deposited on to 
glass slides prior to the direct application of PSA substrate. Any changes 
in fluorescence intensity were observed using standard fluorescence 
microscopy. Positive substrate reactions successfully identified all semen 
depositions, even at sensitive 1:1000 dilutions (Figure 18). Similar results 
were obtained using simulated dry depositions. Fluorescence emissions 
occurred immediately upon substrate application, promising potential for 
rapid fluid screening without extended incubation times. Background 
reagent fluorescence was not observed at any point during negative 
control testing, allowing for the visualisation of discrete fluid areas. 
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Figure 18: Demonstration of in situ substrate testing of seminal depositions upon glass 
slides across a range of six dilutions. Duplicate measurements were taken and also 
displayed expected results 
Additional studies of inter-fluidic substrate specificity were also 
undertaken with reagent applied to wet and dry depositions of whole 
blood, saliva and urine. In all cases, the PSA substrate did not generate a 
positive reaction, thereby demonstrating both high semen specificity, as 
well as resistance to proteases that may be present within other body 
fluids (results not shown). 
Surface Microscopy 
The successful detection of semen by this substrate clearly confirms the 
high performance of fluorogenic substrates in the simultaneous 
identification and localisation of biological fluids in situ. Nevertheless, 
clean glass slides are not representative of surfaces encountered within 
forensic casework. Surfaces on which fluids are typically deposited may 
potentially prevent the success of fluorescent substrates via absorption, 
movement restriction and physical screening effects. Furthermore, 
surfaces may contain a number of unknown substances that could inhibit 
substrate–target interaction. Fluorogenic PSA substrate was therefore 
applied, utilising the same slide testing procedure, to dry semen 
depositions on eight surfaces relevant to criminal investigation. 
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Figure 19: Successful detection of human semen across eight forensically relevant 
surfaces by fluorogenic PSA substrate. Reagent-only negative controls are provided on 
the left side of each image 
Despite the difficult nature of surface testing, positive results were 
generated on each of the eight surfaces, identifying and visualising all 
semen deposits (Figure 19). Once again, substrate-only negative 
controls did not exhibit any observable fluorescence upon application. 
Furthermore, surface material had little effect on the ability of the 
substrate to generate positive results, with no assay interference 
occurring during testing. 
The direct spray dispersal of reagent over a large evidential surface may 
be considered the most efficient process of localising fluid deposits. 200 
μl of substrate was applied to seminal depositions on leather using a 
common 1 ml atomising spray bottle in order to examine the viability of 
this method. Positive substrate emissions easily localised all semen 
depositions, elucidating discrete staining areas and confirming the validity 
of this technique (results not shown). 
DNA Profiling 
Validation studies by Tobe et al. [37] have previously demonstrated a 
significantly reduced recovery of high molecular weight STR loci from 
biological fluids after some presumptive testing applications. Furthermore, 
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the physical application process of the seminal acid phosphatase test has 
been shown to limit the amount of spermatozoa, and thus DNA, available 
for genetic profiling [202]. 
PSA substrate was applied to semen samples, which underwent 
extraction, quantification, amplification and profiling according to standard 
forensic protocols to examine the effects of assay application on the 
recovery of genetic material from biological fluids. Comparisons were 
then made to reagent-less semen standard (Figure 20). 
Figure 20: Genetic profiles generated from: a) semen reference profile and b) semen 
sample with applied PSA substrate. Profiles display no significant differences. 
Successful genetic recovery from substrate-applied semen was 
established by Picogreen quantification, with an average concentration of 
8.99 ng/μl DNA per sample extraction falling within expected values. 
Furthermore, full STR profiles were obtained from all assay applications, 
with no detrimental effects on high molecular weight loci. Differentiation of 
reagent-applied samples from their reference profiles was not observed at 
any stage of the profiling process outside the limits of normal 
experimental variation 
Conclusion 
This study successfully demonstrates for the first time the ability of 
fluorescent substrates to identify biological fluid depositions in situ. 
Human semen was detected across a range of surfaces typical to 
forensic investigation with additional visualisation via a direct spraying 
application. 
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This particular substrate exhibited ideal increases in fluorescence 
intensity upon target interaction, even at sensitive 1:1000 seminal 
dilutions, giving opportunity for its use in contaminated fluid depositions or 
those washed in removal attempts. 
Importantly, substrates were found to have no effect on DNA profiling 
processes after application to biological fluids and thereby negate the 
potential forfeit of fluid identification in order to maximise genetic material 
recovery. 
An ideal application of fluid-specific substrates would likely exploit a 
number of different peptide sequences, each with separate emission 
wavelengths for simultaneous enzyme detection within several fluid types 
in a multiplex sensing system. 
Displaying both an immediate and specific response to analyte presence, 
fluorogenic substrates have the potential to prevent month-long visual 
evidence searches by localising fluid depositions within a matter of 
seconds. Serious thought should therefore be given to the development 
of fluorogenic substrates as replacements to current presumptive testing 
techniques. 
3.4 Published Article 2: ‘Solid-phase Synthesis of Rhodamine-
110 Fluorogenic Substrates and their Application in Forensic 
Analysis’ 
The content of following section was published as an original research 
communication in:   
Gooch, J., et al., Solid-phase synthesis of Rhodamine-110 
fluorogenic substrates and their application in forensic analysis. 
Analyst, 2016. 141(8): p. 2392-2395. 
All experimental work was performed by the candidate, who also drafted 
the initial manuscript. Help with peptide synthesis, as well as access to 
the Institute of Pharmaceutical Science research laboratories and high-
performance liquid chromatography (HPLC) and mass spectrometry 
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instruments, was provided Dr. Vincenzo Abbate. Dr. Barbara Daniel and 
Dr. Nunzianda Frascione provided supervisory and technical support 
throughout the research and had final approval over manuscript 
submission. 
3.4.1 Manuscript 
Authors: James Gooch,a Vincenzo Abbate,b Barbara Daniela and 
Nunzianda Frascione.a* 
Authors Address: a) Analytical & Environmental Sciences Division, 
King’s College London, 150 Stamford Street, Waterloo, SE19NH, 
London, b) Institute of Pharmaceutical Science, King’s College London, 
150 Stamford Street, Waterloo, SE19NH, London. 
Abstract: A novel synthetic route for the rapid and efficient preparation of 
fluorogenic substrates utilising Rhodamine-110 or similar fluorophores is 
reported. Applicability of the synthesized peptide substrate within a 
forensic casework context is also presented. 
Last year, over 10,000 exhibits were submitted to the Evidence Recovery 
Unit (ERU) of the Metropolitan Police Service. Body fluid stains such as 
blood, semen and saliva are often the most important forms of biological 
evidence encountered in forensic casework. Determining the identity of 
such deposits can be used to further a criminal investigation as it may 
provide information on both the nature of the offence and the genetic 
origin of the fluid (through DNA profiling) [3]. Consequently, over 90% of 
these submitted exhibits required examination for the presence of 
biological fluids.  
However, with meticulous visual examination by trained personnel being 
the most common method of detection, determining the presence and 
location of any fluid deposits may be very challenging, especially with 
small, or latent traces on dark backgrounds which may be easily 
overlooked [3]. Long wave UV or violet light sources may aid detection by 
exploiting the auto-fluorescent properties of some intra-fluidic molecules 
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but their use is restricted to a select number of surface types [36]. The 
colorimetric presumptive assays used in order to identify the type of fluid 
present are also considered by many in the forensic community to be 
limited by issues of specificity [208], safety [209] and their detrimental 
effects on DNA recovery [37]. Developing a fast, dependable and specific 
method of fluid detection would save time and money.  Biosensors that 
simultaneously detect and identify body fluids could represent a cost and 
time efficient alternative to present day techniques. The development of 
fluorogenic peptide substrates specific to each body fluid type could 
improve body fluid search efficiency through the identification of fluid-
specific proteases in situ via fluorescence emission [131, 210].  
Rhodamine-110 (Rh-110) is a xanthene-based fluorescent dye containing 
two aromatic amine moieties, the symmetric or asymmetric modification 
of which may shift the existing equilibrium of the molecule from a highly 
fluorescent quinoid towards a colourless lactone formation, quenching 
fluorescence emission [180]. This has cemented Rhodamine-110 as a 
popular pro-fluorophore for use within many protease substrates via the 
direct attachment of specific amino acid chains (with a positive 
fluorescence signal achieved via the proteolytic separation of peptide and 
fluorophore in the presence of a target enzyme) [180]. The physical and 
spectral characteristics of Rh-110 are considered highly desirable for 
biological fluid detection, as they display a high quantum yield and are 
relatively pH insensitive. Moreover, Rh-110 based substrates exhibit an 
almost non-existent emission upon peptide conjugation, preventing 
background fluorescence and ensuring high enzymatic assay sensitivities 
[180].  
However, all reported symmetric and asymmetrically labelled Rh-110 
peptide substrates have so far been synthesized through solution 
chemistry, a task that is made problematic due to the poor nucleophilicty 
of the Rh-110 aromatic amines [211], and often leads to inefficient 
peptide-fluorophore acylations. Final product yields are inevitably very 
low, as each intermediate must undergo substantial purification [185]. 
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This makes the cost of Rh-110-based substrates high and since the aim 
of the research is to produce a spray that could be used directly on 
forensic evidence, this cost would be unacceptable.  
Figure 21: Schematic of Rh-110 PSA substrate development: a) 2-ct resin (0.27 
mmol), DCM, DIPEA, 24 hrs, b) MeOH, 10 min, c) Fmoc-Gln(Trt)-OH (3 mmol), 
DMF/pyridine, EDC (2.5 mmol), 24 hrs, ×2, d) 20% piperidine/DMF, 30 min, e) 6 × AA, 
oxyma, DIPCDI, DMF, 1 hr, f) 10 × (CH3CO)2O, DIPEA, DMF, 1 hr, g) AcOH : TFE : 
DCM, 1 hr, h) CH3COCl, DIPEA, DMF, 48 hrs, i) TFA : TIPS : TA : phenol 
We surmised that preparing large quantities of peptide substrates in a 
rapid and efficient manner could be achieved via the direct attachment of 
Rh-110 to a solid support. In this procedure (Figure 21), it is envisioned 
that one of the aromatic amine groups of Rh-110 may be anchored to a 
functionalized solid support, keeping the remaining amine group available 
for the subsequent stepwise incorporation of amino acids by standard 
Fmoc-SPPS. This route offers advantages over typical solution-phase 
conjugation techniques by allowing the incubation of fluorophores with 
large molar excesses of any desired amino acid residue, which may be 
removed without extensive liquid-liquid extraction and chromatographic 
purification steps, thereby increasing overall product yield. Instead, 
excess amino acids, coupling reagents and other by-products may be 
removed by simple resin wash and filtration processes. Therefore, a 
fluorogenic substrate for the purpose of detecting seminal fluid within a 
forensic casework framework was constructed through the sequential 
coupling of immobilized Rh-110 to amino acids HSSKLQ, a sequence 
previously reported by Denmeade et al. [193] as a proteolytic cleavage 
site of seminal fluid-specific protease prostate specific antigen (PSA). 
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Rh-110 was successfully anchored to the 2-chlorotrityl chloride resin 
(known to react with aromatic amines in the presence of a base such as 
pyridine or N,N-Diisopropylethylamine (DIPEA)) [212] in the first step 
towards substrate preparation. Upon reaction, the resin exhibited a deep 
red coloration that was retained after extensive washing, indicating 
successful dye incorporation. Cleavage of a small portion of the acid-
labile resin, followed by ESI-MS analysis confirmed the presence of free 
Rh-110 (Supplementary - Figure 24).  
With a number of workers previously reporting the unsuccessful 
conjugation of bulky peptides to Rh-110 within solution [213], product 3 
was instead assembled via the stepwise addition of single amino acids in 
a series of individual reactions. Multiple large excesses of Fmoc-
protected glutamine were first incubated with Rh-110-attached resin 2 in 
order to ensure complete coupling (which was confirmed via ESI-MS 
analysis after ‘soft’ cleavage of a small portion of resin (Supplementary - 
Figure 25)), with successive amino acids incorporated through standard 
SPPS deprotection-wash-coupling-wash cycling to form a PSA-specific 
peptide backbone. Acetylation of the histidine N-terminus was performed 
to prevent substrate degradation from environmental aminopeptidase 
activity [214]. 
As previously mentioned, many substrates utilising Rh-110 fluorophores 
are bis-substituted, having been synthesized through the symmetric 
conjugation of identical peptides to both aromatic amines in order to 
quench fluorescence.  However, in such substrates, a two-step enzymatic 
hydrolysis is required in order to cleave both peptide chains before a full 
fluorescence signal is restored, consequently limiting the dynamic linear 
range of the assay [215]. As a result, the majority of fluorogenic Rh-110 
peptide substrates now produced are mono-substituted, with secondary 
aromatic amines ‘capped’ through amide, carbamate or urea 
modifications [180]. This not only permits the assay to be completed 
within a single hydrolysis step, but also produces the same complete 
emission quenching effects as bis-peptide modification [216]. Therefore, 
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a ‘soft’ cleavage of the resin was performed under mild acidic conditions 
to generate 5 from the solid support, allowing all tert-butyloxycarbonyl and 
trityl amino acid side-chain protecting groups to remain intact (preventing 
accidental amino acid side-chain modification) during the capping of the 
remaining Rh-110 aromatic amine by acetylation. Liquid-liquid extraction 
was then performed to separate aqueous-reactive acetyl chloride from 
organic-soluble products, which were subsequently treated with TFA and 
precipitated in ether to remove acid-labile side-chain protecting groups. 
RP-HPLC and high-resolution mass spectrometry were used to confirm 
the purity and identity of final substrate product 7 respectively 
(Supplementary - Figure 26 and Figure 27). 
Spectrofluorometry was employed to observe the emission response of 7 
quantitatively towards its intended enzymatic target. Whilst the final goal 
of this substrate is to identify the presence of whole semen, it is important 
to confirm that a fluorescence response is only elicited as a result of PSA 
hydrolysis and not from interaction with any other molecule within the 
seminal fluid matrix. Therefore in addition to dilutions of seminal fluid, 
substrate 7 was incubated with varying concentrations of purified PSA 
protein. Immediate fluorescence signal increases upon the addition of 
both PSA (Figure 22a) and seminal fluid (Figure 22b) successfully 
demonstrated cleavage between Rh-110-Ac and the attached glutamine 
residue, consequently establishing the potential use of this substrate as a 
semen-specific biosensor.  
Responses generated by seminal fluid were found to be much higher 
compared to that of tested purified protein concentrations, which was 
expected considering the significantly larger levels of PSA usually 
contained within whole semen (approximately 0.5-3.0 mg/ml) [206]. As it 
is important to determine the proteolytic specificity of fluorogenic 
substrates prior to their application (especially within the context of 
forensic casework, in which a false-positive signal may represent an 
incorrect evidential identification), final substrate 7 was also incubated
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Figure 22: Fluorescence response of final substrate 7 to a) concentrations of purified 
PSA protein and b) seminal fluid dilutions over time. 
with identical concentrations of trypsin, proteinase K and aminopeptidase 
M as a measure of PSA selectivity. In all cases the substrate did not 
exhibit a positive response, thereby demonstrating a high specificity 
towards seminal fluid, as well as an inherent resistance to protease 
enzymes present within other body fluids or the surrounding environment 
(Supplementary - Figure 28). With one of the advantages of this assay 
over current forensic testing techniques being the ability to simultaneously 
locate and identify fluid stains in situ via fluorescence, it is pertinent to 
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establish that a positive substrate emission will not be affected by the 
physical nature of the evidential surface on which a body fluid is 
deposited. Substrate 7 was therefore applied to small volumes of semen 
deposited on six surfaces routinely examined within criminal investigation, 
with subsequent signal responses observed by fluorescence microscopy.  
Figure 23: Detection of semen across six surfaces by substrate 7. Reagent-only 
negative controls are provided on the left side of each image. 
Upon reagent application, all deposits were successfully visualised, with 
surface material displaying little effect on resulting substrate emission 
(Figure 23). Similar visualisation was also achieved via the use of a 
hand-held Crime-lite® portable excitation source (Ex 480-560 nm with 
549 nm filter goggles). As an additional method of observing reagent 
specificity, substrate 7 was also incubated with volumes of blood and 
saliva in situ. No signal was observed upon application (Supplementary - 
Figure 29). 
The identification of seminal fluid by PSA detection is currently achieved 
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immunochromatographic testing strip [217]. However, this technique is 
not only unable to locate the position of stains upon an evidential item but 
furthermore, consumes the fluid during the testing process, preventing 
further DNA analysis. An in situ PSA detection assay that allows 
downstream genetic profiling would consequently be considered 
advantageous. Therefore, substrate 7 was applied to a volume of seminal 
fluid deposited on a glass slide, with the resultant mixture being 
recovered by use of a cotton swab. Samples then underwent standard 
DNA extraction, quantification, amplification and capillary electrophoresis 
according to forensic protocols. Comparisons were then made to an 
untreated but identically processed reference sample to examine the 
effects of substrate application on genetic recovery. Differentiation of 
samples was not observed at any stage of the profiling process with the 
DNA concentrations of reagent-applied fluid and reference sample 
calculated at 0.66 and 0.61 ng/μl respectively. A full STR profile from both 
samples was also obtained (Supplementary - Figure 30).  
In summary, we have described a versatile synthetic route for the simple, 
rapid and inexpensive preparation of Rh-110-based fluorogenic 
substrates. Moreover, a substrate produced by this method has already 
shown great potential as a replacement for currently employed forensic 
body fluid testing techniques. This substrate allowed the specific 
detection of seminal fluid traces both within solution and in situ, without 
compromising subsequent genetic profiling processes. Future work will 
centre on the use of this method to produce fluorogenic substrates 
towards other biological fluids and latent fingermarks (something that has 
not currently been achieved). However, with fluorogenic substrates 
routinely employed in a variety of industrial and biomedical applications, 
the disclosed synthetic protocol is also likely to have a much larger 
implication beyond the field of forensic science. 
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3.4.2 Supplementary Information 
Reagents 
All amino acids and peptide coupling reagents were purchased from 
Sigma Aldrich (Dorset, UK). Rhodamine-110 was obtained from Fisher 
Scientific Ltd (Loughborough, UK), whilst 2-Chlorotrityl Chloride Resin 
(1.45 mmol/g loading capacity) was purchased from Cambridge 
Bioscience (Cambridge, UK). All reagents were used without further 
modification, except DMF which was kept under constant nitrogen flow. 
Resin-Rh-110-NH2 
Chlorotrityl resin (175 mg, 0.27 mmol) was stirred in DCM (1 ml) in the 
presence of N,N-Diisopropylethylamine (DIPEA, 700 µl, 4.11 mmol) for 10 
min and subsequently added to a round-bottom flask containing a 
solution of Rhodamine-110 (136 mg, 0.411 mmol) in DCM (5 ml) and 
DMF (2 ml).  The mixture was gently agitated for 24 hrs before being 
transferred to an empty fritted polypropylene tube where the resin was 
filtered and washed with DMF (×5) and DCM (×10). Finally, the resin was 
incubated with methanol for 10 min to cap remaining chloride groups 
before being re-washed with DMF and DCM. Conjugation was monitored 
via a ‘hard’ cleavage of 5 mg of resin to isolate Rhodamine-110 from the 
solid support via treatment with a 95:0.5:0.5:0.5:0.25 solution of 
trifluoroacetic acid (TFA): water: phenol: thioanisole (TA): 
triisopropylsilane (TIPS) for 3 hrs at room temperature. Ice cold diethyl 
ether was then added to precipitate products, with organic solvent, 
scavengers and by-products removed by centrifugation. Obtained solids 
were washed several times with diethyl ether to remove any residual 
scavenger traces and finally dissolved in 50% acetonitrile (ACN) in water 
containing 0.1% TFA and freeze-dried for 24 hrs Correct product mass 
was verified by ESI-MS on a Waters/Micromass (Manchester, UK) ZQ 
mass spectrometer (Figure 24). 
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Figure 24: ESI-MS data demonstrating free Rhodamine-110 presence after cleavage 
from a solid support (calculated m/z for [M+H]+ = 331.11). 
Resin-Rh-110-Gln(Trt)-NH2 
1.83 g (3 mmol) of Fmoc-Gln(Trt)-NH2 was added in a round-bottom flask 
to 8 ml of cold DMF/pyridine (1:1. v/v) and stirred in an ice bath until 
dissolved. To this was added 479 mg (2.5 mmol) of N-(3-
Dimethylaminopropyl)-N’-ethylcarbodiimide (EDC). After 5 min of stirring, 
100 mg (0.1 mmol) of Rhodamine-110 resin, suspended in 2 ml of 
DMF/pyridine (1:1 v/v), was added. Gentle stirring was continued for 24 
hrs at room temperature. The resin was transferred to an empty fritted 
polypropylene tube, filtered and washed with DMF (×5) and DCM (×10) 
before being re-incubated with additional Fmoc-Gln(Trt)-OH for another 
24 hrs using the above-described procedure. Successful amino acid 
coupling was monitored by a ‘soft’ cleavage of 5mg of resin to isolate 
2HN-Rh-110-Gln(Trt)-NH2 from the solid support whilst keeping acid-labile 
side-chain protecting groups intact. This was achieved by treating the 
resin with a 1 ml solution of 1:1:8 acetic acid:TFE:DCM for 1 hr at room 
temperature. Next, the resin was filtered off and washed with cleavage 
solution, with the collected filtrate concentrated under a stream of 
nitrogen at 40°C. Hexane (×15 volume excess) was added to precipitate 
the product, and subsequently removed by rotary evaporation. The 
obtained products were finally dissolved in 50% ACN in water containing 
0.1% TFA and freeze-dried for 24 hrs. The correct mass of the products 
were once again confirmed via ESI-MS as already outlined (Figure 25). 
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Figure 25: ESI-MS data demonstrating successful Resin-Rhodamine-110-Glutamine 
conjugation after ‘soft’ cleavage from a solid support (calculated m/z for [M+H]+ = 
923.34). 
Resin-Rh-110-QLKSSH-Ac  
Remaining amino acids were added to Rh-110-Gln(Trt)-NH2-conjugated 
resin via a standard Fmoc-Solid Phase Peptide Synthesis (SPPS) 
strategy. Initial Fmoc deprotection was accomplished by treatment with 
20% (v/v) piperidine in DMF for 10 min. The following acylation steps 
were conducted using six equivalents of Fmoc amino acids, which were 
pre-activated with ethyl 2-cyano-2-(hydroxyimino)acetate (Oxyma) and 
N,N'-Diisopropylcarbodiimide (DIPCDI) in DMF in a molar ratio of 1:1:1 of 
amino acid, Oxyma and DIPCDI, respectively. The N-terminal histidine 
was acetylated via the addition of ten equivalents of acetic anhydride and 
twenty equivalents of DIPEA in DMF. All coupling reactions were 
conducted for at least 1 hr. Excess reagents and impurities were removed 
by extensive washing with DMF, methanol and DCM. A ‘soft’ cleavage 
was once again performed using the above described method to remove 
2HN-Rh-110-QLKSSH-Ac from the solid support.  
Ac-Rh-110-QLKSSH-Ac 
To 2HN-Rh-110-QLKSSH-Ac (7mg) dissolved in DMF (1 ml) were added 
forty equivalents of DIPEA (28 µl) and twenty equivalents of acetyl 
chloride (5.7 µl). The resulting mixture was stirred for 48 hrs before the 
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addition of 1 ml DCM and 1ml distilled water to isolate a final product by 
liquid-liquid extraction. The organic phase was isolated prior to the re-
extraction of the aqueous layer with 1ml of fresh DCM. The organic layers 
were combined and washed with 5% NaHCO3 (1 ml) and brine (1 ml) 
solutions and dried with sodium sulfate. Following filtration the solvent 
was removed via rotary evaporation. 
Figure 26: HPLC data demonstrating purity of final substrate product Ac-Rh-110-
QLKSSH-Ac 
To remove acid-labile amino acid side-chain protecting groups, products 
were treated with using the same ‘hard’ cleavage cocktail solution and 
precipitation methods as previously outlined. Product purity was 
examined by analytical RP-HPLC (Figure 26), carried out on a HP1050 
HPLC system equipped with an autosampler, quaternary pump and 
Diode-Array Detector and employing a Zorbax SB C-18 2.1mm x 10cm 
(particle size 3.5 micron) column. A linear gradient of mobile phase B 
(acetonitrile containing 0.1% TFA) over mobile phase A (0.1% TFA in 
water) from 0-90% B in 20 min was performed with a flow rate of 0.2 
ml/min. Eluents were monitored at wavelengths between 210-280 nm with 
data collected and analyzed using ChemStation software. Correct product 
mass was determined by HRMS on an Exactive Plus Orbitrap Mass 
Spectrometer (Figure 27). 
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Figure 27: High-resolution MS data of final substrate product Ac-Rh-110-QLKSSH-Ac 
(calculated m/z for [M+H]+ = 1095.4900) and doubly charged [M + 2H]2+ ion 
(calculated m/z = 548.2489) 
Body Fluid Collection and Storage 
Semen samples were taken after informed consent and stored at 4 °C 
until analysis. Tissue collection for this project has full ethical clearance 
under the King’s College London Biomedical Sciences, Dentistry, 
Medicine and Natural & Mathematical Sciences Research Ethics 
Subcommittee (Reference number BDM/13/14-26). 
Spectrofluorometry 
Final substrate Ac-Rh-110-QLKSSH-Ac (0.9 mg, 0.82 μmol) was 
dissolved in DMSO (82 μl) to make a 10 mM stock solution before dilution 
in 10 mM Tris reaction buffer to a 50 μM working concentration. Substrate 
performance was observed via the 100 μl addition of 50 μM Ac-Rh-110-
QLKSSH-Ac to 100 μl of both purified PSA protein (100, 50, 25, 12.5, 
6.25 μg/ml) and seminal fluid dilutions (1:1, 1:2, 1:4, 1:8, 1:16) and 
measured with appropriate negative controls (100 μl 10 mM Tris Buffer, 
100 μl assay reagent). Additional observations of substrate specificity 
were undertaken via the incubation of 50 μM Ac-Rh-110-QLKSSH-Ac 
with 100 μg/ml concentrations of Proteinase K (Fisher Scientific Ltd, 
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Loughborough, UK), Aminopeptidase M (Merck Millipore, Darmstadt, 
Germany) and Trypsin (Sigma Aldrich, Dorset, UK) (Figure 28). All 
fluorescence measurements were conducted on a BioTek Synergy HT 
spectrophotometer (Vermont, USA). Emissions were recorded at room 
temperature in triplicate using Ex485±20/Em528±20 nm wavelengths (for 
the measurement of emissions at 535 nm) over the course of 30 min.  
Figure 28: Fluorescence response of Ac-Rh-110-QLKSSH-Ac to 100 µg/ml 
concentrations of Proteinase K, Aminopeptidase M, Trypsin and PSA. 
In Situ Microscopy 
Six different surfaces consisting of cotton, glass, leather, paper, plastic 
and wood were chosen to reflect materials on which body fluids are 
commonly deposited within criminal investigations. All surfaces were cut 
to fit the size of a microscope slide. Semen volumes of 5 μl were applied 
to the centre of each surface before the direct 5 μl addition of substrate 
Ac-Rh-110-QLKSSH-Ac. Negative reagent-only and blank semen-only 
controls were used to limit the possibility of background fluorescence. 
Images were taken in the dark immediately after application on an 
Olympus SZX12 fluorescence microscope. GFP filtration (Ex 460-490 
nm) was used for substrate excitation, whilst all additional microscopy 
parameters were kept constant (Hue = 359, Saturation = 255, White 
Balance = 0, Contrast = 1023, Brightness = 0, Gamma = 10, 
Magnification = ×8.5) in order to restrict result variation. 
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In Situ Specificity 
An additional observation of substrate specificity against other body fluid 
types was undertaken via the incubation of 5 μl substrate Ac-Rh-110-
QLKSSH-Ac with 5 μl of blood and 5 μl saliva deposited on glass slides. 
Controls and fluorescence microscopy were utilised in the same manner 
previously described. 
Figure 29: Incubation of substrate Ac-Rh-110-QLKSSH-Ac with a) blood and b) saliva. 
No positive signals were observed upon application. 
DNA Profiling   
5 μl of Ac-Rh-110-QLKSSH-Ac at working concentration was added to 5 
μl of human semen deposited on glass slides to observe effects on DNA 
recovery after application. The resulting mixture was then recovered via 
the use of a cotton swab. DNA was extracted using the QIAmp® DNA 
Mini kit (Qiagen, Manchester, UK) according to the supplied protocol and 
quantified with the Quantifiler® Human DNA Quantification Kit (Fisher 
Scientific Ltd, Loughborough, UK). Samples were diluted to 0.5 ng/μl prior 
to amplification with the PowerPlex® ESI 17 Pro System (Promega, 
Southampton, UK) using a Perkin Elmer 9700 thermal cycler (Cambridge, 
UK). STR amplicons were resolved on an ABI3130XL genetic analyser 
and evaluated using GeneMapper® software. Generated profiles were 
compared to a semen reference profile (5 μl semen + 5 μl H2O to 
examine potential inhibition (Figure 30). 
 
a) b) 
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Figure 30: Generated STR profiles from a) human semen sample treated with 5 µl substrate Ac-Rh-110- QLKSSH-Ac and (b) reference human 
semen sample treated with 5 µl H2O. No significant differences between profiles was observed.  
b)a)
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3.5 Published Article 3: ‘Fluorogenic Substrates for the 
Detection of Saliva’ 
The content of following section was published as an original research 
article in: 
Gooch, J., et al., Fluorogenic substrates for the detection of saliva. 
Forensic Science International: Genetics Supplement Series, 2017. 6: p. 
e565-e567. 
Experimental work was performed by the candidate with assistance from 
Chang Rong Chua. The candidate also produced the manuscript. Help 
with peptide synthesis, as well as access to the Institute of 
Pharmaceutical Science research laboratories and HPLC and MS 
instruments, was provided Dr. Vincenzo Abbate. Dr. Nunzianda Frascione 
provided supervisory and technical support throughout the research. 
3.5.1 Manuscript 
Authors: James Gooch,a Chang Rong Chua,b Vincenzo Abbate,a 
Nunzianda Frascione.a* 
Authors Address: a) King’s Forensics, Analytical & Environmental 
Sciences Division, King’s College London, 150 Stamford Street, London, 
SE1 9NH, UK, b) Department of Biological Sciences, National University 
of Singapore, 14 Science Drive 4, 117543, Singapore. 
Abstract: The potential of fluorogenic substrates to detect and identify 
human saliva in situ was first explored using commercially available 
substrate Boc-VPR-AMC. The substrate was applied to a range of saliva 
dilutions deposited on glass microscope slides. A positive fluorescence 
response was observed immediately after application against each 
deposit up to a 1:8 dilution. In an attempt to improve assay sensitivity, a 
novel substrate Ac-VPR-Rh-110-Ac, utilising a Rhodamine-110 
fluorophore, was prepared using a solid-phase peptide synthesis protocol 
previously reported by our research group. Application of Ac-VPR-Rh-
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110-Ac to saliva deposits demonstrated a successful increase in assay 
sensitivity limits, allowing stains of up to 1 in 128 dilution to be detected.    
Introduction 
The Office for National Statistics estimates that in 2016/2017 alone, over 
5 million criminal offences occurred within the UK [218]. Of these 
offences, almost 50% remain unsolved with no recorded suspect [219]. 
As the vast majority of criminal identifications made by forensic means 
involve the use of DNA, there is continuing pressure to develop rapid and 
sensitive techniques capable of detecting and identifying genetic material 
deposited as biological fluid traces during a criminal act. At present, the 
most widely used methods to identify deposits of saliva include the 
Phadebas® test, the RSID™-Saliva test and the SALIgAE® test, all of 
which exploit reactions with the single most abundant salivary protein, α-
amylase [3]. Although these tests have proven effective within a casework 
scenario, they often suffer from caveats of low specificity [30] and lack of 
ability to localise fluids and attribute their tissue type at the same time. 
Our research group has recently demonstrated the use of fluorogenic 
peptide substrates as successful assays for the simultaneous detection 
and identification of body fluid targets in situ [210]. These substrates 
utilise fluorophores that are quenched as a result of conjugation to an 
amino acid chain. Incubation of the substrate with a body fluid-specific 
protease results in the separation of the peptide-fluorophore bond and 
emission of fluorescence. These assays were shown to possess both 
high target specificity and sensitivity, whilst a ‘turn-on’ fluorescence signal 
allowed for the visualisation of discrete fluid staining areas. Furthermore, 
this fluorescence approach was shown to be highly compatible with 
current DNA profiling processes. 
In the course of testing a number of commercially available fluorogenic 
substrates against different biological fluids in solution, it was observed 
that substrate Boc-VPR-AMC exhibited a strong positive reaction in the 
presence of saliva. This substrate utilises a 7-amino-4-methylcoumarin 
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(AMC) fluorophore, which is liberated upon target interaction to produce a 
fluorescence emission at 440 nm (Figure 31).  
This study therefore documents the use of Boc-VPR-AMC, to visualise in 
situ deposits of saliva within a forensic context, as well as the synthesis of 
a novel substrate (Ac-VPR-Rh-110-Ac) based on the same reactive 
amino acid sequence, in an attempt to increase testing sensitivity. 
Figure 31: Boc-VPR-AMC − A short peptide chain (VPR) terminally labelled with a 
fluorophore, creating a non-fluorescent substrate system. Resulting protease activity 
relieves quenching to release highly fluorescent 7-amino-4-methylcoumarin. 
Materials and Methods 
Materials 
Saliva was collected upon informed consent from three donors (KCL 
Ethics BDM/13/14-26). Substrate Boc-VPR-AMC was purchased from 
R&D Systems (Abingdon, UK) and diluted to a working concentration of 
100 μM. All amino acids and coupling reagents were purchased from 
Sigma-Aldrich Ltd (Dorset, UK), while Rhodamine-110 (Rh-110) was 
purchased from Fisher Scientific Ltd (Loughborough, UK). 
Ac-VPR-Rh-110-Ac Synthesis 
Substrate Ac-VPR-Rh-110-Ac was prepared using a solid-phase peptide 
synthesis protocol previously reported [220]. Electrospray Ionisation Mass 
Spectrometry (ESI-MS) on a Waters/Micromass (Manchester, UK) ZQ 
mass spectrometer was used to confirm the identity of the product at 
each key step of the synthesis (data not shown).  
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Microscopy 
Saliva dilutions (1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128) were applied in 
duplicate to glass slides in 5 μl deposits and allowed to dry overnight. 
Working concentration Boc-VPR-AMC (100 μM) or Ac-VPR-Rh-110-Ac 
(500 μM) was pipetted in 5 μl volumes onto the dried saliva. Fluorescence 
response of the substrates was recorded immediately after application by 
an Olympus SZX12 fluorescence microscope using UV (Ex 330-385/Em 
420 nm) or GFP (Ex 460-490/Em 510 nm) filters for the commercial and 
synthesized substrates respectively. Negative reagent-only and saliva-
only controls were also utilised and recorded in the same manner. 
Results and Discussion 
Immediate ‘turn-on’ signal responses of substrate Boc-VPR-AMC were 
observed against all saliva deposits up to a 1:8 dilution (Figure 32a). 
Stains beyond this limit could not be visualised successfully. The use of 
negative controls also demonstrated the inherent lack of fluorescence 
emission of both saliva deposits and unreacted substrate.  
Our research group recently reported the development of a solid-phase 
peptide synthesis protocol for the construction of fluorogenic substrates 
using the fluorophore Rhodamine-110 [220]. Such substrates are likely to 
be more sensitive than those using coumarin dyes due to Rhodamine-
110’s superior spectral characteristics. Attempts were therefore made to 
improve assay performance through the construction of a novel substrate 
Ac-VPR-Rh-110-Ac. After confirming the success of substrate synthesis 
by mass spectrometry, Ac-VPR-Rh-110-Ac was applied to saliva deposits 
in the same manner as commercial substrate testing. Successful 
visualisation of in situ saliva samples up to a 1:128 dilution, demonstrated 
a significant increase in assay detection limits (Figure 32b).  
During the application of Ac-VPR-Rh-110-Ac, it was noted that the 
substrate solution exhibited some background fluorescence. However, 
this was successfully corrected for through changes to microscope 
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parameters. This background signal is likely to originate from dye 
molecules that were not completed conjugated during synthesis. Further 
purification to remove any free Rhodamine-110 from the substrate 
product should therefore be undertaken to prevent potential limitations to 
assay sensitivity.  
Figure 32: Fluorescence response of (a) Boc-VPR-AMC and (b) Ac-VPR-Rh-110-Ac to 
saliva dilutions deposited on glass slides. Negative reagent-only controls are provided 
on the left side of each image 
Conclusion 
This proof-of-concept study has demonstrated the potential of fluorogenic 
substrates as a rapid, portable and simple method for the visualisation of 
saliva. Commercially available Boc-VPR-AMC was first utilised to detect 
deposited saliva in situ before assay sensitivity was increased through the 
construction of synthetic substrate Ac-VPR-Rh-110-Ac. With substrates 
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now designed by our group for the detection of both semen and saliva, 
future work is likely to focus on the development of a multiplex substrate 
system for the detection of multiple fluid types simultaneously. 
3.6 Fluorogenic Substrates for the Detection of Blood 
With the successful in situ detection of semen and saliva by both 
commercial and synthesized fluorogenic peptide substrates, similar 
efforts were also made in the application of substrate-based biosensors 
towards the forensic analysis of blood.  
Initial research focused on the ability of Bz-FVR-AMC, a commercially 
available peptide substrate commonly employed within coagulation 
studies [221], to detect samples of plasma and whole blood both in 
solution and in situ. This sensor, originally produced as part of a large 
substrate development study conducted by Svendsen et al. [194], is 
cleaved in the presence of proteolytic thrombin, which is able to hydrolyse 
arginine-aromatic amine bonds in small synthetic peptides [222]. 
Subsequent attempts to develop a custom thrombin-specific substrate 
employing the pro-fluorophore cresyl violet (CV) were then conducted 
using the solid-phase synthesis strategy previously developed. 
3.6.1 Materials and Methods 
3.6.1.1 Reagents 
Thrombin substrate III (Bz-FVR-AMC) was purchased from Merck 
Millipore (San Diego, USA) and reconstituted in sterile distilled water 
(SDW) to a recommended working concentration of 100 µM. Ellagic acid 
was obtained from Flurochem Ltd (Derbyshire, UK) and dissolved in 
Dimethyl sulfoxide (DMSO) to a concentration of 10 mM. A thrombin 
triggering solution was produced according to Ramjee [223], through the 
addition of 0.5 µl of 10 mM ellagic acid solution to 20 µl of CaCl₂ (50 mM). 
Human α-thrombin was also purchased from Merck Millipore (San Diego, 
USA). 
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For custom substrate synthesis, all amino acids and peptide coupling 
reagents were purchased from Sigma Aldrich (Dorset, UK), with the 
exception of 2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HATU), which was purchased from Flurochem Ltd 
(Derbyshire, UK). Cresyl violet acetate and 2-Chlorotrityl Chloride resin 
(1.4 mmol/g loading capacity) were obtained from Alfa Aesar 
(Massachusetts, USA). All reagents were used without further 
modification, except DMF which was kept under constant nitrogen flow. 
3.6.1.2 Body Fluid Collection and Storage 
Blood samples were taken upon informed consent from the same healthy 
donor. Samples were drawn by venipuncture and stored in a BD 
Vacutainer® Plus tube (Oxford, UK) containing 3.2% sodium citrate 
coagulation preservative and stored at 4 °C until analysis. Plasma was 
obtained through the centrifugation of whole blood samples for 10 min at 
2000 x g before separation of the supernatant.  
Ethical clearance for the collection of biological fluids for this specific 
study was granted by the King’s College London Biomedical Sciences, 
Dentistry, Medicine and Natural & Mathematical Sciences Research 
Ethics Subcommittee (reference number HR-17/18-5057). 
3.6.1.3 Commercial Substrate Testing 
3.6.1.3.1 Spectrofluorometry 
Working concentrations of Bz-FVR-AMC (100 µl) were mixed with 100 µl 
of both plasma and whole blood dilutions (1:1, 1:2, 1:4, 1:8, 1:16) in a 96-
well microplate before the addition of 20.5 µl thrombin triggering solution 
(as prepared in Section 3.6.1.1). Fluorescence emission signals were 
measured on a BioTek Synergy HT spectrophotometer (Vermont, USA) 
over 60 min using Ex360±40/Em460±40 nm wavelengths (for 
measurement of emissions at 450 nm). Appropriate negative controls 
(100 μl water + 100 μl substrate solution) were also utilised. All samples 
were prepared in triplicate. 
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3.6.1.3.2 Slide Microscopy 
The ability of Bz-FVR-AMC to detect in situ wet fluid deposits was tested 
through the application of 5 µl working substrate solution and 0.5 µl of 
thrombin triggering solution to a range of plasma dilutions (1:1, 1:2, 1:4, 
1:8, 1:16, 1:32, 1:64, 1:128) deposited in 5 µl volumes on glass slides. 
Reagent-only negative and plasma-only blank controls were also used. 
Images were taken immediately after trigger application using an 
Olympus SZX12 fluorescence microscope (Tokyo, Japan) and internal 
CCD camera. UV filtration (Ex 330-385 nm) was used for substrate 
excitation, with all additional microscopy parameters kept constant 
throughout testing (Exposure = -2, Hue = 359, Saturation = 255, White 
Balance = 0, Contrast = 1023, Brightness = 0, Gamma = 10, 
Magnification = ×8.5). 
3.6.1.3.3 DNA Profiling 
Substrate Bz-FVR-AMC (50 µl + 5 µl of thrombin triggering solution) was 
added to 100 µl of whole blood to observe effects on DNA recovery after 
application. A reference DNA sample was then prepared through the 
addition of 50 µl SDW to a second blood volume in place of substrate 
reagent. Both samples were then subjected to DNA extraction using the 
QIAamp® DNA Investigator kit (Qiagen, Manchester, UK) according to 
manufacturer protocols. Extracts were quantified using the Quantifiler™ 
Human DNA Quantification Kit (Thermo Fisher Scientific, California, 
USA), diluted to 0.1 ng/µl and amplified utilising the AmpFLSTR® NGM 
SElect Express Kit (Thermo Fisher Scientific, California, USA) on a Perkin 
Elmer 9700 thermal cycler (Cambridge, UK). Amplified STR products 
were resolved via capillary electrophoresis on an Applied Biosystems® 




Page | 98  
3.6.1.4 Custom Substrate Synthesis and Testing 
3.6.1.4.1 Resin-CV-NH2 
A total of 500 mg of 2-chlorotrityl chloride resin (1.4 mmol/g loading 
capacity) was swelled using DCM in a SPE fritted polypropylene tube for 
30 min. After draining, 112.5 mg (0.35 mmol) of Cresyl Violet and 1.219 
ml (7 mmol) of DIPEA in 6ml of DMF were added to the resin. This 
suspension was incubated on a roller at room temperature for 24 hrs and 
subsequently washed with DMF and DCM until the filtrate was clear. The 
resin was then incubated with methanol for 30 min to cap any remaining 
chloride groups before re-washing with DMF (×5) and DCM (×10). 
Conjugation was monitored via the ‘hard’ cleavage of 5mg of resin 
through treatment with a 1 ml solution of 95:0.5:0.5:0.5:0.25 TFA: water: 
phenol: TA: TIPS for 3 hrs at room temperature. Ice cold diethyl ether was 
then added to precipitate products, with organic solvent, scavengers and 
by-products removed through centrifugation. Obtained solids were 
washed several times with diethyl ether to remove any residual scavenger 
traces and finally dissolved in 50% ACN in water containing 0.1% TFA.  
Product purity was examined by reverse-phase HPLC (RP-HPLC) on a 
HP1050 HPLC system (Hewlett Packard, California, USA) equipped with 
an autosampler, quaternary pump and Diode-Array Detector and using a 
Zorbax SB C-18 2.1mm x 10cm (particle size 3.5 micron) column. A linear 
gradient of mobile phase B (A containing 0.1% TFA) over mobile phase A 
(0.1% TFA in water) from 0-90% B in 37 min was performed with a flow 
rate of 0.2 ml/min. Eluents were monitored at 280 and 621 nm 
absorbance wavelengths with data collected and analyzed using 
ChemStation software. Correct product mass was verified by ESI-MS on 
a Waters/Micromass (Manchester, UK) ZQ mass spectrometer. 
3.6.1.4.2 Resin-CV-R(Pbf)-OH 
First, 4.541 g of Fmoc-Arg(Pbf)-OH (7 mmol) was dissolved in 15 ml DMF 
before the addition of 2.395 g of HATU (6.3 mmol) and 2.438 ml DIPEA 
(14 mmol). This mixture was stirred for 10 min before addition to the 
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washed CV-resin. Coupling was allowed to occur for ~96 hrs at room 
temperature on a roller, whereupon the resin was transferred to an empty 
fritted polypropylene tube, filtered and washed with DMF (×5) and DCM 
(×10). Successful coupling was monitored by subjecting 5 mg of resin to 
the ‘hard’ cleavage and RP-HPLC and ESI-MS instrumental analysis 
procedures previously described (Section 3.6.1.4.1). 
3.6.1.4.3 Resin-CV-R(Pbf)VF-Bz 
All remaining amino acids were added to CV-R(Pbf)-OH-conjugated resin 
via a standard SPPS strategy. Acylation steps were conducted using six 
equivalents of Fmoc amino acids (1.425 g Fmoc-Val-OH and 1.627g 
Fmoc-Phe-OH), which were pre-activated with ethyl 2-cyano-2-
(hydroxyimino)acetate, potassium salt (K-Oxyma) and DIPCDI in DMF in 
a molar ratio of 1:1:1 of amino acid, K-Oxyma (756 mg) and DIPCDI (650 
µI), respectively. All couplings were allowed to occur for 1 hr at room 
temperature, whereupon the resin was washed with DMF (×5) and DCM 
(×10). Fmoc protecting groups were removed through treating the resin 
with 10 ml of 20:80 v/v Piperidine:DMF for 30 min before further washing 
with DMF (×5) and DCM (×10). Capping of the N-terminus of 
phenylalanine residues was achieved through the incubation of de-
protected resin for 1 hr with 10 molar equivalents (1.583 g) of Benzoic 
Anhydride and 20 equivalents of DIPEA (2.438 ml) in 6 ml DMF. A final 
wash of the resin was then conducted using DMF (×5) and DCM (×10). 
Coupling success was monitored by subjecting 5 mg of resin to the ‘hard’ 
cleavage and RP-HPLC and ESI-MS instrumental analysis procedures 
previously described (Section 3.6.1.4.1). 
3.6.1.4.4 Ac-CV-RVF-Bz 
A 200 mg portion of the resin was treated with 5 ml of a ‘soft’ cleavage 
cocktail of 0.5% TFA in DCM for 1 hr to isolate 2HN-CV-R(Pbf)VF-Bz 
without disturbing Pbf side-chain protecting groups. Filtrate was collected 
and allowed to evaporate in a fume hood to a total volume of 1 ml. 
Products were then precipitated in 10 ml of cold diethyl ether, centrifuged 
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at 4000 RPM for 20 mins and washed twice with two volumes of 10 ml 
ether. 
To 93.9 mg of 2HN-CV-R(Pbf)VF-Bz (91.5 µmol) dissolved in DMF (3 ml) 
were added twelve equivalents of DIPEA (191 µl) and six equivalents of 
acetyl chloride (39 µl). This solution was allowed to incubate at room 
temperature for 1 hr before being split into three separate 1ml portions. 
To each portion, 1 ml DCM and 1 ml distilled water was added to isolate 
final products by liquid-liquid extraction. Each organic phase was isolated 
prior to the re-extraction of the aqueous layer with 1 ml of fresh DCM. The 
organic layers were then combined and washed with 5% NaHCO3 (1 ml) 
and brine (1 ml) solutions before being filtered through a sterile 
membrane. To remove Pbf side-chain protecting groups, products were 
treated using the ‘hard’ cleavage procedures previously described 
(Section 3.6.1.4.1). Instrumental analysis of the final substrate product 
was also conducted using the RP-HPLC and ESI-MS methods already 
outlined (Section 3.6.1.4.1). 
3.6.1.4.5 Spectrofluorometry 
The ability of Ac-CV-RVF-Bz to detect purified thrombin protein, as well 
as both plasma and whole blood samples, was investigated by dissolving 
final synthesis products in sterile distilled water to an estimated 
concentration of 100 µM (based on product weight). Working 
concentrations (100 µl) of Ac-CV-RVF-Bz were then mixed with 100 µl of 
thrombin at a range of concentrations (50, 25, 10, 5, 2.5 µg/ml) and 
dilutions of plasma/whole blood (1:1, 1:2, 1:4, 1:8, 1:16) in a 96-well 
microplate before the addition of 20.5 µl thrombin triggering solution. 
Fluorescence signals were measured on a CytoFlour® 4000 
spectrophotometer (Applied Biosystems®, California, USA) over the 
course of 60 min using Ex590±20/Em645±50 nm wavelengths (for the 
measurement of emissions at 632 nm). Appropriate negative controls 
(100 μl water + 100 μl substrate solution) were also utilised. All samples 
were prepared in triplicate. 
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3.6.2 Results and Discussion 
3.6.2.1 Commercial Substrate Testing 
3.6.2.1.1 Spectrofluorometry 
Substantial increases in fluorescence signals over time were observed 
upon the addition of substrate Bz-FVR-AMC to different dilutions of 
human plasma (Figure 33a), demonstrating the potential of peptide 
substrates for use in the detection of blood-specific components. 
However, emission intensities were found to be significantly reduced 
during the application of the same substrate to whole blood samples 
(Figure 33b). Such effects were not unexpected, due to the established 
spectral overlap between AMC emission and blood absorbance 
wavelengths. In fact, a similar experiment has already established the 
quenching of AMC-based substrates in whole blood as a result of 
fluorescence absorption by haemoglobin at 440-460 nm [223].  
It must also be noted that unlike the previous substrates tested against 
enzymes present in semen and saliva, Bz-FVR-AMC also requires the 
use of an additional assay component in the form of an enzyme-triggering 
solution. This is due to the fact that thrombin in circulating blood is largely 
present as a zymogen precursor, which does not possess enzymatic 
activity [224]. Whilst this precursor, known as prothrombin, is readily 
activated by Factor Xa as part of the coagulation cascade during clotting, 
this process is inhibited in blood containing an anti-coagulant [225]. 
Enzyme-triggering compounds (as well as calcium ions) are therefore 
used to overcome anti-coagulative effects within blood samples taken by 
venipuncture, allowing thrombin generation to take place. In this particular 
study, ellagic acid, a compound able to enhance the activation of clotting 
factor XII, was utilised as a pro-coagulant. However, it remains to be seen 
whether such enzyme-triggering methods would still be required during 
the application of thrombin substrates to bloodstains deposited at crime 
scenes, which naturally clot as a result of tissue factor activation during 
bleeding. 
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Figure 33: Fluorescence response of substrate Bz-FVR-AMC over time to different 
dilutions of a) plasma and b) whole blood. Data represents the mean ± SD, samples 
performed in triplicate. 
3.6.2.1.2 Slide Microscopy 
Positive fluorescence emissions were observed in all samples during the 
in situ testing of Bz-FVR-AMC against deposits of human plasma on 
glass slides, even at sensitive 1:128 dilutions (Figure 34). Responses 
were found to be immediate upon the addition of thrombin triggering 
solution and increased in intensity over the next 60 min. However, no 
signals were detected from all substrate solutions applied to each whole 
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blood dilution (data not shown). This is likely due to the haemoglobin 
AMC-quenching effects already discussed. 
Figure 34: Demonstration of in situ substrate testing of plasma depositions upon glass 
slides across a range of eight dilutions. Reagent-only negative controls are provided on 
the left side of each image. Duplicate measurements were taken and also displayed 
similar results. 
3.6.2.1.3 DNA Profiling 
To investigate potential interference with downstream DNA profiling 
processes, Bz-FVR-AMC and thrombin triggering solution were applied to 
a sample of whole blood, which was then subjected to DNA extraction, 
quantification, amplification and detection using techniques standard to 
most forensic casework laboratories. Comparisons (both in terms of DNA 
quantification values and electropherogram allele numbers/peak heights) 
were then made to a blood reference standard, in which SDW was added 
in place of substrate reagent. No differences between substrate-added 
and reference samples outside the limits of normal experimental variation 
were observed at any stage of the profiling process. DNA extracted from 
whole blood containing Bz-FVR-AMC and thrombin triggering solution 
was quantified at 4.05 ng/µl. Furthermore, a full STR profile was obtained 
from this sample (Figure 35), with no detrimental effects to high 
molecular weight loci (amplicons less likely to undergo PCR as a result of 
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Figure 35: STR profiles generated from whole blood samples containing a) Bz-FVR-
AMC and thrombin triggering solution and b) SDW.  
3.6.2.2 Custom Substrate Synthesis and Testing 
3.6.2.2.1 Substrate Synthesis 
With significant reductions of Bz-FVR-AMC emissions occurring as a 
result of blood absorption, it was subsequently theorised that a custom 
thrombin substrate utilising pro-fluorophores emitting within the red region 
of the visible spectrum (620-750 nm), where haemoglobin does not 
typically absorb [226], may potentially be used to overcome such 
quenching effects. Attempts were therefore made to construct a blood-
specific sensor based on the amino acid sequence employed within 
fluorogenic thrombin substrate III (Bz-RVF) and cresyl violet, an oxazine-
based fluorophore with an emission maxima of 632 nm (Figure 36).  
Substrate Ac-CV-RVF-Bz was synthesized using a similar solid-phase 
strategy to that previously employed in the development of Rh-110-based 
sensors (Section 3.4.2) [220, 227]. This approach was chosen over 
traditional solution-based preparation due to the higher final product 
yields and cost-efficiency associated with SPPS. Furthermore, substrates 
produced using this method are mono-substituted, with amino acids 
attached at only one site of the pro-fluorophore molecule, allowing 
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Figure 36: Solid phase peptide synthesis of cresyl violet based thrombin substrate: a) 2-ct resin (0.7 mmol), DMF, DIPEA, 24 hrs, b) MeOH, 30 min, 
c) Fmoc-R(Pbf)-OH (7 mmol), DMF, HATU (6.3 mmol), DIPEA (14 mmol), 96 hrs, d) 20% piperidine/DMF, 30 min, e) 2 x AA, K-Oxyma, DIPCDI, 
DMF, 1 hr, f) Benzoic anhydride (7 mmol), DIPEA (14 mmol), DMF, 1 hr, g) 0.5% TFA/DCM, 1 hr, h) Acetyl chloride (0.55 mmol), DIPEA (1.1 mmol), 
DMF, 1 hr, i) TFA:TA:TIPS:water:phenol. 
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Figure 37: Confirmation of final substrate product Ac-CV-RVF-Bz purity and identity as 
established by a) RP-HPLC and b) ESI-MS (calculated m/z for [M+H]+ = 812.38) 
respectively. 
Upon attachment of cresyl violet, the 2-chlorotrityl resin displayed a deep-
purple colouration that was retained even after extensive washing, 
indicating successful coupling. A large excess of initial amino acid (Fmoc-
Arg-(Pbf)-OH) was used to ensure high final product yields through the 
comprehensive conjugation of resin-bound pro-fluorophores. Unlike the 
construction of Rh-110-based substrates, this conjugation was achieved 
a)
b)
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in the presence of HATU (a peptide coupling agent commonly used to 
form amide bonds between pro-fluorophores and amino acids during 
fluorogenic substrate development [228]) and DIPEA, rather than an 
EDC/pyridine mixture. Subsequent amino acids (as well as an n-terminal 
benzoyl capping groups) were then added according to the peptide 
sequence of Bz-FVR-AMC. 
After removal from the resin by ‘soft’ TFA cleavage, the free amine of 
2HN-CV-R(Pbf)VF-Bz was acetylated to quench the overall emission of 
the substrate. Pbf protecting groups were lastly removed through 
treatment of Ac-CV-RVF-Bz using a ‘hard’ TFA cleavage solution. 
Analysis by RP-HPLC and ESI-MS was used to confirm the purity and 
identity of the final substrate respectively (Figure 37). RP-HPLC and ESI-
MS analysis results from products obtained at each stage of the synthesis 
process may be found in the appendix (Section A.1) of this thesis. 
3.6.2.2.2 Spectrofluorometry 
Appropriate increases in fluorescence intensity were exhibited by 
substrate Ac-CV-RVF-Bz over time in response to different 
concentrations of thrombin solution (Figure 38) In general, these changes 
occurred much more rapidly than those exhibited by commercial 
substrate Bz-FVR-AMC in response to plasma and whole blood samples, 
with saturation of signals occurring in less than 10 min for some higher 
thrombin concentrations.  
However, no fluorescence emissions were observed upon the application 
of Ac-CV-RVF-Bz to plasma and whole blood dilutions. The reasons 
behind this lack of signal remain unclear, given the obvious response of 
the substrate to the purified thrombin protein. Possible explanations may 
include the prevention of substrate hydrolysis by other components 
present within plasma and blood matrices (such as fibrin and other 
clotting factors), which can restrict fluorescence emission [229]. Some 
authors have also demonstrated a disparity between the concentrations 
of enzymes required to cleave peptide substrates containing the same 
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amino acid sequences but utilising different pro-fluorophore leaving 
groups [165]. As a result, optimisations to increase the sensitivity of this 
substrate may be required in order to detect the low levels of thrombin 
present within deposited bloodstains. 
Figure 38: Fluorescence response of Ac-CV-RVF-Bz over time to different 
concentrations of purified thrombin protein. Data represents the mean ± SD, samples 
performed in triplicate. 
3.6.3 Conclusion 
In this study, a commercially available thrombin fluorogenic substrate has 
been successfully applied for the detection of human plasma both in 
solution and in situ. However, with the quenching of AMC leaving group 
fluorescence as a result of haemoglobin absorption, it is unlikely that this 
substrate will have practical use in the analysis of deposited bloodstains 
within forensic casework. Therefore, the development of a custom 
thrombin substrate utilising a pro-fluorophore that emits outside the region 
of haemoglobin absorbance was also conducted.  
Substrate Ac-CV-RVF-Bz was constructed using a previously employed 
SPPS scheme and was found to be responsive to different concentrations 
of thrombin within solution using spectrofluorometry. However, 
subsequent attempts to apply this substrate towards the detection of 
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plasma and whole blood samples were unsuccessful. Further work to 
optimise this sensor is therefore required before its application to the 
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4.1 Introduction 
Whilst fluorogenic substrates were found to be highly effective in the 
visualisation of semen and saliva deposits, initial attempts in the 
application of these sensors towards the detection of whole blood 
samples were met with mixed success. Inhibition of substrate hydrolysis 
by protein components present within the fluid matrix has been posited as 
one possible reason for the lack of fluorescence emissions from custom-
synthesized thrombin substrates during blood incubation. 
Such inhibition may necessitate the construction of an entirely novel 
fluorogenic peptide substrate towards a different blood-specific target. 
However, with signal transduction affected only as a result of protease 
interaction, this is likely to be a significant challenge, as the number of 
molecules in blood that exhibit proteolytic activity (that are also present in 
concentrations high enough to cause observable peptide hydrolysis) is 
limited [230]. Consequently, it may be considered beneficial to also 
explore the use of other sensing transduction mechanisms that are able 
to detect non-enzymatic targets towards the forensic analysis of biological 
fluids.  
Despite difficulties in the detection of analyte deposits on porous surfaces 
during commercial biosensor testing (Chapter 2 - Section 2.4.3), the 
FluoReporter® Biotin Quantitation Assay Kit was shown to exhibit high 
sensitivity and low background fluorescence, qualities likely essential for 
effective in situ biological fluid sensing. Whilst this assay utilised the 
highly specific interactions that occur between biotin and avidin molecules 
to displace a moderately bound quenching ligand, this approach may 
theoretically be extended to the detection of virtually any target by the 
replacement of avidin sub-units with other biological recognition moieties, 
such as antibodies or aptamers. 
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This chapter therefore documents the design and development of a 
displacement immunosensor specific to the seminal fluid protein PSA. 
First, a brief overview of displacement transduction mechanisms is 
provided, along with an exploration of quantum dots (QDots), fluorescent 
nanoparticles commonly used in such assays. Construction of a ‘turn-on’ 
biosensor employing moderately bound quenching peptide analogues to 
PSA is then reported. 
4.2 Review of Displacement Immunosensors 
4.2.1 Transduction Mechanism 
Antibody-protein binding generally occurs as result of van der Waals, 
hydrogen, hydrophobic and ionic bonding between the specific amino 
acids of the antigenic determinant region of a protein (known as an 
‘epitope’) and the complementarity-determining regions (CDRs) of an 
antibody molecule. The strength of this binding is usually dependent upon 
the valency and precise fit of an antigen within these regions [231]. As a 
result, an antibody may be able to bind to different molecules sharing 
similar structural characteristics. However, the strength (or ‘affinity’) of this 
binding will be distinct for each target. 
Furthermore, those antigens exhibiting a low or moderate degree of 
affinity upon binding to an antibody may be actively displaced by 
molecules of higher binding strength [232]. This phenomenon has been 
extensively exploited in many biological assays for indicating the 
presence of a specific testing antigen by the competitive removal of target 
analogues labelled with observable reporter moieties (such as 
radioisotopes, enzymes or fluorescent dyes) [232, 233]. Such analogues 
may consist of compounds that are structurally similar to the target 
antigen or analytes that have undergone some form of chemical 
modification [232]. In some cases, the process of reporter label 
attachment is often sufficient to decrease the binding affinity of antigenic 
molecules, allowing their use as moderately bound ligands.  
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In this study, a displacement immunosensor specific to PSA was 
constructed via the conjugation of a QDot nanoparticle to an anti-PSA 
antibody to form an initially fluorescent immunological recognition 
complex. This complex was subsequently quenched by the moderate 
binding of an acceptor-labelled peptide (consisting of the amino acids 
responsible for antibody-PSA interaction). As a result of antibody binding, 
this peptide is brought within the distance required for the absorbance of 
the QDot emissions via FRET. However, in the presence of PSA (which 
has a higher affinity towards the antibody molecule) this peptide is 
displaced, relieving FRET quenching effects and restoring fluorescence 
(Figure 39). 
Figure 39: PSA immunosensor assembly: a) antibody-QDot conjugates are incubated 
with a quencher-labelled peptide, b) binding brings QDot and quencher into required 
FRET proximity and decreases emission, c) PSA protein displaces the peptide and 
restores fluorescence. Taken with permission from [234]. 
4.2.2 Quantum Dot Nanoparticles 
Several recent studies have demonstrated the excellent performance of 
QDots as fluorescence reporters within displacement biosensor assays 
[151, 235, 236]. QDots are nano-sized particles or crystals made from 
fluorescent semi-conductor materials, such as cadmium selenide, 
cadmium sulfide and indium arsenide, with diameters of approximately 2-
10 nm. These dots exhibit unique spectral properties due to the quantum 
confinement of excitons within all three spatial dimensions [237]. The 
most distinctive of these properties is the high emissions intensities 
exhibited by particles, the wavelengths of which may also be finely tuned 
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QDots also possess several key advantages over single-molecule 
fluorophores in biological labelling applications, such as greater 
resistance to photobleaching, and the ability to be applied within the 
aqueous environments required for biological use [239]. Furthermore, the 
tuneable absorbance and emission properties of QDots can allow for the 
excitation of multiple nanoparticles, each emitting within entirely different 
regions of the visible spectrum, using a single illumination wavelength 
[240]. QDots are therefore ideal for use within assays that require the 
multiplex detection of several different targets within the same sample.  
The possibility to conjugate QDots to biological recognition moieties (such 
as peptides, aptamers and antibodies) through a variety of labelling 
chemistries has meant that such nanoparticles have been highly 
employed in the development of FRET-based biosensing assays [241]. 
QDot nanoparticles may therefore represent great potential for use within 
the construction of displacement immunosensors for the analysis of 
biological fluid targets. 
4.3 Materials and Methods 
4.3.1 Reagents 
Anti-PSA antibody 8301 was purchased from Abcam (Cambridge, UK), 
whilst the Qdot™ 625 Antibody Conjugation Kit was obtained from 
Thermo Fisher Scientific (California, USA). Black Hole Quencher-3 (BHQ-
3) was obtained from Biosearch Technologies (California, USA). Purified 
PSA protein was purchased from AbD Serotec (Kidlington, UK).  
All amino acids and peptide coupling reagents were purchased from 
Sigma-Aldrich (Dorset, UK), with the exception of NovaPEG Rink Amide 
resin (0.4-0.8 mmol/g loading capacity), which was obtained from Merck 
Millipore (San Diego, USA). All reagents were used without modification, 
except DMF which was kept under constant nitrogen flow. 
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4.3.2 Body Fluid Collection and Storage 
Seminal fluid was obtained upon informed consent from the same healthy 
donor and stored at 4 °C until the point of analysis. Ethical clearance for 
the collection and use of body fluids for this specific study was granted by 
the King’s College London Biomedical Sciences, Dentistry, Medicine and 
Natural & Mathematical Sciences Research Ethics Subcommittee 
(reference number BDM/13/14-26).  
4.3.3 DVCAQV-NH2 
Peptide DVCAQV-NH2 was synthesized manually via a standard Fmoc-
SPPS strategy. NovaPEG Rink Amide resin (100 mg) was first swelled in 
an empty fritted polypropylene tube for 30 minutes using anhydrous DMF.  
All acylation steps were conducted using four equivalents of amino acids, 
pre-activated for 10 min with a solution of O-(1H-6-Chlorobenzotriazole-1-
yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HCTU) and DIPEA 
in DMF in a molar ratio of 1:0.95:2 of amino acid: HCTU: DIPEA, 
respectively.  
Coupling reactions were conducted for 1 hr and monitored by the 
picrylsulphonic acid test. Fmoc deprotection of coupled amino acids was 
accomplished by treatment with 20% (v/v) piperidine in DMF for 30 min 
and confirmed by the picrylsulfonic acid test. Excess reagents and 
impurities were removed by extensive washing with DMF, methanol and 
DCM.  
Cleavage of the peptide from the solid support was achieved by treating 
the amide resin with a 1 ml solution of TFA: water: phenol: TA: TIPS in a 
molar ratio of 95:0.5:0.5:0.5:0.25 respectively for 3 hrs at room 
temperature. The cleavage filtrate was concentrated under a stream of 
nitrogen at 40 °C to a total volume of 0.5 ml. Ice cold diethyl ether was 
added to precipitate the peptide product before the removal of organic 
solvent through centrifugation. The obtained peptide was washed several 
time with diethyl ether to remove any residual scavenger traces, and 
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finally dissolved in 50% ACN in water containing 0.1% TFA and freeze-
dried for 24 hours.  
Product purity was examined by RP-HPLC on a HP1050 HPLC system 
(Hewlett Packard, California, USA) equipped with an autosampler, 
quaternary pump and Diode-Array Detector using a Zorbax SB C-18 
2.1mm x 10cm (particle size 3.5 micron) column. A linear gradient of 
mobile phase B (ACN containing 0.1% TFA) over mobile phase A (0.1% 
TFA in water) from 0-90% B in 26 min was performed with a flow rate of 
0.2 ml/min. Eluents were monitored between 210-280 nm with data 
collected and analysed using ChemStation software. Correct product 
mass was verified by ESI-MS on a Waters/Micromass (Manchester, UK) 
ZQ mass spectrometer. 
4.3.4 Biacore Analysis 
The interactions of Antibody 8301 with native PSA protein and DVCAQV-
NH2 were monitored using a Biacore T200 SPR instrument (GE 
Healthcare, Illinois, USA). Approximately 11,000 response units of 
antibody were immobilised on a carboxy-methylated dextran matrix CM5 
sensor chip after activation with EDC and N-hydroxysuccinimide (NHS). 
Samples were injected at concentrations of 160, 80, 40, 20, 2 and 0.2 nM 
in HBS-P running buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 0.005% 
v/v Surfactant P20) with two injections of 10 mM glycine-HCl pH 1.7 used 
to regenerate the surface of the sensor chip between samples. Antibody 
interaction signals were analysed using BIAevaluation software. 
4.3.5 BHQ-3-DVCAQV-NH2 
Coupling of peptide DVCAQV-NH2 to BHQ-3-N-succinimidyl ester (BHQ-
3-NHS) was accomplished following the procedure reported by Stefflova 
et al. [242]. First, DVCAQV-NH2 was dissolved in DMSO with 1% DIPEA 
before reacting for 2 hrs with equimolar BHQ-3-NHS (also in DMSO) to 
produce BHQ-3-DVCAQV-NH2. Reaction products were precipitated in 
ice cold diethyl ether and dried under vacuum. Peptide identity was 
confirmed through matrix-assisted laser desorption-ionization time of flight 
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(MALDI-TOF) mass spectrometry using a Bruker Daltonics Autoflex 
spectrometer (Massachusetts, USA) with Anchorchip™ targets (600 
µm/384). 
4.3.6 Antibody-QDot Conjugation 
The conjugation of anti-PSA antibody (8301) to amine-functionalised 
QDots was carried out using protocols and reagents supplied with the 
QDot™ 625 Antibody Conjugation Kit. Briefly, 300 μg of antibody was first 
reduced through incubation with a 1 M solution of dithiothreitol (DTT) for 
30 min to expose free thiol groups. During this period, a solution of QDot 
nanoparticles was activated with malemide crosslinkers through the 
addition of 10 mM succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-
carboxylate (SMCC).  
Both reduced antibody and activated QDots were then subjected to buffer 
exchange using a supplied desalting column before being allowed to 
react for 1 hr at room temperature. Unreacted functional groups were 
then blocked through the addition of 10 mM β-mercaptoethanol, with 
further incubation for 30 min. Antibody-QDot conjugates were finally 
separated from any unconjugated components through a supplied gel 
filtration column. 
Separation by agarose gel electrophoresis was used to confirm the 
successful coupling of anti-PSA antibodies to QDot nanoparticles. 
Collected antibody-QDot conjugates, unconjugated QDots and SMCC 
activated nanoparticles were diluted to a concentration of 10 nM in SDW 
and loaded onto a 3% agarose gel in ×0.5 TBE buffer, which was then 
run at 100 V for ~3 hours.  
4.3.7 Displacement Assay 
To investigate the optimal molar ratio of antibody-QDot conjugates to 
BHQ-3-DVCAQV-NH2 required for fluorescence quenching, 100 µl of 
quencher-label peptide at a range of concentrations (5, 10, 20, 40, 80, 
160 nM) was incubated with 10 nM solutions of antibody-QDot (100 µl) for 
Page | 118  
1 hr at room temperature. Emissions were recorded before and after 
peptide incubation on a Biotek HT spectrofluorometer (Vermont, USA) 
using Ex400±30/Em645±40 nm wavelengths (for the measurement of 
emissions at 625 nm). An appropriate negative control (100 μl SDW + 
100 μl antibody-QDot) was also utilised. The displacement of moderately 
bound peptides was then achieved through the addition of 160 nM PSA 
(100 µl) to each sample, whereupon spectra were re-recorded. All 
measurements were performed in triplicate. 
4.3.8 DNA Profiling 
To determine the effects of this sensor on DNA profiling, a 50 μl volume 
of 10 nM antibody-QDot-BHQ-3-peptide solution was added to 150 μl of 
seminal fluid.  A reference DNA sample was then prepared through the 
addition of 50 µl SDW to a second semen volume in place of substrate 
reagent. Both samples were then subjected to DNA extraction using the 
QIAamp® DNA Investigator kit (Qiagen, Manchester, UK) according to 
manufacturer protocols.  
Extracts were quantified using the Quantifiler™ Human DNA 
Quantification Kit (Thermo Fisher Scientific, California, USA), diluted to 
0.1 ng/µl and amplified using the AmpFlSTR® NGM SElect Express Kit 
(Thermo Fisher Scientific, California, USA) on a Perkin Elmer 9700 
thermal cycler (Cambridge, UK). Amplified STR products were then 
resolved through capillary electrophoresis using an Applied Biosystems® 
3130 Genetic Analyser and evaluated using GeneMapper® software 
(California, USA).  
4.4 Results and Discussion 
4.4.1 Immunosensor Design 
The selection of a suitable quencher-labelled analogue that is able to 
undergo indefinite antibody binding until it is preferentially displaced in the 
presence of a target analyte may be considered the most challenging 
aspect of immunosensor development. Due to their lack of secondary 
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folding structure, synthetic peptides based on the specific amino acids 
responsible for protein-antibody interaction are likely to possess a lower 
binding affinity than their native protein counterparts [243]. These 
sequences may therefore have ideal use as moderately bound quenching 
ligands in antibody displacement assays. Furthermore, the small length of 
most protein epitope-based sequences ensures that acceptor molecules 
attached to such ligands will be brought within the required distance for 
the efficient FRET quenching of antibody-bound donor fluorophores.  
Antibody and peptide analogue selection were therefore both based on 
previous research conducted by Piironen et al. [244], in which the 
antigenic epitopes of PSA for a range of monoclonal antibodies were 
determined. In this study, anti-PSA antibody 8301 (designated in Piironen 
as E86) exhibited considerable specificity and binding affinity for free PSA 
protein. Furthermore, this antibody was shown to interact exclusively with 
amino acids 158-164 (DVCAQV) of PSA, which were subsequently 
selected as the basis for the construction of a quenching peptide ligand. 
Figure 40: Normalised spectral overlap of BHQ-3 absorption compared to 605 and 625 




Page | 120  
With the hope that this sensor may eventually be applied towards the 
detection and identification of seminal fluid at crime scenes, QDot 
nanoparticles emitting at 625 nm were specifically chosen for use within 
this assay in order to prevent the potential quenching of sensor 
fluorescence by the broad absorption spectrum of human semen [245]. 
The most suitable quenching partner for QDots was found to be BHQ-3, 
with suitable absorbance overlap of QDot™ 625 emissions previously 
demonstrated by Kattke et al. [151] (Figure 40).  
4.4.2 Quenching Peptide Synthesis 
The construction of a moderate affinity peptide ligand based around 
amino acids 158-164 (DVCAQV) of PSA was accomplished using a 
standard SPPS strategy. Peptide DVCAQV-NH2 was then labelled with 
the succinimidyl ester form of BHQ-3 to produce BHQ-3-DVCAQV-NH2 
(Figure 41).  
Figure 41: Structure of conjugated quenching peptide BHQ-3-DVCAQV-NH2. Taken 
with permission from [234]. 
This particular quencher was not only chosen due to an efficient spectral 
overlap of QDot™ 625 emissions, but also for a lack of native 
fluorescence. Instead, this ‘dark’ quencher dissipates absorbed light via 
non-radiative processes (such as the generation of heat through 
molecular bond vibration), allowing its use at higher concentrations in 
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Analysis via ESI and MALDI-TOF mass spectrometry was used to confirm 
the successful synthesis of DVCAQV-NH2 and BHQ-3-DVCAQV-NH2 
respectively (Figure 42). 
Figure 42: ESI-MS of peptide DVCAQV-NH2 (calculated m/z for [M+H]+ = 633.3, main 
peak reported = 633.1). Inset: MALDI-TOF of BHQ-3-DVCAQV-NH2 (calculated m/z for 
[M+H]+ = 1162.5, main peak reported = 1162.770). Taken with permission from [234]. 
4.4.3 Biacore Analysis  
Differences in the binding affinity of anti-PSA antibody 8301 with both 
native PSA protein and DVCAQV-NH2 were monitored in real-time using a 
Biacore SPR instrument. In this technique, antibody ligands are first 
covalently attached to the surface of a carboxy-methylated dextran-
functionalised gold-coated sensor chip. A polarized light source focused 
through a glass prism is then used to illuminate the chip, causing light to 
be reflected at a specific angle of incidence (θ). At this angle, light will 
excite plasmons at the surface of the gold, causing SPR to occur. 
Analytes are then passed over the surface of the chip within a continuous 
buffer solution and captured by immobilised ligands. Accumulation of 
mass as a result of target capture affects a change in resonance angle, 
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which is measured by the instrument [247]. A schematic overview of this 
process is provided in (Figure 43). 
Small response unit increases observed upon 40 nM peptide injection 
indicated a successful binding of DVCAQV-NH2 to immobilised anti-PSA 
antibodies, whilst the same concentration of PSA showed much larger 
interaction, requiring three injections of 10 mM glycine-HCl (pH 1.7) to 
regenerate the surface of the sensor chip. This reflects the significantly 
large affinity constant of 1×1011 L mol-1 given by the antibody 
manufacturer.  
Figure 43: Schematic representation of Biacore affinity analysis. 
However, attempts to gain a quantitative measurement of peptide binding 
affinity were unsuccessful. This is usually achieved via the construction of 
a calibration curve of immobilised antibody resonance responses against 
a range of different analyte concentrations. Whilst such responses were 
adequately observed upon peptide injections of 40, 20, 2 and 0.2 nM, 
concentrations above this level could not be detected, preventing 
accurate curve plotting. The reason for this lack of signal remains 
unresolved but may involve the dimerization of peptides at higher 
concentrations through cysteine residue disulphide bridge formation, 














Page | 123  
4.4.4 Antibody-QDot Conjugation 
Anti-PSA antibodies were conjugated to amine-functionalised QDot 
nanoparticles using a sulfhydryl-reactive antibody conjugation kit, 
allowing for the site-specific labelling of hinge region thiols [248]. This 
approach was chosen over the traditional non-specific labelling of amine 
groups through EDC chemistry in order to better control the distance 
between QDots and quenching ligands and ensure that all FRET 
components are within the 10 nm distance required for quenching. 
Many authors have noted the difficulties associated with confirming 
conjugation between antibodies and QDots [249]. Some studies have 
found moderate success in the separation of antibody-QDot complexes 
from unconjugated nanoparticles by agarose gel electrophoresis [250, 
251], but with electrophoretic mobility based on both size and charge, 
results are often unpredictable.  
Figure 44: A 3% agarose gel demonstrating the separation of a) unconjugated QDots, 
b) SMCC- activated QDots and c) anti-PSA antibody-QDot conjugates. Taken with 
permission from [234]. 
According to the manufacturer protocols supplied with the QDot™ 625 
Antibody Conjugation Kit, the ratio of antibodies conjugated to each QDot 
during labelling is approximately 4:1. Assuming this information is correct, 
the weight of antibody-QDot conjugates will be ~800 kDa. Such 
conjugates are therefore likely to run significantly slower on a gel 
compared to ~200 kDa unconjugated nanoparticles. SMCC-activated 
QDots would also be expected to travel slightly slower due to the addition 
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of malemide cross-linkers. A small amount of separation that reflects 
these size differences was seen during electrophoresis experiments, 
which may be taken as an indication of successful antibody-QDot 
conjugation (Figure 44). 
4.4.5 Displacement Assay 
In a preliminary assay optimisation study, varying concentrations of BHQ-
labelled peptide were incubated with 10 nM antibody-QDot conjugates to 
determine the ideal molar ratio of ligand required to quench biosensor 
fluorescence. Significant decreases in nanoparticle emission intensities 
were observed within all samples, even at lower BHQ-3-DVCAQV-NH2 
concentrations, successfully establishing the binding of peptide ligands to 
the antibody-QDot complex (Figure 45). However, a large peptide 
concentration of 160 nM was required for the complete quenching of 
QDot signals. 
Figure 45: Fluorescence emissions of antibody-QDot conjugates before and after 
incubation with quencher-labelled peptides. Data represents the mean ± SD, samples 
performed in triplicate. 
The subsequent addition of 160nM PSA to quenched conjugates resulted 
in the immediate restorations of antibody-QDot fluorescence comparable 
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to pre-peptide incubation emission intensities (Figure 46), indicating the 
successful displacement of moderately bound ligands. Statistical analysis 
of datasets from samples both pre and post-PSA addition across all BHQ-
3-DVCAQV-NH2 concentrations using a Wilcoxon signed-ranks test found 
these fluorescence increases to be statistically significant (p = 0.018). 
Figure 46: Fluorescence emissions of antibody-QDot conjugates incubated with 
quencher-labelled peptide before and after PSA addition. Data represents the mean ± 
SD, samples performed in triplicate. 
4.4.6 DNA Profiling 
Whilst no detrimental effects on DNA profiling processes were observed 
during the application of fluorogenic substrate-based biosensors to body 
fluid samples, this may not be the case for sensors employing 
immunological or nanoparticle components. Therefore a solution of 
antibody-QDot conjugates was applied to a 150 µl volume of seminal 
fluid, which was then subjected to standard forensic DNA extraction, 
quantification, amplification and electrophoresis procedures. A DNA 
reference sample was also prepared through the addition of 50 µl SDW to 
a second volume of semen, which was processed in an identical manner. 
No differences between immunosensor-added and reference samples 
outside the limits of normal experimental variation were observed at any 
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stage of the profiling process. DNA extracted from semen containing 
immunosensor reagent was quantified at 2.21 ng/µl, whilst the semen 
reference sample was found to contain DNA at a concentration of 2.33 
ng/µl. Furthermore, a full STR profile was obtained from this sample, with 
no negative effects to high molecular weight loci (Figure 47).  
Figure 47: STR profiles generated from seminal fluid samples containing a) 
immunosensors and b) SDW. Taken with permission from [234]. 
4.5 Conclusion 
Promising results were demonstrated in the construction of an 
immunological displacement sensor towards PSA. Fluorescent signal 
transduction involved the displacement of a moderately bound quenching 
peptide ligand from an antibody-binding site by native PSA protein to 
restore labelled nanoparticle fluorescence. This sensor demonstrated an 
immediate response to PSA within solution, with ‘turn-on’ QDot emission 
signals easily observed via spectrofluorometry. 
Work presented in this chapter primarily focused on the design and 
development of an entirely novel biosensor rather than its application 
within a forensic context. As a result, investigations into this sensor were 
limited to the detection of purified PSA protein within solution. However, 
the promising performance demonstrated by this assay is likely to justify 
further exploration of its use within the analysis of whole seminal fluid 
both in solution and deposited in situ.  
a)
b)
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Future studies are likely to involve modifications to individual sensor 
components to optimise assay specificity, sensitivity and robustness to 
varying environmental conditions. This may include alterations to the 
amino acid sequence of BHQ-3-labelled peptides, which may increase 
initial biosensor quenching by enhancing binding affinity with antibody-
QDot conjugates. Selection of ideal sequences may be achieved via the 
use of peptide microarrays, such as those exploited within epitope 
mapping studies, or through computer modelling. An extensive validation 
of final sensor constructs, encompassing a comprehensive evaluation of 
cross-reactivity, limit of detection, variability, comparison with other 
biological fluid tests and performance against mock casework samples 
should also be undertaken.  
An ideal application of this sensor is likely to involve the exploitation of 
several different antibody-QDot conjugates (each with a separate 
emission wavelength) for the simultaneous detection of several protein 
targets within a multiplex fluid sensing system. The interchangeable 
nature of QDots and antibodies may allow for this application to be 
realised and would likely depend upon the elucidation of amino acid 
sequences attributed to antibody interaction with forensically relevant 
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5.1 Introduction 
After successfully demonstrating detection of an intra-fluidic target, further 
efforts to construct displacement-based sensors for the analysis of 
biomarkers in other fluid types were deemed justified. However, during 
immunosensor investigation, significant challenges were encountered in 
the use of antibodies as recognition elements. Protocols required for the 
site-specific conjugation of nanoparticles to antibody fragments were 
found to be complex and time-consuming. Furthermore, this conjugation 
came at significant expense, with each QDot-labelling kit costing 
approximately £500 (in addition to costly antibody components). Such 
expense is likely to increase the overall cost of produced assay reagents, 
limiting potential use in forensic casework to targeted stain identification 
rather than large volume biological screening. 
It was subsequently hypothesised that bio-recognition elements based on 
nucleic acid aptamers may be a more suitable alternative to antibodies in 
displacement-based biosensors for the detection of body fluid targets. 
These molecules usually consist of short strands of single stranded DNA 
(ssDNA) or RNA raised in vitro to bind to virtually any given target [252]. 
Aptamers possess several advantages that make them ideal for use 
within fluorescent biosensing assays. Whilst comparable to antibodies in 
terms of specificity and affinity [253], aptamers are entirely synthetic, 
making them easy to produce at low a cost with no batch-to-batch 
variation [254]. Aptamers may also be selected against significantly large 
targets (such as whole cells and tissues [255]), which may be especially 
useful in fluid identification assays. 
This chapter opens with a comprehensive review on aptamer-based 
sensors (aptasensors) for the purpose of forensic analysis. This review, 
which underwent publication in 2017, includes a brief overview of the 
aptamer selection process, the types of sensors that may be constructed 
using aptamer recognition moieties and developed aptasensors that have 
been previously reported for the detection of forensically-relevant targets.  
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The chapter then explores the construction of a displacement-based 
multiplex body fluid detection sensor using several different fluorescently-
labelled aptamer sequences that are initially quenched through 
adsorption to graphene oxide (GO) nanosheets. Both the presence and 
identity of fluids is then indicated through the production of emissions at 
specific wavelengths (corresponding to each type of fluid) after the 
liberation of sequences from the GO surface as a result of intra-fluidic 
protein interaction. Attempts to increase the specificity of this aptasensor 
through the selection of ssDNA aptamers towards whole cell targets are 
lastly explored. Aptamers were successfully generated against human 
sperm cells using a modified Cell-SELEX protocol with sequence 
elucidation achieved through next generation sequencing (NGS) and a 
novel bioinformatics pipeline.  
5.2 Published Article 4: ‘Developing Aptasensors for Forensic 
Analysis’ 
The content of following section was published as a review article in: 
Gooch, J., Parkin, M., & Frascione, N., Developing aptasensors for 
forensic analysis. TrAC Trends in Analytical Chemistry, 2017. 94: p. 
150-160. 
Drafting of the manuscript was performed by the candidate. Dr. Mark 
Parkin and Dr. Nunzianda Frascione had final approval over manuscript 
submission. 
5.2.1 Manuscript 
Authors: James Gooch,a Mark Parkin,a Nunzianda Frascione.a*  
Authors Address: a) Analytical and Environmental Sciences Division, 
King’s College London, 150 Stamford Street, London, SE1 9NH, UK 
Abstract: Aptamer-based biosensors may be of significant benefit to 
forensic analysis by allowing the rapid, sensitive and specific detection of 
molecular targets relevant to criminal investigation. However, despite the 
production efficiency, stability and cost effectiveness of aptamer 
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recognition moieties, aptasensors have yet to find commercial 
employment within any area of forensic science. This review therefore 
attempts to encourage aptasensor development by initially identifying the 
methods of selection, sequence analysis and affinity measurement most 
appropriate for the discovery of suitable aptamers against analytes of 
forensic interest. A range of optical, electrochemical and mass-sensitive 
transduction platforms that may be considered amenable to current 
forensic testing procedures are then discussed. The specific analytical 
disciplines in which aptasensing technology is likely to be of greatest 
value, including forensic drug analysis, forensic toxicology and biological 
evidence and explosives detection are lastly highlighted to stimulate 
researchers to consider the development of sensors towards these 
particular target types. 
Introduction 
Forensic science may be considered one of the broadest analytical 
disciplines due to the extensive spectrum of analytes and sample types 
used to add value to a criminal investigation. For example, in the field of 
human identification alone, examinable material may range from 
simplistic visual patterns (e.g. fingermarks) to complex biological 
molecules (e.g. DNA) [256]. Challenges associated with the growing 
variety of analytical techniques and instrumentation required by forensic 
laboratories to meet comprehensive testing demands have prompted the 
search for new and flexible methods that are able to detect, identify and 
quantify analytes of forensic interest. 
Immunological analysis methods have long been an integral part of 
forensic serological and toxicological screening processes [3]. However, 
with the recent discovery of aptamer-based recognition, research groups 
are beginning to question the efficiency of the ELISA and lateral flow strip 
testing strategy’s currently employed by forensic laboratories. Nucleic 
acid aptamers are short single-stranded DNA or RNA sequences that are 
able to undergo selective antigen association as a result of three-
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dimensional structure formation [257]. These structures (usually a 
combination of k-turn, loop, pseudoknot and quadruplex motifs) facilitate 
intermolecular interaction with targets via van der Waal forces, hydrogen 
bonding and aromatic ring stacking [258]. Through the in vitro enrichment 
of random oligonucleotide libraries (consisting of approximately 1012-1015 
individual sequences) aptamers may be developed towards almost any 
small molecule [259], virus [260], large protein [261] or whole-cell target 
[262], giving potential for their use as recognition moieties in the analysis 
of diverse forensic samples. 
While analogous to antibodies in terms of binding affinity (often displaying 
Kd values in the nanomolar or picomolar range [263]), aptamers possess 
a number of key advantages over their protein counterparts. Once 
selected, aptamer sequences can be mass-produced using automated 
solid-phase synthesis techniques, resulting in the production of highly 
purified oligonucleotides within a number of hours and at a fraction of the 
cost of biological antibody generation methods [264]. Aptamers also 
display greater thermal stability affording long shelf-lives without loss of 
activity, easy transport and storage and ability to return to a native 
confirmation being subjected to high-temperature assay conditions [265].  
Although demonstrating success as effective therapeutic agents [266], 
aptamers, since their discovery, have been predominately developed as 
recognition molecules for use in a range of biological chemical analysis 
techniques. This has mainly focused on the use of immobilized aptamers 
within traditional ELISA, western blot, flow cytometry and lateral flow 
assays as replacements for expensive and cumbersome antibody 
moieties [264]. In addition, aptamers have also found beneficial 
application within the field of separation science, having been used to 
successfully resolve enantiomeric molecules within High Performance 
Liquid Chromatography (HPLC) systems by the inclusion stereospecific 
aptamers on solid chromatographic supports [267].  
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Nevertheless, Hamaguchi et al. argue that the most powerful application 
of nucleic acid aptamers is within analytical biosensing platforms [145]. 
Biosensors are compact devices capable of the real-time transduction of 
biological interaction events into a number of measurable signal outputs 
[268]. Some authors have recently recognized the potential of biosensors 
to provide the highly specific detection and quantification of forensically 
relevant materials (such as body fluids, drugs, explosives and toxins) 
without the need for extensive sample processing steps [121, 131, 234]. 
Displaying significant conformational changes upon target binding and 
allowing an extensive range of chemical modifications (including the 
incorporation of various optical, electrochemical or nanoparticle reporters 
[269]) at various sites without loss of binding affinity, aptamers may be 
considered as ideal recognition moieties for use within molecular sensing 
purposes [270]. 
Despite great promise, aptasensors (or indeed any form of aptamer 
technology) have yet to find commercial employment within the field of 
forensics. This lack of success has been attributed to a number of factors, 
including the limited number of aptamer sequences raised against 
analytically relevant targets [270], the need for further investigation into 
the use of developed sensors within complex matrices [121] and the high 
investment already made by analytical laboratories in antibody-based 
testing methods [271]. This review therefore attempts to outline the 
current state of aptasensor development processes, with a specific focus 
on those techniques most likely to aid the construction of forensic analyte 
sensing devices. Recent advances in aptamer selection, sequencing and 
affinity testing are first explored, along with signal transduction 
mechanisms most amenable to current forensic testing capabilities. A 
number of forensic disciplines liable to benefit from aptasensor 
application are lastly identified in the hope of encouraging experts within 
the field of biosensor design to produce aptasensors towards valuable 
evidential targets. 
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Aptamer Development 
Aptamer Selection 
In recent years, a substantial number of modifications have been made to 
the SELEX (Systematic Evolution of Ligands by EXponential enrichment) 
protocol initially developed by Gold’s [272] and Szostak’s [273] groups. 
While generally based on the same library incubation, target binding and 
sequence amplification principles exploited within the original method, 
these modified techniques differ in their approach to the separation and 
removal of non-specific ligands [274]. By altering the means in which 
aptamer-target complexes are partitioned from unbound oligonucleotides, 
aptamers may be selected against particular target types with a higher 
specificity and affinity than would be possible using conventional SELEX 
protocols [275]. As the physical properties of forensically relevant targets 
are extremely diverse, it is vital that an optimal selection method is 
chosen and carried out prior to aptasensor development. A summary of 
SELEX protocols that may be useful in the selection of aptamers against 
forensically relevant targets can be found in Table 9. 
.These modifications are especially pertinent in the selection of aptamers 
towards low-molecular weight forensic analytes (e.g. toxic chemicals and 
explosives), where separation is problematic due to the similar masses of 
bound complexes and unbound nucleic acid sequences [253]. The 
immobilization of such targets to a solid support surface (e.g. sepharose, 
agarose or magnetic beads) may be used to increase separation 
efficiency but can also result in the amplification of non-specific 
sequences that bind to the support matrix or immobilization linkers [259]. 
Furthermore, the creation of a chemical link between the small molecule 
target and the solid support can introduce an unfavourable selection bias 
through the removal of least one potential aptamer binding site. 
Fortunately, a number of SELEX processes that allow for the selection of 
aptamers against small-molecules without the need for target 
immobilization have recently been developed. 
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Table 9: SELEX protocols that may be used to select aptamers against forensic 
targets 




Aptamer-target complexes are 
separated from unbound 
nucleotide sequences according to 
electrophoretic mobility. 
- Selection may be 
completed within 2-4 rounds.          
- Useful for small molecule 
targets. 
[276] 
Capture-SELEX Library sequences are displaced 
from magnetic beads by target 
binding. Unbound ligands are then 
removed magnetically. 
- Aptamers display large 
structural changes.           
- Useful for small molecule 
targets. 
[277] 
Cell-SELEX A panel of membrane biomarker-
specific aptamer sequences is 
produced as a result of exposure 
to live cell targets. 
- Counter-selection used to 
increase specificity.                        
- Selection performed on 
targets in native state. 
[278] 
FluMag SELEX Complexes formed between bead-
immobilized analytes and 
fluorescent library sequences are 
collected magnetically. 
- Selection rounds and 
dissociation values may be 





Graphene oxide is used to adsorb 
and separate unbound ssDNA 
sequences from aptamer-target 
complexes in solution.  
- Requires less than 5 rounds 
of selection.               
- Useful for small molecule 
targets. 
[280] 
In-Silico SELEX Theoretical oligonucleotide 
libraries are screened against a 
target using computational tools to 
identify potential binders. 
- Atomic-level mechanisms of 
nucleotide-target binding can 




Ligands bound to magnetic or sol-
gel bead-conjugated targets are 
purified by continuous washing 
within a microchannel. 
- Lower target molecules and 
reagent volumes are required 
as a result of miniaturization.  
[282] 
MonoLEX Affinity columns used to partition 
aptamer-target complexes are 
physically segregated to elute 
highest affinity sequences.  
- Requires a single round of 
selection.                    
- Diminishes competition 
between sequences. 
[283] 
NanoSelection High affinity aptamers are detected 
and recovered via the use of 
fluorescence and Atomic Force 
Microscopy (AFM).  
- Requires a single round of 
selection.                    
- Binding affinity may be 
measured by AFM.      
[284] 
 
Capture-SELEX (also known as structure-switching SELEX), involves the 
conjugation of oligonucleotide libraries themselves to DNA-functionalized 
magnetic particles by use of a complimentary ‘docking’ sequence [277, 
285]. When incubated with a target molecule, sequences that undergo 
conformational changes as a result of binding are displaced from the 
beads (which can then be removed with unbound ligands through the 
application of a magnetic field). Aptamers isolated using this capture 
Page | 136  
method may be considered particularly attractive recognition moieties for 
use in analytical biosensing platforms due to their significant structure-
switching abilities [286].  
Another immobilization-free method, GO-SELEX, makes use of the ability 
of graphene oxide (GO) to bind single stranded DNA through π-π 
stacking interactions [280]. In this technique, target molecules are first 
incubated with an oligonucleotide library in solution, allowing binding to 
occur. Unbound sequences are then adsorbed onto the surface of the 
graphene oxide, allowing separation from aptamer-target complexes via 
centrifugation. Ethanol precipitation is finally used to purify and recover 
bound ssDNA sequences. As partitioning is purely based on interaction 
between DNA libraries and graphene, GO-SELEX is largely independent 
of target size (and has already been successfully employed to produce 
aptamer sequences towards low-molecular weight pesticide compounds 
[287]).  
One class of forensic analytes that may also benefit from aptamer-
sensing application is that of whole-cells. The immunological analysis of 
cellular material is currently undertaken by forensic laboratories as a 
method of confirming the identity of biological fluid deposits left behind at 
crime scenes [3]. Unlike conventional SELEX procedures, the selection of 
aptamers against whole-cells does not require the use of a single highly 
purified (or even known) target. First described by Morris et al., Cell-
SELEX instead involves concurrent binding of library oligonucleotides to 
multiple biomarkers exposed on the surface of intact live cells [278]. As a 
result, this approach generates a panel of aptamer sequences (each 
targeting a particular membrane protein or lipid) that can then be used for 
cell recognition purposes [288]. The use of live targets within Cell-SELEX 
ensures that aptamers are raised towards the native conformational 
structure of such membrane molecules, allowing for the high-affinity 
binding of natural cellular material during subsequent analysis [262].  
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In comparison to other selection protocols, the partitioning of unbound 
nucleotides within Cell-SELEX is relatively simplistic and may be 
achieved by basic centrifugation or washing steps [289]. A counter-
selection stage, in which enriched libraries are incubated with a negative 
control cell line, is also often included in cell-selection protocols to remove 
non-specific ligands that bind to universally shared membrane motifs 
[290]. Cell-SELEX techniques have in fact already been used to produce 
aptamers against sperm [291] and red-blood cell targets [278], which may 
already be of potential use within forensic assays for the analysis of 
biological fluids.  
Sequence Analysis 
Following sufficient enrichment, aptamer pools are sequenced in order to 
elucidate the nucleotide structures of high-affinity binders [274]. 
Conventionally, this process was performed via the ligation of selected 
sequences into commercially available cloning vectors, which are then 
transformed into competent bacterial cell colonies. Approximately 50-100 
individual clones (each possessing one aptamer sequence) are then 
recovered before plasmids are extracted and subjected to standard 
Sanger sequencing [292]. However, whilst able to indicate the most 
abundant aptamers present within an enriched pool, these cloning 
techniques only involve the sequencing of a small fraction of the total 
binders obtained during selection (which may be up to 1,000,000 
sequences) [293]. As a result, the majority of new aptamer development 
protocols now make use of next generation sequencing (NGS) platforms 
for the comprehensive analysis of potential binding candidates [294]. 
Such high-throughput methods not only allow the discovery of millions of 
sequences from enriched pools without laborious cloning processes, but 
can also be used to shorten selection processes by identifying aptamers 
during early SELEX rounds [295].  
Commercially available NGS platforms previously used for aptamer 
discovery include Ion Torrent’s Personal Genome Machine (PGM) [296]
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Figure 48: Workflow of the Illumina sequencing-by-synthesis approach - Specialist 
adapter sequences are first ligated to the end of aptamers obtained from SELEX-
enriched pools. These adapters aid the anchoring of selected oligonucleotides to the 
surface of a flow cell, allowing solid-phase bridge amplification. Fluorescently labeled 
nucleotides are then added to the cell, which is imaged after the incorporation of each 
base into DNA strands. The emission wavelengths of each nucleotide dye are then 
monitored in order to determine aptamer sequences.   
Illumina’s Genome Analyzer/HiSeq system [297, 298], Roche’s GS FLX 
system [299, 300] and Applied Biosystem’s SOLiD system [301]. 
However, with extensive sequence reads and higher total read lengths, a 
greater level of detail on the structural features of target binders may be 
provided by Illumina instruments, making them the most preferable choice 
for aptamer sequencing (Figure 48) [292]. Furthermore, these platforms, 
based upon the principle of cyclic reversible termination, are already 
widely used within the forensic community for the analysis of human 
genomic material [302] and may therefore be readily applied by forensic 
researchers to determine aptamer sequences for the recognition of 
forensic analytes. 
While NGS use may significantly enhance the resolution and sampling 
depth of enriched aptamer pools, additional computational bioinformatic 
tools are currently required to process the sheer quantity of raw sequence 
data obtained [294]. Web-based and offline pre-processing software, 
such as Galaxy [303], cutadapt [304] and AptaTools [305] are often used 
to first isolate variable aptamer regions of a defined length by removing 
adapter and constant region sequences.  
Further programs are then employed to filter this data in order to narrow 
down aptamer candidates for subsequent experimental testing. The 
FASTaptamer toolkit achieves such filtering by monitoring the relative 
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enrichment of specific aptamer sequences between selection rounds 
[306], whereas APTANI examines both the total read counts of each 
sequence as well as shared structural homology between sequences 
[307]. After aptamer discovery has taken place, sequences may be 
further analysed by programs such as mfold [308] to provide more 
information on secondary oligonucleotide structure. 
Affinity Measurement 
In order to ensure adequate aptasensor performance, it is vital that 
integrated aptamers demonstrate strong affinity towards target molecules 
[309]. Aptamer affinity is usually expressed in terms of a dissociation 
constant (Kd), the value of which may be determined by a range of 
separation-based, mass-sensitive, spectroscopic or other label-free 
techniques [259]. A summary of methods that may be able to assess the 
performance of aptamers with potential use in forensic testing may be 
found in Table 10. 
Variations in the size and physical properties of forensically relevant 
analytes make the evaluation of aptamer-target affinities challenging. 
Much like similar SELEX processes, measuring Kd via the separation of 
unbound ligands from aptamer-target complexes is often problematic for 
compounds of a smaller molecular weight than nucleotide binding 
sequences. Other techniques, such as fluorescence polarization or 
surface plasmon resonance (SPR), are additionally disadvantaged by the 
chemical labelling or immobilization of aptamers or targets, which may 
reduce Kd calculation accuracy by altering binding interactions [259]. 
A resolution to these issues may be provided by isothermal titration 
calorimetry (ITC), a label-free solution-based method that allows the 
characterization of binding energy by monitoring temperature increases 
during complex formation [310]. ITC methods are currently considered the 
‘gold standard’ for quantifying biomolecular interactions and have already 
been used to assess the affinity of aptamers towards several forensically  
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Table 10: Techniques that may be used to determine the affinity of aptamers. 
Technique Type Mechanism Ref. 
Affinity 
Chromatography 
Separation - Binding is measured after labelled aptamers or 
target molecules are incubated with corresponding 
components that are conjugated to a solid support 




Separation - Concentrations of aptamers, targets and aptamer-
target complexes are determined after size and 
charge-based separation. Fluorescent labelling of 




Separation - Unbound ligands within an aptamer-target mixture 
are allowed to diffuse through a semi-permeable 




Separation - Like capillary electrophoresis, binding 
components are separated by size and charge but 
by a non-denaturing agarose or polyacrylamide gel. 
Visualisation is required to observe isolated 
components. 
[313] 
Ultrafiltration Separation - Unbound ligands are measured after partitioning 
across a membrane (typically nitrocellulose) under 





Spectroscopic - Changes in the refractive index of a sample 
through the association of aptamer-target 





Spectroscopic - Differences in the absorption of left and right 
circularly polarized light are monitored during the 
titration of DNA against increasing concentrations 




Spectroscopic - The increase/decrease in fluorescence intensity of 
targets or labelled aptamers as a result of complex 




Spectroscopic - The rotational diffusion of fluorescent dyes 
conjugated to aptamers or targets is decreased as 
a result of binding. Subsequent increases in signal 




Spectroscopic - Affinity is inferred from variations in the 
wavelength or intensity of UV-Vis absorption of 




Mass-Based - Accumulation of aptamer-target complexes on the 
surface of functionalized piezoelectric crystals 





Mass-Based - Ligands immobilized on a sensor flow cell are 
subjected to an aqueous flow of binding partners. 
The formation of target complexes then results in a 




Other - The relative levels of aptamers protected from 
digestion (by association with varying 
concentrations of target molecules) are determined 





Other - The amount of energy required to maintain the 
temperature of a cell is monitored during 
exothermic aptamer-complex binding. 
[310] 
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relevant targets, including cocaine [322] and organophosphate pesticides 
[323]. 
 In this technique, targets are titrated into a cell containing an aptamer of 
interest and allowed to react. Heat released as a result of exothermic 
binding processes is monitored and compared to an identical reference 
cell containing buffer or water. Power required by the calorimeter to 
maintain equal temperature between the cells at each molar ratio of 
target/aptamer may then be used to construct a binding isotherm, 
allowing affinity to be determined [324].  
However, while ITC may provide detailed information on the 
thermodynamic parameters of aptamer-target interactions (such as 
changes in entropy, enthalpy and Gibb’s energy), relatively high amounts 
of target are required for detectable amounts of heat to be generated 
[261]. This may be considered problematic for some forensic analytes 
that are expensive to purchase or only available from commercial 
providers in low concentrations (although micro and nano-ITC 
instruments may be utilised to overcome these challenges). 
Biosensing Platforms 
Optical 
Reported by Kleinjung et al. in 1998, the first biosensor to use aptamers 
as moieties for target recognition involved the competitive binding of L-
adenosine and FITC-labelled analogues to an RNA ligand immobilized on 
the surface of an optical fibre [325]. As a result, the vast majority of early 
aptasensing platforms also focused on the use of optical methods to 
signal biological interaction occurrence [326]. Such sensing generally 
relies on the structural transitions that aptamers undergo during target 
binding to create measurable variations in the spectroscopic properties of 
optical transduction components [269]. These components (typically 
organic dyes, luminophores, nanoparticles or conjugated polymers) may 
be incorporated into conformationally labile regions of oligonucleotide 
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sequences by covalent attachment or as ‘label-free’ reporters by indirect 
intercalation [327]. Subsequent alterations in the microenvironment of 
these reporters as a result of aptamer folding may then prompt changes 
in the intensity, wavelength or anisotropy of label emissions [270]. 
Alternatively, multiple reporters can be used to achieve transduction 
through distance-dependent fluorescence (FRET) or chemiluminescence 
(CRET) resonance energy transfer processes [252].  
Two popular forms of optical aptasensing include aptamer-beacons and 
hybridized DNA displacement assays [328]. Based on the conventional 
molecular-beacon format for the detection of specific DNA molecules, 
aptamer-beacons are constructed by the addition of short complementary 
nucleotides (alternately labelled with a fluorophore or quencher) to each 
end of a specific aptamer sequence [145]. Under normal conditions these 
nucleotides allow the aptamer to take on a closed hairpin structure, 
bringing the quencher and fluorophore moieties within close proximity and 
restricting fluorescence output. However, in the presence of target 
molecules, aptamer interaction causes the hairpin to unfold, resulting in 
the production of a ‘signal-on’ fluorescence emission [328]. Hybridized 
DNA displacement assays (Figure 49a) work via a similar premise but 
instead employ a separate quencher-labelled antisense sequence bound 
to fluorescent aptamers through Watson-Crick base pairing that then 
dissociates in the presence of higher affinity target analytes [329]. 
One of the main advantages of optical sensing is the ability to offer real-
time analyte detection without extensive sample processing steps or 
specialized equipment [330]. Such advantages may give the potential for 
optical aptasensors to be used as chemical reagents for the simultaneous 
detection and identification of latent (i.e. non-visible) evidence deposited 
at crime scenes or on evidential items. This concept has already been 
explored within Li et al. in which two aptamers labelled with emitting gold 
nanoparticles (Au-NPs) reassembled in the presence of cocaine doped 
within latent fingermarks [331]. While the adherence of the nanoparticles 
themselves to deposited marks was sufficient to visualize identifiable 
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ridge detail, aggregation of the Au-NPs as a result of cocaine binding also 
resulted in a shift in emission wavelength of scattered light from 550-
580nm.  
Figure 49: Schema of aptamer-based sensing formats - a) Optical transduction. 
Aptamers labelled with fluorescence reporters (F) are hybridized to quencher (Q)-
conjugated DNA sequences, which absorb emission via FRET. Upon binding to targets 
(T), aptamers separate from complimentary strands, allowing fluorescence to be 
restored. b) Electrochemical transduction. Changes in aptamer confirmation as a result 
of target interaction allow redox-active labels to interact with the surface of electrodes 
to produce an electrical signal. c) Mass-sensitive. An increase in the mass of surface-
immobilized binders through aptamer-target complex formation is detected either 
optically or electrically.   
Electrochemical 
Cho et al. note that despite the significant amount of optical detection 
platforms reported during the early stages of aptasensor research, 
greater attention is now being paid to the use of electrochemical 
strategies for the transduction of aptamer interactions [270]. Biosensing 
assays incorporating such methods are becoming increasingly attractive 
to researchers due to their relative portability, ease of operation, 
robustness and low cost (to both develop and operate) [332]. 
Electrochemical aptasensors are further benefitted by excellent 
sensitivities and can be used in conjunction with a number of electrical 
signal amplification techniques (such a biocatalytic labelling) to provide 
extremely low limits of analyte detection [333]. For example, Hanson et al. 
employed the use of a single-step replacement aptasensor exploiting 
electrochemical nanoparticle stripping-based signal amplification for the 
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While electrochemical aptasensors may make use of amperometric, 
potentiometric, conductometric, impedimetric and semiconductor field-
effect principles, signals are generally derived from changes in electric 
current as a result of aptamer-mediated redox reactions occurring at the 
surface of an electrode [332]. Much like optical aptasensing mechanisms, 
these reactions are generated by reporter molecules incorporated within 
aptamer sequences, which are then bought closer to or further away from 
electrodes as a result of target binding interactions [252]. Popular 
reporters for electrochemical aptasensors include methylene blue (MB), 
ferrocene, ferricyanide, ruthenium complexes, enzymes, quantum dots 
(QDs) and metal nanoparticles [335].  
According to Han et al., electrochemical aptasensor assays may be 
designed in four broad formats: target-induced structure switching (TISS), 
sandwich, target-induced displacement (TID) or competitive replacement 
[336]. TISS assays exploit the ability of surface-immobilized aptamers to 
form rigid tertiary structures in the presence of analytes in order to 
change the proximity of signalling moieties in relation to an electrode 
(Figure 49b). Sandwich assays conversely involve the assembly of a 
complex between an immobilized primary aptamer, a target, and a 
second reporter-labelled recognition molecule (which may be an aptamer 
or an antibody). In TID sensors, complementary nucleotide sequences 
are instead immobilized and are used to anchor labelled aptamers to 
electrodes via base pairing. Upon target interaction these aptamers 
dissociate, causing a decrease in electron transfer (eT) signals. 
Competitive replacement lastly involves the incubation of targets with 
reporter-attached analytes, which then compete for aptamer binding 
space. As a result, signal intensities obtained from competitive 
replacement assays are inversely proportional to the amount of target 
present within a sample. 
Electrochemical detection platforms may be considered especially 
amenable to forensic analysis due to their excellent performance in turbid 
matrices [337]. Such sensing platforms are able to negate the effects of 
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optically absorbing and fluorescent molecules present within complex 
samples (that often interfere with spectroscopic analysis) and therefore 
represent great potential as toxicological assays for the detection of trace 
compounds within biological matrices. Work conducted by Baker et al. 
has already proven this capability through the production of an 
electrochemical TISS aptasensor that was successfully able to detect 
micromolar concentrations of cocaine in saliva and blood serum samples 
[338]. 
Mass-Sensitive 
Unlike both optical and electrochemical transduction mechanisms, mass-
sensitive aptasensing techniques do not utilise the conformational 
changes that aptamers undertake in order to indicate biological 
interaction events [270]. Instead, sequences are tethered to a variety of 
solid supports and used as simple capture ligands to create discernible 
increases in mass at sensor surfaces upon target binding (Figure 49c). 
As a result, such methods do not require the use of molecular reporters to 
generate detectable signals and are therefore classified as ‘label-free’ 
techniques [252]. Popular mass-based aptasensing formats include: 
SPR, surface acoustic wave (SAW), quartz crystal microbalance (QCM) 
and microcantilever assays [252].  
Employing the same principles for the characterization of binding affinity 
constants, SPR methods have also found use as platforms for the 
aptamer-based detection of numerous target compounds [339]. One of 
the most frequently used instruments for SPR sensing is the Biacore™ 
system manufactured by GE Healthcare [340]. In this system, aptamers 
are first covalently immobilized onto a thin gold film attached to a glass 
slide, which is then illuminated by monochromatic p-polarised light. 
Solutions containing an analyte of interest are then introduced into the 
sensor at a continuous flow through microfluidic channels. As these 
analytes interact with aptamer sequences, increases in mass bound to 
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the film surface cause changes in the refractive index of incident light, 
which is then registered by the instrument [341]. 
SAW and QCM-based aptasensors both involve the generation and 
detection of acoustic waves by electrodes patterned on the surface of 
aptamer-functionalized piezoelectric crystals [342]. The propagation 
speed of such waves (either on the surface or in the bulk of crystals for 
QCM and SAW respectively) is highly influenced by mass associated with 
the crystal itself. Increases in this mass as a result of aptamer-target 
binding subsequently cause a reduction in crystal resonance frequencies, 
which are then observed by electrical means [270]. Whilst these devices 
are normally only applicable for the sensing of large analytes such as 
proteins or cells (which provide more measurable mass changes) a 
number of modified protocols, such as QCM with dissipation monitoring 
(QCM-D), have been developed to allow the aptamer-based detection of 
lower molecular weight analytes [253]. 
Microcantilever assays typically consist of thin silicon or polymer-based 
micromechanical beams (approximately one micron thick), which respond 
to changes in physical stress [343]. A gold coating is often applied to one 
side of the beam in order to allow the immobilization of biological 
receptors, including aptamers, onto cantilever surfaces [344]. The binding 
of target molecules to these receptors creates stress differences between 
the functionalized and non-functionalized sides of the surface, causing 
the cantilever to bend by a matter of nanometres [345]. The degree of 
bending (also known as cantilever deflection or Δχ) is then detected 
optically and compared to a reference cantilever containing non-
interacting nucleotide sequences [346]. As this deflection is directly 
proportional to the amount of target present within a sample, 
microcantilever methods represent a great opportunity for the quantitative 
sensing of forensically relevant analytes.  
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Aptasensor Applications 
Biological Evidence 
Chemical reagents used for the detection and identification of biological 
evidence (i.e. body fluids and fingermarks) are currently limited by issues 
of low specificity and sensitivity, environmental and safety concerns, ease 
of application and effect on downstream DNA profiling processes [131, 
347]. Other antibody-based devices (such as immunochromatographic 
test cartridges) are conversely able to provide absolute confirmation of 
body fluid identity with a sufficient degree of sensitivity and safety, but 
cannot be used to locate latent stains on evidential surfaces [117]. As 
previously mentioned, optical aptasensing strategies may have the 
opportunity to overcome these challenges by allowing the simultaneous 
detection and highly specific identification of biological evidence in situ. 
Furthermore, a number of optical aptasensors have already been 
constructed towards biomarkers that may be (or currently are) used for 
the confirmation of body fluid presence. For example, Kong et al. recently 
reported the production of a fluorescent aptasensor towards prostate 
specific antigen (PSA), a serine protease enzyme already used in 
forensic analysis for the immunological detection of seminal fluid [348]. In 
this assay, fluorophore-labelled aptamers adsorbed onto the surface of 
emission-quenching MoS2 nanosheets were used to detect sub-
nanogram concentrations of PSA after dissociation upon target binding.  
Since its isolation by Bock et al. in 1992, the thrombin-binding aptamer 
has become one of the most commonly exploited DNA receptor 
sequences for the construction of new aptamer-based sensing platforms 
[349]. As a result, a number of these aptasensing assays may find 
application in the specific detection of thrombin for the purposes of 
identifying bloodstains deposited on evidential surfaces. One such 
sensor, developed by Wang et al., involves the use of aptamer-
functionalized upconverting phosphors, which are initially quenched by 
the binding of carbon nanoparticles to DNA strands through π-π stacking 
Page | 148  
interactions (Figure 50). In the presence of thrombin, these nanoparticles 
dissociate from ligand sequences, relieving FRET quenching effects and 
producing ‘signal-on’ fluorescence emission. [350]. 
Figure 50: Schema of a FRET-based aptasensor for the detection of thrombin 
developed by Wang et al. [350]. Here, 5’ amino-modified aptamer sequences are first 
covalently linked to poly-acrylic acid (PAA)-functionalized up-conversion phosphors 
(UCP’s). Subsequent incubation with carbon nanoparticles results in quenching of the 
sensor through aptamer-abridged fluorescence resonance energy transfer (FRET). 
This sensor demonstrated a linear detection range of 0.5-20 nM and was even used to 
detect Thrombin concentrations of 0.25 nM within spiked human serum samples. 
Forensic Drug Analysis 
Routinely employed methods for detecting trace quantities of illicit drugs 
include presumptive chemical tests, immunoassays and a wide selection 
of chromatographic techniques [351]. With a high sensitivity, selectivity 
and reliability, gas chromatography coupled with mass spectrometry (GC-
MS) or liquid chromatography coupled with mass spectrometry (LC-MS) 
is currently considered the ‘gold-standard’ for the forensic analysis of bulk 
drug samples. However, such approaches are costly and may be 
considered inappropriate for high-throughput analysis due to extensive 
run times. Rapid, cheap and portable drug-screening assays based on 
aptasensor technology are therefore likely to be welcomed by the forensic 
community. 
Much like the thrombin-binding sequence previously discussed, a 
cocaine-specific aptamer constructed by Stojanovic et al. [146] has also 
+
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been extensively used as a model ligand for proof-of-concept 
aptasensing assays. Demonstrated by Hilton et al., a particularly sensitive 
example of such assays involved the target-induced displacement of 
Dabcyl quencher-attached complementary oligonucleotides from 
carboxyfluorescein (FAM) labelled aptamers immobilized within 
microfluidic channels. This assay was subsequently shown to enable the 
detection of cocaine at picomolar levels, without the need for sample 
cleanup and derivatization processes required for GC-MS analysis [352]. 
Beyond cocaine-based assays, initial explorations are also being made 
into the use of aptasensing platforms for the detection of amphetamine 
derivatives. Yarbakht and Nikkhah recently exploited the ability of single 
stranded aptamers to shield Au-NPs from salt-induced aggregation in 
order to allow the colorimetric signalling of MA and MDMA presence 
[353]. In this sensor (Figure 51), an aptamer able to bind both MA and 
MDMA is incubated with a given sample. If target molecules are 
contained within the sample, conformational changes in the aptamer take 
place as a result of binding. Such changes prevent the association of 
aptamer sequences with Au-NPs, which then aggregate upon salt 
addition, turning the colour of sample solutions from red to blue. If target 
molecules are absent from the sample, aptamers are instead able to 
interact freely with AuNPs, protecting them from aggregation.  
In an alternative transduction approach, Huang  et al. [354] were able to 
successfully develop an electrochemical biosensor based on Au-
mesoporous silica nanoparticles (Au-MSN) after selecting a 37-mer 
aptamer sequence against the opiate alkaloid codeine. Here, thiolated 
codeine aptamers were conjugated to Au-MSN’s immobilized on the 
surface of a glassy carbon electrode. Changes in electrical impedance at 
the electrode surface associated with aptamer-target binding were used 
to monitor codeine concentrations across a linear range of 10 pM to 100 
nM. Furthermore, denaturation of the aptamer sequences by incubation 
with heated distilled water allowed the sensor to be reused for 
subsequent measurements. 
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Figure 51: Schema of a colorimetric Au-NP aptasensor for the detection of 
methamphetamine developed by Yarbakht and Nikkhah [353]. In this assay, aptamers 
are initially adsorbed onto the surface of gold nanoparticles (au-NP’s) through 
hydrophobic and electrostatic interactions to stabilize them within solution. However, in 
the presence of methamphetamine (MA) or 3,4-Methylenedioxymethamphetamine 
(MDMA), alterations in the structural conformation of the aptamers allow salt-induced 
aggregation of the particles to occur, prompting surface plasmon resonance-based 
colour changes. A purely visual detection of MA was found to occur at concentrations 
as low as 5 mM.  
With relatively fast selection and isolation times compared to antibodies 
(i.e. a matter of weeks), nucleic acid aptamers also represent a great 
opportunity to rapidly develop forensic assays for the detection of new 
psychoactive substances (NPS). These substances (typically scheduled 
drugs slightly modified to circumvent legal restrictions) are emerging at an 
unprecedented rate, with over 450 new compounds identified by the EU 
early warning system since 2005 [355]. At present, the majority of NPS 
compounds are poorly or not detected by standard immunoassay tests, 
forcing analysts to rely on mass-spectrometry techniques [356]. Despite 
the excellent potential of aptasensor platforms as drug-screening assays, 
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Forensic Toxicology 
The synthetic nature of SELEX protocols means that aptamer recognition 
moieties may be selected against toxic compounds that would likely kill 
animal hosts during standard in vivo antibody-generation methods [357]. 
Such moieties may be therefore of great benefit to toxicology practices, 
where determining cause of death is often dependent upon the detection 
and quantitation of hazardous substances. This branch of forensic 
chemistry heavily relies on the use of expensive and labour-intensive 
analytical techniques to confirm the identify of various poisons and toxins 
[358]. 
Figure 52: Schema of a graphene-quenching fluorescence aptasensor for the 
detection of ochratoxin A developed by Sheng et al. [359]. Here, aptamers are made 
initially fluorescent via 5’ labelling with 6-carboxyfluorescein (6-FAM). Under normal 
conditions, these aptamers are readily adsorbed onto the basal plane of PVP-protected 
graphene oxide, which subsequently quenches 6-FAM emission by energy transfer. 
However, in the presence of ochratoxin A, antiparallel G-quadruplex formation prevents 
such adsorption and fluorescence signals are generated. Using this sensor, Sheng et 
al. were able to monitor ochratoxin A with high selectivity in a liner range from 50-500 
nM. 
Ochratoxin A (OTA) is a toxic metabolite secreted by aspergillus and 
penicillium fungi species that can exert severe nephrotoxic, immunotoxic, 
and carcinogenic effects [360]. As such toxins represent a threat to health 
through the contamination of commercialized food systems, significant 
efforts have been made towards the development of a simple and flexible 
sensing platform for the detection of OTA compounds [361]. In a strategy 
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use of FAM-modified aptamers which, in the absence of OTA, are 
adsorbed onto a basal plane of graphene oxide and quenched [359]. 
However, in the presence of target molecules, aptamers are induced into 
particular three-dimensional confirmations and resist adsorption, allowing 
fluorescence to be monitored.  
In an extension of the Au-NP aggregation assay exploited by Yarbakht 
and Nikkhah for the detection of amphetamines, Wu et al. also utilised an 
aptamer-based sensor for the detection of arsenic within aqueous 
solutions [362]. In this method, a cationic surfactant 
Hexadecyltrimethylammonium bromide (CTAB) was employed instead of 
salts to stimulate nanoparticle aggregation, allowing the colorimetric 
detection of arsenic concentrations in the range of 1-500 parts per billion. 
Work from Lamont et al. resulted in the selection of an aptamer (SSRA1) 
specific to the B-chain of ricin [363]. Ricin, a cytotoxic protein of biological 
origin, is considered as a potential threat agent for terrorist use because 
of its high toxicity and relative availability. The selected aptamer displayed 
superior detection capabilities compared to a commercially available 
ELISA kit for ricin. Following this study, attempts have been made in 
order to embed the SSRA1 aptamer into a biosensing platform for rapid 
and sensitive ricin detection. Esteban-Fernández de Ávila et al. reported 
a micromotor sensing strategy for the fluorescent detection of ricin [364]. 
Self-propelled reduced graphene-oxide (rGO)/platinum (Pt) micromotors 
were synthesized and were modified with the ricin-specific aptamer 
tagged with a fluorescent dye. The resulting complex is non-fluorescent 
due to the quenching effect of the graphene surface. In the presence of 
the target toxin, the aptamer is displaced from the graphene-oxide 
quenching motor surface and its fluorescence is restored. By this method, 
real-time detection of trace amounts of ricin toxin could be achieved in 
biological and environmental samples. Li et al. further developed a 
detection system for ricin based on isothermal strand-displacement 
polymerase reaction [365]. The ricin-specific aptamer SSRA1 was first 
hybridized with a single stranded DNA blocker and then immobilized on 
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the surface magnetic beads. When ricin binds to the aptamer, the blocker 
is released and then hybridizes with a dye-modified hairpin probe 
triggering an isothermal strand-displacement polymerase reaction. The 
fluorescent double stranded DNA product cannot be quenched as it does 
not interact with the graphene oxide surface, resulting in an increase of 
the fluorescence intensity.  
Scientific efforts have been made in the forensic field towards the 
development of new methods for the detection of chemical weapon 
agents with emphasis been placed on the real-time, on-site analysis of 
nerve agents (e.g. sarin). Zhao et al. developed a cantilever-based 
aptasensor for dimethyl methylphosphonate (DMMP), a nerve agent 
simulant [366]. The piezoresistive cantilever sensor was designed with 
four cantilevers (two sensing and two reference cantilevers). A 
biotinylated anti-DMMP aptamer was immobilized on the surface of the 
sensing cantilevers. In the presence of DMMP, binding takes place 
between the immobilised aptamers and the target; this results in a surface 
stress and a bending of the sensing cantilevers which can be recorded 
and measured. The method resulted in sensitive (50 nM-1.0 μM) and 
specific detection of DMMP in aqueous solutions. 
Explosives 
The development of rapid, cost-effective and reliable assays for the 
detection of explosive molecules in both aqueous and gaseous samples 
is a high priority for forensic investigators, counter-terrorism agencies and 
global de-mining projects [367]. Ehrentreich-Förster et al. argue that 
aptamers are likely to make ideal recognition moieties for such assays, as 
immunological methods are often disadvantaged by the poor specificity of 
antibodies raised against low molecular weight explosive analytes [368]. 
Furthermore, aptamers are known to retain their activity in a number of 
organic solvents (such as methanol and acetonitrile) commonly used for 
the solubilisation and detection of explosive compounds.  
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To prove this concept the same group demonstrated the construction of 
an optical aptasensor towards the detection of 2,4,6-trinitrotoluene (TNT). 
In this sensing strategy, activated TNT derivatives are first immobilized on 
the surface of silanised optical fibres. TNT-specific aptamers mixed within 
sample solutions are then introduced into the flow cell and bind to the 
surface-bound analytes unless already captured by TNT present within 
the sample itself (Figure 53). Nanobeads covalently attached to these 
aptamer sequences are then used to report the amount of ligands bound 
to the fibre (with emission intensities inversely proportional to the 
concentration of TNT present in measured samples).  
Figure 53: Schema of an optical fibre-based aptasensor for the detection of TNT 
developed by Ehrentreich-Förster et al. [368]. Silanised optical fibres functionalized 
with TNT competitors are first embedded within the surface of a flow cell. Under normal 
conditions, a sample solution containing fluorescently labelled aptamers is introduced 
into the cell, which subsequently bind to the competitive analogues. Excitation by a 
laser at 480 nm allows the detection of aptamer presence on the fibre. However, a 
reduction in signal occurs when free TNT molecules present within the sample solution 
capture available aptamers, preventing interaction with the surface-attached 
analogues.  
Whilst aptasensing assays towards explosive targets other than TNT 
remain extremely limited, it is hoped that this review will encourage 
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detection for compounds such as hexahydro-1,3,5-trinitro-1,3,5-triazine 
(RDX). 
Conclusion 
Challenges associated with the immunological and instrumental analysis 
methods currently employed within both crime scene and laboratory-
based testing procedures have resulted in the demand for new 
techniques able to allow the rapid, sensitive and specific detection of 
forensically relevant analytes. In this review, we have highlighted the 
potential of biosensing technology that incorporates aptamer recognition 
moieties to address this demand. Moreover, we have reported on a wide 
range of aptasensors that, although being successfully developed for use 
in other analytical disciplines, could be readily adapted to forensic 
analysis. Whilst research in the development of aptasesnsors for forensic 
purposes is extremely limited, it is hoped that recent technological 
advances (e.g. NGS) will make aptamer-based sensor development more 
accessible to researchers working within the field of forensic science. 
5.3 Graphene Oxide Displacement Multiplex Sensor 
The above review describes a number of aptasensors that have been 
produced for the detection of forensically-relevant targets based on the 
displacement of fluorescently-labelled aptamer sequences from various 
quenching materials. One particularly prominent example of such 
materials is GO nanosheets, monolayers of oxidized graphene arranged 
within a two-dimensional honeycomb lattice [369]. Such nanosheets 
possess several unique physical and optical properties which may make 
them ideal for use in fluorescent aptasensing assays for the forensic 
analysis of biological fluids.  
In the presence of high ionic strength buffers, ssDNA is adsorbed to the 
surface of GO nanosheets as a result of π-π stacking interactions 
between nucleotide bases and GO [370]. The strength of these non-
covalent interactions is sufficiently high for ssDNA to be retained on the 
GO surface over long periods of time, yet weak enough for the rapid 
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desorption of sequences in response to target binding [370]. Furthermore, 
as this adsorption is not sequence-specific, multiple different ssDNA 
molecules may be bound to the surface of single nanosheets, with each 
liberated independently via interactions with a different type of target 
molecule.  
GO is also noted for its broad fluorescence absorbance capabilities, with 
several recent studies demonstrating the concurrent quenching of 
multiple fluorophores emitting at vastly different wavelengths of visible 
spectrum upon GO adsorption [371, 372]. The exact mechanism behind 
this quenching is still debated, although reductions in fluorophore 
emission intensities have been shown to occur in a distance-dependent 
manner similar to FRET, albeit over a longer range [373]. 
This combination of non-specific ssDNA adsorption and universal 
quenching has already resulted in the application of GO nanosheets 
towards the construction of multiplex fluorescent aptasensing assays 
[374]. In these assays, several distinct aptamer sequences (each raised 
against a separate target and labelled with a different fluorophore) are 
first quenched via adsorption to a graphene monolayer. Displacement of 
each sequence occurs as a result of higher affinity interaction with 
corresponding target molecules, relieving quenching effects and allowing 
the observation of emissions at specific wavelengths (depending on the 
type of analyte present). 
Sensors based on this signal transduction method are therefore likely to 
possess great potential for use as multiplex biological fluid testing 
reagents, allowing the simultaneous detection and identification of 
multiple fluid biomarkers through the production of specific emission 
wavelengths. Attempts were therefore made in the construction of a 
displacement-based GO aptasensor, utilising fluorescently-labelled 
aptamer sequences towards α-thrombin, PSA and lysozyme for the 
analysis of blood, semen and saliva respectively (Figure 54). 
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Figure 54: GO multiplex displacement aptasensor design. The emission of 
fluorescently-labelled aptamers is first quenched through adsorption to GO 
nanosheets. Sequences specific to α-thrombin, PSA and lysozyme are displaced 
individually upon interaction with corresponding targets. Emission signals are produced 
at particular wavelengths to determine which analytes are present within a sample, 
providing an indication of body fluid identity. 
5.3.1 Materials and Methods 
5.3.1.1 Reagents 
All fluorescently-labelled ssDNA aptamer sequences (Table 11) were 
purchased from Sigma-Aldrich (Dorset, UK) and reconstituted in SDW to 
an initial stock concentration of 100 µM. GO (4 mg/ml in H2O), human α-
thrombin and lysozyme were also obtained from Sigma-Aldrich, whilst 
PSA was purchased from 2B Scientific (Oxfordshire, UK).  
Table 11: Fluorescent ssDNAs used to construct a GO displacement aptasensor. 
Target Label Sequence (5'-3') Ref. 
Thrombin Cy5 GGTTGGTGTGGTTGG [375] 
PSA  6-FAM ATTAAAGCTCGCCATCAAATA [376] 
Lysozyme  ROX ATCTACGAATTCATCAGGGCTAAAGAGTGCAGAGTTACTTAG [377] 
 
5.3.1.2 Body Fluid Collection and Storage 
Blood, semen and saliva was obtained upon informed consent from the 
same healthy donor. Blood samples were drawn by venipuncture and 
stored in a BD Vacutainer® Plus tube (Oxford, UK) containing 3.2% 
sodium citrate coagulation preservative. All samples were stored at 4 °C 
until the point of analysis. Ethical clearance for the collection and use of 
body fluids for this specific study was granted by the King’s College 
London Biomedical Sciences, Dentistry, Medicine and Natural & 
PSA
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Mathematical Sciences Research Ethics Subcommittee (reference 
number HR-17/18-5057).  
5.3.1.3 GO Quenching  
Investigations into the ability of GO to quench each fluorescently-labelled 
aptamer were conducted in a similar manner to that reported by Liu et al. 
[378]. GO was first diluted in SDW to a concentration of 1 mg/ml and 
sonicated for 5 hrs at room temperature to disperse nanosheets in 
solution, before undergoing centrifugation at 12,000 RPM for 10 min to 
precipitate un-dispersed graphene powder. The resulting supernatant 
was then collected for further experimental use. 
Measurements of the fluorescence emission spectra of aptamer solutions 
(1ml), diluted to a working concentration of 50 nM in 50 mM Tris-HCl, 100 
mM NaCl, pH 7.4, were made using a Perkin Elmer LS-50B 
Luminescence Spectrophotometer (Massachusetts, USA), with excitation 
wavelengths of 640±7, 483±7 and 575±7 nm for the measurement of Cy5, 
6-FAM and ROX fluorophores respectively. A 20 µl volume of previously 
collected GO dispersion was then incubated with each aptamer solution 
for 1 hr, followed by a re-measurement of all fluorescence spectra. 
5.3.1.4 Buffer Optimisation 
Aliquots (200 µl) of each aptamer solution were prepared to a 
concentration of 50 nM using previously utilised buffer (50 mM Tris-HCl, 
100 mM NaCl, pH 7.4) also containing varying concentrations of MgCl2 (0, 
0.1, 1, 5 and 10 mM). All samples were prepared in triplicate. 
Fluorescence emission intensities of each solution were subsequently 
measured on a CytoFlour® 4000 spectrophotometer (Applied 
Biosystems®, California, USA) with Ex/Em 590±20/645±50, 
485±20/540±30 and 560±20/620±40 nm wavelength filters for the 
measurement of Cy5, 6-FAM and ROX fluorophores respectively. A 5 µl 
volume of GO at a concentration of 1 mg/ml (prepared using the methods 
previously described) was then incubated with each sample for 1 hr, 
whereupon all spectra were re-measured. 
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5.3.1.5 Quencher Optimisation 
To determine the optimal concentration of GO required to quench the 
emission of fluorescently-labelled sequences, a 50 nM working solution of 
each aptamer was prepared in 50 mM Tris-HCl, 100 mM NaCl, 5 mM 
MgCl2 pH 7.4 to a final volume of 200 µl. A 5 µl volume of various 
concentrations of GO (0, 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1, 2, 4 mg/ml), 
prepared using the methods previously described, was then incubated 
with each aptamer solution for 1 hr and room temperature. All samples 
were prepared in triplicate. The emission intensities of aptamer-GO 
solutions were then recorded in the same manner as buffer optimisation 
studies.  
5.3.1.6 Purified Protein and Whole Fluid Spectrofluorometry 
Individual displacement aptasensors towards the detection of thrombin, 
PSA and lysozyme were prepared through the incubation of 10 ml of 
each respective aptamer solution (100 nM in 50 mM Tris-HCl, 100 mM 
NaCl, 5 mM MgCl2 pH 7.4) with 500 µl volumes of GO at a concentration 
of 0.25 mg/ml prepared using the method previously described (Section 
5.3.1.3) for 1 hr at room temperature. 
Table 12: Protein concentrations and fluid dilutions used for single aptasensor testing. 
Aptamer Target Protein Concentrations Whole Fluid Dilutions  
Thrombin 0, 0.05, 0.1, 0.25, 0.5, 1, 2.5, 5 (µg/ml) 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64 
PSA 0, 1, 2.5, 5, 10, 25, 50, 100 (µg/ml) 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64 
Lysozyme 0, 0.25, 0.5, 1, 2.5, 5, 10, 25 (mg/ml) 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64 
 
Aliquots of quenched sensor solutions (100 µl) were then incubated for a 
further 1 hr with various concentrations of corresponding purified protein 
(thrombin, PSA and lysozyme) or whole body fluids (plasma/blood, 
semen and saliva), diluted in SDW to 100 µl volumes. A list of protein 
concentrations and fluid dilutions used during testing is provided in Table 
12. All samples were prepared in triplicate. Emission intensities were then 
recorded in the same manner as previous buffer and quencher 
optimisation studies.  
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5.3.1.7 Multiplex Spectrofluorometry 
Construction of a final multiplex aptasensor complex was achieved 
through the combined incubation of 1 ml of all fluorescently-labelled 
ssDNA sequences (100 nM in 50 mM Tris-HCl, 100 mM NaCl, 5 mM 
MgCl2 pH 7.4) with 150 µl of GO at a concentration of 0.5 mg/ml 
(prepared using the method previously described) for 1 hr at room 
temperature. Aliquots of this solution (100 µl) were then incubated with 
each purified protein and whole body fluid target previously tested (at 
concentrations or dilutions that provided the largest fluorescence 
response during individual sensor testing), as well as bovine serum 
albumin (BSA) at a concentration of 25 mg/ml and SDW. All samples 
were prepared in triplicate. Emission intensities were then recorded in the 
same manner as previous buffer and quencher optimisation studies. 
5.3.2 Results and Discussion 
5.3.2.1 GO Quenching 
Multiplex displacement assay design was based on the premise of 
combining three separate aptamer sequences previously used for the 
analysis of thrombin [379], PSA [348] and lysozyme [378], in a single 
aptasensor construct. As these protein targets are present in relatively 
high concentrations within blood, semen and saliva respectively, this 
aptasensor may potentially be used as a method for the detection of 
multiple body fluid types simultaneously. Furthermore, if each of these 
aptamer sequences is labelled with a different fluorophore, the production 
of emissions at wavelengths specific for each target may be used to 
provide an indication of the identity of fluids present within a sample. 
Studies have demonstrated that the adsorption of fluorescently-labelled 
ssDNA to the surface of GO nanosheets (as well as any associated 
emission quenching) is highly dependent upon both the length of the 
nucleotide sequence [380] and the position/type of fluorophores 
employed [371]. As these properties differ between each of the 
sequences used for sensor construction, a preliminary investigation of the  
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Figure 55: Fluorescence emissions of Cy5, 6-FAM and ROX-labeled aptamers specific 
to a) thrombin, b) PSA and c) lysozyme respectively, before (solid lines) and after 
(dotted lines) the addition of GO.  
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relative degree of quenching experienced by each aptamer upon 
graphene interaction was conducted. This was achieved through the 
incubation of 50 nM ssDNAs with a standardised concentration (1 mg/ml) 
of GO. 
Different levels of quenching were observed for each of the fluorescently-
labelled aptamers upon GO addition, with reductions in emission maxima 
intensities of 59.9%, 42.6% and 33.7% for thrombin, PSA and lysozyme 
aptamers respectively (Figure 55). Increased levels of emission 
quenching were found to correlate with a reduction in overall sequence 
length, which is consistent with results reported in a number of recent 
studies [371, 380, 381]. This length-dependent quenching phenomenon 
has been previously attributed to the structure of GO nanosheets, which 
contain intact crystalline regions that augment ssDNA binding, as well as 
amorphous areas of anionic functionalization [382]. DNA sequences of 
significant size are more likely to interact with the latter of these areas, 
limiting adsorption as a result of electrostatic repulsion [380]. 
5.3.2.2 Buffer Optimisation 
It should be noted that during the initial investigation of GO-ssDNA 
interactions, none of the fluorescently-labelled aptamers tested were able 
to be completely quenched upon graphene addition. As background 
reagent fluorescence is likely to prevent the application of this biosensor 
towards the visualisation of body fluid staining in situ, attempts were 
made to increase aptamer emission quenching by enhancing the initial 
adsorption of ssDNA to GO. 
One factor previously established as having a high influence on the 
interactions between DNA and graphene is the ionic strength of 
surrounding buffer solutions [383]. High concentrations of mono or 
divalent salts are often required to screen the long-range electrostatic 
repulsion effects of GO, in order to bring nucleotide sequences close 
enough to the nanosheet surface for π-π stacking to occur [380]. As 
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Figure 56: Fluorescence emissions of a) thrombin, b) PSA and c) lysozyme aptamers 
before and after GO addition in the presence of varying concentrations of MgCl2. Data 
represents the mean ± SD, samples performed in triplicate. 
0
0.







15000 Lysozyme Binding Aptamer


























6000 PSA Binding Aptamer















































Page | 164  
previous optimization studies have demonstrated that the quenching of 
fluorescently-labelled aptamers by GO can be significantly enhanced in 
response to increasing salt concentrations (such as NaCl and MgCl2) 
[380, 383, 384], each of the ssDNA sequences employed in aptasensor 
construction were incubated with GO in the presence of variable amounts 
of MgCl2. 
For all aptamer sequences, a general reduction in fluorescence emission 
signals was observed with increased MgCl2, up until a concentration of 5 
mM, beyond which, changes in fluorescence intensity were negligible 
(Figure 56). A one-way analysis of variance (ANOVA) followed by a 
Dunnett post hoc test, was used to statistically assess the effects of 
added MgCl2 concentrations on the quenching of all aptamer sequences 
compared to negative 0 mg/ml MgCl2 controls. For both PSA and 
lysozyme aptasensor complexes, all added magnesium concentrations 
were found to have a statistically significant effect on signal quenching (p 
values <0.0001). However, this was not the case for thrombin aptamer 
samples, where emission intensities were found to be comparable to a 
magnesium-free negative control. These results may be attributed to the 
fact that aptasensor complexes employing thrombin-specific ssDNA 
sequences already exhibited a high degree of quenching compared to 
PSA and lysozyme aptamers prior to MgCl2 addition (possibly as a result 
of reduced sequence length). Therefore, all assay buffers were 
supplemented with 5 mM MgCl2 for all further experiments (even in the 
case of thrombin aptasensors for the sake of testing consistency). 
5.3.2.3 Quencher Optimisation 
With different degrees of quenching observed across all ssDNA 
sequences, even after adjustments to buffer ionic strength, it was 
envisaged that incubation with increased concentrations of GO may be 
required for each aptamer to undergo further fluorescence reduction. 
Therefore, varying amounts of GO, ranging from 0.01 to 4 mg/ml, were 
added to each ssDNA sequence in order to establish the optimal ratios of 
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Figure 57: Fluorescence emission intensities of a) thrombin, b) PSA and c) lysozyme 
aptamers after incubation with varying concentrations of GO. Data represents the 
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GO:aptamer needed for highest emission quenching. All three aptamer 
sequences displayed similar patterns of fluorescence intensity reduction 
in response to increased graphene, all reaching maximum quenching 
limits upon addition of 0.25 mg/ml GO (Figure 57). At this concentration, 
mean quenching values of 81.2%, 88.1% and 76.4% were shown for 
thrombin, PSA and lysozyme aptamers respectively. Surprisingly, none of 
the sequences were able to be fully quenched, even at GO 
concentrations of 4 mg/ml. Therefore, a ratio of 1.25 µg GO (5 µl of 0.25 
mg/ml) to 10 pmol of ssDNA was used for all further studies. 
5.3.2.4 Purified Protein and Whole Fluid Spectrofluorometry 
Before construction of a final multiplex aptasensor, investigations were 
made into the ability of each ssDNA to be desorbed from the surface of 
GO in response to target interaction under the assay conditions 
previously optimised. This involved the initial incubation of 100 µl of each 
aptamer (at concentrations doubled from previous experiments in order to 
keep the total amount of ssDNA consistent) with 5 µl of 0.25 mg/ml GO, 
before the addition of different concentrations of relevant purified protein 
targets. Emission changes of thrombin, PSA and lysozyme GO-
aptasensor constructs in response to different dilutions of whole 
blood/plasma, semen and saliva respectively, were also observed.  
In the case of purified targets, all GO-aptamers complexes demonstrated 
distinct increases in emission intensity upon protein incubation (Figure 
58). Furthermore, these increases were found to correlate with the 
concentration of analyte added, indicating that fluorescence is restored as 
a direct result of target interaction. It must be noted that such emission 
intensities were found to be significantly lower than those exhibited by 
aptamer sequences prior to GO addition (as seen within previous 
experiments), suggesting that not all aptamer sequences were able to be 
desorbed from the graphene surface. Whilst the protein concentration 
ranges used within this study were limited by the cost and availability of 
analytes, higher amounts of these targets may be able to liberate a 
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Figure 58: Emission intensities of a) thrombin, b) PSA and c) lysozyme GO-aptamer 
complexes after incubation with varying concentrations of relevant purified protein 
targets. Data represents the mean ± SD, samples performed in triplicate. Negative 
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Figure 59: Emission intensities of a) thrombin, b) PSA and c) lysozyme GO-aptamer 
complexes after incubation with varying concentrations of relevant whole fluid targets. 
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higher number of ssDNA sequences from the GO surface, resulting in 
increased fluorescence restoration. 
Increases in emission signals were also observed from all aptasensor 
complexes upon the addition of respective fluids. However, the particular 
patterns of signal exhibited in response to different fluid dilutions were 
found to vary significantly between each ssSDNA sequence (Figure 59). 
Emissions from aptamers specific to PSA were found to be relatively 
consistent with those gained during purified protein testing, with general 
decreases in intensity observed as a result of greater fluid dilution.  
Conversely, emission patterns for both thrombin and lysozyme-specific 
aptamers were found to be more complex, with fluorescence intensities 
first increasing with higher fluid dilutions up to a specific value (1:8, 1:16 
and 1:32 for plasma, blood and saliva respectively), after which point 
signals began to reduce. Such effects may potentially be attributed to the 
absorption of emissions by other biomolecular components found within 
the fluid matrices. As fluids are progressively diluted, these components 
become less concentrated, resulting in lower levels of signal absorbance 
and greater detectable fluorescence. Further dilution subsequently 
decreases the amount of target available to desorb ssDNA sequences 
from the GO surface, thereby reducing aptasensor transduction. Lower 
emission signals exhibited by thrombin-specific aptamers towards whole 
blood in comparison to plasma samples (which are likely to contain less 
highly-absorbing haemoglobin) seem to support this theory. 
One other interesting phenomenon encountered during whole fluid 
aptasensor testing was the large increases in fluorescence intensity 
displayed by lysozyme-specific aptamer-GO constructs upon whole saliva 
addition. Such increases were found to be significantly larger than those 
observed during sensor incubation with protein samples, despite the fact 
that lysozyme has been shown to be present in human saliva at 
concentrations between 0.5-4 ng/ml, amounts much lower than those 
used within previous purified target assay tests. From these results, it 
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may be inferred that aptamers are potentially being non-specifically 
desorbed from the GO surface, although the mechanisms behind this 
effect remain unclear. 
5.3.2.5 Multiplex Spectrofluorometry 
Attempts were undertaken to construct a multiplex aptasensing complex 
for the simultaneous detection of different protein/fluid targets via the 
incubation of all fluorescently-labelled ssDNA sequences with a 
previously optimized ratio of GO. Concentrations of purified protein 
targets (5 µg/ml thrombin, 100 µg/ml PSA and 25 mg/ml lysozyme) or 
dilutions of fluids (1:8 plasma, 1:16 blood, 1:1 semen and 1:32 saliva) 
generating the largest fluorescence response during previous single 
aptamer experiments were then incubated with aliquoted aptasensor 
constructs. Fluorescence responses were subsequently monitored at the 
Cy5, 6-FAM and ROX emission wavelengths previously utilised for sensor 
optimisation studies. 
Disappointingly, increases in sensor fluorescence were observed in 
response to incubation with the majority of both protein and body fluid 
targets at all measured wavelengths (Figure 60). The relative intensities 
of emissions signals produced for each target were also found to be 
consistent between Cy5, 6-FAM and ROX wavelengths. Such results are 
likely to indicate that the non-specific desorption of ssDNA from the GO 
surface in the presence of general protein molecules is the primary 
mechanism behind fluorescence restoration, rather than competitive 
displacement of sequences via higher-affinity target interaction. This 
hypothesis is supported by the fact that BSA, a target for which all of the 
aptamers utilised in sensor construction have already been shown to 
have little affinity towards [385-387], was also able to induce sensor 
fluorescence at 6-FAM and ROX emissions. In fact, such non-specific 
desorption effects have already been reported by some research groups 
in similar aptamer displacement constructs [388, 389]. 
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Figure 60: Fluorescence intensities of multiplex GO-aptasensors at a) Cy5 (thrombin), 
b) 6-FAM (PSA) and c) ROX (lysozyme) emission wavelengths after incubation with a 
various protein targets and body fluids. Data represents mean ± SD, samples 
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5.3.3 Conclusion 
Despite initial promise in the development and optimisation of single 
aptamer-GO complexes, testing of final multiplex displacement sensor 
constructs revealed the non-specific nature of protein detection. This lack 
of selectivity currently prevents the use of this biosensor for the attribution 
of biological fluid identity based on the production of light at specific 
wavelengths, as all ssDNA sequences are likely to be desorbed in the 
presence of each fluid type.  
It may be argued that such sensors may still have potential application 
towards the detection of biological evidence sources in general (either as 
single or multi-aptamer assays) without providing an indication of cellular 
origin.  However, such assays are unlikely to offer significant advantages 
over currently utilised forensic body fluid testing strategies. 
Efforts to improve aptasensor specificity should therefore be undertaken 
in order to ensure that ssDNA sequences are only displaced from the 
surface of GO as a result of binding to intra-fluidic targets. Such 
improvements are likely to focus on adjustments the sequence or 
structure of employed aptamer moieties. 
5.4 Aptamer Selection against Human Sperm Cells 
Any new method developed for the analysis of forensic evidence, must be 
shown to possess a high level of specificity before it can be deployed 
within operational casework. With demonstrated increases in fluorescent 
signal upon the addition of non-target proteins, application of the 
developed displacement-based aptasensor (Section 5.3) towards the 
detection of body fluid samples (either as a single or multiplex assay) in 
operational forensic casework currently remains impractical. 
As previously mentioned, several authors have already noted similar 
restorations of aptasensor fluorescence emission after incubation with 
proteins other than the target analyte [388, 389]. Recent attempts have 
also been made to increase the general specificity of such biosensing 
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methods. These include the use of various blocking agents to prevent 
non-specific absorption of molecules to the nanosheet surface [388], as 
well as the hybridization of aptamers to complementary ssDNA 
sequences immobilised on the quenching material, which are then 
displaced via target interaction [390]. However, the latter of these may 
defeat the purpose of using such materials as moderately bound 
quenchers.  
It has been noted that aptamers raised towards single purified protein 
targets are typically less specific when placed in a biological environment, 
which is dissimilar from the controlled conditions utilised for selection 
[391]. Conversely, sequences specific to whole cells (which are mainly 
raised in conditions best mimicking the physiological environment of a 
target) are more likely to retain binding selectivity during biological 
applications [391]. It was therefore theorised that cell-specific aptamer 
sequences would be less likely to be non-specifically displaced from the 
surface of GO nanosheets as a result of general protein interaction. 
Efforts were therefore made towards the selection of ssDNA aptamers 
against intra-fluidic cells that may be used for the purposes of body fluid 
attribution. Initial attempts focused on the elucidation of sequences 
specific to human sperm cells, the microscopic identification of which is 
often used for confirming the presence of seminal fluid in forensic 
casework. This was achieved via a modified version of a popular Cell-
SELEX protocol reported by Sefah et al. [289]. 
5.4.1 Materials and Methods 
5.4.1.1 Reagents 
For sperm cell isolation, Percoll® was obtained from Sigma-Aldrich 
(Dorset, UK). Human tubal fluid (HTF) was prepared as a ×10 
concentrate through the addition of 29.655 g NaCl, 1.75 g KCl, 250 mg 
MgSO4·7H2O, 250 mg KH2PO4, 2.5 g glucose, 2.6 g HEPES, 1 g 
NaHCO3, 1.5 g CaCl2·2H2O and 3 g human serum albumin (HSA) to 350 
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ml SDW. This solution was then adjusted to pH 7.4 and made up to a 
total volume of 500 ml using SDW. Dilution of this concentrate in SDW 
was used to prepare all ×1 HTF solutions. 
For cell incubation and elution, an ssDNA library comprised of two fixed 
regions, each 18 nucleotides in length, flanking randomised N40 bases 
(5′-ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT-3′) 
was obtained (HPLC purified) from Integrated DNA technologies (Iowa, 
USA). Aptamer binding buffer was prepared through the addition of 2.25 
g glucose, 500 mg BSA and 238 mg MgCl2 to 500 ml of ×1 phosphate-
buffered saline (PBS). 
All PCR reaction components, including ×10 PCR buffer, 50 mM MgCl2 
solution, 10 mM dNTP mixture and Platinum™ Taq DNA polymerase 
were obtained from Thermo Fisher Scientific (California, USA). 
Fluorescently-labelled forward (5’-6-FAM-ATCCAGAGTGACGCAGCA-3’) 
and biotin-functionalised reverse (5’-biotin-ACTAAGCCACCGTGTCCA-
3’) primers were both obtained (HPLC purified) from Integrated DNA 
technologies (Iowa, USA). Non-labelled versions of both forward and 
reverse sequences were also procured.  
Agarose was obtained from Sigma-Aldrich (Dorset, UK). Tris-Acetate-
EDTA (TAE) buffer (×50) and GelRed nucleic acid gel stain (×10,000 in 
H2O) were both purchased from Cambridge Bioscience (Cambridge, UK), 
whilst HyperLadder™ 25bp (also containing  6 loading dye) was obtained 
from Bioline (Toronto, Canada).  
For the separation of double stranded DNA (dsDNA), Pierce™ 
NeutrAvidin™ agarose resin was purchased from Thermo Fisher 
Scientific (California, USA). Corning® Costar® Spin-X® and Amicon™ 
Ultra-0.5 ml (3 kDa MWCO) filter units were both obtained from Sigma-
Aldrich (Dorset, UK). 
All DNA sequencing reagents, including the NEBNext® Ultra™ DNA 
Library Prep Kit for Illumina®, NEBNext® Multiplex Oligos for Illumina® 
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(both New England Biolabs, Massachusetts, USA) and Agencourt 
AMPure® XP Beads (Beckman Coulter, California, USA), were provided 
by Dr David Ballard from DNA Analysis at King’s, King’s College London. 
5.4.1.2 Body Fluid Collection and Storage 
Seminal fluid was obtained upon informed consent from the same healthy 
donor and stored at 4 °C until the point of analysis. Ethical clearance for 
the collection and use of body fluids for this specific study was granted by 
the King’s College London Biomedical Sciences, Dentistry, Medicine and 
Natural & Mathematical Sciences Research Ethics Subcommittee 
(reference number HR-17/18-5057).  
5.4.1.3 Cell Isolation 
Isolation of sperm cells from whole seminal fluid was performed using 
density gradient centrifugation methods outlined by the World Health 
Organization [392]. First, an isotonic gradient was prepared through the 
addition of 9 ml of Percoll® to 1 ml of ×10 HTF. This gradient was 
separated into two fractions which were then diluted in ×1 HTF to form 
80% and 40% (v/v) Percoll® suspensions. A 2ml volume of the 40% 
suspension was then layered over the top of 2ml of the 80% suspension 
in a 15 ml tube to create a discontinuous density gradient. Seminal fluid 
(1ml) was then added to the top of the gradient and centrifuged for 20 min 
at 1600 RPM. The ensuing supernatant was removed from the pelleted 
cells, which were then re-suspended and washed twice with 5 ml of ×1 
HTF. Final pelleted sperm cells were lastly re-suspended in 2 ml of SDW.  
Cell concentrations were calculated using a Countess II automated cell 
counter (Thermo Fisher Scientific, California, USA) after mixing 10 µl of 
suspended cells with 10 µl of trypan blue solution. 
5.4.1.4 Incubation and Elution 
For the first round of the Cell-SELEX process, 100 μl of 100 µM (10 nmol) 
N40 ssDNA library was added to 270 μl of aptamer binding buffer, heated 
to 95 °C for 5 min and allowed to cool to room temperature. During this 
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period, a volume of sperm cell suspension yielding a total of 1 × 107 cells 
was transferred into a 15 ml tube and centrifuged at 6700 RPM for 3 min. 
The resulting supernatant was then removed before the re-suspension of 
pelleted cells in 330 μl of aptamer binding buffer. These cells were then 
added to the 370 μl of cooled ssDNA library previously prepared and 
incubated for 1 hr at 4 °C on a rotary shaker.  
After incubation, this mixture was centrifuged at 6700 RPM for 3 min in 
order to pellet cells and bound ssDNA sequences. The resulting 
supernatant (comprised of remaining unbound sequences was removed 
before cells were re-suspended and washed (×3) with 1 ml of aptamer 
binding buffer. Bound ssDNA sequences were then eluted from cells 
through the addition of 500 μl DNase-free SDW with heating at 95 °C for 
10 min. A final centrifugation step at 13,100 RPM for 10 min was then 
used to pellet cells so that eluted sequences could be collected in the 
ensuing supernatant.  
In all subsequent selection rounds (2-14), incubation was achieved 
through the addition of 200 μl ssDNA, diluted to a concentration of 1 μM 
in aptamer binding buffer, to cells also suspended in 200 μl of binding 
buffer. The total number of cells used for incubation was reduced by one 
million each cycle between SELEX rounds 2-5 (from 5 × 106 to 1 × 106 
cells), in order to increase the stringency of the selection process [289]. A 
total of 1 × 106 cells were used in all further incubations (from rounds 6-
14). Elution of sequences from cells in rounds 2 to 14 was also conducted 
using 600 μl of binding buffer, rather than 500 μl of SDW. 
5.4.1.5 PCR Amplification 
In total, three different types of PCR amplification were performed 
throughout the SELEX process: 1) pre-PCR, 2) trial PCR and 3) 
preparative PCR. However, the former of these was only carried out 
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Table 13: Reaction mixtures used for pre, trial and preparative PCR during SELEX.  
Reagents Pre-PCR (µl)  Trial PCR (µl) Prep PCR (µl)  
×10 PCR Buffer 100.00 35.00 100.00  
dNTP Mixture (10 mM) 20.00 7.00 20.00  
MgCl2 (50 mM) 40.00 14.00 40.00  
Forward Primer (100 µM) 5.00 1.75 5.00  
Reverse Primer (100 µM) 5.00 1.75 5.00  
DNase-free SDW 327.00 254.45 727.00  
Platinum Taq Polymerase 3.00 1.05 3.00  
Eluted ssDNA Pool 500.00 - 100.00  
 
After the first incubation of N40 ssDNA library with cells, pre-PCR 
amplification of the entire eluted pool was conducted to create multiple 
representative copies of all possible bound sequences, thereby avoiding 
the potential loss of aptamers during subsequent pipetting processes. 
This was achieved through the addition of 500 μl eluted sequences to 500 
μl of a pre-PCR mix (Table 13), which was then run as 20 separate 50 μl 
reactions for 9 cycles on a Perkin-Elmer 9700 thermal cycler (Cambridge, 
UK) using the temperature programme found in Table 14.  
Table 14: Thermal cycling conditions used for pre, trial and preparative amplification. 
Cycle Temperature (°C) Time (s)   
Denature 95.0 120   
Denature 95.0 30   
Annealing 56.3 30  Cycling stage 
Extension 72.0 30   
Extension 72.0 180   
Hold 4.0 ∞   
 
Trial PCR reactions of ssDNA eluted during each round of selection were 
carried out in order to determine the optimum number of amplification 
cycles required for subsequent preparative PCRs. This was conducted 
through the preparation of a trial PCR reaction mix (Table 13), which was 
then split into six individual 45 μl volumes. To each of these volumes was 
added 5 μl of eluted ssDNA, with the exception of one sample, to which 
SDW was instead used in order to act as a negative control. All samples 
were run using the same thermal cycling methods and temperature 
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programme previously outlined, with one tube containing eluted ssDNA 
removed after 6, 8, 10, 12 and 14 cycles. Negative control samples were 
run for a maximum number of 14 cycles. Amplification products were then 
loaded alongside a HyperLadder™ 25bp size determination marker onto 
a 4% agarose gel (made in ×1 TAE and containing 0.01% GelRed), which 
was then run in ×1 TAE buffer at 80 V for 100 min. 
In order to generate the amount of ssDNA required for input into further 
selection rounds, 100 µl of ssDNA eluted from each incubation was lastly 
amplified after addition to a preparative PCR mix (Table 13) using the 
optimum number of cycles established in trial PCR. Samples were run in 
20 separate 50 µl reactions using the thermal cycling methods and 
temperature programme previously described. Agarose gel 
electrophoresis was used to confirm successful amplification in the same 
manner as trial PCR studies. 
5.4.1.6 Strand Separation 
With dsDNA generated as a result of the amplification process, strand 
separation of PCR products from each round of selection was conducted 
via the use of an avidin-labelled resin to capture biotin-functionalised 
antisense strands. First, 200 μl Pierce™ NeutrAvidin™ agarose resin was 
added to two Corning® Costar® Spin-X® filter units, which were then 
centrifuged at 2730 RPM for 1 min in order to remove storage buffer. 
Resin beads were then preconditioned for 30 min using 500 μl of 200 mM 
NaOH to remove any labile avidin molecules, before further centrifugation 
under the same conditions. Resins were then washed ( 5) with 500 μl of 
×1 PBS buffer with further centrifugation.  
Incubation of resin beads with 500 μl of preparative PCR products 
obtained from each round of selection was then conducted for 30 min on 
an orbital shaker to bind dsDNA through biotin-avidin interaction. After 
this incubation, resins were centrifuged and washed (×5) with PBS in the 
same manner previously described. A 500 μl volume of 200 mM NaOH 
was then added to the NeutrAvidin™ beads in order to separate 
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fluorescently-labeled sense strands, which were then collected via 
centrifugation at 3800 RPM for 10 min.  
To remove NaOH, obtained ssDNA was placed into two Amicon™ Ultra-
0.5 ml (3 kDa MWCO) filter units and centrifuged at 14,500 RPM for 30 
min. DNase-free H2O (450 μl) was then added to the filters, which were 
then subjected to further centrifugation under the same conditions. De-
salted ssDNA was finally collected by placing the filter units upside down 
in clean microfuge tubes and centrifuging at 3800 RPM for 7 min. The 
concentration of ssDNA was lastly quantified using a NanoDrop® ND-
1000 Spectrophotometer (Thermo Fisher Scientific, California, USA). 
5.4.1.7 Flow Cytometry 
The ability of selected aptamer pools to bind sperm cells was monitored 
between Cell-SELEX rounds via flow cytometry. First, strand-separated 
ssDNA collected from each round of selection was diluted to a 
concentration of 500 nM in aptamer binding buffer. A negative control 
sample, consisting of fluorescently-labelled N40 library template, was also 
prepared in the same manner. Each of these samples was then added in 
a 100 μl volume to 100 μl of human sperm cells at a concentration of 1 × 
107 cells/ml (prepared via the same cell-isolation methods previously 
described) and incubated at room temperature for 30 min on an orbital 
shaker. Cells were then centrifuged at 6700 RPM for 3 min before the 
removal of unbound sequences within the resulting supernatant. Pelleted 
cells were then washed twice and re-suspended in a final volume of 400 
μl aptamer binding buffer.  
Analysis of fluorescence emission intensity at 515 nm from cells 
incubated with either selected aptamer pools or N40 library was 
conducted using a Beckman Coulter FC 500 flow cytometer (California, 
USA), measuring 20,000 events. Data analysis was performed using CXP 
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5.4.1.8 Next Generation Sequencing and Data Analysis 
Enriched aptamer pools obtained from rounds 1, 2, 3, 8, 9, 10 and 14 of 
selection were subjected to NGS to elucidate the structure of potential 
binding sequences. First, dsDNA products were prepared from each pool 
by PCR amplification using the same reaction mix (with the exception of 
non-labelled primer sets), number of cycles and temperature programme 
previously employed during the preparative PCRs for each respective 
round. Amplified products were then quantified using a NanoDrop® ND-
1000 Spectrophotometer (Thermo Fisher Scientific, California, USA) 
before being diluted in SDW to a concentration of 2 ng/µl. 
Samples were then prepared for sequencing using the NEBNext® Ultra™ 
DNA Library Prep Kit for Illumina®. Briefly, 1.4 µl End Prep Enzyme Mix 
and 2.9 µl End Repair Reaction Buffer (×10) was added to 25 µl of each 
dsDNA sample, which were then incubated for 30 min at room 
temperature and 30 min at 65 °C. Adaptors were then ligated to the ends 
of dsDNA sequences through the addition of 7.5 µl Blunt/TA Ligase 
Master Mix, 1.25 µl NEBNext adaptor for Illumina® and 0.5 µl Ligation 
Enhancer. This mixture was then incubated at room temperature for 15 
min before the addition of 2 µl USER™ Enzyme, with further incubation at 
37°C for 15 min. A post ligation cleanup was then conducted using 
AMPure® XP Beads with sequences eluted in 10 µl of 10 mM Tris-HCl, 
pH 8.5. A further PCR amplification of sequences was performed through 
the addition of 7.5 µl adaptor-ligated dsDNA to 12.5 µl NEBNext Ultra II 
Q5 Master Mix, 2.5 µl index primer and 2.5 µl Universal PCR primer. This 
mixture was run for 8 cycles in a thermal cycler using the temperature 
programme found in Table 15. A final cleanup procedure was lastly 
conducted using AMPure® XP Beads before elution in ×1 TE buffer. All 
prepared samples were loaded onto a V2 reagent cartridge and 
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Table 15: Thermal cycling temperature programme used for NGS sample preparation. 
Cycle Temperature (°C) Time (s)                               
Denature 98.0 30        
Denature 98.0 10        
Annealing 65.0 75        
Extension 65.0 300        
Hold 4.0 ∞        
 
Data analysis of raw sequence reads was performed using Galaxy, an 
open source bioinformatics platform, following a custom-developed 
pipeline similar to that reported by Thiel et al. [303].  
5.4.2 Results and Discussion 
5.4.2.1 Aptamer Selection 
Aptamers were selected according to a Cell-SELEX protocol previously 
reported by Sefah et al. [289] with several modifications. First, as human 
sperm cells used for in vitro studies are typically obtained from whole 
seminal fluid, rather than via traditional culture techniques, pre-selection 
cell growth and preparation methods were substituted with a density 
gradient centrifugation-based sperm cell isolation process. Microscopic 
examination of cells pre- and post-centrifugation confirmed the successful 
separation of spermatozoa from other seminal leukocyte and epithelial 
cell components (Figure 61). 
Figure 61: Microscopic examination of haemotoxylin and eosin-stained sperm cells a) 
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A randomised N40 ssDNA library was incubated with a defined number of 
sperm cells (which were progressively decreased between SELEX 
cycles) at the start of each round of selection. Aptamer sequences able to 
bind to sperm targets were then recovered through centrifugation and 
eluted from the surface of cells before undergoing PCR amplification (to 
increase relative representation in subsequent selection rounds).  
Trial PCRs were first conducted to determine the number of amplification 
cycles needed in order to generate the amounts of DNA required for 
future aptamer-cell incubations. Amplified products were successfully 
detected across all selection cycles using agarose gel electrophoresis. 
These products were found to run at approximately the same speed as 
the 75 bp fragment of a utilised Hyperladder™ DNA standard, which is 
consistent with the theoretical size (76 base pairs plus additional 6-FAM 
and biotin functionalisation) of dsDNA sequences (Figure 62a).  
Figure 62: Gel electrophoresis images of a) trial and b) preparative PCR amplifications 
from the 4th round of the sperm cell aptamer selection process. Lane legends 
represent the number of amplification cycles performed or negative (Neg.) control 
samples. 
One interesting effect observed during trial PCR analysis, was the 
presence of a secondary DNA band running slightly slower than identified 
dsDNA products in samples amplified over a certain number of cycles 
(which were different for each selection round). Previous studies have 
attributed such effects to the formation of PCR by-products as a result of 
a) b)
 6  8  10  12  14Neg.  8
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the repetitive amplification of randomised ssDNA libraries [393]. These 
by-products are likely to originate from the hybridization of ssDNA 
sequences to complementary bases within the random N40 region, which 
then serve as PCR primers. Extension of sequences at these priming 
regions by DNA polymerases then results in the formation of longer 
dsDNA products which run at a marginally reduced speed on 
electrophoretic gels. Consequently, optimal PCR cycle numbers used for 
subsequent preparative amplifications were chosen based on the trial 
PCR samples where only single product bands were observed (Figure 
62b). 
Figure 63: Concentrations of ssDNA recovered after strand separation from each 
round of the Cell-SELEX process. 
Double-stranded amplification products were then subjected to strand 
separation using a Pierce™ NeutrAvidin™ agarose resin and NaOH 
denaturation to recover sense ssDNA sequences. After desalting, 
aptamers pools were quantified before being diluted for input into 
subsequent cell incubations. A general increase in the concentration of 
recovered ssDNA during each round of selection was observed across 
the entire Cell-SELEX process (Figure 63). This increase may indicate 
the success of aptamer selection, with greater target-sequence binding 
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resulting in increased amounts of eluted ssDNA template available for 
amplification (which in turn results in higher PCR product concentrations). 
However, this effect was not consistent between all selection rounds, 
especially between rounds 11-14, where recovered DNA concentrations 
actually reduced (the reason for which is currently unclear). 
5.4.2.2 Flow Cytometry 
Attempts to monitor the progress of aptamer selection between SELEX 
rounds were made using flow cytometry as described in Sefah et al. 
[289]. Samples of enriched ssDNA pools from rounds 4, 7, 10 and 14 of 
selection, as well as N40 library template (acting as a negative control), 
were incubated with sperm cells before the measurement of emissions at 
515 nm.  
Fluorescent signals were observed from each of the selected samples, 
indicating the occurrence of aptamer cell binding (Figure 64). However, 
signal intensities were found to vary significantly across samples, with no 
distinct correlation to the amount of SELEX cycles performed. Such 
results may potentially be attributed to the presence of artefacts or 
impurities in prepared sperm cell suspensions (such as seminal leukocyte 
or epithelial components that were not removed during the cell isolation 
process), which may affect analysis.  
This hypothesis is supported by the fact that most of the histograms 
generated exhibited two discrete peaks, a characteristic of samples 
containing multiple cell populations [394]. Importantly, no fluorescence 
emissions were detected for N40 library-incubated cells, giving further 
indication that sequences contained within enriched pools are present as 
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Figure 64: Flow cytometry histograms of sperm cells incubated with enriched aptamer 
pools obtained from a) round 4, b) round 7, c) round 10 and d) round 14 of selection 
and e) N40 library template sequences.  
5.4.2.3 Next Generation Sequencing and Data Analysis 
Other modifications made to the employed Cell-SELEX protocol [289] 
included the use of NGS technologies to elucidate the sequences of 
potential binding ligands. Such technologies were chosen for use in this 
study to illicit a greater amount of sequence information from enriched 
aptamer pools, as well as to avoid the time-intensive cloning and colony-
picking methods associated with traditional Sanger sequencing. Although 
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recently begun to be explored, such techniques may allow for both the 
detection of ligands at earlier rounds of selection and a greater 
characterisation of the evolution of enriched pools between SELEX cycles 
[395]. 
Three separate instances of high-throughput sequencing were conducted 
using the Illumina® Miseq platform to determine the sequence and 
relative abundance of ssDNAs contained within early (rounds 1-3), mid 
(rounds 8-10) and late (round 14) SELEX cycle aptamer pools. As raw 
sequence reads obtained from these experiments were output as FASTQ 
sequence files, significant data processing was required to isolate 
random N40 bases from fixed flanking regions, as well as to remove any 
undesirable selection and/or sequencing artefacts. Such artefacts include 
sequences of incorrect length (originating as amplification by-products as 
already discussed) or those containing mismatched constant regions. 
This was achieved using Galaxy, an online bioinformatics management 
system that allows the construction of custom data processing workflows 
for the analysis of complex genomics datasets [396]. A Cell-SELEX 
workflow (made available at https://usegalaxy.org/u/jamesgooch/w/cell-
selex) for the processing of NGS data obtained from this study was 
developed according to methods reported by Thiel et al. [303]. This 
automated pipeline is able to provide collated sequence and read count 
information from a single input of generated raw forward and reverse-read 
FASTQ files without further user contribution (Figure 65). The individual 
steps of this workflow (as separate Galaxy ‘tools’) were as follows: 
1) Upload - FASTQ files from both forward and reverse sequences 
reads for a given round of selection are first uploaded to the 
Galaxy web server. 
2) FASTQ.Joiner - Both forward and reverse paired-end sequence 
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Figure 65: Scheme of the developed Cell-SELEX Galaxy pipeline and example data 
outputs. 
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3) FASTA-to-Tabular - Files are then converted to a text-based 
format that allows for easier sequence manipulation.  
4) Cut - The unique identifier assigned to each read is removed, 
leaving only raw sequence data. 
5) Text Formatting - Sequences that do not meet specific text-
based criteria are removed from the dataset. In this workflow, 
sequences are retained if both constant flanking regions, as well 
as a central series of nucleotides of 38-42 bases in length, are 
present. Longer amplification by-products are removed at this 
stage. 
6) Replace - A comma character is placed at the end of 5’ constant 
flanking sequences, separating them from central N38-42 base 
regions. 
7) Convert - Sequences are split based on the position of inserted 
comma values, placing 5’ constant regions into a separate 
column. 
8) Cut - Columns containing 5’ constant region sequences are 
subsequently removed from the dataset. 
9) Replace, convert, cut - Steps 6-8 of the workflow are repeated in 
order to remove 3’ flanking regions, which are separated by 
placing a comma character at the beginning of the constant 
sequence. After this stage, only N38-42 sequences are present 
within the dataset. 
10) Add Column - An additional column is added to the dataset 
containing arbitrary ‘+’ character values against each sequence. 
These values act as sequence identifiers, allowing file conversion 
to a FASTA format. 
11) Tabular-to-FASTA - Files are converted back from tabular to 
FASTA file formats, allowing sequences to be collapsed.  
12) Collapse - Repeated identical sequences are reduced into a 
single read and assigned a count value corresponding to the 
number of duplicated sequences present within a sample.  
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The total number of raw sequence reads obtained from NGS analysis 
was found to vary significantly between samples from each round of 
selection (Figure 66). Such results were unexpected given the fact that 
all sample DNA concentrations were quantified and normalised both prior 
to and during NGS library preparation. This variation may potentially be 
attributed to PCR bias effects, in which samples are differentially enriched 
during library amplification processes. Previous studies have found that 
such effects are a major contributor to the established sample-to-sample 
(as well as run-to-run) variation often exhibited by the Illumina® Miseq 
platform [397].  
Figure 66: Total number of NGS reads obtained from sequenced aptamer pool 
samples before and after data processing using a custom Galaxy bioinformatics 
workflow. 
Whilst application of the developed Galaxy data processing workflow 
resulted in a general decrease in the total number of sequence reads in 
all NGS datasets, this reduction was found to be less significant for the 
sample obtained from the final round of selection (Figure 66). Such 
results may potentially be taken as an indication of successful selection, 
with increased enrichment of viable aptamer sequences (that meet data 
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processing parameters) compared to amplification or sequencing 
artefacts.  
NGS-analysed samples obtained from early (rounds 1-3) and mid (rounds 
8-10) Cell-SELEX cycles did not contain any sequences that were 
repeated more than twice (after data processing). These findings were 
consistent with the majority of previously reported Cell-SELEX studies, 
which generally required between 10-20 rounds of positive selection to 
identify potential ssDNA aptamer candidates [398]. 
However, a total of 13,138 sequences were found to be repeated multiple 
times in the NGS dataset obtained from the final round of selection (round 
14). In fact, 15 sequences were found to possess read counts greater 
than 25 (Table 16). Many of these showed elements of structural 
similarity, thereby demonstrating the potential of these sequences for the 
recognition of human sperm cells.  




Sequence Reads Length 
(bp) 
SP1 CACTCTCACCTTCCTGTCACTCCTTTTTTCACTCTCACTC  252 40 
SP2 CACTCACTCTTTCCCTTATCTGCTCACTCTTCATTCACTC  61 40 
SP3 CACCGTCCTTTTCTAGCATCTCTGTCACTCTTTCTCACTC  53 40 
SP4 CACTCTCACCTTCCTGTCACTCCTTTTTCACTCTCACTC  48 39 
SP5 TCACTCGCAATATCCGTCACTTCCTCCTACCTCTTCACTC  41 40 
SP6 TCGACACTCTTTCCCTAACTACTCTGGATTCGCTCATCTC  37 40 
SP7 CCACTCGTCAACTTCCCTTCATCGTCACTCGCTCACACTC  37 40 
SP8 CACTCACTCTTTCCCTTATCTGCTCACTCTTCATTCACTC  37 40 
SP9 CCGACACTCACCTACCTTTATCTCTCTGGATTCCGCACTC  33 40 
SP10 CGACCTATCACTCTCTTTTTCACTTGGATTTAACTCACTC  30 40 
SP11 CCACCCCAACCTTTCGCGTCCTCTTACTCACTCTTCACTC  29 40 
SP12 CGGCACCCTACCCCCCTTTCTCCTCTCTGGATCGTCTCTC  28 40 
SP13 CGCTCATCTCCTTCATTTTTGTCACTCTTCTCTTCACTC  28 39 
SP14 CGCCGCTCATTCTGGTCACGTCATCTCTTTCTTTTCACTC  28 40 




Page | 191  
Although not covered within the scope of this study, further work to cluster 
highly represented sequences should be undertaken using informatics 
tools such as FASTAptamer [306] or AptaCluster [399] to elucidate the 
specific structural motifs responsible for aptamer-sperm cell binding. 
5.4.3 Conclusion 
A number of promising ssDNA aptamer candidates have been raised 
towards the recognition of human sperm cells using in vitro Cell-SELEX 
and NGS methods. A novel data processing pipeline was also 
constructed using the online informatics workflow management system 
Galaxy, for elucidating the sequence structure of potential binding 
ligands. Whilst specifically developed for the analysis of data obtained 
within this study, this pipeline may have potential use in future SELEX 
experiments (towards both cellular and non-cellular targets) employing 
the same N40 library template (and associated constant region 
sequences).  
Whilst these sperm-cell specific sequences were primarily raised for use 
within displacement-based aptasensing assays, it is also envisioned that 
such ligands may also have application to other areas of forensic 
analysis. This may include the incorporation of sequences into solid-
phase aptamer-functionalised materials (AFMs) for the capture and 
isolation of spermatazoa from vaginal epithelial cells. Such materials 
would be considered extremely useful in sexual assault casework for the 
separation of male and female cellular components in the biological fluid 
mixtures, allowing for the complete deconvolution of mixed DNA profiles.  
However, further assessments of analyte binding affinities and secondary 
folding structure are likely to be required before selected ssDNAs may be 
employed as biological recognition elements. This may be achieved 
through Kd measurement techniques (including ITC, SPR or 
ultrafiltration), with subsequent bioinformatics analysis (using programs 
such as mfold [308]). 
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6.1 Introduction 
Biosensors developed within the scope of this study were originally 
designed to be applied to latent body fluid stains as sprayable liquid 
reagents. Such reagents would be able to both visualise and identify the 
type of fluid present on an item, providing investigators with more 
information about an offence at a ‘source’ level (i.e. the donor and tissue 
origin of recovered genetic material).  
However, authors have argued that greater emphasis should be placed 
on the ability of analytical techniques to generate ‘activity’ level 
information from biological evidence, such as intelligence on the 
movements and/or actions of individuals during an offence [400]. This is 
evidenced by the growth of research in areas such as metagenomic 
analysis, which may be used to discern the locations an individual has 
previously visited (as well as any objects they have touched) by 
examining the presence of specific microbes present on the surface of 
their skin/clothing [401]. 
One method of achieving such intelligence (within specific criminal 
scenarios) is through the use of ‘taggants’, materials containing encoded 
marker elements that act as unique identifiers. In locations in which a 
crime is suspected to potentially occur, these materials may be applied to 
the surface of an object, which is then handled by an offender, causing 
the taggant to be transferred. The subsequent detection of the taggant by 
investigators may then be used to empirically link an individual to a 
specific offence. A secondary transfer of taggants from a suspect to 
another surface may also provide additional insights into the movements 
and actions of an individual. 
However, one challenge associated with current taggant materials is 
evasion by criminals who are familiar with the technology and able to 
detect areas of reagent application [402]. It was therefore envisaged that 
fluorogenic substrate biosensors may make for ideal ‘reactive’ taggant 
materials that remain completely invisible (even under excitation lighting) 
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until handling. Such handling may result in the digestion of substrates as 
a result of interaction with enzymatic moieties present in sweat (or 
possibly saliva transferred to the surface of the individual’s hands), 
activating a detectable fluorescence signal.  
This chapter therefore opens with a review (which underwent publication 
in 2016) of the prevailing state and future perspectives of taggant 
technology in forensic analysis. The different potential applications of 
taggant materials are first outlined before a discussion of the types of 
unique coding components used for taggant batch identification.  
This review is followed by two published original research articles; the first 
of which involves ‘proof of concept’ investigation into the use of the 
peptide and fluorophore moieties previously employed for the 
construction of custom PSA-specific fluorogenic substrates, as taggant 
coding and detection components respectively.  
A subsequent follow-up study is then reported, which documents a more 
comprehensive assessment of the developed taggant stability, resistance 
to varying environmental conditions and secondary transfer ability. An 
introduction to each published manuscript is given explaining the 
contributions of each of the listed authors to the work.  
6.2 Published Article 5: ‘Taggant Materials in Forensic Science: 
A Review’ 
The content of following section was published as a review article in: 
Gooch, J., Daniel, B., Abbate, V., & Frascione, N., Taggant materials in 
forensic science: A review. TrAC Trends in Analytical Chemistry, 2016. 
83: p. 49-54. 
Drafting of the manuscript was performed by the candidate. Dr. Barbara 
Daniel, Dr. Vincenzo Abbate and Dr. Nunzianda Frascione had final 
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6.2.1 Manuscript 
Authors: James Gooch,a Barbara Daniel,a Vincenzo Abbate,b and Nunzianda 
Frascione. a* 
Authors Address: a) Analytical and Environmental Sciences Division, 
King’s College London, 150 Stamford Street, London, U.K., SE1 9NH, b) 
Institute of Pharmaceutical Science, King’s College London, 150 
Stamford Street, London, U.K., SE1 9NH. 
Abstract: The use of taggant technology to mark objects for the purpose 
of identification is becoming a significant part of national crime reduction 
strategies. Taggants may be able to prevent or monitor criminal offences 
by associating an object with a specific piece of information. While the 
material properties of a taggant will largely vary between application 
purposes, a specific ‘coding’ element will generally be incorporated to 
infer marker uniqueness. With the speed, simplicity and accuracy of 
coding component analysis largely determining the overall efficacy of 
taggants, continuing advances in portable in-field analysis, 
nanotechnology and material science should have allowed for the 
development of new and improved forensic marking agents. However, the 
limited amount of recent research in this area suggests that this is not the 
case. This critical review therefore examines the current state of presently 
available taggants before attempting to offer insight into the future 
direction of forensic marking technology. 
Introduction 
Costing approximately £24 billion a year, the social and economic effect 
of organised criminal activity in the UK is substantial. Offences related to 
the trafficking of illicit drugs (£10.7 billion), organised fraud (£8.9 billion) 
and acquisitive crime (£1.8 billion) are reported to be the largest sources 
of criminal revenue [403]. With actual costs likely to be even greater (as 
such estimates are only based on data from recorded crimes), developing 
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strategies that are able to prevent or aid in the investigation of these 
offences is a significant priority of the forensic science community. 
Among the number of products made commercially available for the 
purpose of reducing criminal activity, forensic taggants may be seen as 
one of the most successfully employed. Taggant materials have been 
widely accepted for use as evidence within the UK court system since 
2008, with certain marking agents having aided in the conviction of over 
one thousand criminal offenders since that time. Based on statistics 
published by the Metropolitan Police Service, household burglary across 
London was decreased by nearly 30% in areas where forensic taggants 
were applied (i.e. SmartWater®). Taggants are a class of materials that 
can be applied to or incorporated within an object in order to make it 
identifiable [402]. This is achieved by producing each ‘batch’ of taggant in 
an entirely unique formulation, allowing the particular molecular 
composition to be registered against a specific piece of information. Once 
recovered at a later date, this composition can be analysed in order to 
reveal the identity of the taggant and thus, the object it is marking [404].   
Figure 67: The four main applications utilising forensic taggants. 
A forensic taggant displaying entirely ideal characteristics should be of 
low cost to produce, have high coding capacity, be non-toxic to 
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inexpensive to detect and analyse via non-destructive means and be of a 
complex enough nature to prevent duplication. The majority of taggant 
manufacturers claim that their products are versatile enough to be applied 
in a broad range of circumstances. However, forensic marking materials 
are most extensively utilised for four distinct purposes (Figure 67):  
• Property marking - Taggants may be applied upon valuable items 
such as vehicles and electronics in order to associate them with a 
specific owner. If that property becomes subject to theft but is later 
recovered, it may be returned to the original purchaser [405, 406]. 
Property taggants are usually invisible to the naked eye in order to 
prevent spoiling the item’s aesthetic or to avoid detection by 
offenders. 
• Anti-counterfeiting - Industries at risk of counterfeiting activities 
(pharmaceuticals, clothing, currency, etc.) may choose to 
incorporate taggants into their products to distinguish them from 
potential forgeries [407]. Marking agents used for this application 
are typically non-visible and have replaced traditional barcoding 
and hologram anti-counterfeit technologies, which are more easily 
duplicated [408]. 
• Tracking - Materials used in the manufacture of hazardous or 
potentially illegal products may be tagged by law enforcement 
agencies to aid detection or track initial origin. Such marking agents 
are predominantly applied during the production of industrial 
explosives that are susceptible to illicit use [409]. Robust taggants 
able to survive detonation may be detected to reveal information 
regarding type of explosive, supplier or batch ID. Taggants may 
also be covertly added to bulk volumes of illegal narcotics, allowing 
their distribution to be monitored [410].  
• Monitoring - Taggants may be placed on exterior surfaces of 
houses, commercial properties or objects of value. As a result of 
criminal activity (such as trespassing or out-of-hours burglary), 
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these taggants may be transferred to an individual, providing strong 
physical evidence to associate them with that offence [411]. 
Additional information of the suspect’s subsequent activity can also 
be gained if the taggant undergoes a secondary object-to-person-
to-object transfer.  
The physical characteristics of a taggant will depend largely upon which 
of these four purposes it is being used for (Figure 68). For example, 
markers utilised to stain currency stolen during a CViT (Cash-and-
valuables-in-transit) robbery should remain permanent after application 
and should not be easily removed [406]. Conversely, a forensic coating 
applied to firearms and cartridge casings in an attempt to establish 
handling, should be designed to be as transferrable as possible [412]. 
The range of taggant formulations is therefore extensive. Markers may be 
dispersed within a medium such as grease, paint or ink, sprayed via 
aerosol, applied directly as a powder or embedded into materials during 
manufacturing processes [413]. 
Figure 68: Forensic taggants may include different components (i.e. code, dye and 
material/medium), which can determine its physical characteristics. 
 Taggants designed to be covertly applied (in order to avoid destruction or 
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allow detection at a later time point. Being invisible to the naked eye, 
these taggants require localization in order to be successfully recovered 
for analysis. This is most often achieved by adding fluorescent 
compounds to the taggant, which will then emit light when excited at 
certain wavelengths of the UV or visible spectrum [414]. Other detection 
methods involve the inclusion of volatile chemicals for vapour 
identification [415] or radioactive isotopes [404]. 
While these detection constituents may not always be required within a 
taggant, all forensic markers will include a main ‘coding’ element in order 
to infer a required statistical uniqueness. By creating a formulation that is 
unable to be duplicated, a taggant may effectively ‘store’ information 
regarding the object it is marking [414].  
As the success of a taggant will be largely influenced by the ability of this 
code to be recovered and analysed, all marker coding methods produced 
within the UK are subject to validation by the British Standards Institution 
(BSI) under Publicly Available Specification 820:2012 (PAS 820:2012). In 
this process, taggants are exposed to a number of accelerated UV light, 
temperature and humidity conditions in order to simulate the longevity of 
coding materials within a variety of circumstances. 
Figure 69: Code uniqueness provided by differences in: a) physical characteristics (i.e. 
multiple coloured layer particles), b) optical spectra, c) chemical composition and d) 
DNA sequences. 
A G C T
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Table 17: Commercially available forensic taggants 
Coding Type Manufacturers Taggants Produced Analysis Methods Uses 
Physical  Alpha•Dot Alpha•Dot [416] Optical microscopy Property marking, vehicle marking  
DataDot DataDots® [417] Optical microscopy Property marking, anti-counterfeiting  
Microtrace Microtaggant® [418] Optical microscopy Anti-counterfeiting, explosives detection 
Spectroscopic DNA Technologies SmartDye™[419] Spectrofluorometry Anti-counterfeiting 
Luminex MagPlex® spheres [420] Flow Cytometry Anti-counterfeiting, biological labeling 
Microtrace Spectral Taggant™ [421] Spectrofluorometry Currency marking, security printing 
Spectra Systems SpectraFluor™ [422] Spectrofluorometry Currency marking, product tracking 
Chemical Authentix Authentix [423] Immunoassay, GC-MS Fuel Adulteration, anti-counterfeiting 
SmartWater SmartWater® [405] LA-ICP-MS Property Marking, activity monitoring 
Polysecure Brandproof® [424] XRF spectroscopy Anti-counterfeiting 
DNA 
 
Applied DNA Sciences SigNature® [425] DNA sequencing Property marking, anti-counterfeiting, CViT 
DataDot dDotDNA® [426] DNA sizing analysis Property marking, anti-counterfeiting 
DNA Technologies DNA Matrix™ [427] DNA sequencing Anti-counterfeiting 
SelectaMark SelectaDNA® [428] DNA sequencing Property marking, activity monitoring 
TraceTag CypherMark™ [429] DNA sequencing Property marking, anti-counterfeiting 
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Despite the extensive commercialisation of taggant technology (Table 
17), detailed information regarding the synthesis and manufacturing 
procedures of such marking agents is extremely limited within academic 
literature. Whilst publishing such protocols within the public domain may 
result in a decrease in taggant efficiency (by allowing offenders to 
become familiar with such materials), it is still pertinent to conduct a 
thorough exploration into the different encoding methods used in 
commercially established forensic marking agents (Figure 69). This 
critical review therefore attempts to examine these coding mechanisms, 
as well as explore recent research that may indicate how forensic taggant 
technology is likely to progress within the near future. 
Current Technology 
Physical Taggants 
Renowned for being one of the earliest existing forensic marking 
materials; physical taggants possess coding systems that are based on 
the simple morphological properties of their components. These taggants 
are generally made unique by exploiting solid particles of a specific size, 
appearance or structural arrangement [430]. Such encoding mechanisms 
may also be described as ‘graphical’, as analysis is usually achieved by 
basic visual methods such as low-power microscopy [414]. 
One coding element commonly used in physical taggants is the microdot, 
a small polymer disc between 2-1000 μm in size containing minute 
photographic information. Text or images etched onto microdots are 
usually too small to be observed by the naked eye alone but may be 
revealed upon optical magnification [431]. Although initially developed as 
a covert means of transferring data during World War II, companies such 
as DataDot and Microtrace have taken advantage of microdot technology 
by including them in a number of ink and varnish based suspensions 
[404]. The dots within these suspensions are then able to act as simplistic 
tagging mechanisms by being imprinted with a unique numeric code, 
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which is then registered against a particular owner on an electronic 
database [417]. 
Another physical tagging approach pioneered in the 1970’s by the US 
company 3M, focuses on the use of small plastic particles, constructed 
using a number of different proprietary coloured materials. These 
materials are combined in a sequence of layers, the order of which will be 
specific to each formulation of taggant produced [418]. A visual inspection 
of the layers then reveals the identity of the marker and the batch from 
which it originated. The robust nature of the materials used in layer 
construction has resulted in these particles becoming a predominant 
tagging agent for the identification of post-detonation explosive materials 
[432].  
However, in a number of circumstances the utilisation of physical type 
taggants may be considered disadvantageous. Marking agents based on 
graphical identification strategies will generally have very little ‘space’ in 
which coding can take place [402]. This consequently limits the amount of 
statistically unique particles (and thus taggant formulations) that may be 
produced. Applications such as property marking, which necessitate a 
continuous stream of distinct codes, may benefit better from the use of 
molecular-based tagging agents, which have a higher coding capacity. 
Other drawbacks include the easy observability of physical taggants due 
to the relatively large size of incorporated solid particles, limiting their use 
within covert situations [413]. 
Spectroscopic Taggants 
In spectroscopic taggants, a number of molecules possessing differing 
optical qualities are combined together to create a single mixture with a 
spectrally unique signature. These taggants utilise multi-component 
encoding strategies, achieving their individuality from a precise 
combination of different emission wavelengths or intensities [414]. 
However, in certain taggant designs, these optically distinct molecules 
may be enclosed together within solid particles (to increase taggant 
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stability or simplify analysis) and may thus be described as single-
component systems [433]. Determining the identity of these marking 
agents is usually performed via the analysis of overall emission signature 
by simple spectrophotometry techniques. 
The materials most often utilised within spectroscopic taggants are simple 
non-toxic organic dyes that fluoresce in different regions of the visible 
spectrum [434]. Companies such as Luminex and Spectra Systems 
manufacture a number of marking agents based on the integration of 
several cyanine, phthalocyanine or squaraine-based fluorophores [420, 
422]. The low cost and wide availability of organic dyes ensures that the 
production of spectroscopic markers remains inexpensive, but may also 
result in the illegal reproduction of taggants themselves if fluorophores 
are recognised and acquired by counterfeiters [408]. Organic dyes are 
also disadvantaged by broad spectral emission overlaps, short 
fluorescence lifetimes and sensitivity to photobleaching [413].  
Industrial and academic research has attempted to overcome these 
challenges by developing spectroscopic taggants that include more 
sophisticated optical components. Guillo et al. recently reported the 
development and commercialisation of a large array of spectroscopic 
coding materials based on non-toxic lanthanide ion complexes [435]. The 
unique temporal and spectral characteristics associated with these 
complexes are considered extremely difficult to duplicate by materials 
available to forgers, which may significantly deter potential attempts at 
taggant duplication. The narrow emission bands of rare-earth materials 
may also serve to increase the discriminatory power of a taggant by 
allowing more optically distinct components to be added to a marker 
without spectral overlap [414]. As the number of existing lanthanide 
elements is limited, varying the emission intensity ratios as well as the 
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Chemical Taggants 
Much like spectroscopic markers, inorganic taggants rely on a multiplex of 
molecules within a specific combination to infer identity. However, instead 
of optical signature detection, chemical encoding is achieved from a fixed 
set of trace materials, which may be either present or absent from a 
mixture [436]. Each of these materials is tested for on an individual basis, 
essentially creating a form of ‘binary string’ data in which each position of 
the string represents a different compound. The presence of a particular 
trace may be indicated by a "1" in that position of the string, whilst its 
absence may be denoted by a "0" [437]. Taggant identity is determined 
by the comparison of binary sequence data generated from trace analysis 
with a list of strings registered on a database. 
The UK’s largest manufacturer of forensic marking technology 
SmartWater, bases the majority of their commercially available reagents 
on this premise. In these taggants rare-earth lanthanides are also utilised 
but are identified by their individual mass through laser ablation 
inductively coupled plasma mass spectrometry (LA-ICP-MS) rather than 
fluorescence emission [405]. A method of using isotopic materials as 
chemical encoding components for the authentication of fuels, consumer 
products and agrochemicals has also been developed by U.S. firm 
Authentix. These trace elements usually consist of deuterated organic or 
inorganic compounds that are then detected by either gas-
chromatography mass spectrometry (GC-MS) or multiplex immunoassay 
systems [423, 438]. The increased sensitivity of chemical analysis 
methods over spectroscopic techniques allows coding materials to be 
included at much lower quantities (as little as parts per billion) than other 
taggant types. This is turn prevents the physical properties of a marker 
from being altered (unlike those containing large insoluble particles, 
which may appear more ‘granular’ in nature) and may thus lower the risk 
of unwanted detection. Once again, these taggant classes are not without 
limitations. Binary string data can be compromised if one or more 
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components within a mixture is removed or destroyed, or if extraneous 
materials are added (for example, by accidental mixing of two different 
taggant formulations) [436]. Chemical multi-component encoding may 
also not be compatible with highly transferrable marking agents as the 
different underlying chemical structures of tracing elements may cause 
them to be transferred at dissimilar rates, leading to incomplete recovery 
and subsequent erroneous identification. 
DNA Taggants 
Discovered in the early 1950’s as the foundation of information storage 
for all known life forms, the immense coding ability of deoxyribonucleic 
acid (DNA) has been recognised for a considerably long period [439]. 
Since that time, a range of methods have been developed for the storage 
of non-genetic data within DNA molecules [414]. As a result, 
manufacturers such as Selectamark Security Systems [428], TraceTag 
[429] and Applied DNA Sciences [425] now produce forensic marking 
agents that can infer identity via the use of unique oligonucleotide 
sequences. Such sequences may be naturally occurring, entirely 
synthetic or a combination of both (e.g. botanical DNA shuffled into a 
random arrangement) [440]. The order of single nucleotide units 
comprising a sequence will be individual to each formulation of taggant 
produced, allowing separate batches to be distinguished.  
The benefits of near-unlimited coding capacity, straightforward synthesis 
and low toxicity of genetic material have ensured that DNA taggants are 
one of the most prevalent forms of forensic marking agents commercially 
available. However, challenges regarding the application of DNA-based 
tagging approaches are twofold. Sequencing techniques employed for the 
analysis of oligonucleotides are typically more cost, reagent and labour-
intensive than methods used to identify other types of taggant coding 
components [441]. As the genetic material recovered from a taggant also 
requires amplification by the polymerase chain reaction (PCR) prior to 
testing, this method of analysis can be especially expensive [402].  
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Furthermore, DNA is a relatively sensitive molecule and can degrade 
under the normal temperature, oxidation, radiation and chemical and 
enzymatic activity levels associated with ambient environmental 
conditions [442, 443]. While DNA damages caused by these stresses 
may be repaired by a number of processes within living organisms, the 
same cannot be said of the synthetic oligonucleotides included within 
forensic taggants. Concerns have therefore been raised over the general 
stability of DNA-based tagging materials and the subsequent compromise 
of genetic coding sequences [402, 414, 444]. However, encapsulation of 
nucleotides within silica microbeads [445] or plant materials [446] may be 
carried out in order to protect against this potential degradation. 
Future Perspectives 
Each of the commercially available taggant mechanisms included within 
this review displays a distinct set of strengths and weaknesses, either in 
terms of coding capacity, covert usage, overall stability or method of 
analysis (Table 18). These disadvantages currently prevent a single 
taggant type from being used as a universal product identification system, 
necessitating the application of separate marking methods for different 
purposes [404].  
Table 18: Summary of the advantages and disadvantages of commercial taggants. 
Coding Type Advantages Disadvantages 
Physical Simplistic analysis Limited coding capacity 
Inexpensive Less covert 
Spectroscopic Simplistic analysis Subject to counterfeiting 
Inexpensive Limited coding capacity 
Chemical Analysis sensitivity Prone to misidentification 
More covert Incomplete recovery 
DNA High coding capacity Expensive analysis 
Low toxicity Possible degradation 
 
However, it must also be noted that major practical innovations in the 
fields of nanotechnology, material science and analytical instrument 
portability have occurred since the scientific technologies behind these 
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coding mechanisms were established. These advances are now being 
exploited by a number of research groups in an attempt to develop 
forensic tagging reagents that can identify any object, regardless of 
situation or circumstance.  
Nanoscale particles, wires and tubes all show great potential as next 
generation tagging mechanisms due to their small size (preventing 
detection and the physical alteration of marker properties), range of 
potential analysis methods and ease of formulation within traditional 
marking reagent media [413]. Semi-conductive quantum dot 
nanoparticles are currently being utilised to create spectroscopic taggants 
with optical qualities superior to those employing organic dyes or 
lanthanide ion complexes [447]. With narrow emission wavelengths, 
colour-tuneable signals and environmental-independent fluorescence 
properties, quantum dots may represent an excellent opportunity to 
improve the multi-component spectral encoding mechanisms presently 
utilised by spectroscopic taggants [414, 448]. Commercialisation of this 
technology may have been hindered by the relative cytotoxicity of metal 
ions used in the synthesis of quantum dot particles [449]. Efforts to 
reduce these potential damages to human health and the surrounding 
environment are currently underway through the development of heavy 
metal-free quantum dots [450]. 
However, there has been debate over whether fluorescent molecules 
should be included within tagging materials at all, as many offenders are 
now familiar with optical anti-counterfeit methods and are able to identify 
markers with obvious visible emissions [413]. In an attempt to resolve this 
issue, a number of taggants have recently been produced that can only 
be analysed via the use of Raman spectroscopy [451, 452]. Much like 
other forms of spectroscopic coding mechanisms, these reagents 
comprise compounds mixed in a specific combination to produce a 
unique spectral signature (which in this case, is generated through the 
inelastic scattering of monochromatic laser light). The main advantage of 
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this method is that Raman spectroscopy may also be used for the initial 
detection of tagging materials as well as identification, avoiding the 
requirement of additional tracing components that may result in unwanted 
discovery [413]. The sensitivity of such detection may also be greatly 
increased through the phenomenon of surface enhanced Raman 
scattering (SERS) by the direct conjugation of  Raman-active compounds 
to a number of metallic nanoparticles [453]. 
Another coding technique designed by Duong et al. utilises the properties 
of nanomaterials beyond fluorescence, which involves deriving the 
individual melting-temperatures of a panel of solid particles within a 
taggant mixture to provide it with an unique thermal barcode [402]. The 
presence or absence of these so called ‘phase-change’ nanoparticles 
within a taggant is assessed using differential scanning calorimetry (DSC) 
in a linear thermal scan, which generates a specific melting-point peak for 
each component [408]. However, only a limited selection of nanoparticles 
has currently been developed for this purpose [454]. It is likely that this 
number will have to be increased in order for this system to possess the 
level of statistical differentiation required from a universal tagging system.  
Figure 70: Schematic of peptide-based taggant application and analysis. Adapted from 
[455]. 
Aside from nanoparticle-based encoding methods, recent developments 
in novel tagging technology have also been achieved by the use of 
synthetic polypeptide sequences [456]. The principle of inferring identity 
through the unique order of successive amino acids has been theorised 
since the early 1980’s [457]. However, only within the last year have 
methods been realised for their practical application and analysis within 
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which an oil-based medium containing hydrophilic peptide molecules is 
first applied onto the surface of an object. As a result of handling during 
criminal activity, this reagent is transferred to an individual, associating 
them with the offence. Detection by added fluorescence tracers is 
performed to permit recovery of the taggant by targeted swabbing. 
Hydrophilic peptides may be then isolated from the medium by simple 
liquid-liquid extraction, allowing their mass (and therefore sequence) to be 
determined by electrospray ionisation mass spectrometry (ESI-MS). 
As an alternative form of single-component biomolecular coding, peptide 
taggants possess a number of advantages over current commercially 
available DNA-based marking systems. The statistical coding capacity of 
polypeptide chains is significantly greater than that of oligonucleotides, 
owing to the 22 different natural amino acids that may be used as 
individual sequence units (compared to the four bases possessed by 
DNA) [458]. Kydd reports that a string of 10 random amino acids can 
code up to 4 × 1013 unique sequences [457]. ESI-MS methods are also 
quicker than DNA sequencing (with processes from detection to analysis 
able to be completed in less than one hour) and are becoming 
increasingly more portable, which could allow the point-of-care testing of 
peptide tagging reagents. Peptides are additionally easy to produce at 
low cost, are environmentally harmless and relatively inert (with stability 
being further increased by simple chemical modifications) [458]. 
Conclusions 
By authenticating objects, deterring theft and monitoring illegal activity, 
forensic taggants continue to play a pivotal role in the reduction of 
criminal enterprise. This review has attempted to highlight the significant 
abilities of tagging materials to infer identity in an enormous range of 
products, as well as document the most prominent commercially available 
coding mechanisms used for achieving this aim. Whilst it is quite clear 
that none of the commercial marking methods available currently possess 
every single one of the qualities demanded of a universally applicable 
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forensic taggant, the recent research covered within this article 
demonstrates that concerted efforts towards taggant improvement are 
occurring. The myriad of surfaces, environments and time-frames in 
which a taggant may be applied makes the technical innovation and 
validation of forensic marking materials relatively challenging. Only 
through continuing advances in material science, nanotechnology and 
instrumental analysis, can steps be made towards the development of a 
single versatile platform for object identification. It is hoped that this 
review will encourage researchers working within the field of analytical 
chemistry to take interest in taggant technology and engage with this 
development in order to make universal marking systems a reality. 
6.3 Published Article 6: ‘Establishing Evidence of Contact 
Transfer in Criminal Investigation by a Novel ‘Peptide Coding’ 
Reagent’ 
The content of following section was published as an original research 
article in: Gooch, J., et al., Establishing evidence of contact transfer 
in criminal investigation by a novel ‘peptide coding’ reagent. Talanta, 
2015. 144: p. 1065-1069.  
Experimental work was performed by the candidate with assistance from 
Clarissa Koh. The candidate also produced the manuscript. Help with 
peptide synthesis, as well as access to the Institute of Pharmaceutical 
Science research laboratories and HPLC and MS instruments, was 
provided Dr. Vincenzo Abbate. Dr. Barbara Daniel and Dr. Nunzianda 
Frascione provided supervisory and technical support throughout the 
research. Additional materials for this article may be found in the 
appendix of this thesis (Section A.2). 
6.3.1 Manuscript 
Authors: James Gooch,a Clarissa Koh,a Barbara Daniel,a Vincenzo 
Abbate,b and Nunzianda Frascione. a* 
Authors Address: a) Analytical & Environmental Sciences Division, 
King’s College London, Franklin Wilkins Building, 150 Stamford Street, 
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London, SE1 9NH, b) Institute of Pharmaceutical Science, King’s College 
London, Franklin Wilkins Building, 150 Stamford Street, London, SE1 
9NH. 
Abstract: Forensic investigators are often faced with the challenge of 
forming a logical association between a suspect, object or location and a 
particular crime. This article documents the development of a novel 
reagent that may be used to establish evidence of physical contact 
between items and individuals as a result of criminal activity. Consisting 
of a fluorescent compound suspended within an oil-based medium, this 
reagent utilises the addition of short customisable peptide molecules of a 
specific known sequence as unique owner-registered ‘codes’. This 
product may be applied onto goods or premises of criminal interest and 
subsequently transferred onto objects that contact target surfaces. 
Visualisation of the reagent is then achieved via fluorophore excitation, 
subsequently allowing rapid peptide recovery and analysis. Simple liquid-
liquid extraction methods were devised to rapidly isolate the peptide from 
other reagent components prior to analysis by ESI-MS.  
Introduction 
The Home Office estimates that billions of pounds in social and economic 
costs arise every year as a direct result of organised criminal activity 
within the UK [459], the majority of which may be attributed to physical 
crimes, including significant theft and drug trafficking offences. 
Consequently the reduction of this activity remains a high priority for the 
UK government and its criminal investigators. This has been recently 
reflected by the growing number of commercially available forensic 
‘taggants’, chemical reagents which may be applied to a particular 
surface in order to monitor items of criminal interest or associated activity 
[402, 445]. These products, usually consisting of a coloured compound 
mixed within an oil-based medium, are easily transferred onto persons or 
objects that come into contact with marked surfaces. The subsequent 
detection of these compounds may then be used to form a logical 
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association between an individual and the object in question, providing 
strong evidence of criminal intent. For ‘covert’ operations, in which 
indication of transfer should remain hidden from the offender, coloured 
materials may be replaced by fluorescent ones, the presence of which is 
only revealed through excitation with specialist light sources [460]. For 
example, the US based company Sirchie has developed several visible 
and fluorescent transferrable products designed for home and business 
owners to protect their property from trespassers and to mark valuable 
goods that are likely to be the subject of theft. However, the disadvantage 
of such products is that they are comprised of a single standard 
formulation and cannot be used to differentiate the source of two 
separate objects on which the same medium has been applied, thereby 
limiting investigative potential.  
Others have sought to address this problem by inserting a unique ‘code’ 
within the medium itself, which may be traced back to the original owner 
upon analysis. Many of the UV-vis emitting products developed by Cleary 
[461] contain a mixture of trace metals and organic moieties, with coding 
achieved by the unique combination in which the materials are present. 
Subsequent analysis of reagent samples recovered from individuals or 
stolen goods may then be able to determine the address to which that 
particular elemental composition is registered [461]. However, the 
disadvantage of using a large variety of compounds within a single 
formulation is twofold; first that differences in chemical structure will 
cause molecules to be transferred at different rates. An incomplete or 
erroneous code may therefore be given in cases in which only trace 
amounts of medium are recovered that may not contain a full range of 
materials added to the formulation. This is further dependant on the type 
of surface on which the medium has been applied, making the estimation 
of transfer unpredictable. Furthermore, the relative stability of each 
molecule is also governed by these same structural differences, which will 
be different for each additive. Incorrect codes may once again be given if 
certain compounds break down prior to recovery and analysis. This would 
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be especially pertinent in scenarios where media have been applied on a 
long-term basis. 
In recent years, Brown and Reichert [428] have made attempts to avoid 
using a coding system based upon multiple identifying additives by 
synthesizing a number products that contain a unique synthetic DNA 
sequence [440]. Despite negating differential transfer rates by using a 
single molecular identification system, the labile nature of DNA in 
exposed environmental conditions is well documented [462, 463], making 
overall reagent stability a cause of concern. Moreover, sequencing DNA 
to determine its associated address can be expensive and time 
consuming, requiring trained personnel and large-size laboratory based 
instrumentation, as well as specific procedures for sample collection and 
preservation. This also applies to DNA synthesis itself, in which pure 
sequences are difficult to achieve in a high yield [464]. Although 
circumvention of this issue may be achieved through the PCR 
amplification of low amounts of starting material, extensive extraction 
procedures are likely to be required in order to remove any additional 
materials that may cause downstream inhibition. 
We therefore present the development of a novel reagent used to 
establish evidence of contact transfer in order to provide a more robust 
method of monitoring items associated with criminal activity. The 
proposed reagent, like those previously described, is comprised of a 
fluorescent compound dispersed within an oil-based medium that is 
transferred to an offender or object that comes into contact with a marked 
surface. However, this reagent employs an innovative single molecule 
coding system based on the addition of a unique synthetic peptide. This 
peptide, made up of a short known sequence of amino acids, is specific 
to every formulation of the reagent produced, allowing its registration to 
an individual or address. Once transferred as a result of criminal activity, 
this product may be visualised by excitation with a specialist light source 
to produce fluorescence. 
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Unlike other DNA based coding systems, peptides can be isolated from 
the rest of the reagent components via a simpler liquid-liquid workup 
procedure. Analysis of the sequence may then be rapidly achieved via 
standard Electrospray Ionisation Mass Spectrometry, with each peptide 
generating a specific m/z ratio that can be used to determine its identity 
(Figure 71). Such analysis affords significant advantages over time-
consuming and costly DNA sequencing processes. Amino acids are also 
amenable to a wide array of structural modifications [465], which can 
either be used to further increase stability or increase the exclusivity of a 
coded sequence. There are numerous potential applications for this 
reagent. In addition to linking a person to a target surface via primary 
transfer (i.e. surface-to-person), it may also be possible to deduce their 
subsequent activity by tracking secondary transfer (i.e. surface-to-person-
to-object). For example, if a person handles a specific item (i.e. a 
package or document) after coming into contact with the reagent, it may 
be possible to also link them to that item through secondary transfer.  
Figure 71: Demonstration of peptide recovery and analysis: a) the reagent is 
visualised through wavelength excitation, b) the collected medium undergoes liquid–
liquid extraction to isolate coding peptide, and c) peptides are analysed and unique m/z 
value generated to identify sequence. 
This study focuses on the reagent design and investigating optimum 
conditions for its successful detection and analysis. The in-field stability of 
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application to a number of surfaces routinely encountered within forensic 
casework. 
Materials and Methods 
Medium Selection 
Glycerol (Sigma Aldrich, UK), Castor Oil (Holland and Barrett, UK), a 
mixed hydrocarbon formulation (MHF) (Vaseline, UK) and a Lithium-
based lubricant (Comma, US) were spread evenly in 100 mg amounts on 
2.5 cm2 areas of aluminium foil, ceramic, plastic and glass. Surfaces were 
contacted after 24 hours with a white vinyl gloved index finger at a 
standardised force of 30 g. A brief qualitative visual examination was 
used to establish the two media displaying greatest transfer. A 
quantitative indication of MHF and lubricant transference was achieved 
through the process described above but with surfaces weighed before 
and after contact to calculate deposited media. 
Peptide Synthesis 
Peptide Ac-HSSKL was manually synthesised by Fmoc-Solid Phase 
Peptide Synthesis using 2-chlorotritylchloride resin (Sigma Aldrich, UK), 
which was swollen in dichloromethane (DCM) for 10 minutes prior to 
coupling. Acylation steps were conducted using six equivalents of FMOC 
amino acids, pre-activated with DIPCDI and Ethyl 
(hydroxyimino)cyanoacetate (Oxyma) in anhydrous N,N-
Dimethylmethanamide (DMF). Coupling reactions were conducted for 1 
hour and monitored by the picrylsulphonic acid test. FMOC deprotection 
of coupled amino acids was achieved by treatment with 20% (v/v) 
piperidine in DMF for 10 minutes and confirmed by the picrylsulfonic acid 
test. Impurities and excess reagents were removed by washing at each 
stage with DMF, methanol and dichloromethane.  
Capping acetylation was performed by the addition of ten equivalents of 
acetic anhydride and twenty equivalents of N,N-Diisopropylethylamine 
(DIPEA) in DMF. Resin cleavage was achieved through treatment with a 
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95:0.5:0.5:0.5:0.25 solution of trifluoroacetic acid (TFA): water: phenol: 
thioanisole (TA): triisopropylsilane (TIPS) for 3 hours at room 
temperature. Next, the filtrate was concentrated under nitrogen at 40 °C. 
Ice cold diethyl ether was added to precipitate peptides which were 
washed several times with diethyl ether, dissolved in 50% acetonitrile in 
water containing 0.1% TFA and finally freeze-dried for 24 hours. The 
purity and correct mass of the final peptides were confirmed by analytical 
reverse-phase high-performance liquid chromatography (RP-HPLC) and 
ESI-MS, respectively. All peptide synthesis reagents were purchased 
from Bachem, UK and used as received. 
Peptide Concentration Selection 
Synthesised peptide in 1 mg, 2.5 mg and 5 mg quantities was mixed into 
100mg of MHF, which was subsequently spread evenly on a 2.5 cm2 area 
of a glass microscope slide. Slides were contacted with a gloved finger as 
previously described (refer to the Medium Selection section). Portions of 
gloves containing transferred media were removed and placed in a 2 ml 
Eppendorf tube. A liquid-liquid extraction to isolate the peptide for 
analysis was performed through the addition of 1 ml hexane and 0.5 ml 
distilled water. Samples were vortexed and glove fragments removed 
before centrifugation at 13,000 RPM for two minutes. Aqueous phases 
were placed into a fresh tube. The original sample was then further 
extracted with an additional 0.5 ml of distilled water. Both aqueous layers 
were combined before undergoing counter extraction with 1 ml of hexane. 
After removal of hexane layer, formic acid was added to the aqueous 
phase at a final concentration of 0.1% v/v prior to ESI-MS analysis using 
a Waters ZQ micromass 2000 mass spectrometer. 
Fluorophore Studies 
Rhodamine 110 (Sigma Aldrich, UK) and 7-amino-4-
trifluoromethylcoumarin (AFC) (Santa Cruz Biotechnology, US) 
fluorophores were reconstituted in methanol to concentrations of 10 
mg/ml, 1 mg/ml and 0.1 mg/ml. 50 µl of each fluorophore concentration 
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was added to 100 mg of MHF and mixed thoroughly before being spread 
evenly on a 2.5 cm2 area of a glass microscope slide. Samples were 
visualized in the dark using an Olympus SZX12 fluorescence microscope 
(Tokyo, Japan) and photographed with an internal CCD camera. 
Photostability of both fluorophore-containing media was monitored once a 
week over a six week period. Lastly, 50µl of 0.1 mg/ml rhodamine 
solution was added to 100mg of peptide-mixed media before extraction 
and ESI-MS analysis.  
Stability Studies 
40 mg of peptide-mixed medium was applied to surfaces of aluminium 
foil, ceramic, plastic and glass, cotton, polyester, leather and denim. 
Liquid-liquid extractions were performed as previously described in order 
to isolate peptides for ESI-MS analysis. Extractions were performed from 
each surface once a week for a period of six weeks. 
Results and Discussion 
Transferability Studies 
The initial priority of every forensic taggant reagent design is the selection 
of an appropriate medium in which fluorophore and coding additives are 
dispersed. It is crucial that the medium transfers well by itself so that 
identification components carried within it will be of a high enough 
concentration for subsequent analysis. Additionally, media should not dry 
out, allowing them to be applied over extended periods of time, as well as 
transparent, to avoid detection within covert investigation.  
Glycerol, castor oil, MHF and a Lithium-based lubricant were chosen to 
be investigated as potential media due to their low volatility, odourless 
and colourless properties. Each medium was applied to four surfaces that 
are often encountered within forensic casework (i.e. plastic, ceramic, 
glass and metal) before being contacted with a gloved finger after a 
period of 24 hours (Appendix - Figure 85). This was carried out to ensure 
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that the final reagent is able to operate efficiently in a range of 
environments where it is likely to be applied.  
Both castor oil and glycerol samples showed significant decreases in 
transfer after a 24 hour time period, which was especially evident in 
samples taken from the glass and metal surfaces. This may be due to the 
fact that both substances are known to undergo a high degree of 
hydrogen bonding [466, 467]. Whilst theoretically the high viscosity 
caused by this bonding should allow for greater transfer, it is possible that 
the extensive intermolecular interaction also caused molecules to 
aggregate, leading to a more uneven transfer. In contrast, both semi-solid 
MHF and lubricant media showed greatest and most consistent 
transferability over time, likely benefiting from fixed molecular 
arrangements. These substances were therefore taken forward for further 
quantitative indication of transfer efficiency, in which the average 
percentage of media transferred was calculated by recording of surface 
weight before and after contact (Figure 72). 
Figure 72: Quantitative analysis of MHF and lubricant transfer rates from forensically 
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Quantitative studies confirmed transfer efficiency in both semi-solid 
media. Whilst a two-way ANOVA test determined transfer rates between 
lubricant and MHF were not statistically significant (P-value = 0.178309), 
a slightly higher percentage transfer on average across the majority of 
surfaces selected MHF as the basis for further reagent development.  
Whilst the use of a gloved finger allowed us to conduct this study within 
the remit of existing ethical approval, further studies are currently in 
progress to assess this transfer via skin contact. 
Peptide Sequence Selection 
With non-polar hydrocarbon-based MHF chosen as the basis for this 
reagent, use of a hydrophilic peptide coding sequence would allow for its 
rapid isolation via a simple liquid-liquid extraction. Amino acid sequence 
HSSKL was therefore synthesised after GenScript peptide property 
calculator analysis determined its suitable hydrophilicty through the 
inclusion of histidine and lysine residues. N-terminal acetylation was also 
performed to enhance peptide solubility during extraction. This peptide 
length was chosen such that synthesis would be rapid and inexpensive, 
while allowing enough variability to ensure unique coding.  
Figure 73: Positive ESI–MS spectrum of synthesised peptide Ac-HSSKL and inset: 
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Additionally, a search of the RCSB Protein Databank yielded no results 
for this sequence, thus reducing the risk of generating false positive 
results from naturally occurring peptides. RP-HPLC analysis was 
performed to check for peptide purity (data not shown) and an analysis 
via ESI-MS was conducted to confirm that the desired product had been 
obtained (Figure 73). Extraction protocols were subsequently devised 
with hexane and distilled water selected to isolate the peptide in an 
aqueous phase and separate the remainder of the non-polar medium 
prior to further analysis.  
Peptide Concentration Selection 
With competing interests in designing a reagent that allows for maximum 
sequence detectability, whilst simultaneously being inexpensive to 
produce, it is crucial to determine the most suitable concentration of 
peptide required for successful MS analysis.  After confirming identity, 5 
mg of synthesised peptide was mixed into MHF (100 mg) and spread on 
glass slides. Liquid-liquid extraction was conducted on the traces of 
reagent obtained from primary transfer onto a glove, and the extract was 
analysed via ESI-MS. All samples and replicates generated positive 
results with peptides still remaining easily detectable in concentrations 
reduced to 2.5 mg and even 1 mg (Appendix - Figure 86). Based on the 
results obtained in the transferability studies, following liquid-liquid 
extraction an aqueous solution of the peptide at a concentration of ~150 
µg/ml (corresponding to the lowest amount of peptide employed in the 
present study) was used for the ESI-MS analysis. Our research group is 
currently engaged in establishing the lowest amount of peptide that may 
be added to a reagent in which full detection may be achieved. This is 
focusing on the application of High Resolution Mass spectrometry, which, 
in many cases, has detected a number of similar peptides to a fentomolar 
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Fluorophore Studies 
Ideally, fluorophores incorporated into forensic taggants should allow for 
easy visualisation as well as an increased resistance to exposed 
environmental conditions. Rhodamine 110 and AFC, both noted for their 
fluorescence lifetimes, quantum yield and photostability [173, 180] were 
therefore investigated as additives for the overall visualisation of the 
reagent upon transfer. In this study, fluorophores were added 
independent to peptide concentration to provide end users with more 
flexibility over how the reagent is applied.  
Both fluorophores were mixed in to MHF as stock solutions starting at 
10mg/ml concentrations. While all samples displayed an intense emission 
under appropriate fluorescence microscopy filtration (Appendix - Figure 
87) unexcited formulations still exhibited an obvious visual colouration 
inappropriate for marking surfaces within a covert scenario. Thus, both 
solutions were diluted to a concentration of 0.1 mg/ml in which no colour 
was observed under visible light but fluorescence remained highly 
detectable. This fluorescence was qualitatively monitored over a period of 
six weeks and was found to remain detectable.  
With appropriate fluorophore concentrations established, Rhodamine 110 
was added to a sample of peptide-mixed media to test final reagent 
performance, before being successfully extracted and analysed by ESI-
MS as previously described (Appendix - Figure 88). Rhodamine is 
consequently present in the final mass spectrum due to its affinity for the 
analysed aqueous extraction phase. As an identical fluorophore is added 
to every formulation of reagent produced, rhodamine presence will not 
add value to the unique coding system provided by the peptide. However, 
the detection of a water-soluble fluorophore may infer added confidence 
that a successful extraction has taken place. Whilst advantageous 
stability and emission properties selected Rhodamine-110 for use within 
the scope of this study, any fluorescent compound exhibiting desirable 
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properties may be used as a replacement detection element, further 
increasing the versatility of a final reagent for surface application. 
Stability Studies 
As the majority of forensic taggants are applied to surfaces for extensive 
periods of time, it is important that coding peptides stored within a reagent 
remain stable. This is especially pertinent in those that are left within 
exposed environmental conditions. Samples of peptide-mixed medium 
were therefore applied once again to aluminium foil, ceramic, plastic and 
glass, and left without the application of atmospheric or temperature 
controls (laboratory temperature and humidity: 23±2 ºC, 25±5%) for a 
period of six weeks before undergoing extraction and analysis at one 
week intervals. Furthermore, as high coding sequence stability is crucial 
in the period between surface contact and reagent recovery, the same 
procedure was repeated on cotton, denim, polyester and leather 
substrates to simulate typical contact with clothing.  
All peptides proved to be detectable over the six week period on all eight 
surfaces with no evidence of deterioration (Appendix - Figure 89). Whilst 
the scope of this particular study aimed to assess the possibility of 
peptide breakdown as a result of time, subsequent research examining 
the effect of temperature and moisture upon reagent persistence is 
needed to ensure full validation, and is currently being undertaken by our 
research group. A larger validation study will be able to investigate 
resistance of the regent to harsh environmental conditions so that the 
efficiency of the technique may be fully demonstrated. 
Conclusion 
We have successfully designed and developed a reagent for the rapid 
and specific determination of contact transfer arising as a result of 
criminal activity. When applied to surfaces this reagent becomes virtually 
undetectable to the naked eye, rendering it particularly useful within 
covert investigation.  
 
 
Page | 223  
A novel two-step identification system was employed; firstly the area in 
which the reagent has been deposited is initially visualised through 
fluorescence excitation, before being subsequently recovered for 
standard MS analysis to reveal the identity of a unique registered peptide 
sequence. This process offers extremely rapid results compared to 
currently available reagents, with recovery, extraction and analysis 
performed in less than two hours.  
Analysis time is further likely to be decreased considering continuing 
advances in portable MS techniques. Environmental stability of the 
reagent was also proven over a six-week period. Our research group is 
currently investigating a number of further refinements to this reagent, 
including the use of a combination of fluorophores which emit at different 
wavelengths to confer added discrimination against possible background 
fluorescence.  
This is centred upon the application of compounds emitting in the IR 
region of the electromagnetic spectrum which offenders, now 
knowledgeable of UV-based marking, would be unable to detect. While 
naturally occurring amino acids were used within this study, investigation 
has been undertaken to examine the benefits of incorporating unnatural 
or modified peptide sequences. This would not only serve to increase 
sequence distinctiveness but is also likely to enhance peptide resistance 
to hydrolytic enzymes present in biological fluids [469]. 
6.4 Published Article 7: ‘Monitoring Criminal Activity through 
Invisible Fluorescent ‘Peptide Coding’ Taggants’ 
The content of following section was published as an original research 
article in: Gooch, J., et al., Monitoring criminal activity through 
invisible fluorescent ‘peptide coding’ taggants. Analytical Chemistry, 
2016. 88: p. 4456-4460.  
Experimental work was performed by the candidate with assistance from 
Hilary Goh. The candidate also produced the manuscript. Help with 
peptide synthesis, as well as access to the Institute of Pharmaceutical 
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Science research laboratories and HPLC and MS instruments, was 
provided Dr. Vincenzo Abbate. Dr. Barbara Daniel and Dr. Nunzianda 
Frascione provided supervisory and technical support throughout the 
research. Additional materials for this article may be found in the 
appendix of this thesis (Section A.3). 
6.4.1 Manuscript 
Authors: James Gooch,a Hilary Goh,b Barbara Daniel,a Vincenzo 
Abbate,c and Nunzianda Frascione. a* 
Authors Address: a) Analytical and Environmental Sciences Division. 
King’s College London. 150 Stamford Street. London, UK. SE1 9NH, b) 
Department of Biological Sciences. National University of Singapore. 14 
Science Drive 4. Singapore. 117543, c) Institute of Pharmaceutical 
Science. King’s College London. 150 Stamford Street. London, UK. SE1 
9NH.  
Abstract: Complementing the demand for effective crime reduction 
measures are the increasing availability of commercial forensic ‘taggants’, 
which may be used to physically mark an object in order to make it 
uniquely identifiable. This study explores the use of a novel ‘peptide 
coding’ reagents to establish evidence of contact transfer during criminal 
activity.  The reagent, containing a fluorophore dispersed within an oil-
based medium, also includes a unique synthetic peptide sequence that 
acts as a traceable “code” to identify the origin of the taggant. The 
reagent is detectable through its fluorescent properties, which then allows 
the peptide to be recovered by swabbing and extracted for ESI-MS 
analysis via a simple liquid-liquid extraction procedure. The performance 
of the reagent in variable conditions that mimic the limits of a real world 
use are investigated.  
Introduction 
Continuing efforts to reduce the substantial costs of crime on society have 
in recent years produced a number of highly effective criminal prevention 
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technologies. The invention of forensic ‘taggants’ is a successful example 
of such advances. Taggants are defined as  materials that may act as a 
means of physically or chemically marking an item in a way that allows it 
to become uniquely identifiable [405]. Usually consisting of three 
molecular components, taggants will include: a ‘coding’ element (to infer 
uniqueness in the taggant), a system that allows the taggant to be 
visually detected and a medium where these molecules are dispersed.  
There are largely four forensic purposes for such materials. The first 
attempts to combat counterfeiting activities via the addition of a taggant to 
products (medicines, bank notes, official documents, etc.) to signify that 
they are of a genuine origin [404]. The second aims at marking valuable 
property (vehicles, electronic items) to associate them with a particular 
owner and discourage theft [413]. The third involves the surreptitious 
addition of taggants into illicit substances (illegal drugs, explosives), so 
that their distribution or use may be monitored by law enforcement 
agencies [402]. The last comprises the covert transfer of taggants to 
individuals during criminal activity in order to link them to a specific 
offence (e.g. handling firearms, trespassing) [412]. The physical nature of 
a taggant reagent will be highly dependent on which of the above 
purposes it is required. For example, taggants employed in covert 
operations should be invisible to the naked eye, to avoid undesired 
detection by the offenders [413]. The medium of each taggant will also 
vary depending on whether it needs to be easily transferred to an 
individual or remain anchored upon the product it is marking [413]. Only 
the coding element remains largely consistent across all tagging 
purposes.   
One of the most popular methods to obtain this taggant coding is through 
the inclusion of unique DNA markers. Companies such as Applied DNA 
Sciences, Obiex and SelectaDNA produce taggants containing either 
botanically derived or synthetic DNA oligonucleotides. The specific 
sequence of these oligonucleotides is then registered to a particular 
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owner via an internal database [406]. When required, the taggant may be 
recovered to extract and ‘match’ DNA to the owner’s information. Whilst 
DNA taggants have been shown to decrease the number of Cash and 
Valuables in Transit (CViT) offences [406], limitations in their analysis 
have been identified. The extraction, amplification and sequencing 
methods employed to isolate and match DNA are expensive and time 
consuming. Moreover, the labile nature of DNA has raised significant 
concerns over the general stability of DNA taggants [445]. Research into 
their use in monitoring fuel adulteration determined that short sequences 
of DNA within taggants, had poor stability and were often susceptible to 
erroneous identification [444].  
Another recently emerging method of encoding focuses on the use of 
varying trace elements to identify taggants. Reagents produced by the 
UK manufacturer Smartwater, contain a number of rare elements that are 
combined in unique formulations, allowing each taggant to be registered 
against a specific owner ID. After a reagent is detected  (via the use of an 
incorporated fluorescent dye), laser ablation inductively coupled plasma 
mass spectrometry (LA-ICP-MS) is used to determine the individual 
formulation of the taggant and the owner that it is registered to (once 
again via internal database) [405]. However, much like DNA-based 
coding systems, these tracer taggants are once again limited in their 
analysis. The use of multiple elements within a single taggant carries the 
potential of the formulation being incompletely recovered, which could 
then lead to erroneous identification. This problem stems from the 
differing transfer rates and stability of each individual tracer component, 
resulting from their chemical differences. 
The development of a forensic taggant that is stable and can be rapidly 
and completely recovered is therefore critical to advancing crime 
reduction.  In light of this, our research group recently suggested a novel 
‘peptide coding’ reagent (or peptide taggant) as an alternative to 
inefficient taggant analysis procedures [456]. This reagent has been 
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designed to be covert and transferrable so that it may be used to mark an 
individual or object during criminal activity without the knowledge of the 
offender. Like the majority of taggants, our reagent comprises three 
distinct components. The base medium consists of a mixed hydrocarbon 
formulation (MHF) which is easily transferred to persons or clothing. 
Detection is achieved by Rhodamine-110 fluorophores, added in such a 
concentration as to make the taggant invisible under normal lighting 
conditions but highly fluorescent upon excitation by an appropriate light 
source.  
The specificity of this reagent (and main advantage over currently 
available taggants) is derived from the insertion of a unique peptide, 
where the amino acid sequence acts as an identifiable code for that 
particular taggant. The wide variety of natural and unnatural amino acids 
available ensures that the peptide may be sufficiently individual, without 
extensive length. Once the reagent is transferred as a result of criminal 
activity, it may be easily and rapidly recovered. First, areas of taggant 
presence may be indicated through fluorescence excitation, allowing 
complete recovery of the reagent by targeted swabbing. The peptide may 
then be isolated from the oil-based medium and swab via simple liquid-
liquid extraction. The mass-to-charge ratio of the amino acid sequence is 
then revealed via Electrospray Ionization Mass Spectrometry (ESI-MS), 
identifying the particular taggant. 
Whilst developed as an initial proof of concept, this taggant may have the 
potential to be used within criminal investigation to establish evidence of 
primary (object-to-person); and possibly even secondary (object-to-
person-to-object) contact transfer. This work therefore involves a 
comprehensive investigation into the ability of peptide coding reagents to 
operate effectively within a real-world setting. Significant examination of 
the transfer, detection, recovery and stability of multiple peptide reagents 
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Experimental Section 
Peptide Synthesis 
Peptides Ac-KQQSP-NH2 (Sequence 1), Ac-HSSKL-COOH (Sequence 
2), and Ac-hsskl-COOH (Sequence 3) were manually synthesized by 
Fmoc-Solid Phase Peptide Synthesis. NovaPEG rink amide (Merck 
Chemicals Ltd, UK) and 2-chlorotritylchloride (Sigma Aldrich, UK) resins 
were used to prepare sequences 1 and 2-3 respectively. Resins were 
swollen in dimethylformamide (DMF) inside empty fritted polypropylene 
tubes for 30 minutes prior to coupling. All amino acid coupling steps for 
sequence 1 were performed using 4 equivalents of Fmoc amino acids 
with DIPCDI and Ethyl (hydroxyimino)cyanoacetate (Oxyma) in DMF in a 
molar ratio of 1:1:1 of amino acid, DIC and Oxyma, respectively. The first 
coupling step for sequences 2-3 was performed using 1 equivalent of 
Fmoc amino acid with 5 equivalents of N,N-Diisopropylethylamine 
(DIPEA) in dichloromethane (DCM).  
Subsequent coupling steps were performed using the same procedure 
utilised in the assembly of Sequence 1. Coupling reactions were allowed 
to take place for 1 hour with successful conjugation monitored by the 
picrylsulphonic acid test. After coupling, Fmoc de-protection of all amino 
acids was achieved via treatment with 20% (v/v) piperidine in DMF for 30 
minutes and confirmed by the picrylsulphonic acid test. Impurities and 
excess reagents were removed at each stage via multiple washes using 
DCM, and DMF.  The N-terminus of each peptide was acetylated using 
ten equivalents of acetic anhydride and twenty equivalents of DIPEA in 
DMF for 1 hr. Resins were lastly treated with a solution of Trifluoroacetic 
acid (TFA): distilled water: phenol: thioanisole (TA): triisopropylsilane 
(TIPS): 2,2’-(Ethylenedioxy)diethanethiol in a 90:5:5:5:2.5:2.5 molar ratio 
for 3 hrs at room temperature to remove the completed peptides from the 
solid support. The filtrate was then concentrated under nitrogen at 40 °C 
before the addition of 10 equivalents of ice cold diethyl ether to precipitate 
the peptides. The wash and precipitation process was repeated several 
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times before the final obtained peptide pellets were freeze-dried for 24 
hrs. The identities of the synthesized peptides were confirmed using a 
Waters/Micromass (Manchester, UK) ZQ ESI-mass spectrometer in 
positive ionisation mode prior to use.  
Experimental Conditions 
The effects of four experimental conditions: i) surface material, ii) 
temperature, iii) humidity, and iv) fluorophore addition, on reagent stability 
were investigated. For monitoring the effect of surface material, peptide 
sequences 1-3 were mixed into MHF medium (Vaseline, UK) at a 
concentration of 2.5:100 mg of peptide:medium. Mixtures containing 
sequence 1 and 3 were then applied in 40 mg deposits onto 10 different 
surfaces (ceramic, glass, plastic, aluminium foil, wood, paper, denim, 
polyester, leather, and cotton) cut into 2 cm x 2 cm squares. The mixture 
in sequence 2 was applied in the same method to surfaces of wood and 
paper (as the stability of this sequence on the other 8 surfaces was 
already proven within the previous proof of concept study). The surfaces 
were then left exposed to standard laboratory conditions (temperature 
and humidity: 23±2 °C, 40±5%), constantly monitored using a data logger. 
Liquid-liquid extractions were then performed to isolate the peptides for 
ESI-MS analysis at time points of two weeks, four weeks, and six weeks 
for a total period of six weeks.  
For experimental condition studies ii), iii), and iv), the same concentration 
of peptide-MHF medium was applied to glass slides and exposed to their 
respective conditions. The effect of temperature was assessed via 
incubation of slides at both 4 °C and 39 °C and extracted at time points of 
six hours, 24 hours, one week, and six weeks. For the effect of humidity, 
surfaces were left in containers of 70% and 90% (as monitored by a 
hygrometer) and were once again extracted at the same time points as 
the temperature study. Humidity containers were prepared by enclosing 
wet paper towels within plastic boxes. 
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The effect on fluorophore presence on peptide detection was observed 
through the addition of Rhodamine-110 (Sigma Aldrich, UK) to peptide-
MHF at a concentration of 0.25:100 mg fluorophore:peptide-medium. This 
mixture was then applied in 40 mg deposits on glass slides, which were 
then exposed to the standard, temperature and humidity conditions 
previously investigated. Extractions of fluorophore-peptide-MHF reagent 
were undertaken at time points of three weeks and six weeks for a total 
period of six weeks. 
Taggant Extraction and Analysis 
Extraction surfaces were placed into a 30 ml multipurpose container 
(Greiner Bio-One, UK) before the addition of 1 ml of hexane. Samples 
were vortexed for 1 minute and the surfaces were removed using sterile 
forceps prior to the addition of 0.5 ml of distilled water. The samples were 
vortexed again and allowed to settle before the aqueous phase was 
removed into a fresh container via pipette. The original organic phase 
was then further extracted with an additional 0.5 ml of distilled water 
before both aqueous layers were pooled together. Counter extraction 
against the pooled aqueous layers was next performed with 1mL of 
hexane. The final aqueous layer was then isolated into an Eppendorf tube 
before the addition of 0.1% v/v Formic Acid to enhance ionisation. ESI-
MS analysis of the samples was conducted using a Waters ZQ 
micromass 2000 mass spectrometer in positive ionization. 
Casework Application 
A thin layer of peptide reagent (containing sequence 2) was spread 
across a 25 x 25 cm glass tile to mimic a real-world application to a 
known surface. A transparent latex glove worn over the hand (with the 
glove pre-weighted) was then used to contact the surface at a 
standardised force of ~20 N (monitored by analytical balance). 
Transferred reagent was visualised using a Crime-lite handheld light 
source (Foster and Freeman, UK) at an excitation wavelength of 460-510 
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nm and a supplied 495 nm viewing filter. The glove was then reweighed 
to assess the amount of taggant transferred upon physical contact.  
Depletion Series 
To establish the overall sensitivity of the reagent and determine its 
persistence after multiple contact transfers, a depletion series was 
prepared. A thin layer of peptide reagent (containing sequence 2) was 
once again spread over a glass tile before being contacted by a single 
gloved finger at a standardised force of ~10 N. A series of contacts after 
the initial reagent transfer were then performed by successively touching 
either 1, 2, 3, 4 or 5 clean glass slides with the glove. A sterile cotton 
swab of the entire surface of the finger was used to collect any taggant 
remaining at the end of each depletion series. Peptide sequence 2 was 
lastly extracted from all of the swabs and analysed using the methods 
previously described. 
Results and Discussion 
Peptide Synthesis 
Three different peptides were used to demonstrate the flexibility of the 
reagents coding system. These sequences were chosen due to their 
hydrophilicity, allowing them to be easily isolated from the non-polar MHF 
medium by simple liquid-liquid extraction. The properties of each peptide, 
including hydrophilicity, were derived from GenScript’s peptide property 
calculator (Table 19). The sequences were also ensured to be non-
naturally occurring using UniProt’s BLAST function, thereby reducing the 
possibility of generating false positive results from ubiquitous 
environmental peptides.  
Table 19: Peptide characteristics obtained from Genscript’s property calculator 
Peptide Sequence GenScript PPC 
1: Ac-KQQSP-NH2 (L-amino acids) MW = 627.69, attribute = basic (hydrophilic). 
2: Ac-HSSKL-COOH (L-amino acids) MW = 612.68, attribute = basic (hydrophilic). 
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Developing a coding system that is able to remain stable and recoverable 
over extended periods of time is a crucial aspect of taggant design. We 
therefore decided to explore the effect of a number of modifications on 
our peptide sequences, with the ideal aim of maximising code detection 
post taggant recovery. N-terminal acetylation was carried out on all 
peptides to increase resistance to degradation by aminopeptidase activity 
[214]. Further protection against enzymatic destruction was conferred by 
the C-terminal amidation [470] of sequence 1 (Ac-KQQSP-NH2) and the 
introduction of D-amino acids in peptide sequence 3 (Ac-hsskl-COOH). 
ESI-MS analysis was used to confirm the identity of the synthesized 
products, which all exhibited correct masses (Appendix - Figure 90) 
Experimental Conditions 
With popular uses in marking vehicles, objects, fabrics and premises, the 
nature of the surface on which a taggant may be applied can be highly 
variable. It is consequently crucial that newly developed taggants 
demonstrate sufficient robustness to be detected and identified over 
extended periods of time, without being affected by the material on which 
they are deposited. The stability of all three peptide-MHF formulations 
was therefore monitored by their application on 10 different surfaces 
routinely encountered during forensic casework.  
Figure 74: ESI-MS spectra of a) peptide sequence 1: Ac-KQQSP-NH2, (theoretical 
[M+H]+ m/z ratio = 628.34) b) peptide sequence 2: Ac-HSSKL-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) and c) peptide sequence 3: Ac-hsskl-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) reagent samples extracted six weeks after application to 
paper. Similar results were seen on all other surfaces 
All taggants were then left in standard laboratory conditions (temperature 
and humidity: 23±2 °C, 40±5%) before being extracted at several time 
 a b c
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points over a period of six weeks. Figure 74 shows the mass spectra of 
analysed reagent samples containing peptide sequence 1, 2 and 3 from 
paper at the 6-week time point. The same results were achieved across 
all peptide, surface and time combinations, with no observable reagent 
degradation (Appendix - Figure 91-93) 
Another facet of forensic taggant application that is highly variable is the 
environmental conditions to which a reagent may be exposed [471]. By 
marking items both outside and in sheltered locations, taggants are often 
subjected to a wide range of temperatures and humidities. However, the 
effect of such conditions on the detection and identification a taggant 
should ideally remain negligible. To establish the environmental 
resistance of our peptide coding reagent, formulations containing 
sequences 1-3 were deposited on glass slides and incubated over six 
weeks in temperatures of 4°C and 39°C or in humidity’s of 70% and 90%. 
Extraction and analysis of the reagents at various time points 
demonstrated that all peptides remained detectable despite incubation 
conditions, with no differentiation in the achieved mass spectra being 
displayed between samples (Appendix - Figure 94-95) 
The foremost purpose of Rhodamine-110 addition to the peptide-MHF 
formulation is to allow taggants to be detected via fluorescence emission 
after transfer. This fluorescence not only quickly establishes evidence of 
contact between an object and a suspect but may also be used for a 
more targeted swabbing by indicating where identifying peptides are likely 
to be present. Moreover, as water-soluble Rhodamine-110 is co-extracted 
with peptides into the same aqueous phase, a dual detection of the 
reagent is provided by the presence of both fluorophore and peptide ion 
peaks in the ESI-MS spectrum.  
To establish this dual-detectability, three final fluorophore-peptide-MHF 
formulations for each of the peptide sequences utilised were prepared 
and deposited on glass slides in the same manner previously described. 
Slides were exposed over six weeks to the standard laboratory, 
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temperature and humidity conditions already explored and were once 
again extracted and analysed at a number of time points. Figure 75 
displays both fluorophore and peptide components detected by ESI-MS 
after extraction of final reagent (containing peptide sequence 1) after six 
weeks of standard laboratory exposure. In all cases, similar results were 
achieved regardless of peptide or environmental condition, with no 
observable fluorophore or peptide degradation (Appendix - Figure 96-
98).  
Figure 75: ESI-MS spectrum of Sequence 1: Ac-KQQSP-NH2 (theoretical [M+H]+ m/z 
ratio = 628.34, theoretical [M+Na]+ m/z ratio = 650.32) and Rhodamine-110 
(theoretical [M+H]+ m/z ratio = 331.11) extracted from full reagent samples applied to 
glass slides and incubated for six weeks in standard laboratory conditions. 
Casework Application and Depletion Series 
To successfully operate in the field, touch contacts must result in enough 
fluorophore and peptide transfer to ensure taggant visualisation and 
identification respectively. Demonstration of the reagents practical use in 
a real world scenario was therefore achieved by applying a thin layer of 
fluorophore-peptide-MHF formulation   over a large glass tile, which was 
subsequently contacted by a transparent glove worn over the hand. As 
expected, the reagent remained imperceptible under natural light but was 
easily viewed upon the hand after illumination with a portable light source 
(Figure 76). Approximately 0.44 mg of taggant was transferred to each 
cm2 of the glove’s surface. 
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Figure 76: Peptide coding reagent successfully transferred upon physical contact. Left: 
prior to visualization. Right: fluorescence emission upon excitation. 
Whilst this rate of transfer may be considered ideal after an initial contact, 
the amount of taggant recovered in a practical setting may actually be far 
less, depending upon the subsequent activity of the offender. For 
example, it is possible that the reagent may be removed if a suspect 
contacts other surfaces after touching a marked object, thereby 
diminishing the amount of peptide available for analysis. Designing a 
taggant to persist on an individual even after multiple contacts is therefore 
important. A depletion series was created to measure the overall retention 
of our reagent by contacting the tile previously prepared with a gloved 
finger. Taggant was then collected and recovered from the entire surface 
of the finger by direct swabbing and liquid-liquid extraction respectively. 
This process was then repeated but with additional secondary contacts 
on clean glass slides (increasing from 1 to 5 contacts) prior to reagent 
recovery. ESI-MS analysis successfully detected the presence of both 
peptide and fluorophore ion peaks within all samples, establishing the 
excellent persistence of our reagent (Appendix - Figure 99). 
Conclusions 
The ability of a novel ‘peptide coding’ taggant to monitor contact transfer 
during criminal activity has been successfully established. The reagent is 
invisible to the naked eye but highly fluorescent when excited by an 
appropriate light source. If recovered from an individual, this reagent has 
the power to physically link a person to a specific object or offence 
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through uniquely identifying amino acid sequences. The high 
transferability of the employed medium allows these peptides to persist 
on a person even after five additional contacts with other surfaces. 
Remaining detectable and recoverable over a period of six weeks, our 
developed peptide taggant has proven to be successfully stable and 
resistant to all variable experimental conditions. A greater degree of 
confidence can therefore be given in the taggants efficacy to operate over 
extended periods of time on different surfaces and in a range of 
environments. 
This reagent promises significant advantages over currently available 
forensic taggants; liquid-liquid extraction allows coding sequences to be 
rapidly isolated with little expense. Taggant analysis via ESI-MS is also 
significantly less time consuming than sequencing techniques used in 
DNA-based taggants and may be completed within 1 hour of reagent 
recovery. Continuing advances in portable mass spectrometry technology 
are likely to result in this time being further reduced, by allowing analysis 
to be performed at the point of taggant discovery. 
Whilst not explored further within this study, this taggant was designed 
with a high intrinsic flexibility so that it may be easily adapted for 
application in a variety of crime reduction strategies. This is likely to 
centre on the substitution of the reagents individual components to suit a 
specific purpose. For example, the replacement of Rhodamine-110 with a 
near-infrared fluorophore may provide enhanced contrast against certain 
coloured or auto-fluorescent surfaces [472]. The discriminatory power of 
the taggants code may also be further increased by the use amino acids 
that feature unnatural modifications.  
Whilst this reagent was developed for observing physical contact transfer 
during criminal activity, many taggants are designed to remain immobile 
upon the object they mark. Our peptide coding system may also be 
utilised in such an application by a simple change of dispersal media.  
Page | 237 
Chapter 7   

























Page | 238  
7.1 Biosensors 
Biosensors are fast becoming the molecular detection methods of choice 
within a variety of analytical disciplines, including pharmaceutical 
discovery, agricultural quality control and biomedical diagnostics [473-
475]. Research efforts in this area have often focused on the 
development of rapid, low-cost and simple to use biosensing assays that 
can be utilised for ‘in-field’ analysis (such as ‘point-of-care’ testing of 
hospitalised patients or continuous monitoring of environmental samples 
[476]). Despite this, only a small number of research groups have 
explored the use of biosensors for the detection and identification of 
targets that are relevant to forensic investigation. Furthermore, the vast 
majority of previously reported biosensors (forensic or otherwise) have 
largely been designed for the analysis of targets within solution, with 
limited explorations into the detection of analytes in situ. 
Initial work in this project was therefore conducted to determine which 
biosensing transduction mechanisms (with specific emphasis on 
fluorescence signal outputs) are likely to demonstrate the most potential 
as methods for the visualisation and attribution of body fluid stains left 
behind at crime scenes (Chapter 2). This was first achieved through an 
in-depth review of fluorescent biosensors previously reported for use in a 
variety of comparable in situ applications (such as detection of wound-
infecting bacteria or biofilms on historic window glass [137, 142]). This 
review subsequently identified several promising sensing transduction 
mechanisms, which were based on: 1) the enzymatic digestion of 
fluorescently-labelled substrates, 2) the competitive displacement of 
quenched ligands or 3) fluorophores sensitive to changes in local 
environment. 
Four commercial biosensor assays based on these chosen transduction 
methods were then evaluated on their performance within a forensic 
context, by examining the ability of each sensor to detect relevant 
analytes deposited in situ on a series of surfaces commonly encountered 
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within criminal casework. Varying degrees of success were demonstrated 
by each assay during different stages of testing. The FluoReporter® 
Biotin Quantitation Assay Kit (intermolecular FRET) was shown to be the 
most sensitive assay during application to analytes present on glass 
slides (being able to detect concentrations of biotin as little as 100 ng/ml), 
but displayed poor performance in forensic surface testing due to reagent 
absorption by porous surfaces. 
Conversely, two biosensors reliant on the enzymatic hydrolysis of 
fluorescent substrates, the EnzChek® Protease/Peptidase and 
EnzChek® Ultra Amylase assay kits, were able to detect analytes across 
all testing phases. These results prompted further investigations into the 
use of fluorogenic peptide substrates for the in situ analysis of body fluid 
deposits based on digestion by intra-fluidic protease enzymes (as 
explored within Chapter 3). The Quant-iT™ PicoGreen® dsDNA assay 
kit, an environmentally-sensitive DNA detection dye, displayed poor 
performance during glass slide testing as a result of reagent-analyte 
immiscibility and was excluded from all further studies.  
Importantly, all biosensors selected for further study were found to have 
no effect on downstream DNA profiling processes after addition to human 
biological fluids. Such results demonstrate potential for the integration of 
biosensor technologies within routine casework practices without 
detrimental effects to the recovery of genetic material contained within 
biological fluid stains (although a much more comprehensive validation of 
developed sensors is likely to be required prior to operational 
deployment). 
However, it must be noted that any comparisons made between the 
fluorescent transduction mechanisms utilised within this study are 
somewhat limited by both the variability of measured analyte 
concentrations and the composition of assay reagents. Concentration 
ranges used for testing were determined based upon the amount of target 
that could be reasonably purchased. A lower range of 100-0.001 µg/ml 
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DNA was therefore employed to assess the performance of the Quant-
iT™ PicoGreen® dsDNA assay kit compared to other biosensors, which 
were all tested against relevant analytes at concentrations between 10-
0.0001 mg/ml (although these amounts are also not consistent in terms of 
molarity). This target variation, whilst largely impossible to control, is likely 
to have some impact on the perceived performance of this sensor and the 
decision to exclude it from further testing.  
The specific preparation of commercial assay reagents is also likely to 
affect the performance of studied sensors. The poor detection ability 
demonstrated by both the Quant-iT™ PicoGreen® dsDNA and 
FluoReporter® Biotin Quantitation assay kits (as a result of reagent 
immiscibility and surface absorption) may be a result  of the 
solvent/buffers in which sensing components are dissolved, rather than 
the biosensors themselves. In an ideal experimental set-up, such 
solutions would be standardised, however this could not be achieved 
within the scope of this study, as all assays are procured as pre-dissolved 
stock solutions.  
This study represents the first investigations into the use of biosensor 
technology for the forensic detection and identification of biological fluids. 
Fluorescent signal transduction mechanisms demonstrating the most 
promise towards fluid-specific sensing were identified and were 
subsequently confirmed to possess the ability to detect relevant analytes 
in situ. 
7.2 Fluorogenic Substrates 
With promising in situ detection performance demonstrated across all 
surfaces by both the EnzChek® Protease/Peptidase and EnzChek® Ultra 
Amylase assay kits, initial efforts in the development of biosensing assays 
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Whilst a myriad of such substrates are already commercially available, 
many are unlikely to offer any additional specificity advantages over 
current biological fluid testing strategies. For example, the SensoLyte® 
MFP Acid Phosphatase Assay Kit, a fluorogenic substrate available from 
the company AnaSpec, may potentially be used for the detection of acid 
phosphatase enzymes in seminal fluid stains. However, consisting of a 
simple phosphate group coupled to the fluorophore 3-O-Methylfluorescein 
[477], this substrate is likely to be cleaved by other phosphatase enzymes 
present within the majority of body tissues [478]. Specific emphasis was 
therefore placed on the application of peptide substrates, which offer 
increased enzymatic selectivity as a result of sequence-specific 
hydrolysis [479]. 
An initial search of commercial peptide substrates that could potentially 
be used for the forensic detection of intra-fluidic proteases yielded MU-
HSSKLQ-AFC, a fluorogenic substrate specific to PSA [193]. Successful 
‘turn-on’ emissions were generated by MU-HSSKLQ-AFC in response to 
dilutions of seminal fluid (up to 1:1000) both in solution and deposited on 
glass slides. This substrate was further able to detect semen present on a 
selection of surfaces commonly encountered within forensic casework 
and was also shown to have no effect on DNA profiling processes. 
With the ideal aim of developing a multiplex fluorogenic substrate assay 
for the simultaneously sensing of multiple proteolytic targets, efforts were 
then made in the synthesis of peptide substrates employing fluorophores 
emitting in different regions of the visible spectrum, starting with the 
xanthene-based dye Rh-110. Whilst not described within the contents of 
Chapter 3, a series of unsuccessful attempts to conjugate peptides to 
Rh-110 in solution were first conducted. These involved the direct 
coupling of a peptide AC-HSSKLQ-COOH to acetylated Rh-110 through 
the EDC/pyridine chemistry reported by Leytus et al. [175] (Figure 77a), 
as well as transformation of Rh-110 amines to more reactive azide groups 
by incubation with tert-butyl nitrite (tBuONO) and azidotrimethylsilane 
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(TMSN3), following Barral et al. [480] (Figure 77b). However, neither of 
these procedures resulted in the production of viable fluorophore-peptide 
products. In the case of in solution peptide coupling, this lack of success 
may be attributed to the poor nucleophilicty of Rh-110 aromatic amine 
groups, which often leads to inefficient peptide-fluorophore acylations 
[211].  Attempts at Rh-110 azide formation instead resulted in the 
formation of several unidentifiable by-products (as observed by ESI-MS 
analysis which could not be separated from the transformed Rh-110 
molecule via preparative RP-HPLC. 
Figure 77: Schemes of unsuccessful Rh-110 substrate development attempts: a) Rh-
110 is coupled directly to peptide Ac-HSKKLQ-COOH in solution after incubation with 
EDC/pyridine, b) Rh-110 amine groups are transformed into azides through incubation 
with tBuONO and TMSN3. 
A novel solid-phase synthesis route was therefore devised, which 
subsequently led to the successful construction of two Rh-110-based 
substrates specific to PSA and KLK8 (for the analysis of semen and 
saliva respectively). This route not only allowed for the production of Rh-
110-based substrates in higher quantities, due to the ability to incubate 
immobilised fluorophores with large amino acid excesses, but also 
reduced substrate preparation time by preventing the need for extensive 
reaction purification steps. Both of the substrates prepared using this 
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fluid targets (both in solution and in situ), and were also found to have no 
detrimental effects on downstream DNA profiling.  
This synthetic route was further employed the production of a peptide 
substrate utilising the fluorophore CV towards the detection thrombin 
within whole blood. This fluorophore was chosen for use within this assay 
due to its emission outside the broad absorbance spectrum of 
haemoglobin (Figure 78). Whilst fluorescence signals were observed 
from this substrate in response to different concentrations of purified 
thrombin protein within solution, both blood and plasma samples could 
not be detected. 
Figure 78: Normalised spectral overlap of haemoglobin absorption compared to CV 
emissions. 
Despite the difficulties encountered in the construction of CV-based 
sensors, the work reported within Chapter 3 still signifies the first 
successful application of fluorogenic peptide substrates to the forensic 
detection of biological fluids. It is further hoped that the novel SPPS 
routes developed as part of this study may be used for the future 
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7.3 Immunosensors 
In Chapter 4, attempts were made into adapting the displacement-based 
FRET fluorescence transduction mechanism of the FluoReporter® Biotin 
Quantitation Assay Kit towards the detection of intra-fluidic protein 
targets. This was achieved through the use of antibody recognition 
moieties specific to PSA, rather than the biotin-avidin binding interactions 
exploited by the commercial assay. These anti-PSA antibodies were 
conjugated to highly fluorescent QDot nanoparticles, which were utilised 
for the purpose of emission signalling. An initial quenching of QDot 
fluorescence was then achieved through the moderate binding of a 
quencher-labelled peptide sequence consisting of amino acids 
responsible for antibody-PSA interaction. Immunosensor complexes 
displayed immediate restorations of emission signals upon the addition of 
purified PSA protein, indicating successful displacement of quenching 
ligands by higher affinity targets.  
A follow-up to this study was recently conducted in 2017 as part of a 
three-month research project conducted by a student on the King’s 
College London Forensic Science MSc programme. In this project, a 
similar immunosensor complex was constructed using antibody 
recognition elements specific to Mucin 5B (MUC 5B), a protein present at 
high concentrations within human saliva [481]. Modifications to the 
original PSA immunosensor design were also made in the use of QDot™ 
nanoparticles emitting at 525 nm, with black hole quencher-1 (BHQ-1) 
employed for emission quenching (with absorbance of fluorescence 
between 480-580 nm).  
However, incubation of the antibody-QDot complex with BHQ-1 ligands 
failed to achieve the same degree of quenching observed in previous 
PSA immunosensor studies (Figure 79). Such results may be attributed 
to the increased length of the amino acid sequence used for moderate 
binding (BHQ-1-RNREQVGKF-CONH2), which may prevent proximity-
based FRET effects. Furthermore, no fluorescence emission signals were 
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exhibited by antibody-QDot complexes upon the addition of MUC5B 
protein. A more comprehensive characterisation of factors affecting the 
performance of this specific immunosensor design is therefore needed. 
Figure 79: Fluorescence emissions of anti-MUC5B antibody-QDot conjugates after 
incubation with quencher-labelled peptide. 
Nevertheless, it must be noted that this particular sensing format 
represents the first of its kind to be reported. It is hoped that the 
increased analytical specificity gained from the use of antibody elements 
for target recognition will make this type of assay format an attractive 
option in the future development of biosensors for molecular detection 
purposes (both within and outside of forensic analysis). 
7.4 Aptasensors 
Efforts towards the development of a second FRET displacement-based 
sensor utilising ssDNA aptamers as target recognition moieties are also 
described within Chapter 5. In this study, three fluorescently-labelled 
aptamer sequences specific to thrombin, PSA and lysozyme were used to 
construct a multiplex aptasensing complex for the simultaneous detection 
of blood, semen and saliva respectively.  
This was achieved through the initial absorption of sequences to GO 
nanosheets (as a result of π-π stacking interactions), leading to the 
quenching of conjugated fluorophore emissions via energy transfer 
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processes similar to FRET. A series of sensor optimisations were also 
performed to determine the buffer conditions and GO-aptamer ratios 
required to achieve maximum fluorescence quenching. Whilst appropriate 
restorations of fluorescence signal were observed in response to the 
incubation of single graphene-quenched aptamers with relevant purified 
proteins, multiplex analysis of both protein and whole fluid targets later 
demonstrated that such signals are largely due to the non-specific 
desorption of all ssDNA from the GO surface in the presence of general 
protein molecules.  
Further attempts to increase the analytical specificity of the multiplex 
aptasensor complex were then conducted through the selection of novel 
aptamer sequences towards whole human sperm cell targets. A total of 
14 rounds of selection were performed following a previously reported 
Cell-SELEX protocol [289], which was modified to include an additional 
step for the isolation of sperm cells from human seminal fluid. Selection 
progress was monitored between SELEX rounds using flow cytometry 
analysis, with NGS performed on enriched aptamer pools in order to 
elucidate the sequence structure of potential binding ligands. Whilst 
relatively unexplored for use within SELEX studies, NGS analysis was 
chosen for use in this work for its ability to generate greater sequence 
information from enriched aptamer pools, with the additional possibility of 
identifying promising aptamer candidates within a reduced number of 
selection rounds. A custom bioinformatics workflow was also developed 
using Galaxy for the automated processing of NGS datasets. This data 
revealed several promising aptamer candidates that may find use not only 
within GO displacement-based aptasensing assays for the detection of 
biological fluids, but also within other areas of forensic analysis (such as 
the separation of sperm and epithelial cell components within body fluid 
mixtures). 
Although not discussed within the contents of Chapter 5, an initial 
investigation into the application of a thrombin-specific molecular aptamer 
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beacon towards the detection of whole blood was also conducted. 
Originally reported by Hamaguchi et al. [145], this sensor consisted of a 
thrombin binding sequence able to undergo self-hybridization as a result 
of the 5’ extension with nucleotides complementary to 3’ bases. Such 
complementarity allowed this sequence to form a stable ‘stem-loop’ 
structure that may be used to bring terminally-labelled donor and acceptor 
fluorophores within the proximity required for FRET. Subsequent 
incubation with thrombin disrupts this hybridization, relieving quenching 
effects and generating observable fluorescence emissions (Figure 80). 
Figure 80:  Thrombin molecular aptamer beacon design: a) the emission of terminally-
labelled donor fluorophores is quenched by acceptor dyes through proximity-based 
FRET as a result of beacon self-hybridization, b) thrombin-aptamer binding results in a 
disruption of the beacon’s ‘stem-loop’ structure, separating fluorophores and restoring 
fluorescence. 
To overcome the possible absorption of donor fluorophore emissions as a 
result of haemoglobin absorbance (as seen in Chapter 3), modifications 
to the reported sensor were also made by replacing the original donor 
and acceptor fluorophores with Cy5 and Iowa Black® dyes respectively. 
However, whilst no emissions were observed from this sensor prior to 
target incubation, no signal increases occurred after addition of thrombin, 
plasma or whole blood samples. The reason for this lack of detection 
ability remains unclear but ultimately influenced the decision to exclude 
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7.5 Taggants 
Initiated as part of a collaborative project with the National Crime Agency 
(NCA), investigations were undertaken into the development of novel 
forensic taggants for the monitoring of contact transfers occurring during 
a criminal offence (Chapter 6). These taggants were comprised of three 
main components: 1) an amino acid sequence, acting as a unique 
molecular marker for the identification of particular taggant formulations, 
2) a fluorescent dye, allowing for the detection of the taggant and 3) an 
oil-based medium to facilitate transfer upon contact. With the ultimate aim 
of developing a ‘reactive’ taggant only able to be detected after 
interaction with a biological source (such as sweat or saliva), peptide and 
fluorophore molecules already utilised within the synthesis of custom 
fluorogenic substrates (Ac-HSSKL and Rh-110) were used for taggant 
construction. 
An optimisation of taggant components was first undertaken to determine 
both the type of medium needed to achieve greatest contact transfer, as 
well as the concentrations of incorporated peptide and fluorophore 
molecules required for maximum taggant detectability. The stability of 
selected taggant constituents, both over time and in response to changes 
in environmental conditions (including temperature and humidity) was 
then assessed in a subsequent validation study. In all cases, taggant 
samples were able to be detected (even after an application period of six 
weeks) through ESI-MS analysis, demonstrating the potential use of this 
reagent within long-term criminal monitoring activities.  
Such materials are likely to offer additional advantages over currently 
available taggants, including a simplistic detection, extraction and 
analysis procedure, as well as an increased coding ability through the use 
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7.6 Future Work 
Work conducted during the course of this project represents the first 
application of biosensor technology towards the detection and 
identification of biological fluid stains. However, further efforts in the 
optimisation and validation of all developed sensors is likely to be 
required in order to bring this technology beyond an initial ‘proof of 
concept’ stage and allow sensors to be deployed within an operational 
casework setting. This optimisation may be achieved through the 
modification of individual sensing components to enhance the specificity, 
stability and detection limit of each assay. Comprehensive validation 
studies should then be undertaken to assess sensor performance within a 
variety of environmental conditions (such as different temperature, 
humidity and pH ranges), as well as towards biological fluid stains aged 
over extended periods of time. Studies examining the potential for false 
negative or positive signals to occur as a result of sensor inhibition and 
cross-reactivity (both between fluid types and with other non-fluid 
substances) respectively, should also be conducted. 
Another important aspect of validating new technologies for the analysis 
of biological fluids is assessing the performance of techniques against 
fluid samples from different donors. This is particularly pertinent for 
methods that base detection on the presence/absence or quantification of 
single biomarkers, which may be differentially expressed between 
individuals. For example, PSA protein concentrations within human 
seminal fluid are known to exist over a significant range (from 0.2-5 mg/ml 
[217]. Such differences in expression may affect the analytical robustness 
of a fluid detection technique, thereby limiting its usefulness. The sensors 
reported within the scope of this study were all developed from a ‘proof-
of-concept’ perspective and were therefore only qualitatively tested 
against samples from one fluid donor. Future work should therefore focus 
on establishing the ability of each sensor to detect and identify respective 
fluids from an extensive range of different individuals. 
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With unsuccessful detection of whole fluids demonstrated by both 
commercially available and custom-synthesized thrombin assays, future 
investigations into the use of fluorogenic substrate-based sensors are 
likely to involve additional efforts to adapt this signal transduction 
mechanism towards the detection of blood. This may potentially be 
achieved through the use of novel pro-fluorophores emitting with the NIR 
region of the electromagnetic spectrum, such as QCy7 [482]. With 
emission signals able to penetrate through greater depths of organic 
tissue [482], such fluorophores may be able to compensate for the low 
concentration of free-thrombin enzymes present within blood by 
increasing the overall sensitivity of the substrate. 
Further investigations are also warranted into the application of 
constructed PSA-specific immunosensor complexes towards the 
detection of whole seminal fluid, both in solution, as well as deposited on 
surfaces commonly encountered within criminal investigation. This may 
be achieved following experimental procedures similar to those utilised in 
fluorogenic substrate testing. Furthermore, if adequate in situ detection 
performance is demonstrated by such complexes, subsequent attempts in 
adapting this transduction mechanism towards the analysis of other intra-
fluidic targets (beyond the MUC5B-specific sensor discussed within 
Section 7.3) may also be justified.  
As demonstrated within Chapter 5, construction of a multiplex GO 
displacement-based aptasensor for the simultaneous detection of blood, 
semen and saliva was hindered by the non-specific desorption of ssDNA 
from graphene in the presence of all protein targets. An attempt to 
prevent this desorption should therefore be explored. Possessing a lower 
surface charge density compared to traditional GO nanosheets, reduced 
graphene oxide (rGO) may provide an ideal resolution to this issue by 
enhancing the strength of initial ssDNA adsorption to the graphene 
surface (as a result of decreased electrostatic repulsion effects) [389].  
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A selection of aptamer sequences towards whole human sperm cell 
targets using a modified Cell-SELEX protocol was also conducted for the 
purpose of improving aptasensor specificity. Whilst NGS analysis of 
enriched selection pools revealed a number of promising aptamer 
candidates, subsequent efforts are still required to identify the particular 
structural motifs responsible for sperm-cell interaction, as well as to 
determine the binding affinities of selected sequences. Further work in 
the selection of aptamers towards cellular targets present within other 
body fluids (such as blood and saliva) should also be undertaken in order 
to identify ssDNA sequences that may have potential use in multiplex fluid 
detection aptasensors. 
Developed as part of two initial ‘proof of concept’ studies, forensic 
taggants for monitoring contact transfer during a criminal offence were 
constructed utilising fluorophores and amino acid sequences previously 
employed within fluorogenic substrate synthesis. However, with both of 
these components originally included within taggants as separate 
molecules, future investigations should be conducted into the 
development of ‘reactive’ taggants containing whole substrates, which 
allow detection only on contact with a biological source, such as sweat or 
saliva.  
7.7 Final Remarks 
A substantial number of new biosensing formats are reported within the 
literature every year. Many of these assays offer analytical specificities 
and detection limits that significantly outperform those of current forensic 
body fluid testing strategies. However, despite such performance, 
biosensors have yet to be fully integrated within any area of forensic 
analysis. The reason for this lack of sensor use is not clear but may be 
potentially attributed to the disruptive nature of adopting novel analysis 
methods within forensic laboratories. It is therefore hoped that the results 
gained from this project, originally designed as a joint enterprise between 
King’s College London and the Metropolitan Police Forensic Service 
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Directorates, realises the first step towards the use routine use of 
biosensor technology in enhancing the detection and identification of 
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A.1 Fluorogenic Substrates for the Detection of Blood 
Figure 81: Confirmation of substrate product 2HN-CV-NH2 purity and identity as 
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Figure 82: Confirmation of substrate product 2HN-CV-R-Fmoc purity and identity as 
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Figure 83: Confirmation of substrate product 2HN-CV-RVF-Bz purity and identity as 
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Figure 84: Confirmation of substrate product Ac-CV-RVF-Bz purity and identity as 
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A.2 ‘Establishing Evidence of Contact Transfer in Criminal 
Investigation by a Novel ‘Peptide Coding’ Reagent’ 
Figure 85: Microscopy images of four chosen media transferred from different surfaces 
a) plastic, b) ceramic, c) glass and d) metal to a gloved finger after 0, 6 and 24 hr from 
application.   
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Figure 86: Mass spectra obtained from MHF extracts after primary transfer of reagent 
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Figure 87: Fluorescence microscopy images obtained after mixing different 
concentrations of AFC and Rhodamine-110 with MHF. 
Figure 88: Mass spectrum of the reagent containing both fluorophore (Rh-110) and 
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Figure 89: Mass spectra of reagent samples extracted six weeks after application to 
surfaces (upper panel; a) ceramic; b) glass; c) plastic; d) aluminium) and fabrics (lower 
panel; a) denim; b) polyester; c) leather; d) cotton). Similar results were obtained for all 
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A.3 ‘Monitoring Criminal Activity through Invisible Fluorescent 
‘Peptide Coding’ Taggants’ 
Figure 90: ESI-MS spectra of a) peptide sequence 1: Ac-KQQSP-NH2, (theoretical 
[M+H]+ m/z ratio = 628.34) b) peptide sequence 2: Ac-HSSKL-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) and c) peptide sequence 3: Ac-hsskl-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) after synthesis. 
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Figure 91: ESI-MS spectra of peptide sequence 1: Ac-KQQSP-NH2, (theoretical 
[M+H]+ m/z ratio = 628.34) reagent samples extracted six weeks after application to 
surfaces: a) ceramic, b) glass, c) plastic, d) aluminium, e) wood, f) paper, g) denim, h) 
polyester, i) leather, j) cotton. Similar results were obtained for all previous time point 
extractions. 
Figure 92: ESI-MS spectra of peptide sequence 2: Ac-HSSKL-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) reagent samples extracted six weeks after application to 
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Figure 93: ESI-MS spectra of peptide sequence 3: Ac-hsskl-COOH (theoretical [M+H]+ 
m/z ratio = 613.33) reagent samples extracted six weeks after application to surfaces: 
a) ceramic, b) glass, c) plastic, d) aluminium, e) wood, f) paper, g) denim, h) polyester, 
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Figure 94: ESI-MS spectra of a) peptide sequence 1: Ac-KQQSP-NH2, (theoretical 
[M+H]+ m/z ratio = 628.34) b) peptide sequence 2: Ac-HSSKL-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) and c) peptide sequence 3: Ac-hsskl-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) reagent samples extracted after exposure to 4°C or 39°C 
for six weeks. Similar results were obtained for all previous time point extractions. 
Figure 95: ESI-MS spectra of a) peptide sequence 1: Ac-KQQSP-NH2, (theoretical 
[M+H]+ m/z ratio = 628.34) b) peptide sequence 2: Ac-HSSKL-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) and c) peptide sequence 3: Ac-hsskl-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) reagent samples extracted after exposure to 70% or 90% 
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Figure 96: ESI-MS spectra of peptide sequence 1: Ac-KQQSP-NH2, (theoretical 
[M+H]+ m/z ratio = 628.34) and Rhodamine 110 (theoretical [M+H]+ m/z ratio = 
331.11) samples extracted after exposure to all experimental conditions: a) standard 
laboratory conditions, b) 4°C, c) 39°C, d) 70% humidity, e) 90% humidity for six weeks. 
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Figure 97: ESI-MS spectra of peptide sequence 2: Ac-HSSKL-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) and Rhodamine 110 (theoretical [M+H]+ m/z ratio = 
331.11) samples extracted after exposure to all experimental conditions: a) standard 
laboratory conditions, b) 4°C, c) 39°C, d) 70% humidity, e) 90% humidity for six weeks. 
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Figure 98: ESI-MS spectra of peptide sequence 3: Ac-hsskl-COOH (theoretical [M+H]+ 
m/z ratio = 613.33) and Rhodamine 110 (theoretical [M+H]+ m/z ratio = 331.11) 
samples extracted after exposure to all experimental conditions: a) standard laboratory 
conditions, b) 4°C, c) 39°C, d) 70% humidity, e) 90% humidity for six weeks. Similar 
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Figure 99: ESI-MS spectra of peptide sequence 2: Ac-HSSKL-COOH (theoretical 
[M+H]+ m/z ratio = 613.33) and Rhodamine 110 (theoretical [M+H]+ m/z ratio = 
331.11) samples extracted from the surface of a finger after a) one, b) two, c) three, d) 
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a b s t r a c t
The forensic identification of body fluids frequently presents an important source of genetic material and
investigative interpretation. However, presumptive testing techniques presently employed in the
discrimination of biological fluids are subject to criticism for poor specificity, lack of fluid localisation
ability and detrimental effects on DNA recovery rates. The recognition of fluid-specific biomarkers by
fluorogenic substrates may provide a novel resolution to these issues but research has yet to establish
any pertinent in situ fluid detection applicability. This study therefore utilises a fluorogenic substrate
(Mu-HSSKLQ-AFC) specific to the seminal protein prostate specific antigen in an effort to detect human
semen deposited on a number of surfaces typical to criminal investigation. The ability of fluorescent
fluorogenic substrates to simultaneously identify and visualise biological fluids in situ is demonstrated
for the first time, whilst the production of complete STR profiles from fluid sources is also confirmed to
be completely unaffected by substrate application.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Locating and identifying body fluids such as semen, blood and
saliva can often aid the progression of criminal investigation by
providing intelligence on the nature and circumstance of an
offence and may additionally associate or exonerate a suspect
through the isolation of genetic material.
A number of ‘presumptive’ screening assays exist to rapidly
exclude or indicate fluid presence, employing simple biochemical
processes in order to generate colorimetric changes within a given
substrate. Those indicating the presence of blood rely on the
oxidation of haem to catalyse substrate-specific reactions [1–3],
whilst intra-fluidic enzyme activity provides the basis for the testing
of semen and saliva [4,5]. However, previous validation studies have
established limitations in the usefulness and evidential strength of
these assays. With the exception of the chemiluminescence phenom-
enon exploited in the detection of blood by Luminol, presumptive
tests cannot be used to localise fluid depositions, thereby necessitat-
ing time-consuming visual searches prior to analysis. Furthermore,
the molecular targets examined by these tests are not fluid-specific,
often leading to false positives between different fluid types and
other non-fluid substances [6–8]. Detrimental effects on the recovery
of DNA from fluid depositions have also been demonstrated after
some presumptive test applications [9,10].
Currently the most widely used presumptive test for semen
identification is the Brentamine assay for the detection of acid
phosphatase, an enzyme secreted into semen by the prostate
gland [4]. However, the requirement of specialist knowledge and
equipment often makes this test problematic. Results are subject
to a high level of expert interpretation [11–13], whilst Brentamine
toxicity also necessitates use of a fume hood.
Recent improvements in fluid assay specificity have utilised
immunological testing strips for the detection of fluid-endogenous
protein biomarkers [14–16]. However, these testing processes
do not allow for the retention of fluids following application,
potentially sacrificing a valuable source of material for genetic
profiling [17].
Our research group has made initial efforts in the design of
novel body fluid analysis techniques, developing a fluorescent
biosensor complex specific to Glycophorin A, an erythrocyte
membrane protein used in the identification of human blood
[18]. However, whilst demonstrating effective glycophorin
detection via decreases in fluorescence intensity, the ‘turn-off’
nature of signalling restricts the use of this sensor in visualising
discrete fluid deposits in situ. A ‘turn-on’ fluorescence based
assay is therefore preferable for simultaneous identification and
localisation purposes.
The proteolytic digestion of peptide substrates to release fluor-
escent by-products within the same molecular unit may be con-
sidered an attractive signalling mechanism for in situ fluid detection.
High specificities make enzyme recognition elements ideal candi-
dates for fluid analysis, whilst ‘turn-on’ increases in fluorescence
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intensity upon target interaction may allow the visualisation
of in situ fluid depositions. Furthermore, unlike irreversible
antibody-based reactions, enzyme targets may interact with
multiple substrate molecules to amplify signal production. Simul-
taneous detection of multiple fluid enzymes may also potentially
be achieved by exploiting fluorophores of differing wavelengths
in a single multiplex assay.
A central appeal of fluorogenic substrates as an alternative to
current presumptive assays is that DNA-degrading oxidative
processes, such as those exploited by Luminol and Leucomala-
chite green, are not required to generate a positive response [6].
With research yet to explore the effect of substrates on genetic
material, investigation into the possible interference of reagents
with DNA amplification, quantitation or profiling may be con-
sidered pertinent.
This study therefore explores the use of fluorogenic peptide
substrates specific to prostate specific antigen (PSA) for the
simultaneous visualisation and identification of human seminal
fluid. PSA is a semen-endogenous protein responsible for proteo-
lysis of gel-forming Semenogelin 1 and 2 [19]. The unique expres-
sion level of PSA within seminal fluid, often produced in milligram
levels per millilitre [19], has established its wide acceptance as a
forensic biomarker for semen identification.
Denmeade et al. [20] produced 12 peptide substrates for monitor-
ing PSA activity based on amino acid sequences directly adjacent to
mapped PSA cleavage sites of Semenogelin 1 and 2. These substrates
utilise 7-amino-4-methylcoumarin fluorophores, which after amide
bond conjugation to peptides undergo excitation and emission wave-
length shifts, restricting fluorescence output. Subsequent separation of
the fluorophore from the peptide by serine protease hydrolysis occurs
in the presence of PSA and restores fluorescence.
The particular substrate MU-HSSKLQ-AFC (Fig. 1) displayed
the highest specificity for PSA, arising from its resistance to
similar proteolytic enzymes found within body fluids. Whilst
this substrate has found routine use in the recognition of
prostate cancer markers, it has yet to be applied towards the
detection of human semen.
The fluorescence response of substrate MU-HSSKLQ-AFC to dilu-
tions of semen within solution, as well as to whole semen extracted
from in situ swabs, was measured via spectrofluorometry to deter-
mine the ability of the fluorogenic substrate to detect free PSAwithin
seminal fluid. Further in situ detection ability was examined, testing
substrate performance against semen deposits on glass slides and a
number of surfaces typically encountered within forensic casework.
Assay reagent was also applied to depositions of blood, saliva and
urine to confirm substrate specificity. MU-HSSKLQ-AFC was lastly
applied to semen samples for subsequent SGM plus profiling to
assess reagent effect on each stage of the profiling process.
2. Materials and methods
2.1. Reagents
2.1.1. Fluorogenic PSA substrate
Lyophilised Prostate Specific Antigen Fluorogenic Substrate (Mu-
HSSKLQ-AFC) was purchased from EMD Millipore (Massachusetts,
USA) and dissolved in 109.5 μl DMSO to make an 8 mM stock
solution before dilution in PBS to a working concentration of 400 μM.
2.1.2. Body fluid collection and storage
Blood, semen, saliva and urine samples were taken after
informed consent. Blood samples were drawn by venipuncture
and stored in a BD Vacutainers Plus tube (Oxford, UK) containing
3.2% sodium citrate coagulation preservative. All tissue samples
were stored at 4 1C until analysis.
2.2. Instrumentation and procedures
2.2.1. Spectrofluorometry
Fluorescence measurements were conducted on a BioTek
Synergy HT spectrophotometer (Vermont, USA). Dilution curves
were constructed through the addition of 100 μl of diluted semen
(1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64) in a 96-well microplate to 100 μl
of 400 μM PSA fluorogenic substrate and measured with appro-
priate blank (200 μl PBS) and negative controls (100 μl PBS, 100 μl
assay reagent). Swabs taken from in situ semen depositions were
extracted in 100 μl of PBS and added to 100 μl of working
concentration substrate. All fluorescence emissions were recorded
at room temperature in duplicate using Ex400/Em528720 nm
wavelengths (for the measurement of emissions at 508 nm)
immediately after mixing.
2.2.2. Slide microscopy
Fluorogenic PSA reagent was tested against seminal dilutions
(1:25, 1:50, 1:100, 1:200, 1:500, 1:1000) deposited on glass slides
as a demonstration of in situ substrate sensitivity. Semen volumes
of 10 μl were applied to the centre of each slide before the direct
10 μl addition of substrate. Duplicates of each dilution were
performed. Negative reagent-only controls were applied on the
same slide as a measure of background reagent fluorescence,
whilst blank controls consisting of semen-only applications were
also used to monitor possible analyte auto-fluorescence. The
simulation of dry depositions was achieved through the applica-
tion of 10 μl of seminal fluid to glass slides, which were subse-
quently allowed to dry overnight. Reagent was then applied
directly at the point of analysis.
Fig. 1. PSA fluorogenic substrate – a hexapeptide consisting of amino acid sequence HSSKLQ, terminally labelled with a fluorescent coumarin derivative. Specific digestion of
the peptide by PSA yields highly fluorescent 7-amino-4-trifluoromethyllcoumarin.
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Images were taken in the dark immediately after application on
an Olympus SZX12 fluorescence microscope (Tokyo, Japan) and
internal CCD camera. BV filtration (Ex 400–440 nm) was used for
substrate excitation, whilst all additional microscopy parameters
were kept constant (hue¼359, saturation¼255, white balance¼64,
contrast¼0, brightness¼1023, gamma¼10, magnification¼ 8.5)
in order to restrict result variation.
Investigations into substrate specificity were also undertaken
with application to depositions of whole blood, urine and saliva on
slides in order to exclude the possibility of inter-fluidic cross-
reaction.
2.2.3. Surface microscopy.
Eight different surfaces consisting of cotton, denim, felt, leather,
paper, plastic, polyester and wood were chosen to reflect materials
on which body fluids are commonly deposited within criminal
investigations. All surfaces were cut to fit the size of a microscope
slide. In a similar manner as commercial assay testing, 10 μl
depositions of human semen were applied to the surfaces and
allowed to dry overnight. PSA substrate was applied directly to
depositions in 10 μl volumes with the same negative and blank
controls previously described.
Images were once again recorded on an Olympus SZX12
fluorescence microscope utilising BV filtration (Ex 400–440 nm).
All measurements were performed in duplicate.
200 μl of working concentration substrate was lastly dispersed
directly over a semen deposition on leather using a common
atomising spray bottle to reflect ideal future application methods.
2.3. DNA profiling
50 μl of PSA substrate at working concentration was added to
150 μl of human semen to observe effects on DNA recovery after
application. DNA was extracted using the QIAmps DNA Mini kit
(Qiagen, Manchester, UK) according to the supplied protocol and
quantified with the Quant-iT™ PicoGreens dsDNA Assay Kit
(Invitrogen, Paisley, UK). Samples were diluted to 0.1 ng/μl prior
to amplification with the AmpFlSTRs SGM Pluss PCR Amplifica-
tion Kit (Applied Biosystems, Paisley, UK) using a Perkin-Elmer
9700 thermal cycler (Cambridge, UK). STR amplicons were
resolved on an ABI3130 genetic analyser and evaluated using
GeneMappers software. Generated profiles were compared to a
semen reference profile to examine potential inhibition.
3. Results and discussion
3.1. Spectrofluorometry
Whilst regularly demonstrating detection of purified PSA pro-
tein within solution [20,21], this fluorogenic substrate has never
been used to target the native PSA contained within seminal fluid.
The potential for reagent inhibition or physical fluorescence
screening by other biomolecules present in a complex matrix
makes it pertinent to investigate whether a positive signal can be
generated from whole semen.
Appropriate fluorescence intensity changes to varying dilutions
of seminal fluid were observed through spectrofluorometry. Con-
structed calibration curves were found to be consistent with those
demonstrated by Niemelä et al. [21] for the detection of PSA
within solution and established a quantitative linear relationship
between semen concentration and substrate fluorescence (Fig. 2).
A commonplace practice within forensic investigation is to
swab potential fluid depositions that require analysis at a later
point. It is consequently vital that substrates react to material
extracted from these swabs in the same manner as whole fluid.
Swabs were therefore taken of semen deposited on a leather
surface prior to extraction in PBS via brief vortexing. The collected
material was analysed using the same procedure as whole fluid
and did not display any differentiation in fluorescence response
from its neat fluid counterpart (results not shown).
3.2. Slide microscopy
The main benefit of many presumptive tests is their ability to
be performed at the point of fluid discovery. It is important that
substrate reagents designed to detect biological fluids may do so
in situ with only basic instrumental assistance for fluorescence
observation, such as a portable alternative light source.
Human semen was deposited both on to glass slides prior to
the direct application of PSA substrate. Any changes in fluores-
cence intensity were observed using standard fluorescence micro-
scopy. Positive substrate reactions successfully identified all semen
depositions, even at sensitive 1:1000 dilutions (Fig. 3). Similar
results were obtained using simulated dry depositions.
Fluorescence emissions occurred immediately upon substrate
application, promising potential for rapid fluid screening without
extended incubation times. Background reagent fluorescence was
not observed at any point during negative control testing, allowing
for the visualisation of discrete fluid areas.
Additional studies of inter-fluidic substrate specificity were also
undertaken with reagent applied to wet and dry depositions of
whole blood, saliva and urine. In all cases, the PSA substrate did
not generate a positive reaction, thereby demonstrating both high
semen specificity, as well as resistance to proteases that may be
present within other body fluids (results not shown).
3.3. Surface microscopy
The successful detection of semen by this substrate clearly
confirms the high performance of fluorogenic substrates in the
simultaneous identification and localisation of biological fluids in situ.
Nevertheless, clean glass slides are not representative of
surfaces encountered within forensic casework. Surfaces on which
fluids are typically deposited may potentially prevent the success
of fluorescent substrates via absorption, movement restriction and
physical screening effects. Furthermore, surfaces may contain a
number of unknown substances that could inhibit substrate–
target interaction. Fluorogenic PSA substrate was therefore
applied, utilising the same slide testing procedure, to dry semen
depositions on eight surfaces relevant to criminal investigation.
Despite the difficult nature of surface testing, positive results
were generated on each of the eight surfaces, identifying and
Fig. 2. Dilution curve demonstrating the relationship between seminal concentra-
tion and fluorogenic PSA substrate emission.
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visualising all semen deposits (Fig. 4). Once again, substrate-only
negative controls did not exhibit any observable fluorescence upon
application. Furthermore, surface material had little effect on the
ability of the substrate to generate positive results, with no assay
interference occurring during testing.
The direct spray dispersal of reagent over a large evidential
surface may be considered the most efficient process of localising
fluid deposits. 200 μl of substrate was applied to seminal deposi-
tions on leather using a common 1 ml atomising spray bottle in
order to examine the viability of this method. Positive substrate
emissions easily localised all semen depositions, elucidating dis-
crete staining areas and confirming the validity of this technique
(results not show).
3.4. DNA profiling
Validation studies by Tobe et al. [10] have previously demon-
strated a significantly reduced recovery of high molecular weight
Fig. 3. Demonstration of in situ substrate testing of seminal depositions upon glass slides across a range of five dilutions. Duplicate measurements were taken and also
displayed expected results.
Fig. 4. Successful detection of human semen across eight forensically relevant surfaces by fluorogenic PSA substrate. Reagent-only negative controls are provided on the left
side of each image.
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STR loci from biological fluids after some presumptive testing
applications. Furthermore, the physical application process of the
seminal acid phosphatase test has been shown to limit the amount
of spermatozoa, and thus DNA, available for genetic profiling [13].
PSA substrate was applied to semen samples, which underwent
extraction, quantification, amplification and profiling according to
standard forensic protocols to examine the effects of assay
application on the recovery of genetic material from biological
fluids. Comparisons were then made to reagent-less semen stan-
dard (Fig. 5).
Successful genetic recovery from substrate-applied semen was
established by Picogreen quantification, with an average concentra-
tion of 8.99 ng/μl DNA per sample extraction falling within expected
values. Furthermore, full STR profiles were obtained from all assay
applications, with no detrimental effects on high molecular weight
loci. Differentiation of reagent-applied samples from their reference
profiles was not observed at any stage of the profiling process outside
the limits of normal experimental variation.
4. Conclusion
This study successfully demonstrates for the first time the
ability of fluorescent substrates to identify biological fluid deposi-
tions in situ. Human semen was detected across a range of surfaces
typical to forensic investigation with additional visualisation via a
direct spraying application.
This particular substrate exhibited ideal increases in fluores-
cence intensity upon target interaction, even at sensitive 1:1000
seminal dilutions, giving opportunity for its use in contaminated
fluid depositions or those washed in removal attempts.
Importantly, substrates were found to have no effect on DNA
profiling processes after application to biological fluids and
thereby negate the potential forfeit of fluid identification in order
to maximise genetic material recovery.
An ideal application of fluid-specific substrates would likely
exploit a number of different peptide sequences, each with
separate emission wavelengths for simultaneous enzyme detec-
tion within several fluid types in a multiplex sensing system.
Displaying both an immediate and specific response to analyte
presence, fluorogenic substrates have the potential to prevent
month-long visual evidence searches by localising fluid deposi-
tions within a matter of seconds. Serious thought should therefore
be given to the development of fluorogenic substrates as replace-
ments to current presumptive testing techniques.
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Solid-phase synthesis of Rhodamine-110
fluorogenic substrates and their application
in forensic analysis†
J. Gooch,a V. Abbate,b B. Daniela and N. Frascione*a
A novel synthetic route for the rapid and efficient preparation of
fluorogenic substrates utilizing Rhodamine-110 or similar fluoro-
phores is reported. Applicability of the synthesized peptide sub-
strate within a forensic casework context is also presented.
Last year, over 10 000 exhibits were submitted to the Evidence
Recovery Unit (ERU) of the Metropolitan Police Service. Body
fluid stains such as blood, semen and saliva are often the
most important forms of biological evidence encountered in
forensic casework. Determining the identity of such deposits
can be used to further a criminal investigation as it may
provide information on both the nature of the offence and the
genetic origin of the fluid (through DNA profiling).1 Conse-
quently, over 90% of these submitted exhibits required exam-
ination for the presence of biological fluids.
However, with meticulous visual examination by trained
personnel being the most common method of detection, deter-
mining the presence and location of any fluid deposits may be
very challenging, especially with small, or latent traces on dark
backgrounds which may be easily overlooked.1 Long wave UV
or violet light sources may aid detection by exploiting the auto-
fluorescent properties of some intra-fluidic molecules but
their use is restricted to a select number of surface types.2 The
colorimetric presumptive assays used in order to identify the
type of fluid present are also considered by many in the foren-
sic community to be limited by issues of specificity,3 safety,4
and their detrimental effects on DNA recovery.5 Developing a
fast, dependable and specific method of fluid detection would
save time and money. Biosensors that simultaneously detect
and identify body fluids could represent a cost and time
efficient alternative to present day techniques. The develop-
ment of fluorogenic peptide substrates specific to each body
fluid type could improve body fluid search efficiency through
the identification of fluid-specific proteases in situ via fluo-
rescence emission.6,7
Rhodamine-110 (Rh-110) is a xanthene-based fluorescent
dye containing two aromatic amine moieties, the symmetric or
asymmetric modification of which may shift the existing equi-
librium of the molecule from a highly fluorescent quinoid
towards a colorless lactone formation, quenching fluorescence
emission.8 This has cemented Rhodamine-110 as a popular
pro-fluorophore for use within many protease substrates via
the direct attachment of specific amino acid chains (with a
positive fluorescence signal achieved via the proteolytic separ-
ation of peptide and fluorophore in the presence of a target
enzyme).8 The physical and spectral characteristics of Rho-110
are considered highly desirable for biological fluid detection,
as they display a high quantum yield and are relatively pH
insensitive. Moreover, Rho-110 based substrates exhibit an
almost non-existent emission upon peptide conjugation, pre-
venting background fluorescence and ensuring high enzymatic
assay sensitivities.8
However, all reported symmetric and asymmetrically
labeled Rh-110 peptide substrates have so far been synthesized
through solution chemistry, a task that is made problematic
due to the poor nucleophilicity of the Rh-110 aromatic
amines,9 and often leads to inefficient peptide-fluorophore
acylations. Final product yields are inevitably very low, as each
intermediate must undergo substantial purification.10 This
makes the cost of Rh-110-based substrates high and since the
aim of the research is to produce a spray that could be used
directly on forensic evidence, this cost would be unacceptable.
We surmised that preparing large quantities of peptide sub-
strates in a rapid and efficient manner could be achieved via
the direct attachment of Rh-110 to a solid support. In this pro-
cedure (Fig. 1), it is envisioned that one of the aromatic amine
groups of Rh-110 may be anchored to a functionalized solid
support, keeping the remaining amine group available for the
subsequent stepwise incorporation of amino acids by standard
Fmoc-SPPS. This route offers advantages over typical solution-
phase conjugation techniques by allowing the incubation of
†Electronic supplementary information (ESI) available: Detailed experimental
methods, compound synthesis and characterization (HPLC and MS), substrate
testing. See DOI: 10.1039/c6an00686h
aAnalytical & Environmental Sciences Division, King’s College London, 150 Stamford
Street, Waterloo, SE19NH, London. E-mail: nunzianda.frascione@kcl.ac.uk
bInstitute of Pharmaceutical Science, King’s College London, 150 Stamford Street,
Waterloo, SE19NH, London
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fluorophores with large molar excesses of any desired amino
acid residue, which may be removed without extensive liquid–
liquid extraction and chromatographic purification steps,
thereby increasing overall product yield. Instead, excess amino
acids, coupling reagents and other by-products may be
removed by simple resin wash and filtration processes. There-
fore, a fluorogenic substrate for the purpose of detecting
seminal fluid within a forensic casework framework was
constructed through the sequential coupling of immobilized
Rh-110 to amino acids HSSKLQ, a sequence previously
reported by Denmeade et al.11 as a proteolytic cleavage site of
seminal fluid-specific protease prostate specific antigen (PSA).
Rh-110 was successfully anchored to the 2-chlorotrityl
chloride resin (known to react with aromatic amines in the
presence of a base such as pyridine or N,N-diisopropyl-
ethylamine (DIPEA))12 in the first step towards substrate prepa-
ration. Upon reaction, the resin exhibited a deep red
coloration that was retained after extensive washing, indicating
successful dye incorporation. Cleavage of a small portion of
the acid-labile resin, followed by ESI-MS analysis confirmed
the presence of free Rh-110 (Fig. S1, ESI†).
With a number of workers previously reporting the unsuc-
cessful conjugation of bulky peptides to Rh-110 within solu-
tion,13 product 3 was instead assembled via the stepwise
addition of single amino acids in a series of individual reac-
tions. Multiple large excesses of Fmoc-protected glutamine
were first incubated with Rh-110-attached resin 2 in order to
ensure complete coupling (which was confirmed via ESI-MS
analysis after ‘soft’ cleavage of a small portion of resin (Fig. S2,
ESI†)), with successive amino acids incorporated through stan-
dard SPPS deprotection-wash-coupling-wash cycling to form a
PSA-specific peptide backbone. Acetylation of the histidine
N-terminus was performed to prevent substrate degradation
from environmental aminopeptidase activity.14
As previously mentioned, many substrates utilizing Rh-110
fluorophores are bis-substituted, having been synthesized
through the symmetric conjugation of identical peptides to
both aromatic amines in order to quench fluorescence.
However, in such substrates, a two-step enzymatic hydrolysis is
required in order to cleave both peptide chains before a full
fluorescence signal is restored, consequently limiting the
dynamic linear range of the assay.15 As a result, the majority of
fluorogenic Rh-110 peptide substrates now produced are
mono-substituted, with secondary aromatic amines ‘capped’
through amide, carbamate or urea modifications.8 This not
only permits the assay to be completed within a single hydro-
lysis step, but also produces the same complete emission
quenching effects as bis-peptide modification.16 Therefore, a
‘soft’ cleavage of the resin was performed under mild acidic
conditions to generate 5 from the solid support, allowing all
tert-butyloxycarbonyl and trityl amino acid side-chain protecting
groups to remain intact (preventing accidental amino acid side-
chain modification) during the capping of the remaining Rh-
110 aromatic amine by acetylation. Liquid–liquid extraction was
then performed to separate aqueous-reactive acetyl chloride
from organic-soluble products, which were subsequently treated
with TFA and precipitated in ether to remove acid-labile side-
chain protecting groups. RP–HPLC and high-resolution mass
spectrometry were used to confirm the purity and identity of
final substrate product 7 respectively (Fig. S3 and S4, ESI†).
Spectrofluorometry was employed to observe the emission
response of 7 quantitatively towards its intended enzymatic
target. Whilst the final goal of this substrate is to identify the
presence of whole semen, it is important to confirm that a
fluorescence response is only elicited as a result of PSA hydro-
lysis and not from interaction with any other molecule within
the seminal fluid matrix. Therefore in addition to dilutions of
seminal fluid, substrate 7 was incubated with varying concen-
trations of purified PSA protein. Immediate fluorescence
signal increases upon the addition of both PSA (Fig. 2a) and
seminal fluid (Fig. 2b) successfully demonstrated cleavage
between Rh-110-Ac and the attached glutamine residue, conse-
quently establishing the potential use of this substrate as a
semen-specific biosensor. Responses generated by seminal
fluid were found to be much higher compared to that of tested
purified protein concentrations, which was expected considering
Fig. 1 Schematic of Rh-110 PSA substrate development: (a) 2-ct resin (0.27 mmol), DCM, DIPEA, 24 h, (b) MeOH, 10 min, (c) Fmoc-Gln(Trt)-OH
(3 mmol), DMF/pyridine, EDC (2.5 mmol), 24 h, ×2, (d) 20% piperidine/DMF, 30 min, (e) 6 × AA, oxyma, DIC, DMF, 1 h, (f ) 10 × (CH3CO)2O, DIPEA,
DMF, 1 h, (g) AcOH : TFE : DCM, 1 h, (h) CH3COCl, DIPEA, DMF, 48 h, (i) TFA : TIPS : TA : phenol.
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the significantly larger levels of PSA usually contained within
whole semen (approximately 0.5–3.0 mg ml−1).17 As it is
important to determine the proteolytic specificity of fluoro-
genic substrates prior their application (especially within the
context of forensic casework, in which a false-positive signal
may represent an incorrect evidential identification), final sub-
strate 7 was also incubated with identical concentrations of
trypsin, proteinase K and aminopeptidase M as a measure of
PSA selectivity. In all cases the substrate did not exhibit a posi-
tive response, thereby demonstrating a high specificity towards
seminal fluid, as well as an inherent resistance to protease
enzymes present within other body fluids or the surrounding
environment (Fig. S5, ESI†).
With one of the advantages of this assay over current foren-
sic testing techniques being the ability to simultaneously
locate and identify fluid stains in situ via fluorescence, it is per-
tinent to establish that a positive substrate emission will not
be affected by the physical nature of the evidential surface on
which a body fluid is deposited. Substrate 7 was therefore
applied to small volumes of semen deposited on six surfaces
routinely examined within criminal investigation, with sub-
sequent signal responses observed by fluorescence microscopy.
Upon reagent application, all deposits were successfully visual-
ised, with surface material displaying little effect on resulting
substrate emission (Fig. 3). Similar visualization was also
achieved via the use of a hand-held Crime-lite® portable
excitation source. As an additional method of observing
reagent specificity, substrate 7 was also incubated with
volumes of blood and saliva in situ. No signal was observed
upon application (Fig. S6, ESI†).
The identification of seminal fluid by PSA detection is cur-
rently achieved through absorption of a reconstituted suspect
stain onto an immunochromatographic testing strip.18
However, this technique is not only unable to locate the
position of stains upon an evidential item but furthermore,
consumes the fluid during the testing process, preventing
further DNA analysis. An in situ PSA detection assay that
allows downstream genetic profiling would consequently be
considered advantageous. Therefore, substrate 7 was applied
to a volume of seminal fluid deposited on a glass slide, with
the resultant mixture being recovered by use of a cotton swab.
Samples then underwent standard DNA extraction, quantifi-
cation, amplification and capillary electrophoresis according
to forensic protocols. Comparisons were then made to an
untreated but identically processed reference sample to
examine the effects of substrate application on genetic
recovery. Differentiation of samples was not observed at any
stage of the profiling process with the DNA concentrations of
reagent-applied fluid and reference sample calculated at
0.66 and 0.61 ng μl−1 respectively. A full STR profile from both
samples was also obtained (Fig. S7, ESI†).
In summary, we have described a versatile detailed a
synthetic route for the simple, rapid and inexpensive prepa-
ration of Rh-110-based fluorogenic substrates. Moreover, a
substrate produced by this method has already shown great
potential as a replacement for currently employed forensic
body fluid testing techniques. This substrate allowed the
specific detection of seminal fluid traces both within solution
and in situ, without compromising subsequent genetic profil-
ing processes. Future work will centre on the use of this
method to produce fluorogenic substrates towards other
biological fluids and latent fingermarks (something that has
not currently been achieved). However, with fluorogenic
substrates routinely employed in a variety of industrial and
Fig. 2 Fluorescence response of final substrate 7 to (a) concentrations
of purified PSA protein and (b) seminal fluid dilutions over time.
Fig. 3 Detection of semen across six surfaces by substrate 7. Seminal
fluid-only negative controls are provided on the left side of each image.
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biomedical applications, the disclosed synthetic protocol is
also likely to have a much larger implication beyond the field
of forensic science.
The authors would like to thank the Metropolitan Police
Service Forensic Science Directorate and the UK Home Office
for the financial support of this project through the Police Inno-
vation Fund. Additional thanks are given to Dr Athena Vidaki
and Gabriella Mason-Buck for their help with DNA profiling.
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A B S T R A C T
The potential of fluorogenic substrates to detect and identify human saliva in situ was first explored using
commercially available substrate Boc-VPR-AMC. The substrate was applied to a range of saliva dilutions de-
posited on glass microscope slides. A positive fluorescence response was observed immediately after application
against each deposit up to a 1:8 dilution. In an attempt to improve assay sensitivity, a novel substrate Ac-VPR-
Rho110-Ac, utilising a Rhodamine-110 fluorophore, was prepared using a solid-phase peptide synthesis protocol
previously reported by our research group. Application of Ac-VPR-Rho110-Ac to saliva deposits demonstrated a
successful increase in assay sensitivity limits, allowing stains of up to 1 in 128 dilution to be detected.
1. Introduction
The Office for National Statistics estimates that in 2016/2017 alone,
over 5 million criminal offences occurred within the UK [1]. Of these
offences, almost 50% remain unsolved with no recorded suspect [2]. As
the vast majority of criminal identifications made by forensic means
involve the use of DNA, there is continuing pressure to develop rapid
and sensitive techniques capable of detecting and identifying genetic
material deposited as biological fluid traces during a criminal act.
At present, the most widely used methods to identify deposits of
saliva include the Phadebas® test, the RSID™-Saliva test and the
SALIgAE® test, all of which exploit reactions with the single most
abundant salivary enzyme, α-amylase [3]. Although these tests have
proven effective within a casework scenario, they often suffer from
caveats of low specificity [4] and lack of ability to localise fluids and
attribute their tissue type at the same time.
Our research group has recently demonstrated the use of fluoro-
genic peptide substrates as successful assays for the simultaneous de-
tection and identification of body fluid targets in situ [5]. These sub-
strates utilise fluorophores that are quenched as a result of conjugation
to an amino acid chain. Incubation of the substrate with a body fluid-
specific protease results in the separation of the peptide-fluorophore
bond and emission of fluorescence. These assays were shown to possess
both high target specificity and sensitivity, whilst a ‘turn-on’ fluores-
cence signal allowed for the visualisation of discrete fluid staining
areas. Furthermore, this fluorescence approach was shown to be highly
compatible with current DNA profiling processes.
In the course of testing a number of commercially available
fluorogenic substrates against different biological fluids in solution, it
was observed that substrate Boc-VPR-AMC exhibited a strong positive
reaction in the presence of saliva. This substrate utilises a 7-amino-4-
methylcoumarin (AMC) fluorophore, which is liberated upon target
interaction to produce a fluorescence emission at 440 nm (Fig. 1).
This study therefore documents the use of Boc-VPR-AMC, to vi-
sualise in situ deposits of saliva within a forensic context, as well as the
synthesis of a novel substrate (Ac-VPR-Rho110-Ac) based on the same
reactive amino acid sequence, in an attempt to increase testing sensi-
tivity.
2. Materials and methods
2.1. Materials
Saliva was collected upon informed consent from three donors (KCL
Ethics BDM/13/14-26). Substrate Boc-VPR-AMC was purchased from
R&D Systems (Abingdon, UK) and diluted to a working concentration
of 100 μM. All amino acids and coupling reagents were purchased from
Sigma-Aldrich Ltd (Dorset, UK), while Rhodamine-110 (Rho110) was
purchased from Fisher Scientific Ltd (Loughborough, UK).
2.2. Ac-VPR-Rho110-Ac synthesis
Substrate Ac-VPR-Rho110-Ac was prepared using a solid-phase
peptide synthesis protocol previously reported [6]. Electrospray Ioni-
sation Mass Spectrometry (ESI–MS) on a Waters/Micromass (Manche-
ster, UK) ZQ mass spectrometer was used to confirm the identity of the
http://dx.doi.org/10.1016/j.fsigss.2017.09.218
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product at each key step of the synthesis (data not shown).
2.3. Microscopy
Saliva dilutions (1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128) were
applied in duplicate to glass slides in 5 μl deposits and allowed to dry.
Working concentration Boc-VPR-AMC (100 μM) or Ac-VPR-Rho110-Ac
(500 μM) was pipetted in 5 μl volumes onto the dried saliva.
Fluorescence response of the substrates was recorded immediately after
application by an Olympus SZX12 fluorescence microscope using UV
(Ex 330-385/Em 420 nm) or GFP (Ex 460-490/Em 510 nm) filters for
the commercial and synthesized substrates respectively. Negative re-
agent-only and saliva-only controls were also utilised and recorded in
the same manner.
3. Results and discussion
Immediate ‘turn-on’ signal responses of substrate Boc-VPR-AMC
were observed against all saliva deposits up to a 1:8 dilution (Fig. 2a).
Stains beyond this limit could not be visualised successfully. The use of
negative controls also demonstrated the inherent lack of fluorescence
emission of both saliva deposits and unreacted substrate.
Our research group recently reported the development of a solid-
phase peptide synthesis protocol for the construction of fluorogenic
substrates using the fluorophore Rhodamine-110 [6]. Such substrates
are likely to be more sensitive than those using coumarin dyes due to
Rhodamine-110′s superior spectral characteristics. Attempts were
therefore made to improve assay performance through the construction
of a novel substrate Ac-VPR-Rho110-Ac. After confirming the success of
substrate synthesis by mass spectrometry, Ac-VPR-Rho110-Ac was ap-
plied to saliva deposits in the same manner as commercial substrate
testing. Successful visualisation of all in situ saliva samples up to a 1:128
dilution, demonstrated a significant increase in assay detection limits
(Fig. 2b).
During the application of Ac-VPR-Rho110-Ac, it was noted that the
substrate solution exhibited some background fluorescence. However,
Fig. 1. Boc-VPR-AMC − A short peptide chain (VPR) term-
inally labelled with a fluorophore, creating a non-fluorescent
substrate system. Resulting protease activity relieves
quenching to release highly fluorescent 7-amino-4-methyl-
coumarin.
Fig. 2. Fluorescence response of (a) Boc-VPR-AMC and (b) Ac-VPR-Rho110-Ac to saliva dilutions deposited on glass slides. Negative saliva-only controls are provided on the left side of
each image.
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this was successfully corrected for through changes to microscope
parameters. This background signal is likely to originate from dye
molecules that were not completely conjugated during synthesis.
Further purification to remove any free Rhodamine-110 from the sub-
strate product should therefore be undertaken to prevent potential
limitations to assay sensitivity.
4. Conclusion
This proof-of-concept study has demonstrated the potential of
fluorogenic substrates as a rapid, portable and simple method for the
visualisation of saliva. Commercially available Boc-VPR-AMC was first
utilised to detect deposited saliva in situ before assay sensitivity was
increased through the construction of synthetic substrate Ac-VPR-
Rho110-Ac. With substrates now designed by our group for the detec-
tion of both semen and saliva, future work is likely to focus on the
development of a multiplex substrate system for the detection of mul-
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a b s t r a c t
Aptamer-based biosensors may be of significant benefit to forensic analysis by allowing the rapid, sen-
sitive and specific detection of molecular targets relevant to criminal investigation. However, despite the
production efficiency, stability and cost effectiveness of aptamer recognition moieties, aptasensors have
yet to find commercial employment within any area of forensic science. This review therefore attempts
to encourage aptasensor development by initially identifying the methods of selection, sequence analysis
and affinity measurement most appropriate for the discovery of suitable aptamers against analytes of
forensic interest. A range of optical, electrochemical and mass-sensitive transduction platforms that may
be considered amenable to current forensic testing procedures are then discussed. The specific analytical
disciplines in which aptasensing technology is likely to be of greatest value, including forensic drug
analysis, forensic toxicology and biological evidence and explosives detection are lastly highlighted to
stimulate researchers to consider the development of sensors towards these particular target types.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
Forensic science may be considered one of the broadest
analytical disciplines due to the extensive spectrum of analytes and
sample types used to add value to a criminal investigation. For
example, in the field of human identification alone, examinable
material may range from simplistic visual patterns (e.g. finger-
marks) to complex biological molecules (e.g. DNA) [1]. Challenges
associated with the growing variety of analytical techniques and
instrumentation required by forensic laboratories to meet
comprehensive testing demands have prompted the search for new
and flexible methods that are able to detect, identify and quantify
analytes of forensic interest.
Immunological analysis methods have long been an integral
part of forensic serological and toxicological screening processes
[2]. However, with the recent discovery of aptamer-based recog-
nition, research groups are beginning to question the efficiency of
the ELISA and lateral flow strip testing strategy's currently
employed by forensic laboratories. Nucleic acid aptamers are short
single-stranded DNA or RNA sequences that are able to undergo
selective antigen association as a result of three-dimensional
structure formation [3]. These structures (usually a combination
of k-turn, loop, pseudoknot and quadruplex motifs) facilitate
intermolecular interaction with targets via van der Waal forces,
hydrogen bonding and aromatic ring stacking [4]. Through the
in vitro enrichment of random oligonucleotide libraries (consisting
of approximately 1012e1015 individual sequences) aptamersmay be
developed towards almost any small molecule [5], virus [6], large
protein [7] or whole-cell target [8], giving potential for their use as
recognition moieties in the analysis of diverse forensic samples.
While analogous to antibodies in terms of binding affinity (often
displaying Kd values in the nanomolar or picomolar range [9]),
aptamers possess a number of key advantages over their protein
counterparts. Once selected, aptamer sequences can be mass-
produced using automated solid-phase synthesis techniques,
resulting in the production of highly purified oligonucleotides
within a number of hours and at a fraction of the cost of biological
antibody generation methods [10]. Aptamers also display greater
thermal stability affording long shelf-lives without loss of activity,
easy transport and storage and ability to return to a native confir-
mation being subjected to high-temperature assay conditions [11].
Although demonstrating success as effective therapeutic agents
[12], aptamers, since their discovery, have been predominately
developed as recognition molecules for use in a range of biological
chemical analysis techniques. This has mainly focused on the use of
immobilized aptamers within traditional ELISA, western blot, flow
cytometry and lateral flow assays as replacements for expensive
and cumbersome antibody moieties [10]. In addition, aptamers
have also found beneficial application with the field of separation
science, having been used to successfully resolve enantiomeric
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molecules within High Performance Liquid Chromatography
(HPLC) systems by the inclusion stereo specific aptamers on solid
chromatographic supports [13].
Nevertheless, Hamaguchi et al. argue that the most powerful
application of nucleic acid aptamers is within analytical biosensing
platforms [14]. Biosensors are compact devices capable of the real-
time transduction of biological interaction events into a number of
measurable signal outputs [15]. Some authors have recently
recognized the potential of biosensors to provide the highly specific
detection and quantification of forensically relevantmaterials (such
as body fluids, drugs, explosives and toxins) without the need for
extensive sample processing steps [16e18]. Displaying significant
conformational changes upon target binding and allowing an
extensive range of chemical modifications (including the incorpo-
ration of various optical, electrochemical or nanoparticle reporters
[19]) at various sites without loss of binding affinity, aptamers may
be considered as ideal recognition moieties for use within molec-
ular sensing purposes [20].
Despite great promise, aptasensors (or indeed any form of
aptamer technology) have yet to find commercial employment
within the field of forensics. This lack of success has been attributed
to a number of factors, including the limited number of aptamer
sequences raised against analytically relevant targets [20], the need
for further investigation into the use of developed sensors within
complex matrices [17] and the high investment already made by
analytical laboratories in antibody-based testingmethods [30]. This
review therefore attempts to outline the current state of aptasensor
development processes, with a specific focus on those techniques
most likely to aid the construction of forensic analyte sensing de-
vices. Recent advances in aptamer selection, sequencing and af-
finity testing are first explored, along with signal transduction
mechanismsmost amenable to current forensic testing capabilities.
A number of forensic disciplines liable to benefit from aptasensor
application are lastly identified in the hope of encouraging experts




In recent years, a substantial number of modifications have been
made to the SELEX (Systematic Evolution of Ligands by EXponential
enrichment) protocol initially developed by Gold's [31] and Szos-
tak's [32] groups. While generally based on the same library incu-
bation, target binding and sequence amplification principles
exploited within the original method, these modified techniques
differ in their approach to the separation and removal of non-
specific ligands [33]. By altering the means in which aptamer-
target complexes are partitioned from unbound oligonucleotides,
aptamers may be selected against particular target types with a
higher specificity and affinity than would be possible using con-
ventional SELEX protocols [34]. As the physical properties of
forensically relevant targets are extremely diverse, it is vital that an
optimal selection method is chosen and carried out prior to apta-
sensor development. A summary of SELEX protocols that may be
useful in the selection of aptamers against forensically relevant
targets can be found in Table 1.
These modifications are especially pertinent in the selection of
aptamers towards low-molecular weight forensic analytes (e.g.
toxic chemicals and explosives), where separation is problematic
due to the similar masses of bound complexes and unbound nucleic
acid sequences [35]. The immobilization of such targets to a solid
support surface (e.g. sepharose, agarose or magnetic beads) may be
used to increase separation efficiency but can also result in the
amplification of non-specific sequences that bind to the support
matrix or immobilization linkers [5]. Furthermore, the creation of a
chemical link between the small molecule target and the solid
support can introduce an unfavourable selection bias through the
removal of least one potential aptamer binding site. Fortunately, a
number of SELEX processes that allow for the selection of aptamers
against small-molecules without the need for target immobiliza-
tion have recently been developed.
Capture-SELEX (also known as structure-switching SELEX), in-
volves the conjugation of oligonucleotide libraries themselves to
DNA-functionalized magnetic particles by use of a complimentary
‘docking’ sequence [22,36]. When incubated with a target mole-
cule, sequences that undergo conformational changes as a result of
binding are displaced from the beads (which can then be removed
with unbound ligands through the application of a magnetic field).
Aptamers isolated using this capture method may be considered
particularly attractive recognition moieties for use in analytical
biosensing platforms due to their significant structure-switching
abilities [37].
Another immobilization-free method, GO-SELEX, makes use of
the ability of graphene oxide (GO) to bind single stranded DNA
through pep stacking interactions [25]. In this technique, target
molecules are first incubated with an oligonucleotide library in
solution, allowing binding to occur. Unbound sequences are then
adsorbed onto the surface of the graphene oxide, allowing sepa-
ration from aptamer-target complexes via centrifugation. Ethanol
precipitation is finally used to purify and recover bound ssDNA
sequences. As partitioning is purely based on interaction between
DNA libraries and graphene, GO-SELEX is largely independent of
target size (and has already been successfully employed to produce
aptamer sequences towards low-molecular weight pesticide com-
pounds [38]). One class of forensic analytes that may also benefit
from aptamer-sensing application is that of whole-cells. The
immunological analysis of cellular material is currently undertaken
by forensic laboratories as a method of confirming the identity of
biological fluid deposits left behind at crime scenes [2]. Unlike
conventional SELEX procedures, the selection of aptamers against
whole-cells does not require the use of a single highly purified (or
even known) target. First described by Morris et al., Cell-SELEX
instead involves concurrent binding of library oligonucleotides to
multiple biomarkers exposed on the surface of intact live cells [23].
As a result, this approach generates a panel of aptamer sequences
(each targeting a particular membrane protein or lipid) that can
then be used for cell recognition purposes [39]. The use of live
targets within Cell-SELEX ensures that aptamers are raised towards
the native conformational structure of such membrane molecules,
allowing for the high-affinity binding of natural cellular material
during subsequent analysis [8]. In comparison to other selection
protocols, the partitioning of unbound nucleotides within Cell-
SELEX is relatively simplistic and may be achieved by basic
centrifugation or washing steps [40]. A counter-selection stage, in
which enriched libraries are incubated with a negative control cell
line, is also often included in cell-selection protocols to remove
non-specific ligands that bind to universally shared membrane
motifs [41]. Cell-SELEX techniques have in fact already been used to
produce aptamers against sperm [42] and red-blood cell targets
[23], which may already be of potential use within forensic assays
for the analysis of biological fluids.
2.2. Sequence analysis
Following sufficient enrichment, aptamer pools are sequenced
in order to elucidate the nucleotide structures of high-affinity
binders [33]. Conventionally, this process was performed via the
ligation of selected sequences into commercially available cloning
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vectors, which are then transformed into competent bacterial cell
colonies. Approximately 50e100 individual clones (each possessing
one aptamer sequence) are then recovered before plasmids are
extracted and subjected to standard Sanger sequencing [43].
However, whilst able to indicate the most abundant aptamers
present within an enriched pool, these cloning techniques only
involve the sequencing of a small fraction of the total binders ob-
tained during selection (which may be up to 1,000,000 sequences)
[44]. As a result, the majority of new aptamer development pro-
tocols now make use of next generation sequencing (NGS) plat-
forms for the comprehensive analysis of potential binding
candidates [45]. Such high-throughput methods not only allow the
discovery of millions of sequences from enriched pools without
laborious cloning processes, but can also be used to shorten se-
lection processes by identifying aptamers during early SELEX
rounds [46].
Commercially available NGS platforms previously used for
aptamer discovery include Ion Torrent's Personal Genome Machine
(PGM) [47] Illumina's Genome Analyzer/HiSeq system [48,49],
Roche's GS FLX system [50,51] and Applied Biosystem's SOLiD
system [52]. However, with extensive sequence reads and higher
total read lengths, a greater level of detail on the structural features
of target binders may be provided by Illumina instruments, making
them the most preferable choice for aptamer sequencing (Fig. 1)
[43]. Furthermore, these platforms, based upon the principle of
cyclic reversible termination, are already widely used within the
forensic community for the analysis of human genomic material
[53] andmay therefore be readily applied by forensic researchers to
determine aptamer sequences for the recognition of forensic
analytes.
While NGS use may significantly enhance the resolution and
sampling depth of enriched aptamer pools, additional computa-
tional bioinformatic tools are currently required to process the
sheer quantity of raw sequence data obtained [45]. Web-based and
offline preprocessing software, such as Galaxy [54], cutadapt [55]
and AptaTools [56] are often used to first isolate variable aptamer
regions of a defined length by removing adapter and constant re-
gion sequences. Further programs are then employed to filter this
data in order to narrow down aptamer candidates for subsequent
experimental testing. The FASTaptamer toolkit achieves such
Table 1
SELEX protocols that may be used in the selection of aptamers against forensic targets.
Protocol Mechanism Advantages Reference
Capillary-Electrophoresis SELEX Aptamer-target complexes are separated from
unbound nucleotide sequences according to
electrophoretic mobility.
- Selection may be completed within 2
e4 rounds.
- Useful for small molecule targets.
[21]
Capture-SELEX Library sequences are displaced from magnetic
beads by target binding. Unbound ligands are
then removed magnetically.
- Aptamers display large structural
changes.
- Useful for small molecule targets.
[22]
Cell-SELEX A panel of membrane biomarker-specific
aptamer sequences is produced as a result of
exposure to live cell targets.
- Counter-selection used to increase
specificity.
- Selection performed on targets in
native state.
[23]
FluMag SELEX Complexes formed between bead-immobilized
analytes and fluorescent library sequences are
collected magnetically.
- Selection rounds and dissociation
values may be quantified by
fluorescence measurement.
[24]
Graphene Oxide (GO) SELEX Graphene oxide is used to adsorb and separate
unbound ssDNA sequences from aptamer-
target complexes in solution.
- Requires less than 5 rounds of
selection.
- Useful for small molecule targets.
[25]
In-Silico SELEX Theoretical oligonucleotide libraries are
screened against a target using computational
tools to identify potential binders.
- Atomic-level mechanisms of
nucleotide-target binding can easily
be determined.
[26]
Microfluidic (M) SELEX Ligands bound to magnetic or sol-gel bead-
conjugated targets are purified by continuous
washing within a microchannel.
- Lower target molecules and reagent
volumes are required as a result of
miniaturization.
[27]
MonoLEX Affinity columns used to partition aptamer-
target complexes are physically segregated to
elute highest affinity sequences.
- Requires a single round of selection.
- Diminishes competition between
sequences.
[28]
NanoSelection High affinity aptamers are detected and
recovered via the use of fluorescence and
Atomic Force Microscopy (AFM).
- Requires a single round of selection.
- Binding affinity may be measured by
AFM.
[29]
Fig. 1. Workflow of the Illumina sequencing-by-synthesis approach e Specialist adapter sequences are first ligated to the end of aptamers obtained from SELEX-enriched pools.
These adapters aid the anchoring of selected oligonucleotides to the surface of a flow cell, allowing solid-phase bridge amplification. Fluorescently labelled nucleotides are then
added to the cell, which is imaged after the incorporation of each base into DNA strands. The emission wavelengths of each nucleotide dye are then monitored in order to determine
aptamer sequences.
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filtering by monitoring the relative enrichment of specific aptamer
sequences between selection rounds [57], whereas APTANI exam-
ines both the total read counts of each sequence as well as shared
structural homology between sequences [58]. After aptamer dis-
covery has taken place, sequences may be further analysed by
programs such as mfold [59] to provide more information on sec-
ondary oligonucleotide structure.
2.3. Affinity measurement
In order to ensure adequate aptasensor performance, it is vital
that integrated aptamers demonstrate strong affinity towards
target molecules [60]. Aptamer affinity is usually expressed in
terms of a dissociation constant (Kd), the value of which may be
determined by a range of separation-based, mass-sensitive, spec-
troscopic or other label-free techniques [5]. A summary of methods
that may be able to assess the performance of aptamers with po-
tential use in forensic testing may be found in Table 2.
Variations in the size and physical properties of forensically
relevant analytes make the evaluation of aptamer-target affinities
challenging. Much like similar SELEX processes, measuring Kd via
the separation of unbound ligands from aptamer-target complexes
is often problematic for compounds of a smaller molecular weight
than nucleotide binding sequences. Other techniques, such as
fluorescence polarization or surface plasmon resonance (SPR), are
additionally disadvantaged by the chemical labelling or immobili-
zation of aptamers or targets, which may reduce Kd calculation
accuracy by altering binding interactions [5].
A resolution to these issues may be provided by isothermal
titration calorimetry (ITC), a label-free solution-based method that
allows the characterization of binding energy by monitoring tem-
perature increases during complex formation [72]. ITC methods are
currently considered the ‘gold standard’ for quantifying biomole-
cular interactions and have already been used to assess the affinity
of aptamers towards several forensically relevant targets, including
cocaine [73] and organophosphate pesticides [74]. In this
Table 2
Techniques that may be used to determine the affinity of aptamers against forensic targets.
Technique Type Mechanism Reference
Affinity chromatography Separation - Binding is measured after labelled aptamers or target
molecules are incubated with corresponding
components that are conjugated to a solid support
(typically agarose or magnetic beads).
[61]
Capillary electrophoresis Separation - Concentrations of aptamers, targets and aptamer-
target complexes are determined after size and
charge-based separation. Fluorescent labelling of
each component is often required for detection.
[21]
Equilibrium dialysis Separation - Unbound ligands within an aptamer-target mixture
are allowed to diffuse through a semi-permeable
membrane before being quantified.
[62]
Gel Electrophoresis Separation - Like capillary electrophoresis, binding components
are separated by size and charge but by a non-
denaturing agarose or polyacrylamide gel. Visualiza-
tion is required to observe isolated components.
[63]
Ultrafiltration Separation - Unbound ligands are measured after partitioning
across a membrane (typically nitrocellulose) under
applied pressure, vacuum or centrifugation.
[64]
Back-Scattering Interferometry (BSI) Spectroscopic - Changes in the refractive index of a sample through
the association of aptamer-target complexes are
detected within a microfluidic channel.
[65]
Circular Dichroism (CD) Spectroscopic - Differences in the absorption of left and right
circularly polarized light are monitored during the
titration of DNA against increasing concentrations of
target.
[66]
Fluorescence Intensity Spectroscopic - The increase/decrease in fluorescence intensity of
targets or labelled aptamers as a result of complex
formation is measured via spectrofluorometry.
[67]
Fluorescence Polarization Spectroscopic - The rotational diffusion of fluorescent dyes
conjugated to aptamers or targets is decreased as a
result of binding. Subsequent increases in signal
polarization are then monitored.
[68]
UVeVis Absorption Spectroscopic - Affinity is inferred from variations in the wavelength
or intensity of UVeVis absorption of aptamers or
targets upon binding.
[7]
Quartz Crystal Microbalance Mass-Based - Accumulation of aptamer-target complexes on the
surface of functionalized piezoelectric crystals results
in a measurable decrease in resonance frequency.
[69]
Surface Plasmon Resonance Mass-Based - Ligands immobilized on a sensor flow cell are
subjected to an aqueous flow of binding partners.
The formation of target complexes then results in a
change in refractive index near the sensor surface.
[70]
DNase Footprinting Other - The relative levels of aptamers protected from
digestion (by association with varying
concentrations of target molecules) are determined
after treatment with DNase I enzymes.
[71]
Isothermal Titration Calorimetry (ITC) Other - The amount of energy required to maintain the
temperature of a cell is monitored during
exothermic aptamer-complex binding.
[72]
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technique, targets are titrated into a cell containing an aptamer of
interest and allowed to react. Heat released as a result of
exothermic binding processes is monitored and compared to an
identical reference cell containing buffer or water. Power required
by the calorimeter to maintain equal temperature between the cells
at eachmolar ratio of target/aptamermay then be used to construct
a binding isotherm, allowing affinity to be determined [75]. How-
ever, while ITC may provide detailed information on the thermo-
dynamic parameters of aptamer-target interactions (such as
changes in entropy, enthalpy and Gibb's energy), relatively high
amounts of target are required for detectable amounts of heat to be
generated [7]. This may be considered problematic for some
forensic analytes that are expensive to purchase or only available
from commercial providers in low concentrations (although micro




Reported by Kleinjung et al. in 1998, the first biosensor to use
aptamers as moieties for target recognition involved the competi-
tive binding of L-adenosine and FITC-labelled analogues to an RNA
ligand immobilized on the surface of an optical fibre [76]. As a
result, the vast majority of early aptasensing platforms also focused
on the use of optical methods to signal biological interaction
occurrence [77]. Such sensing generally relies on the structural
transitions that aptamers undergo during target binding to create
measurable variations in the spectroscopic properties of optical
transduction components [19]. These components (typically
organic dyes, luminophores, nanoparticles or conjugated polymers)
may be incorporated into conformationally labile regions of oligo-
nucleotide sequences by covalent attachment or as ‘label-free’ re-
porters by indirect intercalation [78]. Subsequent alterations in the
microenvironment of these reporters as a result of aptamer folding
may then prompt changes in the intensity, wavelength or anisot-
ropy of label emissions [20]. Alternatively, multiple reporters can be
used to achieve transduction through distance-dependent fluo-
rescence (FRET) or chemiluminescence (CRET) resonance energy
transfer processes [79].
Two popular forms of optical aptasensing include aptamer-
beacons and hybridized DNA displacement assays [80]. Based on
the conventional molecular-beacon format for the detection of
specific DNA molecules, aptamer-beacons are constructed by the
addition of short complementary nucleotides (alternately labelled
with a fluorophore or quencher) to each end of a specific aptamer
sequence [14]. Under normal conditions these nucleotides allow
the aptamer to take on a closed hairpin structure, bringing the
quencher and fluorophore moieties within close proximity and
restricting fluorescence output. However, in the presence of target
molecules, aptamer interaction causes the hairpin to unfold,
resulting in the production of a ‘signal-on’ fluorescence emission
[80]. Hybridized DNA displacement assays (Fig. 2a) work via a
similar premise but instead employ a separate quencher-labelled
antisense sequence bound to fluorescent aptamers through
Watson-Crick base pairing that then dissociates in the presence of
higher affinity target analytes [81].
One of the main advantages of optical sensing is the ability to
offer real-time analyte detection without extensive sample pro-
cessing steps or specialized equipment [82]. Such advantages may
give the potential for optical aptasensors to be used as chemical
reagents for the simultaneous detection and identification of latent
(i.e. non-visible) evidence deposited at crime scenes or on
evidential items. This concept has already been explored within Li
et al. in which two aptamers labelled with emitting gold nano-
particles (Au-NPs) reassembled in the presence of cocaine doped
within latent fingermarks [83]. While the adherence of the nano-
particles themselves to deposited marks was sufficient to visualize
identifiable ridge detail, aggregation of the Au-NPs as a result of
cocaine binding also resulted in a shift in emission wavelength of
scattered light from 550 to 580 nm.
3.2. Electrochemical
Cho et al. note that despite the significant amount of optical
detection platforms reported during the early stages of aptasensor
research, greater attention is now being paid to the use of elec-
trochemical strategies for the transduction of aptamer interactions
[20]. Biosensing assays incorporating such methods are becoming
increasingly attractive to researchers due to their relative porta-
bility, ease of operation, robustness and low cost (to both develop
and operate) [84]. Electrochemical aptasensors are further
benefitted by excellent sensitivities and can be used in conjunction
with a number of electrical signal amplification techniques (such a
biocatalytic labelling) to provide extremely low limits of analyte
detection [85]. For example, Hanson et al. employed the use of a
single-step replacement aptasensor exploiting electrochemical
nanoparticle stripping-based signal amplification for the mea-
surement of thrombin at ultrasensitive attomole levels [86].
While electrochemical aptasensors may make use of ampero-
metric, potentiometric, conductometric, impedimetric and
Fig. 2. Schema of aptamer-based sensing formats e a) Optical transduction. Aptamers labelled with fluorescence reporters (F) are hybridized to quencher (Q)-conjugated DNA
sequences, which absorb emission via FRET. Upon binding to targets (T), aptamers separate from complimentary strands, allowing fluorescence to be restored. b) Electrochemical
transduction. Changes in aptamer confirmation as a result of target interaction allow redox-active labels to interact with the surface of electrodes to produce an electrical signal. c)
Mass-sensitive. An increase in the mass of surface-immobilized binders through aptamer-target complex formation is detected either optically or electrically.
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semiconductor field-effect principles, signals are generally derived
from changes in electric current as a result of aptamer-mediated
redox reactions occurring at the surface of an electrode [84].
Much like optical aptasensing mechanisms, these reactions are
generated by reporter molecules incorporated within aptamer se-
quences, which are then bought closer to or further away from
electrodes as a result of target binding interactions [79]. Popular
reporters for electrochemical aptasensors include methylene blue
(MB), ferrocene, ferricyanide, ruthenium complexes, enzymes,
quantum dots (QDs) and metal nanoparticles [87].
According to Han et al., electrochemical aptasensor assays may
be designed in four broad formats: target-induced structure
switching (TISS), sandwich, target-induced displacement (TID) or
competitive replacement [88]. TISS assays exploit the ability of
surface-immobilized aptamers to form rigid tertiary structures in
the presence of analytes in order to change the proximity of sig-
nalling moieties in relation to an electrode (Fig. 2b). Sandwich as-
says conversely involve the assembly of a complex between an
immobilized primary aptamer, a target, and a second reporter-
labelled recognition molecule (which may be an aptamer or an
antibody). In TID sensors, complementary nucleotide sequences are
instead immobilized and are used to anchor labelled aptamers to
electrodes via base pairing. Upon target interaction these aptamers
dissociate, causing a decrease in electron transfer (eT) signals.
Competitive replacement lastly involves the incubation of targets
with reporter-attached analytes, which then compete for aptamer
binding space. As a result, signal intensities obtained from
competitive replacement assays are inversely proportional to the
amount of target present within a sample.
Electrochemical detection platforms may be considered espe-
cially amenable to forensic analysis due to their excellent perfor-
mance in turbid matrices [89]. Such sensing platforms are able to
negate the effects of optically absorbing and fluorescent molecules
present within complex samples (that often interfere with spec-
troscopic analysis) and therefore represent great potential as toxi-
cological assays for the detection of trace compounds within
biological matrices. Work conducted by Baker et al. has already
proven this capability through the production of an electrochemical
TISS aptasensor that was successfully able to detect micromolar
concentrations of cocaine in saliva and blood serum samples [90].
3.3. Mass-sensitive
Unlike both optical and electrochemical transduction mecha-
nisms, mass-sensitive aptasensing techniques do not utilise the
conformational changes that aptamers undertake in order to indi-
cate biological interaction events [20]. Instead, sequences are
tethered to a variety of solid supports and used as simple capture
ligands to create discernible increases in mass at sensor surfaces
upon target binding (Fig. 2c). As a result, such methods do not
require the use of molecular reporters to generate detectable sig-
nals and are therefore classified as ‘label-free’ techniques [79].
Popular mass-based aptasensing formats include: SPR, surface
acoustic wave (SAW), quartz crystal microbalance (QCM) and
microcantilever assays [79].
Employing the same principles for the characterization of
binding affinity constants, SPR methods have also found use as
platforms for the aptamer-based detection of numerous target
compounds [91]. One of the most frequently used instruments for
SPR sensing is the Biacore™ system manufactured by GE Health-
care [92]. In this system, aptamers are first covalently immobilized
onto a thin gold film attached to a glass slide, which is then illu-
minated by monochromatic p-polarised light. Solutions containing
an analyte of interest are then introduced into the sensor at a
continuous flow through microfluidic channels. As these analytes
interact with aptamer sequences, increases in mass bound to the
film surface cause changes in the refractive index of incident light,
which is then registered by the instrument [93].
SAW and QCM-based aptasensors both involve the generation
and detection of acoustic waves by electrodes patterned on the
surface of aptamer-functionalized piezoelectric crystals [94]. The
propagation speed of such waves (either on the surface or in the
bulk of crystals for QCM and SAW respectively) is highly influenced
bymass associated with the crystal itself. Increases in this mass as a
result of aptamer-target binding subsequently cause a reduction in
crystal resonance frequencies, which are then observed by elec-
trical means [20]. Whilst these devices are normally only applicable
for the sensing of large analytes such as proteins or cells (which
provide more measurable mass changes) a number of modified
protocols, such as QCMwith dissipation monitoring (QCM-D), have
been developed to allow the aptamer-based detection of lower
molecular weight analytes [35].
Microcantilever assays typically consist of thin silicon or
polymer-based micromechanical beams (approximately one
micron thick), which respond to changes in physical stress [95]. A
gold coating is often applied to one side of the beam in order to
allow the immobilization of biological receptors, including
aptamers, onto cantilever surfaces [96]. The binding of target
molecules to these receptors creates stress differences between the
functionalized and non-functionalized sides of the surface, causing
the cantilever to bend by amatter of nanometres [97]. The degree of
bending (also known as cantilever deflection or Dc) is then
detected optically and compared to a reference cantilever con-
taining non-interacting nucleotide sequences [98]. As this deflec-
tion is directly proportional to the amount of target present within
a sample, microcantilever methods represent a great opportunity
for the quantitative sensing of forensically relevant analytes.
4. Aptasensor applications
4.1. Biological evidence
Chemical reagents used for the detection and identification of
biological evidence (i.e. body fluids and fingermarks) are currently
limited by issues of low specificity and sensitivity, environmental
and safety concerns, ease of application and effect on downstream
DNA profiling processes [16,99]. Other antibody-based devices
(such as immunochromatographic test cartridges) are conversely
able to provide absolute confirmation of body fluid identity with a
sufficient degree of sensitivity and safety, but cannot be used to
locate latent stains on evidential surfaces [100]. As previously
mentioned, optical aptasensing strategies may have the opportu-
nity to overcome these challenges by allowing the simultaneous
detection and highly specific identification of biological evidence in
situ.
Furthermore, a number of optical aptasensors have already been
constructed towards biomarkers that may be (or currently are)
used for the confirmation of body fluid presence. For example, Kong
et al. recently reported the production of a fluorescent aptasensor
towards prostate specific antigen (PSA), a serine protease enzyme
already used in forensic analysis for the immunological detection of
seminal fluid [102]. In this assay, fluorophore-labelled aptamers
adsorbed onto the surface of emission-quenching MoS2 nanosheets
were used to detect sub-nanogram concentrations of PSA after
dissociation upon target binding.
Since its isolation by Bock et al. in 1992, the thrombin-binding
aptamer has become one of the most commonly exploited DNA
receptor sequences for the construction of new aptamer-based
sensing platforms [103]. As a result, a number of these aptasens-
ing assays may find application in the specific detection of
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thrombin for the purposes of identifying bloodstains deposited on
evidential surfaces. One such sensor, developed by Wang et al.,
involves the use of aptamer-functionalized upconverting phos-
phors, which are initially quenched by the binding of carbon
nanoparticles to DNA strands through pep stacking interactions
(Fig. 3). In the presence of thrombin, these nanoparticles dissociate
from ligand sequences, relieving FRET quenching effects and pro-
ducing ‘signal-on’ fluorescence emission [101].
4.2. Forensic drug analysis
Routinely employed methods for detecting trace quantities of
illicit drugs include presumptive chemical tests, immunoassays and
a wide selection of chromatographic techniques [104]. With a high
sensitivity, selectivity and reliability, gas chromatography coupled
with mass spectrometry (GC-MS) or liquid chromatography
coupled with mass spectrometry (LC-MS) is currently considered
the ‘gold-standard’ for the forensic analysis of bulk drug samples.
However, such approaches are costly and may be considered
inappropriate for high-throughput analysis due to extensive run
times. Rapid, cheap and portable drug-screening assays based on
aptasensor technology are therefore likely to be welcomed by the
forensic community.
Much like the thrombin-binding sequence previously discussed,
a cocaine-specific aptamer constructed by Stojanovic et al. [106]
has also been extensively used as a model ligand for proof-of-
concept aptasensing assays. Demonstrated by Hilton et al., a
particularly sensitive example of such assays involved the target-
induced displacement of Dabcyl quencher-attached complemen-
tary oligonucleotides from carboxyfluorescein (FAM) labelled
aptamers immobilized withinmicrofluidic channels. This assay was
subsequently shown to enable the detection of cocaine at pico-
molar levels, without the need for sample cleanup and derivatiza-
tion processes required for GC-MS analysis [107].
Beyond cocaine-based assays, initial explorations are also being
made into the use of aptasensing platforms for the detection of
amphetamine derivatives. Yarbakht and Nikkhah recently exploited
the ability of single stranded aptamers to shield Au-NPs from salt-
induced aggregation in order to allow the colourimetric signalling
of MA andMDMA presence [105]. In this sensor (Fig. 4), an aptamer
able to bind both MA and MDMA is incubated with a given sample.
If target molecules are contained within the sample, conforma-
tional changes in the aptamer take place as a result of binding. Such
changes prevent the association of aptamer sequences with Au-
NPs, which then aggregate upon salt addition, turning the colour
of sample solutions from red to blue. If target molecules are absent
from the sample, aptamers are instead able to interact freely with
AuNPs, protecting them from aggregation.
In an alternative transduction approach, Huang et al. [108] were
able to successfully develop an electrochemical biosensor based on
Au-mesoporous silica nanoparticles (Au-MSN) after selecting a 37-
mer aptamer sequence against the opiate alkaloid codeine. Here,
thiolated codeine aptamers were conjugated to Au-MSN's immo-
bilized on the surface of a glassy carbon electrode. Changes in
electrical impedance at the electrode surface associated with
aptamer-target binding were used to monitor codeine concentra-
tions across a linear range of 10 pMe100 nM. Furthermore, dena-
turation of the aptamer sequences by incubation with heated
distilled water allowed the sensor to be reused for subsequent
measurements.
With relatively fast selection and isolation times compared to
antibodies (i.e. a matter of weeks), nucleic acid aptamers also
represent a great opportunity to rapidly develop forensic assays for
the detection of new psychoactive substances (NPS). These sub-
stances (typically scheduled drugs slightly modified to circumvent
legal restrictions) are emerging at an unprecedented rate, with over
450 new compounds identified by the EU early warning system
since 2005 [109]. At present, the majority of NPS compounds are
poorly or not detected by standard immunoassay tests, forcing
analysts to rely onmass-spectrometry techniques [110]. Despite the
excellent potential of aptasensor platforms as drug-screening as-
says, aptamers selected towards any NPS target have yet to be re-
ported in the literature.
4.3. Forensic toxicology
The synthetic nature of SELEX protocols means that aptamer
recognition moieties may be selected against toxic compounds that
would likely kill animal hosts during standard in vivo antibody-
generation methods [111]. Such moieties may be therefore of
great benefit to toxicology practices, where determining cause of
death is often dependent upon the detection and quantitation of
hazardous substances. This branch of forensic chemistry heavily
relies on the use of expensive and labour-intensive analytical
techniques to confirm the identify of various poisons and toxins
[112].
Ochratoxin A (OTA) is a toxic metabolite secreted by aspergillus
and penicillium fungi species that can exert severe nephrotoxic,
immunotoxic, and carcinogenic effects [114]. As such toxins
represent a threat to health through the contamination of
commercialized food systems, significant efforts have been made
towards the development of a simple and flexible sensing platform
Fig. 3. Schema of a FRET-based aptasensor for the detection of thrombin developed by Wang et al. [101]. Here, 50 amino-modified aptamer sequences are first covalently linked to
poly-acrylic acid (PAA)-functionalized up-conversion phosphors (UCP's). Subsequent incubation with carbon nanoparticles results in quenching of the sensor through aptamer-
abridged fluorescence resonance energy transfer (FRET). This sensor demonstrated a linear detection range of 0.5e20 nM and was even used to detect Thrombin concentra-
tions of 0.25 nM within spiked human serum samples.
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for the detection of OTA compounds [115]. In a strategy designed by
Sheng et al. (Fig. 5), this sensing was achieved by the use of FAM-
modified aptamers which, in the absence of OTA, are adsorbed
onto a basal plane of graphene oxide and quenched [113]. However,
in the presence of target molecules, aptamers are induced into
particular three-dimensional confirmations and resist adsorption,
allowing fluorescence to be monitored.
In an extension of the Au-NP aggregation assay exploited by
Yarbakht and Nikkhah for the detection of amphetamines, Wu et al.
also utilised an aptamer-based sensor for the detection of arsenic
within aqueous solutions [116]. In this method, a cationic surfactant
Hexadecyltrimethylammonium bromide (CTAB) was employed
instead of salts to stimulate nanoparticle aggregation, allowing the
colourimetric detection of arsenic concentrations in the range of
1e500 parts per billion.
Work from Lamont et al. resulted in the selection of an aptamer
(SSRA1) specific to the B-chain of ricin [117]. Ricin, a cytotoxic
protein of biological origin, is considered as a potential threat agent
for terrorist use because of its high toxicity and relative availability.
The selected aptamer displayed superior detection capabilities
compared to a commercially available ELISA kit for ricin. Following
this study, attempts have been made in order to embed the SSRA1
aptamer into a biosensing platform for rapid and sensitive ricin
detection. Esteban-Fernandez de Avila et al. reported on a micro-
motor sensing strategy for the fluorescent detection of ricin [118].
Self-propelled reduced graphene-oxide (rGO)/platinum (Pt)
micromotors were synthesized and were modified with the ricin-
specific aptamer tagged with a fluorescent dye. The resulting
complex is non-fluorescent due to the quenching effect of the
graphene surface. In the presence of the target toxin, the aptamer is
displaced from the graphene-oxide quenching motor surface and
its fluorescence is restored. By this method, real-time detection of
trace amounts of ricin toxin could be achieved in biological and
environmental samples. Li et al. further developed a detection
system for ricin based on isothermal strand-displacement poly-
merase reaction [119]. The ricin-specific aptamer SSRA1 was first
hybridized with a single stranded DNA blocker and then it was
immobilized on the surface magnetic beads. When ricin binds to
the aptamer, the blocker is released and it hybridizes to with a dye-
modified hairpin probe triggering an isothermal strand-
displacement polymerase reaction. The fluorescent double
stranded DNA product cannot be quenched as it does not interact
with the graphene oxide surface, resulting in an increase of the
fluorescence intensity.
Scientific efforts have been made in the forensic field towards
the development of new methods for the detection of chemical
weapon agents with emphasis been placed on the real-time, on-site
analysis of nerve agents (e.g. sarin). Zhao et al. developed a
cantilever-based aptasensor for dimethyl methylphosphonate
(DMMP), a nerve agent simulant [120]. The piezoresistive canti-
lever sensor was designed with four cantilevers (two sensing and
two reference cantilevers). A biotinylated anti-DMMP aptamer was
immobilized on the surface of the sensing cantilevers. In the
presence of DMMP, binding takes place between the immobilised
aptamers and the target; this results in a surface stress and a
bending of the sensing cantilevers which can be recorded and
measured. The method resulted in sensitive (50 nMe1.0 mM) and
specific detection of DMMP in aqueous solutions.
4.4. Explosives
The development of rapid, cost-effective and reliable assays for
the detection of explosive molecules in both aqueous and gaseous
samples is a high priority for forensic investigators, counter-
terrorism agencies and global de-mining projects [121]. Ehren-
treich-F€orster et al. argue that aptamers are likely to make ideal
recognition moieties for such assays, as immunological methods
Fig. 5. Schema of a graphene-quenching fluorescence aptasensor for the detection of ochratoxin A developed by Sheng et al. [113]. Here, aptamers are made initially fluorescent via
50 labelling with 6-carboxyfluorescein (6-FAM). Under normal conditions, these aptamers are readily adsorbed onto the basal plane of PVP-protected graphene oxide, which
subsequently quenches 6-FAM emission by energy transfer. However, in the presence of ochratoxin A, antiparallel G-quadruplex formation prevents such adsorption and fluo-
rescence signals are generated. Using this sensor, Sheng et al. were able to monitor ochratoxin A with high selectivity in a liner range from 50 to 500 nM.
Fig. 4. Schema of a colourimetric Au-NP aptasensor for the detection of metham-
phetamine developed by Yarbakht and Nikkhah [105]. In this assay, aptamers are
initially adsorbed onto the surface of gold nanoparticles (au-NP's) through hydro-
phobic and electrostatic interactions to stabilize them within solution. However, in the
presence of methamphetamine (MA) or 3,4-Methylenedioxymethamphetamine
(MDMA), alterations in the structural conformation of the aptamers allow salt-
induced aggregation of the particles to occur, prompting surface plasmon resonance-
based colour changes. A purely visual detection of MA was found to occur at con-
centrations as low as 5 mM.
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are often disadvantaged by the poor specificity of antibodies raised
against low molecular weight explosive analytes [122]. Further-
more, aptamers are known to retain their activity in a number of
organic solvents (such as methanol and acetonitrile) commonly
used for the solubilisation and detection of explosive compounds.
To prove this concept the same group demonstrated the con-
struction of an optical aptasensor towards the detection of 2,4,6-
trinitrotoluene (TNT). In this sensing strategy, activated TNT de-
rivatives are first immobilized on the surface of silanised optical
fibres. TNT-specific aptamers mixed within sample solutions are
then introduced into the flow cell and bind to the surface-bound
analytes unless already captured by TNT present within the sam-
ple itself (Fig. 6). Nanobeads covalently attached to these aptamer
sequences are then used to report the amount of ligands bound to
the fibre (with emission intensities inversely proportional to the
concentration of TNT present in measured samples).
Whilst aptasensing assays towards explosive targets other than
TNT remain extremely limited, it is hoped that this review will
encourage researchers in the field explosives research to consider
their use for the detection for compounds such as hexahydro-1,3,5-
trinitro-1,3,5-triazine (RDX).
5. Conclusions
Challenges associatedwith the immunological and instrumental
analysis methods currently employed within both crime scene and
laboratory-based testing procedures have resulted in the demand
for new techniques able to allow the rapid, sensitive and specific
detection of forensically relevant analytes. In this review, we have
highlighted the potential of biosensing technology that in-
corporates aptamer recognition moieties to address this demand.
Moreover, we have reported on a wide range of aptasensors that,
although being successfully developed for use in other analytical
disciplines, could be readily adapted to forensic analysis.
Whilst research in the development of aptasensors for forensic
purposes is extremely limited, it is hoped that recent technological
advances (e.g. NGS) will make aptamer-based sensor development
more accessible to researchers working within the field of forensic
science.
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A B S T R A C T
The use of taggant technology to mark objects for the purpose of identification is becoming a signifi-
cant part of national crime reduction strategies. Taggants may be able to prevent or monitor criminal
offences by associating an object with a specific piece of information. While the material properties of a
taggant will largely vary between application purposes, a specific ‘coding’ element will generally be in-
corporated to infer marker uniqueness. With the speed, simplicity and accuracy of coding component
analysis largely determining the overall efficacy of taggants, continuing advances in portable in-field anal-
ysis, nanotechnology and material science should have allowed for the development of new and improved
forensic marking agents. However, the limited amount of recent research in this area suggests that this
is not the case. This critical review therefore examines the current state of presently available taggants
before attempting to offer insight into the future direction of forensic marking technology.
© 2016 Elsevier B.V. All rights reserved.
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1. Introduction
Costing approximately £24 billion a year, the social and eco-
nomic effect of organised criminal activity in the UK is substantial.
Offences related to the trafficking of illicit drugs (£10.7 billion),
organised fraud (£8.9 billion) and acquisitive crime (£1.8 billion) are
reported to be the largest sources of criminal revenue [1].With actual
costs likely to be even greater (as such estimates are only based on
data from recorded crimes), developing strategies that are able to
prevent or aid in the investigation of these offences is a significant
priority of the forensic science community.
Among the number of products made commercially available for
the purpose of reducing criminal activity, forensic taggants may be
seen as one of the most successfully employed. Taggant materials
have been widely accepted for use as evidence within the UK court
system since 2008, with certain marking agents having aided in the
conviction of over one thousand criminal offenders since that time.
Based on statistics published by the Metropolitan Police Service,
household burglary across London was decreased by nearly 30% in
areas where forensic taggants were applied (i.e. SmartWater®).
Taggants are a class of materials that can be applied to or incorpo-
rated within an object in order to make it identifiable [2]. This is
achieved by producing each ‘batch’ of taggant in an entirely unique
formulation, allowing the particular molecular composition to be
registered against a specific piece of information. Once recovered
at a later date, this composition can be analysed in order to reveal
the identity of the taggant and thus, the object it is marking [3].
A forensic taggant displaying entirely ideal characteristics should
be of low cost to produce, have high coding capacity, be non-toxic
to individuals and the surrounding environment, be simplistic and
inexpensive to detect and analyse via non-destructive means
and be of a complex enough nature to prevent duplication. The
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majority of taggant manufacturers claim that their products are ver-
satile enough to be applied in a broad range of circumstances.
However, forensic marking materials are most extensively utilised
for four distinct purposes (Fig. 1):
• Propertymarking – Taggants may be applied upon valuable items
such as vehicles and electronics in order to associate them with
a specific owner. If that property becomes subject to theft but
is later recovered, it may be returned to the original purchaser
[4, 5]. Property taggants are usually invisible to the naked eye
in order to prevent spoiling the item’s aesthetic or to avoid de-
tection by offenders.
• Anti-counterfeiting – Industries at risk of counterfeiting activi-
ties (pharmaceuticals, clothing, currency, etc.) may choose to
incorporate taggants into their products to distinguish them from
potential forgeries [6]. Marking agents used for this applica-
tion are typically non-visible and have replaced traditional
barcoding and hologram anti-counterfeit technologies, which are
more easily duplicated [7].
• Tracking – Materials used in the manufacture of hazardous or
potentially illegal products may be tagged by law enforcement
agencies to aid detection or track initial origin. Such marking
agents are predominantly applied during the production of in-
dustrial explosives that are susceptible to illicit use [8]. Robust
taggants able to survive detonation may be detected to reveal
information regarding type of explosive, supplier or batch ID.
Taggants may also be covertly added to bulk volumes of illegal
narcotics, allowing their distribution to be monitored [9].
• Monitoring – Taggants may be placed on exterior surfaces of
houses, commercial properties or objects of value. As a result
of criminal activity (such as trespassing or out-of-hours burgla-
ry), these taggants may be transferred to an individual, providing
strong physical evidence to associate themwith that offence [10].
Additional information of the suspect’s subsequent activity can
also be gained if the taggant undergoes a secondary object-to-
person-to-object transfer.
The physical characteristics of a taggant will depend largely upon
which of these four purposes it is being used for (Fig. 2). For example,
markers utilised to stain currency stolen during a CViT (Cash-and-
valuables-in-transit) robbery should remain permanent after
application and should not be easily removed [5]. Conversely, a fo-
rensic coating applied to firearms and cartridge casings in an attempt
to establish handling, should be designed to be as transferrable as
possible [11]. The range of taggant formulations is therefore ex-
tensive. Markers may be dispersed within a medium such as grease,
paint or ink, sprayed via aerosol, applied directly as a powder or
embedded into materials during manufacturing processes [12].
Taggants designed to be covertly applied (in order to avoid de-
struction or discovery by offenders) may also include an additional
component to allow detection at a later time point. Being invisi-
ble to the naked eye, these taggants require localization in order
to be successfully recovered for analysis. This is most often achieved
by adding fluorescent compounds to the taggant, which will then
emit light when excited at certain wavelengths of the UV or visible
spectrum [13]. Other detectionmethods involve the inclusion of vol-
atile chemicals for vapour identification [14] or radioactive isotopes
[3].
While these detection constituents may not always be re-
quired within a taggant, all forensic markers will include a main
‘coding’ element in order to infer a required statistical unique-
ness. By creating a formulation that is unable to be duplicated, a
taggant may effectively ‘store’ information regarding the object it
is marking [13].
As the success of a taggant will be largely influenced by the ability
of this code to be recovered and analysed, all marker codingmethods
produced within the UK are subject to validation by the British Stan-
dards Institution (BSI) under Publicly Available Specification
820:2012 (PAS 820:2012). In this process, taggants are exposed to
a number of accelerated UV light, temperature and humidity con-
ditions in order to simulate the longevity of coding materials within
a variety of circumstances.
Despite the extensive commercialisation of taggant technology
(Table 1), detailed information regarding the synthesis and manu-
facturing procedures of such marking agents is extremely limited
within academic literature. Whilst publishing such protocols within
the public domain may result in a decrease in taggant efficiency (by
allowing offenders to become familiar with such materials), it is still
pertinent to conduct a thorough exploration into the different en-
coding methods used in commercially established forensic marking
agents (Fig. 3). This critical review therefore attempts to examine
these coding mechanisms, as well as explore recent research that
may indicate how forensic taggant technology is likely to progress
within the near future.
2. Current technology
2.1. Physical taggants
Renowned for being one of the earliest existing forensic marking
materials; physical taggants possess coding systems that are based
on the simple morphological properties of their components. These
Fig. 1. The four main applications utilising forensic taggants.
Fig. 2. Forensic taggants may include different components (i.e. code, dye and
material/medium), which can determine its physical characteristics.
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taggants are generally made unique by exploiting solid particles of
a specific size, appearance or structural arrangement [29]. Such en-
coding mechanisms may also be described as ‘graphical’, as analysis
is usually achieved by basic visual methods such as low-power mi-
croscopy [13].
One coding element commonly used in physical taggants is the
microdot, a small polymer disc between 2–1000 μm in size con-
tainingminute photographic information. Text or images etched onto
microdots are usually too small to be observed by the naked eye
alone but may be revealed upon optical magnification [30]. Al-
though initially developed as a covert means of transferring data
during World War II, companies such as DataDot and Microtrace
have taken advantage of microdot technology by including them in
a number of ink and varnish based suspensions [3]. The dots within
these suspensions are then able to act as simplistic tagging mecha-
nisms by being imprinted with a unique numeric code, which is then
registered against a particular owner on an electronic database [16].
Another physical tagging approach pioneered in the 1970’s by
the US company 3M, focuses on the use of small plastic particles,
constructed using a number of different proprietary coloured ma-
terials. These materials are combined in a sequence of layers, the
order of which will be specific to each formulation of taggant pro-
duced [17]. A visual inspection of the layers is then reveals the
identity of the marker and the batch from which it originated. The
robust nature of the materials used in layer construction has re-
sulted in these particles becoming a predominant tagging agent for
the identification of post-detonation explosive materials [31].
However, in a number of circumstances the utilisation of phys-
ical type taggants may be considered disadvantageous. Marking
agents based on graphical identification strategies will generally have
very little ‘space’ in which coding can take place [2]. This conse-
quently limits the amount of statistically unique particles (and thus
taggant formulations) that may be produced. Applications such as
property marking, which necessitate a continuous stream of dis-
tinct codes, may benefit better from the use of molecular-based
tagging agents, which have a higher coding capacity. Other draw-
backs include the easy observability of physical taggants due to the
relatively large size of incorporated solid particles, limiting their use
within covert situations [12].
2.2. Spectroscopic taggants
In spectroscopic taggants, a number of molecules possessing dif-
fering optical qualities are combined together to create a single
mixture with a spectrally unique signature. These taggants utilise
multi-component encoding strategies, achieving their individual-
ity from a precise combination of different emission wavelengths
or intensities [13]. However, in certain taggant designs, these op-
tically distinct molecules may be enclosed together within solid
particles (to increase taggant stability or simplify analysis) and may
thus be described as single-component systems [32]. Determin-
ing the identity of these marking agents is usually performed via
the analysis of overall emission signature by simple spectropho-
tometry techniques.
The materials most often utilised within spectroscopic taggants
are simple non-toxic organic dyes that fluoresce in different regions
of the visible spectrum [33]. Companies such as Luminex and Spectra
Systems manufacture a number of marking agents based on the in-
tegration of several cyanine, phthalocyanine or squaraine-based
fluorophores [19, 21]. The low cost and wide availability of organic
dyes ensures that the production of spectroscopic markers remains
inexpensive, but may also result in the illegal reproduction of
taggants themselves if fluorophores are recognised and acquired by
counterfeiters [7]. Organic dyes are also disadvantaged by broad spec-
tral emission overlaps, short fluorescence lifetimes and sensitivity
to photobleaching [12].
Industrial and academic research has attempted to overcome
these challenges by developing spectroscopic taggants that include
more sophisticated optical components. Guillo et al. recently re-
ported the development and commercialisation of a large array of
spectroscopic coding materials based on non-toxic lanthanide ion
complexes [34]. The unique temporal and spectral characteristics
associated with these complexes are considered extremely diffi-
cult to duplicate by materials available to forgers, which may
significantly deter potential attempts at taggant duplication. The
narrow emission bands of rare-earth materials may also serve to
increase the discriminatory power of a taggant by allowing more
optically distinct components to be added to amarker without spec-
tral overlap [13]. As the number of existing lanthanide elements is
Table 1
Commercially available forensic taggants
Coding Type Manufacturers Taggants Produced Analysis Method Uses
Physical Alpha•Dot Alpha•Dot [15] Optical microscopy Property marking, vehicle marking
DataDot DataDots® [16] Optical microscopy Property marking, anti-counterfeiting
Microtrace Microtaggant® [17] Optical microscopy Anti-counterfeiting, explosives detection
Spectroscopic DNA Technologies SmartDye™[18] Spectrofluorometry Anti-counterfeiting
Luminex MagPlex® spheres [19] Flow Cytometry Anti-counterfeiting, biological labeling
Microtrace Spectral Taggant™ [20] Spectrofluorometry Currency marking, security printing
Spectra Systems SpectraFluor™ [21] Spectrofluorometry Currency marking, product tracking
Chemical Authentix Authentix [22] Immunoassay, GC-MS Fuel Adulteration, anti-counterfeiting
SmartWater SmartWater® [4] LA-ICP-MS Property Marking, activity monitoring
Polysecure Brandproof® [23] XRF spectroscopy Anti-counterfeiting
DNA Applied DNA Sciences SigNature® [24] DNA sequencing Property marking, anti-counterfeiting, CViT
DataDot dDotDNA® [25] DNA sizing analysis Property marking, anti-counterfeiting
DNA Technologies DNA Matrix™ [26] DNA sequencing Anti-counterfeiting
SelectaMark SelectaDNA® [27] DNA sequencing Property marking, activity monitoring
TraceTag CypherMark™ [28] DNA sequencing Property marking, anti-counterfeiting
Fig. 3. Code uniqueness provided by differences in: a) physical characteristics (i.e.
multiple coloured layer particles); b) optical spectra; c) chemical composition; d)
DNA sequences.
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limited, varying the emission intensity ratios as well as the wave-
lengths of rare-earth materials is often used to further increase this
statistical discrimination.
2.3. Chemical taggants
Much like spectroscopic markers, inorganic taggants rely on a
multiplex of molecules within a specific combination to infer iden-
tity. However, instead of optical signature detection, chemical
encoding is achieved from a fixed set of trace materials, which may
be either present or absent from a mixture [35]. Each of these ma-
terials is tested for on an individual basis, essentially creating a form
of ‘binary string’ data in which each position of the string repre-
sents a different compound. The presence of a particular trace may
be indicated by a “1” in that position of the string, whilst its absence
may be denoted by a “0” [36]. Taggant identity is determined by
the comparison of binary sequence data generated from trace anal-
ysis with a list of strings registered on a database.
The UK’s largest manufacturer of forensic marking technology
SmartWater, bases the majority of their commercially available re-
agents on this premise. In these taggants rare-earth lanthanides are
also utilised but are identified by their individual mass through laser
ablation inductively coupled plasma mass spectrometry (LA-ICP-
MS) rather than fluorescence emission [4]. Amethod of using isotopic
materials as chemical encoding components for the authentica-
tion of fuels, consumer products and agrochemicals has also been
developed by U.S. firm Authentix. These trace elements usually
consist of deuterated organic or inorganic compounds that are then
detected by either gas-chromatography mass spectrometry (GC-
MS) or multiplex immunoassay systems [22, 37]. The increased
sensitivity of chemical analysis methods over spectroscopic tech-
niques allows coding materials to be included at much lower
quantities (as little as parts per billion) than other taggant types.
This is turn prevents the physical properties of a marker from being
altered (unlike those containing large insoluble particles, whichmay
appear more ‘granular’ in nature) and may thus lower the risk of
unwanted detection.
Once again, these taggant classes are not without limitations.
Binary string data can be compromised if one or more compo-
nents within a mixture is removed or destroyed, or if extraneous
material are added (for example, by accidental mixing of two dif-
ferent taggant formulations) [35]. Chemical multi-component
encoding may also not be compatible with highly transferrable
marking agents as the different underlying chemical structures of
tracing elementsmay cause them to be transferred at dissimilar rates,
leading to incomplete recovery and subsequent erroneous
identification.
2.4. DNA taggants
Discovered in the early 1950’s as the foundation of informa-
tion storage for all known life forms, the immense coding ability
of deoxyribonucleic acid (DNA) has been recognised for a consid-
erably long period [38]. Since that time, a range of methods have
been developed for the storage of non-genetic data within DNAmol-
ecules [13]. As a result, manufacturers such as Selectamark Security
Systems [27], TraceTag [28] and Applied DNA Sciences [24] now
produce forensic marking agents that can infer identity via the use
of unique oligonucleotide sequences. Such sequences may be nat-
urally occurring, entirely synthetic or a combination of both (e.g.
botanical DNA shuffled into a random arrangement) [39]. The order
of single nucleotide units comprising a sequence will be individu-
al to each formulation of taggant produced, allowing separate batches
to be distinguished.
The benefits of near-unlimited coding capacity, straightfor-
ward synthesis and low toxicity of genetic material have ensured
that DNA taggants are one of the most prevalent forms of forensic
marking agents commercially available. However, challenges re-
garding the application of DNA-based tagging approaches are
twofold. Sequencing techniques employed for the analysis of oli-
gonucleotides are typically more cost, reagent and labour-intensive
than methods used to identify other types of taggant coding com-
ponents [40]. As the genetic material recovered from a taggant also
requires amplification by the polymerase chain reaction (PCR) prior
to testing, this method of analysis can be especially expensive [2].
Furthermore, DNA is a relatively sensitive molecule and can
degrade under the normal temperature, oxidation, radiation and
chemical and enzymatic activity levels associated with ambient en-
vironmental conditions [41, 42].While DNA damages caused by these
stresses may be repaired by a number of processes within living
organisms, the same cannot be said of the synthetic oligonucle-
otides included within forensic taggants. Concerns have therefore
been raised over the general stability of DNA-based tagging mate-
rials and the subsequent compromise of genetic coding sequences
[2, 13, 43]. However, encapsulation of nucleotides within silica
microbeads [44] or plant materials [45] may be carried out in order
to protect against this potential degradation.
3. Future perspectives
Each of the commercially available taggant mechanisms in-
cluded within this review displays a distinct set of strengths and
weaknesses, either in terms of coding capacity, covert usage, overall
stability or method of analysis (Table 2). These disadvantages cur-
rently prevent a single taggant type from being used as a universal
product identification system, necessitating the application of sep-
arate marking methods for different purposes [3]. However, it must
also be noted that major practical innovations in the fields of nano-
technology, material science and analytical instrument portability
have occurred since the scientific technologies behind these coding
mechanisms were established. These advances are now being ex-
ploited by a number of research groups in an attempt to develop
forensic tagging reagents that can identify any object, regardless of
situation or circumstance.
Much of the research surrounding the design of globally appli-
cable marking systems has focused on the use of nanomaterial-
based encoding strategies. Nanoscale particles, wires and tubes all
show great potential as next generation tagging mechanisms due
to their small size (preventing detection and the physical alter-
ation of marker properties), range of potential analysis methods and
ease of formulation within traditional marking reagent media [12].
Semi-conductive quantum dot nanoparticles are currently being
utilised to create spectroscopic taggants with optical qualities su-
perior to those employing organic dyes or lanthanide ion complexes
[46]. With narrow emission wavelengths, colour-tuneable signals
and environmental-independent fluorescence properties, quantum
dots may represent an excellent opportunity to improve the multi-
component spectral encoding mechanisms presently utilised by
Table 2
Summary of the advantages and disadvantages of commercially available forensic
taggants
Coding Type Advantages Disadvantages
Physical Simplistic analysis Limited coding capacity
Inexpensive Less covert
Spectroscopic Simplistic analysis Subject to counterfeiting
Inexpensive Limited coding capacity
Chemical Analysis sensitivity Prone to misidentification
More covert Incomplete recovery
DNA High coding capacity Expensive analysis
Low toxicity Possible degradation
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spectroscopic taggants [13, 47]. Commercialisation of this technol-
ogy may have been hindered by the relative cytotoxicity of metal
ions used in the synthesis of quantum dot particles [48]. Efforts to
reduce these potential damages to human health and the surround-
ing environment are currently underway through the development
of heavy metal-free quantum dots [49].
However, there has been debate over whether fluorescent mol-
ecules should be included within tagging materials at all, as many
offenders are now familiar with optical anti-counterfeit methods
and are able to identify markers with obvious visible emissions [12].
In an attempt to resolve this issue, a number of taggants have re-
cently been produced that can only be analysed via the use of Raman
spectroscopy [50, 51]. Much like other forms of spectroscopic coding
mechanisms, these reagents comprise compounds mixed in a spe-
cific combination to produce a unique spectral fingerprint (which
in this case, is generated through the inelastic scattering of mono-
chromatic laser light). The main advantage of this method is that
Raman spectroscopy may also be used for the initial detection of
tagging materials as well as identification, avoiding the require-
ment of additional tracing components that may result in unwanted
discovery [12]. The sensitivity of such detection may also be greatly
increased through the phenomenon of surface enhanced Raman scat-
tering (SERS) by the direct conjugation of Raman-active compounds
to a number of metallic nanoparticles [52].
Another coding technique designed by Duong et al. utilises the
properties of nanomaterials beyond fluorescence involves deriv-
ing the individual melting-temperatures of a panel of solid particles
within a taggant mixture to provide it with an unique thermal
barcode [2]. The presence or absence of these so called ‘phase-
change’ nanoparticles within a taggant is assessed using differential
scanning calorimetry (DSC) in a linear thermal scan, which gener-
ates a specific melting-point peak for each component [7]. However,
only a limited selection of nanoparticles has currently been devel-
oped for this purpose [53]. It is likely that this number will have
to be increased in order for this system to possess the level of sta-
tistical differentiation required from a universal tagging system.
Aside from nanoparticle-based encoding methods, recent de-
velopments in novel tagging technology have also been achieved
by the use of synthetic polypeptide sequences [54]. The principle
of inferring identity through the unique order of successive amino
acids has been theorised since the early 1980’s [55]. However, only
within the last year have methods been realised for their practical
application and analysis within forensicmarkingmaterials [56]. Fig. 4
demonstrates this process, in which an oil-based medium contain-
ing hydrophilic peptide molecules is first applied onto the surface
of an object. As a result of handling during criminal activity, this
reagent is transferred to an individual, associating them with the
offence. Detection by added fluorescence tracers is performed to
permit recovery of the taggant by targeted swabbing. Hydrophilic
peptides may be then isolated from the medium by simple liquid-
liquid extraction, allowing their mass (and therefore sequence) to
be determined by electrospray ionisation mass spectrometry
(ESI-MS).
As an alternative form of single-component biomolecular coding,
peptide taggants possess a number of advantages over current com-
mercially available DNA-based marking systems. The statistical
coding capacity of polypeptide chains is significantly greater than
that of oligonucleotides, owing to the 22 different natural amino
acids that may be used as individual sequence units (compared to
the four bases possessed by DNA) [57]. Kydd reports that a string
of 10 random amino acids can code up to 4 × 1013 unique se-
quences [55]. ESI-MSmethods are also quicker than DNA sequencing
(with processes from detection to analysis able to be completed in
less than one hour) and are becoming increasingly more portable,
which could allow the point-of-care testing of peptide tagging re-
agents. Peptides are additionally easy to produce at low cost, are
environmentally harmless and relatively inert (with stability being
further increased by simple chemical modifications) [57].
4. Conclusions
By authenticating objects, deterring theft and monitoring illegal
activity, forensic taggants continue to play a pivotal role in the re-
duction of criminal enterprise. This review has attempted to highlight
the significant abilities of tagging materials to infer identity in an
enormous range of products, as well as document the most prom-
inent commercially available coding mechanisms used for achieving
this aim.
Whilst it is quite clear that none of the commercial marking
methods available currently possess every single one of the quali-
ties demanded of a universally applicable forensic taggant, the recent
research covered within this article demonstrates that concerted
efforts towards taggant improvement are occurring.
The myriad of surfaces, environments and time-frames in which
a taggant may be applied makes the technical innovation and val-
idation of forensic marking materials relatively challenging. Only
through continuing advances in material science, nanotechnology
and instrumental analysis, can steps be made towards the devel-
opment of a single versatile platform for object identification. It is
hoped that this review will encourage researchers working within
the field of analytical chemistry to take interest in taggant tech-
nology and engage with this development in order tomake universal
marking systems a reality.
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a b s t r a c t
Forensic investigators are often faced with the challenge of forming a logical association between a
suspect, object or location and a particular crime. This article documents the development of a novel
reagent that may be used to establish evidence of physical contact between items and individuals as a
result of criminal activity. Consisting of a fluorescent compound suspended within an oil-based medium,
this reagent utilises the addition of short customisable peptide molecules of a specific known sequence
as unique owner-registered ‘codes’. This product may be applied onto goods or premises of criminal
interest and subsequently transferred onto objects that contact target surfaces. Visualisation of the re-
agent is then achieved via fluorophore excitation, subsequently allowing rapid peptide recovery and
analysis. Simple liquid–liquid extraction methods were devised to rapidly isolate the peptide from other
reagent components prior to analysis by ESI–MS.
& 2015 Elsevier B.V. All rights reserved.
1. Introduction
The Home Office estimates that billions of pounds in social and
economic costs arise every year as a direct result of organised
criminal activity within the UK [1], the majority of which may be
attributed to physical crimes, including significant theft and drug
trafficking offences. Consequently the reduction of this activity
remains a high priority for the UK government and its criminal
investigators. This has been recently reflected by the growing
number of commercially available forensic ‘taggants’, chemical
reagents which may be applied to a particular surface in order to
monitor items of criminal interest or associated activity [2,3].
These products, usually consisting of a coloured compound mixed
within an oil-based medium, are easily transferred onto persons or
objects that come into contact with marked surfaces. The sub-
sequent detection of these compounds may then be used to form a
logical association between an individual and the object in ques-
tion, providing strong evidence of criminal intent. For ‘covert’
operations, in which indication of transfer should remain hidden
from the offender, coloured materials may be replaced by fluor-
escent ones, the presence of which is only revealed through ex-
citation with specialist light sources [4]. For example, the US based
company Sirchie has developed several visible and fluorescent
transferrable products designed for home and business owners to
protect their property from trespassers and to mark valuable
goods that are likely to be the subject of theft. However, the dis-
advantage of such products is that they are comprised of a single
standard formulation and cannot be used to differentiate the
source of two separate objects on which the same medium has
been applied, thereby limiting investigative potential.
Others have sought to address this problem by inserting a
unique ‘code’ within the medium itself, which may be traced back
to the original owner upon analysis. Many of the UV–vis emitting
products developed by Cleary [5] contain a mixture of trace metals
and organic moieties, with coding achieved by the unique com-
bination in which the materials are present. Subsequent analysis of
reagent samples recovered from individuals or stolen goods may
then be able to determine the address to which that particular
elemental composition is registered. However, the disadvantage of
using a large variety of compounds within a single formulation is
twofold; first that differences in chemical structure will cause
molecules to be transferred at different rates. An incomplete or
erroneous code may therefore be given in cases in which only
trace amounts of medium are recovered that may not contain a full
range of materials added to the formulation. This is further de-
pendant on the type of surface on which the medium has been
applied, making the estimation of transfer unpredictable. Fur-
thermore, the relative stability of each molecule is also governed
by these same structural differences, which will be different for
each additive. Incorrect codes may once again be given if certain
compounds break down prior to recovery and analysis. This would
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be especially pertinent in scenarios where media have been ap-
plied on a long-term basis.
In recent years, Brown and Reichert [6] have made attempts to
avoid using a coding system based upon multiple identifying ad-
ditives by synthesising a number products that contain a unique
synthetic DNA sequence. Despite negating differential transfer
rates by using a single molecular identification system, the labile
nature of DNA in exposed environmental conditions is well
documented [7,8], making overall reagent stability a cause of
concern. Moreover, sequencing DNA to determine its associated
address can be expensive and time consuming, requiring trained
personnel and large-size laboratory based instrumentation, as well
as specific procedures for sample collection and preservation. This
also applies to DNA synthesis itself, in which pure sequences are
difficult to achieve in a high yield [9]. Although circumvention of
this issue may be achieved through the PCR amplification of low
amounts of starting material, extensive extraction procedures are
likely to be required in order to remove any additional materials
that may cause downstream inhibition.
We therefore present the development of a novel reagent used
to establish evidence of contact transfer in order to provide a more
robust method of monitoring items associated with criminal ac-
tivity. The proposed reagent, like those previously described, is
comprised of a fluorescent compound dispersed within an oil-
based medium that is transferred to an offender or object that
comes into contact with a marked surface. However, this reagent
employs an innovative single molecule coding system based on
the addition of a unique synthetic peptide. This peptide, made up
of a short known sequence of amino acids, is specific to every
formulation of the reagent produced, allowing its registration to
an individual or address. Once transferred as a result of criminal
activity, this product may be visualised by excitation with a spe-
cialist light source to produce fluorescence.
Unlike other DNA based coding systems, peptides can be iso-
lated from the rest of the reagent components via a simpler liquid–
liquid workup procedure. Analysis of the sequence may then be
rapidly achieved via standard Electrospray Ionisation Mass Spec-
trometry, with each peptide generating a specific m/z ratio that
can be used to determine its identity (Fig. 1). Such analysis affords
significant advantages over time-consuming and costly DNA se-
quencing processes. Amino acids are also amenable to a wide array
of structural modifications [10], which can either be used to fur-
ther increase stability or increase the exclusivity of a coded
sequence.
There are numerous potential applications for this reagent. In
addition to linking a person to a target surface via primary transfer
(i.e. surface-to-person), it may also be possible to deduce their
subsequent activity by tracking secondary transfer (i.e. surface-to-
person-to-object). For example, if a person handles a specific item
(i.e. a package or document) after coming into contact with the
reagent, it may be possible to also link them to that item through
secondary transfer.
This study focuses on the reagent design and investigating
optimum conditions for its successful detection and analysis. The
in-field stability of the final reagent was also monitored over a six-
week period via application to a number of surfaces routinely
encountered within forensic casework.
2. Materials and methods
2.1. Medium selection
Glycerol (Sigma Aldrich, UK), castor oil (Holland and Barrett,
UK), a mixed hydrocarbon formulation (MHF) (Vaseline, UK) and a
lithium-based lubricant (Comma, US) were spread evenly in
100 mg amounts on 2.5 cm2 areas of aluminium foil, ceramic,
plastic and glass. Surfaces were contacted after 24 h with a white
vinyl gloved index finger at a standardised force of 30 g. A brief
qualitative visual examination was used to establish the two
media displaying greatest transfer. A quantitative indication of
MHF and lubricant transference was achieved through the process
described above but with surfaces weighed before and after con-
tact to calculate deposited media.
2.2. Peptide synthesis
Peptide Ac-HSSKL was manually synthesised by Fmoc-Solid
Phase Peptide Synthesis using 2-chlorotritylchloride resin (Sigma
Aldrich, UK), which was swollen in dichloromethane (DCM) for
10 min prior to coupling. Acylation steps were conducted using six
equivalents of FMOC amino acids, pre-activated with N,N′-diiso-
propylcarbodiimide (DIPCDI) and ethyl (hydroxyimino)cyanoace-
tate (oxyma) in anhydrous N,N-dimethylmethanamide (DMF).
Coupling reactions were conducted for 1 h and monitored by the
picrylsulphonic acid test. FMOC deprotection of coupled amino
acids was achieved by treatment with 20% (v/v) piperidine in DMF
for 10 min and confirmed by the picrylsulfonic acid test. Impurities
and excess reagents were removed by washing at each stage with
DMF, methanol and dichloromethane. Capping acetylation was
performed by the addition of ten equivalents of acetic anhydride
and twenty equivalents of N,N-diisopropylethylamine (DIPEA) in
DMF. Resin cleavage was achieved through treatment with a
95:0.5:0.5:0.5:0.25 solution of trifluoroacetic acid (TFA): water:
phenol: thioanisole (TA): triisopropylsilane (TIPS) for 3 h at room
temperature. Next, the filtrate was concentrated under nitrogen at
Fig. 1. Demonstration of peptide recovery and analysis: (a) the reagent is visualised through wavelength excitation, (b) the collected medium undergoes liquid–liquid
extraction to isolate coding peptide, and (c) peptides are analysed and unique m/z value generated to identify sequence.
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40 °C. Ice cold diethyl ether was added to precipitate peptides
which were washed several times with diethyl ether, dissolved in
50% acetonitrile in water containing 0.1% TFA and finally freeze-
dried for 24 h. The purity and correct mass of the final peptides
were confirmed by analytical reverse-phase high-performance li-
quid chromatography (RP-HPLC) and ESI–MS, respectively. All
peptide synthesis reagents were purchased from Bachem, UK and
used as received.
2.3. Peptide concentration selection
Synthesised peptide in 1 mg, 2.5 mg and 5 mg quantities was
mixed into 100 mg of MHF, which was subsequently spread evenly
on a 2.5 cm2 area of a glass microscope slide. Slides were contacted
with a gloved finger as previously described (refer to the Medium
Selection section). Portions of gloves containing transferred media
were removed and placed in a 2 ml Eppendorf tube. A liquid–li-
quid extraction to isolate the peptide for analysis was performed
through the addition of 1 ml hexane and 0.5 ml distilled water.
Samples were vortexed and glove fragments removed before
centrifugation at 13,000 rpm for two minutes. Aqueous phases
were placed into a fresh tube. The original sample was then fur-
ther extracted with an additional 0.5 ml of distilled water. Both
aqueous layers were combined before undergoing counter ex-
traction with 1 ml of hexane. After removal of hexane layer, formic
acid was added to the aqueous phase at a final concentration of
0.1% v/v prior to ESI–MS analysis using a Waters ZQ micromass
2000 mass spectrometer.
2.4. Fluorophore studies
Rhodamine 110 (Sigma Aldrich, UK) and 7-amino-4-tri-
fluoromethylcoumarin (AFC) (Santa Cruz Biotechnology, US)
fluorophores were reconstituted in methanol to concentrations of
10 mg/mL, 1 mg/mL and 0.1 mg/mL. 50 ml of each fluorophore
concentration was added to 100 mg of MHF and mixed thoroughly
before being spread evenly on a 2.5 cm2 area of a glass microscope
slide. Samples were visualized in the dark using an Olympus
SZX12 fluorescence microscope (Tokyo, Japan) and photographed
with an internal CCD camera. Photostability of both fluorophore-
containing media was monitored once a week over a six week
period. Lastly, 50 ml of 0.1 mg/mL rhodamine solution was added to
100 mg of peptide-mixed media before extraction and ESI–MS
analysis.
2.5. Stability studies
40 mg of peptide-mixed medium was applied to surfaces of
aluminium foil, ceramic, plastic and glass, cotton, polyester, leather
and denim. Liquid–liquid extractions were performed as pre-
viously described in order to isolate peptides for ESI–MS analysis.
Extractions were performed from each surface once a week for a
period of six weeks.
3. Results and discussion
3.1. Transferability studies
The initial priority of every forensic taggant reagent design is
the selection of an appropriate medium in which fluorophore and
coding additives are dispersed. It is crucial that the medium
transfers well by itself so that identification components carried
within it will be of a high enough concentration for subsequent
analysis. Additionally, media should not dry out, allowing them to
be applied over extended periods of time, as well as transparent,
to avoid detection within covert investigation.
Glycerol, castor oil, MHF and a lithium-based lubricant were
chosen to be investigated as potential media due to their low
volatility, odourless and colourless properties. Each medium was
applied to four surfaces that are often encountered within forensic
casework (i.e. plastic, ceramic, glass and metal) before being
contacted with a gloved finger after a period of 24 h (ESI Fig. S1).
This was carried out to ensure that the final reagent is able to
operate efficiently in a range of environments where it is likely to
be applied.
Both castor oil and glycerol samples showed significant de-
creases in transfer after a 24 h time period, which was especially
evident in samples taken from the glass and metal surfaces. This
may be due to the fact that both substances are known to undergo
a high degree of hydrogen bonding [11,12]. Whilst theoretically
the high viscosity caused by this bonding should allow for greater
transfer, it is possible that the extensive intermolecular interaction
also caused molecules to aggregate, leading to a more uneven
transfer. In contrast, both semi-solid MHF and lubricant media
showed greatest and most consistent transferability over time,
likely benefiting from fixed molecular arrangements. These sub-
stances were therefore taken forward for further quantitative in-
dication of transfer efficiency, in which the average percentage of
media transferred was calculated by recording of surface weight
before and after contact (Fig. 2).
Quantitative studies confirmed transfer efficiency in both semi-
solid media. Whilst a two-way ANOVA test determined transfer
rates between lubricant and MHF were not statistically significant
(P-value¼0.178309), a slightly higher percentage transfer on
average across the majority of surfaces selected MHF as the basis
for further reagent development. Whilst the use of a gloved finger
allowed us to conduct this study within the remit of existing
ethical approval, further studies are currently in progress to assess
this transfer via skin contact.
3.2. Peptide sequence selection
With non-polar hydrocarbon-based MHF chosen as the basis
for this reagent, use of a hydrophilic peptide coding sequence
would allow for its rapid isolation via a simple liquid–liquid ex-
traction. Amino acid sequence HSSKL was therefore synthesised
after GenScript peptide property calculator analysis determined its
suitable hydrophilicty through the inclusion of histidine and lysine
residues. N-terminal acetylation was also performed to enhance
peptide solubility during extraction. This peptide length was
Fig. 2. Quantitative analysis of MHF and lubricant transfer rates from forensically
relevant surfaces through touch contact (error bars represents standard deviation
between replicates).
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chosen such that synthesis would be rapid and inexpensive, while
allowing enough variability to ensure unique coding. Additionally,
a search of the RCSB Protein Databank yielded no results for this
sequence, thus reducing the risk of generating false positive results
from naturally occurring peptides.
RP-HPLC analysis was performed to cheque for peptide purity
(data not shown) and an analysis via ESI–MS was conducted to
confirm that the desired product had been obtained (Fig. 3). Ex-
traction protocols were subsequently devised with hexane and
distilled water selected to isolate the peptide in an aqueous phase
and separate the remainder of the non-polar medium prior to
further analysis.
3.3. Peptide concentration selection
With competing interests in designing a reagent that allows for
maximum sequence detectability, whilst simultaneously being
inexpensive to produce, it is crucial to determine the most suitable
concentration of peptide required for successful MS analysis. After
confirming identity, 5 mg of synthesised peptide was mixed into
MHF (100 mg) and spread on glass slides. Liquid–liquid extraction
was conducted on the traces of reagent obtained from primary
transfer onto a glove, and the extract was analysed via ESI–MS. All
samples and replicates generated positive results with peptides
still remaining easily detectable in concentrations reduced to
2.5 mg and even 1 mg (ESI, Fig. S2). Based on the results obtained
in the transferability studies, following liquid–liquid extraction an
aqueous solution of the peptide at a concentration of 150 mg/ml
(corresponding to the lowest amount of peptide employed in the
present study) was used for the ESI–MS analysis. Our research
group is currently engaged in establishing the lowest amount of
peptide that may be added to a reagent in which full detection
may be achieved. This is focusing on the application of High Re-
solution Mass spectrometry, which, in many cases, has detected a
number of similar peptides to a fentomolar concentration [13].
3.4. Fluorophore studies
Ideally, fluorophores incorporated into forensic taggants should
allow for easy visualisation as well as an increased resistance to
exposed environmental conditions. Rhodamine 110 and AFC, both
noted for their fluorescence lifetimes, quantum yield and photo-
stability [14,15] were therefore investigated as additives for the
overall visualisation of the reagent upon transfer. In this study,
fluorophores were added independent to peptide concentration to
provide end users with more flexibility over how the reagent is
applied.
Both fluorophores were mixed into MHF as stock solutions
starting at 10 mg/ml concentrations. While all samples displayed
an intense emission under appropriate fluorescence microscopy
filtration (ESI, Fig. S3), unexcited formulations still exhibited an
obvious visual colouration inappropriate for marking surfaces
within a covert scenario. Thus, both solutions were diluted to a
concentration of 0.1 mg/ml in which no colour was observed un-
der visible light but fluorescence remained highly detectable. This
fluorescence was qualitatively monitored over a period of six
weeks and was found to remain detectable.
With appropriate fluorophore concentrations established,
Rhodamine 110 was added to a sample of peptide-mixed media to
test final reagent performance, before being successfully extracted
and analysed by ESI–MS as previously described (ESI, Fig. S4).
Rhodamine is consequently present in the final mass spectrum
due to its affinity for the analysed aqueous extraction phase. As an
identical fluorophore is added to every formulation of reagent
produced, rhodamine presence will not add value to the unique
coding system provided by the peptide. However, the detection of
a water-soluble fluorophore may infer added confidence that a
successful extraction has taken place. Whilst advantageous stabi-
lity and emission properties selected Rhodamine-110 for use
within the scope of this study, any fluorescent compound ex-
hibiting desirable properties may be used as a replacement de-
tection element, further increasing the versatility of a final reagent
for surface application.
3.5. Stability studies
As the majority of forensic taggants are applied to surfaces for
extensive periods of time, it is important that coding peptides
stored within a reagent remain stable. This is especially pertinent
in those that are left within exposed environmental conditions.
Samples of peptide-mixed medium were therefore applied once
again to aluminium foil, ceramic, plastic and glass, and left without
the application of atmospheric or temperature controls (laboratory
temperature and humidity: 2372 °C, 2575%) for a period of six
weeks before undergoing extraction and analysis at one week in-
tervals. Furthermore, as high coding sequence stability is crucial in
the period between surface contact and reagent recovery, the
same procedure was repeated on cotton, denim, polyester and
leather substrates to simulate typical contact with clothing. All
peptides proved to be detectable over the six week period on all
eight surfaces with no evidence of deterioration (ESI, Fig. S5).
Whilst the scope of this particular study aimed to assess the
possibility of peptide breakdown as a result of time, subsequent
research examining the effect of temperature and moisture upon
reagent persistence is needed to ensure full validation, and is
currently being undertaken by our research group. A larger vali-
dation study will be able to investigate resistance of the regent to
harsh environmental conditions so that the efficiency of the
technique may be fully demonstrated.
4. Conclusion
We have successfully designed and developed a reagent for the
rapid and specific determination of contact transfer arising as a
result of criminal activity. When applied to surfaces this reagent
becomes virtually undetectable to the naked eye, rendering it
particularly useful within covert investigation. A novel two-step
identification system was employed; firstly the area in which the
reagent has been deposited is initially visualised through fluores-
cence excitation, before being subsequently recovered for standard
MS analysis to reveal the identity of a unique registered peptide
sequence. This process offers extremely rapid results compared to
currently available reagents, with recovery, extraction and analysis
Fig. 3. Positive ESI–MS spectrum of synthesised peptide Ac-HSSKL and inset:
peptide structure and calculated m/z ratio 612.32.
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performed in less than two hours. Analysis time is further likely to
be decreased considering continuing advances in portable MS
techniques. Environmental stability of the reagent was also proven
over a six-week period.
Our research group is currently investigating a number of fur-
ther refinements to this reagent, including the use of a combina-
tion of fluorophores which emit at different wavelengths to confer
added discrimination against possible background fluorescence.
This is centred upon the application of compounds emitting in the
IR region of the electromagnetic spectrum which offenders, now
knowledgeable of UV-based marking, would be unable to detect.
While naturally occurring amino acids were used within this
study, investigation has been undertaken to examine the benefits
of incorporating unnatural or modified peptide sequences. This
would not only serve to increase sequence distinctiveness but is
also likely to enhance peptide resistance to hydrolytic enzymes
present in biological fluids [16].
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ABSTRACT: Complementing the demand for effective crime
reduction measures are the increasing availability of
commercial forensic “taggants”, which may be used to
physically mark an object in order to make it uniquely
identifiable. This study explores the use of a novel “peptide
coding” reagents to establish evidence of contact transfer
during criminal activity. The reagent, containing a fluorophore
dispersed within an oil-based medium, also includes a unique
synthetic peptide sequence that acts as a traceable “code” to
identify the origin of the taggant. The reagent is detectable
through its fluorescent properties, which then allows the
peptide to be recovered by swabbing and extracted for
electrospray ionization-mass spectrometry (ESI-MS) analysis
via a simple liquid−liquid extraction procedure. The performance of the reagent in variable conditions that mimic the limits of a
real world use are investigated.
C ontinuing efforts to reduce the substantial costs of crimeon society have in recent years produced a number of
highly effective criminal prevention technologies. The invention
of forensic “taggants” is a successful example of such advances.
Taggants are defined as materials that may act as a means of
physically or chemically marking an item in a way that allows it
to become uniquely identifiable.1 Usually consisting of three
molecular components, taggants will include a “coding”
element (to infer uniqueness in the taggant), a system that
allows the taggant to be visually detected, and a medium where
these molecules are dispersed.
There are largely four forensic purposes for such materials.
The first attempts to combat counterfeiting activities via the
addition of a taggant to products (medicines, bank notes,
official documents, etc.) to signify that they are of a genuine
origin.2 The second aims at marking valuable property
(vehicles, electronic items) to associate them with a particular
owner and discourage theft.3 The third involves the
surreptitious addition of taggants into illicit substances (illegal
drugs, explosives), so that their distribution or use may be
monitored by law enforcement agencies.4 The last comprises
the covert transfer of taggants to individuals during criminal
activity in order to link them to a specific offense (e.g., handling
firearms, trespassing).5 The physical nature of a taggant reagent
will be highly dependent on which of the above purposes it is
required. For example, taggants employed in covert operations
should be invisible to the naked eye, to avoid undesired
detection by the offenders.3 The medium of each taggant will
also vary depending on whether it needs to be easily transferred
to an individual or remain anchored upon the product it is
marking.3 Only the coding element remains largely consistent
across all tagging purposes.
One of the most popular methods to obtain this taggant
coding is through the inclusion of unique DNA markers.
Companies such as Applied DNA Sciences, Obiex, and
SelectaDNA produce taggants containing either botanically
derived or synthetic DNA oligonucleotides. The specific
sequence of these oligonucleotides is then registered to a
particular owner via an internal database.6 When required, the
taggant may be recovered to extract and “match” DNA to the
owner’s information. While DNA taggants have been shown to
decrease the number of Cash and Valuables in Transit (CViT)
offenses,6 limitations in their analysis have been identified. The
extraction, amplification, and sequencing methods employed to
isolate and match DNA are expensive and time-consuming.
Moreover, the labile nature of DNA has raised significant
concerns over the general stability of DNA taggants.7 Research
into the their use in monitoring fuel adulteration determined
that short sequences of DNA within taggants had poor stability
and were often susceptible to erroneous identification.8
Another recently emerging method of encoding focuses on
the use of varying trace elements to identify taggants. Reagents
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produced by the U.K. manufacturer Smartwater contain a
number of rare elements that are combined in unique
formulations, allowing each taggant to be registered against a
specific owner ID. After a reagent is detected (via the use of an
incorporated fluorescent dye), laser ablation-inductively
coupled plasma-mass spectrometry (LA-ICP-MS) is used to
determine the individual formulation of the taggant and the
owner that it is registered to (once again via internal database).1
However, much like DNA-based coding systems, these tracer
taggants are once again limited in their analysis. The use of
multiple elements within a single taggant carries the potential of
the formulation being incompletely recovered, which could
then lead to erroneous identification. This problem stems from
the differing transfer rates and stability of each individual tracer
component, resulting from their chemical differences.
The development of a forensic taggant that is stable and can
be rapidly and completely recovered is therefore critical to
advancing crime reduction. In light of this, our research group
recently suggested a novel “peptide coding” reagent (or peptide
taggant) as an alternative to inefficient taggant analysis
procedures.9 This reagent has been designed to be covert and
transferrable so that it may be used to mark an individual or
object during criminal activity without the knowledge of the
offender. Like the majority of taggants, our reagent comprises
three distinct components. The base medium consists of a
mixed hydrocarbon formulation (MHF) which is easily
transferred to persons or clothing. Detection is achieved by
Rhodamine-110 fluorophores, added in such a concentration as
to make the taggant invisible under normal lighting conditions
but highly fluorescent upon excitation by an appropriate light
source. The specificity of this reagent (and main advantage over
currently available taggants) is derived from the insertion of a
unique peptide, where the amino acid sequence acts as an
identifiable code for that particular taggant. The wide variety of
natural and unnatural amino acids available ensures that the
peptide may be sufficiently individual, without extensive length.
Once the reagent is transferred as a result of criminal activity, it
may be easily and rapidly recovered. First, areas of taggant
presence may be indicated through fluorescence excitation,
allowing complete recovery of the reagent by targeted
swabbing. The peptide may then be isolated from the oil-
based medium and swab via simple liquid−liquid extraction.
The mass-to-charge ratio of the amino acid sequence is then
revealed via electrospray ionization-mass spectrometry (ESI-
MS), identifying the particular taggant.
While developed as an initial proof of concept, this taggant
may have the potential to be used within criminal investigation
to establish evidence of primary (object-to-person) and
possibly even secondary (object-to-person-to-object) contact
transfer. This work therefore involves a comprehensive
investigation into the ability of peptide coding reagents to
operate effectively within a real-world setting. Significant
examination of the transfer, detection, recovery and stability
of multiple peptide reagents was undertaken to demonstrate
their advantages over currently available forensic taggants.
■ EXPERIMENTAL SECTION
Peptide Synthesis. Peptides Ac-KQQSP-NH2 (sequence
1), Ac-HSSKL-COOH (sequence 2), and Ac-hsskl-COOH
(sequence 3) were manually synthesized by Fmoc-solid phase
peptide synthesis. NovaPEG rink amide (Merck Chemicals
Ltd., U.K.) and 2-chlorotrityl chloride (Sigma-Aldrich, U.K.)
resins were used to prepare sequences 1 and 2−3, respectively.
Resins were swollen in dimethylformamide (DMF) inside
empty fritted polypropylene tubes for 30 min prior to coupling.
All amino acid coupling steps for sequence 1 were performed
using 4 equiv of Fmoc amino acids with N,N′-diisopropylcar-
bodiimide (DIC) and ethyl (hydroxyimino)cyanoacetate
(Oxyma) in DMF in a molar ratio of 1:1:1 of amino acid,
DIC, and Oxyma, respectively. The first coupling step for
sequences 2−3 was performed using 1 equiv of Fmoc amino
acid with 5 equiv of N,N-diisopropylethylamine (DIPEA) in
dichloromethane (DCM). Subsequent coupling steps were
performed using the same procedure utilized in the assembly of
sequence 1. Coupling reactions were allowed to take place for 1
h with successful conjugation monitored by the picrylsulfonic
acid test. After coupling, Fmoc deprotection of all amino acids
was achieved via treatment with 20% (v/v) piperidine in DMF
for 30 min and confirmed by the picrylsulfonic acid test.
Impurities and excess reagents were removed at each stage via
multiple washes using DCM and DMF. The N-terminus of
each peptide was acetylated using 10 equivalents of acetic
anhydride and 20 equivalents of DIPEA in DMF for 1 h. Resins
were last treated with a solution of trifluoroacetic acid (TFA)−
distilled water−phenol−thioanisole (TA)−triisopropylsilane
(TIPS)−2 , 2 ′ - ( e t hy l ened io xy )d i e t h ane th i o l i n a
90:5:5:5:2.5:2.5 molar ratio for 3 h at room temperature to
remove the completed peptides from the solid support. The
filtrate was then concentrated under nitrogen at 40 °C before
the addition of 10 equiv of ice cold diethyl ether to precipitate
the peptides. The wash and precipitation process was repeated
several times before the final obtained peptide pellets were
freeze-dried for 24 h. The identities of the synthesized peptides
were confirmed using a Waters/Micromass (Manchester, U.K.)
ZQ ESI-mass spectrometer in positive ionization mode prior to
use.
Experimental Conditions. The effects of four experimen-
tal conditions, (i) surface material, (ii) temperature, (iii)
humidity, and (iv) fluorophore addition, on reagent stability
were investigated. For monitoring the effect of surface material,
peptide sequences 1−3 were mixed into MHF medium
(Vaseline, U.K.) at a concentration of 2.5:100 mg of
peptide−medium. Mixtures containing sequence 1 and 3
were then applied in 40 mg deposits onto 10 different surfaces
(ceramic, glass, plastic, aluminum foil, wood, paper, denim,
polyester, leather, and cotton) cut into 2 cm × 2 cm squares.
The mixture in sequence 2 was applied in the same method to
surfaces of wood and paper (as the stability of this sequence on
the other 8 surfaces was already proven within the previous
proof of concept study). The surfaces were then left exposed to
standard laboratory conditions (temperature and humidity, 23
± 2 °C; 40 ± 5%), constantly monitored using a data logger.
Liquid−liquid extractions were then performed to isolate the
peptides for ESI-MS analysis at time points of 2 weeks, 4 weeks,
and 6 weeks for a total period of 6 weeks.
For experimental condition studies (ii), (iii), and (iv), the
same concentration of peptide-MHF medium was applied to
glass slides and exposed to their respective conditions. The
effect of temperature was assessed via incubation of slides at
both 4 and 39 °C and extracted at time points of 6 h, 24 h, 1
week, and 6 weeks. For the effect of humidity, surfaces were left
in containers of 70% and 90% (as monitored by a hygrometer)
and were once again extracted at the same time points as the
temperature study. Humidity containers were prepared by
enclosing wet paper towels within plastic boxes.
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The effect on fluorophore presence on peptide detection was
observed through the addition of Rhodamine-110 (Sigma-
Aldrich, U.K.) to peptide-MHF at a concentration of 0.25:100
mg fluorophore−peptide-medium. This mixture was then
applied in 40 mg deposits on glass slides, which were then
exposed to the standard temperature and humidity conditions
previously investigated. Extractions of fluorophore-peptide-
MHF reagent were undertaken at time points of 3 weeks and
6 weeks for a total period of 6 weeks.
Taggant Extraction and Analysis. Extraction surfaces
were placed into a 30 mL multipurpose container (Greiner Bio-
One, U.K.) before the addition of 1 mL of hexane. Samples
were vortexed for 1 min and the surfaces were removed using
sterile forceps prior to the addition of 0.5 mL of distilled water.
The samples were vortexed again and allowed to settle before
the aqueous phase was removed into a fresh container via pipet.
The original organic phase was then further extracted with an
additional 0.5 mL of distilled water before both aqueous layers
were pooled together. Counter extraction against the pooled
aqueous layers was next performed with 1 mL of hexane. The
final aqueous layer was then isolated into an Eppendorf tube
before the addition of 0.1% v/v formic acid to enhance
ionization. ESI-MS analysis of the samples was conducted using
a Waters ZQ micromass 2000 mass spectrometer in positive
ionization.
Casework Application. A thin layer of peptide reagent
(containing sequence 2) was spread across a 25 cm × 25 cm
glass tile to mimic a real-world application to a known surface.
A transparent latex glove worn over the hand (with the glove
preweighted) was then used to contact the surface at a
standardized force of ∼20 N (monitored by analytical balance).
Transferred reagent was visualized using a Crime-lite hand-held
light source (Foster and Freeman, U.K.) at an excitation
wavelength of 460−510 nm and a supplied 495 nm viewing
filter. The glove was then reweighed to assess the amount of
taggant transferred upon physical contact.
Depletion Series. To establish the overall sensitivity of the
reagent and determine its persistence after multiple contact
transfers, a depletion series was prepared. A thin layer of
peptide reagent (containing sequence 2) was once again spread
over a glass tile before being contacted by a single gloved finger
at a standardized force of ∼10 N. A series of contacts after the
initial reagent transfer were then performed by successively
touching either 1, 2, 3, 4, or 5 clean glass slides with the glove.
A sterile cotton swab of the entire surface of the finger was used
to collect any taggant remaining at the end of each depletion
series. Peptide sequence 2 was last extracted from all of the
swabs and analyzed using the methods previously described.
■ RESULTS AND DISCUSSION
Peptide Synthesis. Three different peptides were used to
demonstrate the flexibility of the reagents coding system. These
sequences were chosen due to their hydrophilicity, allowing
them to be easily isolated from the nonpolar MHF medium by
simple liquid−liquid extraction. The properties of each peptide,
including hydrophilicity, were derived from GenScript’s peptide
property calculator (Table 1).
The sequences were also ensured to be non-naturally
occurring using UniProt’s BLAST function, thereby reducing
the possibility of generating false positive results from
ubiquitous environmental peptides.
Developing a coding system that is able to remain stable and
recoverable over extended periods of time is a crucial aspect of
taggant design. We therefore decided to explore the effect of a
number of modifications on our peptide sequences, with the
ideal aim of maximizing code detection post taggant recovery.
N-terminal acetylation was carried out on all peptides to
increase resistance to degradation by aminopeptidase activity.10
Further protection against enzymatic destruction was
conferred by the C-terminal amidation11 of sequence 1 (Ac-
KQQSP-NH2) and the introduction of D-amino acids in
peptide sequence 3 (Ac-hsskl-COOH). ESI-MS analysis was
used to confirm the identity of the synthesized products, which
all exhibited correct masses (see Figure S1).
Experimental Conditions. With popular uses in marking
vehicles, objects, fabrics, and premises, the nature of the surface
on which a taggant may be applied can be highly variable. It is
consequently crucial that newly developed taggants demon-
strate sufficient robustness to be detected and identified over
extended periods of time, without being affected by the material
on which they are deposited. The stability of all three peptide-
MHF formulations was therefore monitored by their
application on 10 different surfaces routinely encountered
during forensic casework. All taggants were then left in standard
laboratory conditions (temperature and humidity, 23 ± 2 °C;
40 ± 5%) before being extracted at several time points over a
period of 6 weeks. Figure 1 shows the mass spectra of analyzed
reagent samples containing peptide sequences 1, 2, and 3 from
paper at the 6-week time point. The same results were achieved
across all peptide, surface, and time combinations, with no
observable reagent degradation (see Figures S2−S4).
Another facet of forensic taggant application that is highly
variable is the environmental conditions to which a reagent may
be exposed.12 By marking items both outside and in sheltered
locations, taggants are often subjected to a wide range of
temperatures and humidities. However, the effect of such
conditions on the detection and identification a taggant should
ideally remain negligible. To establish the environmental
resistance of our peptide coding reagent, formulations
containing sequences 1−3 were deposited on glass slides and
incubated over 6 weeks in temperatures of 4 and 39 °C or in
humidities of 70% and 90%. Extraction and analysis of the
reagents at various time points demonstrated that all peptides
remained detectable despite incubation conditions, with no
differentiation in the achieved mass spectra being displayed
between samples (see Figures S5 and S6).
The foremost purpose of Rhodamine-110 addition to the
peptide-MHF formulation is to allow taggants to be detected
via fluorescence emission after transfer. This fluorescence not
only quickly establishes evidence of contact between an object
and a suspect but may also be used for a more targeted
swabbing by indicating where identifying peptides are likely to
be present. Moreover, as water-soluble Rhodamine-110 is
coextracted with peptides into the same aqueous phase, a dual
detection of the reagent is provided by the presence of both
fluorophore and peptide ion peaks in the ESI-MS spectrum.
Table 1. Summary of Peptide Characteristics Obtained from
Genscript’s Peptide Property Calculator
Peptide Sequence 1: Ac-KQQSP-NH2 (L-amino acids)
GenScript PPC MW = 627.69, attribute = basic (hydrophilic)
Peptide Sequence 2: Ac-HSSKL-COOH (L-amino acids)
GenScript PPC MW = 612.68, attribute = basic (hydrophilic)
Peptide Sequence 3: Ac-hsskl-COOH (D-amino acids)
GenScript PPC MW = 612.68, attribute = basic (hydrophilic)
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To establish this dual-detectability, three final fluorophore-
peptide-MHF formulations for each of the peptide sequences
utilized were prepared and deposited on glass slides in the same
manner previously described. Slides were exposed over 6 weeks
to the standard laboratory temperature and humidity
conditions already explored and were once again extracted
and analyzed at a number of time points. Figure 2 displays both
fluorophore and peptide components detected by ESI-MS after
extraction of final reagent (containing peptide sequence 1) after
6 weeks of standard laboratory exposure. In all cases, similar
results were achieved regardless of peptide or environmental
condition, with no observable fluorophore or peptide
degradation (see Figures S7−S9).
Casework Application and Depletion Series. To
successfully operate in the field, touch contacts must result in
enough fluorophore and peptide transfer to ensure taggant
visualization and identification, respectively. Demonstration of
the reagents practical use in a real world scenario was therefore
achieved by applying a thin layer of fluorophore-peptide-MHF
formulation over a large glass tile, which was subsequently
contacted by a transparent glove worn over the hand. As
expected, the reagent remained imperceptible under natural
light but was easily viewed upon the hand after illumination
with a portable light source (Figure 3). Approximately 0.44 mg
of taggant was transferred to each cm2 of the glove’s surface.
While this rate of transfer may be considered ideal after an
initial contact, the amount of taggant recovered in a practical
setting may actually be far less, depending upon the subsequent
activity of the offender. For example, it is possible that the
reagent may be removed if a suspect contacts other surfaces
after touching a marked object, thereby diminishing the amount
of peptide available for analysis. Designing a taggant to persist
on an individual even after multiple contacts is therefore
important. A depletion series was created to measure the overall
retention of our reagent by contacting the tile previously
prepared with a gloved finger. Taggant was then collected and
recovered from the entire surface of the finger by direct
swabbing and liquid−liquid extraction, respectively. This
process was then repeated but with additional secondary
contacts on clean glass slides (increasing from 1 to 5 contacts)
prior to reagent recovery. ESI-MS analysis successfully detected
the presence of both peptide and fluorophore ion peaks within
all samples, establishing the excellent persistence of our reagent
(see Figure S10).
■ CONCLUSIONS
The ability of a novel “peptide coding” taggant to monitor
contact transfer during criminal activity has been successfully
established. The reagent is invisible to the naked eye but highly
fluorescent when excited by an appropriate light source. If
recovered from an individual, this reagent has the power to
physically link a person to a specific object or offense through
uniquely identifying amino acid sequences. The high trans-
ferability of the employed medium allows these peptides to
persist on a person even after five additional contacts with other
surfaces.
Remaining detectable and recoverable over a period of 6
weeks, our developed peptide taggant has proven to be
successfully stable and resistant to all variable experimental
conditions. A greater degree of confidence can therefore be
given in the taggants efficacy to operate over extended periods
of time on different surfaces and in a range of environments.
This reagent promises significant advantages over currently
available forensic taggants; liquid−liquid extraction allows
Figure 1. ESI-MS spectra of (a) peptide sequence 1, Ac-KQQSP-NH2, (theoretical [M + H]+ m/z ratio = 628.34); (b) peptide sequence 2, Ac-
HSSKL-COOH (theoretical [M + H]+ m/z ratio = 613.33); and (c) peptide sequence 3, Ac-hsskl-COOH (theoretical [M + H]+ m/z ratio =
613.33) reagent samples extracted 6 weeks after application to paper. Similar results were seen on all other surfaces.
Figure 2. ESI-MS spectrum of sequence 1, Ac-KQQSP-NH2
(theoretical [M + H]+ m/z ratio = 628.34, theoretical [M + Na]+
m/z ratio = 650.32) and Rhodamine-110 (theoretical [M + H]+ m/z
ratio = 331.11) extracted from full reagent samples applied to glass
slides and incubated for 6 weeks in standard laboratory conditions.
Figure 3. Peptide coding reagent successfully transferred upon
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coding sequences to be rapidly isolated with little expense.
Taggant analysis via ESI-MS is also significantly less time-
consuming than sequencing techniques used in DNA-based
taggants and may be completed within 1 h of reagent recovery.
Continuing advances in portable mass spectrometry technology
are likely to result in this time being further reduced, by
allowing analysis to be performed at the point of taggant
discovery.
While not explored further within this study, this taggant was
designed with a high intrinsic flexibility so that it may be easily
adapted for application in a variety of crime reduction
strategies. This is likely to center on the substitution of the
reagents individual components to suit a specific purpose. For
example, the replacement of Rhodamine-110 with a near-
infrared fluorophores may provide enhanced contrast against
certain colored or autofluorescent surfaces.13 The discrim-
inatory power of the taggants code may also be further
increased by the use amino acids that feature unnatural
modifications. While this reagent was developed for observing
physical contact transfer during criminal activity, many taggants
are designed to remain immobile upon the object they mark.
Our peptide coding system may also be utilized in such an
application by a simple change of dispersal media.
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